<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="author" content="Tim Woelfle" />

<meta name="date" content="2023-08-15" />


<title>PRECIS-2 Scores in PragMeta: Human Consensus vs LMM (Claude 2) - same prompt as for GPT 3.5</title>

<meta property="og:title" content="PRECIS-2 Scores in PragMeta: Human Consensus vs LMM (Claude 2) - same prompt as for GPT 3.5" />

<meta name='viewport' content='width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no' />

<link rel="icon" href="data:image/x-icon;" type="image/x-icon">


<script type="text/javascript">
window.FlexDashboardComponents = [];
</script>

<script id="flexdashboard-navbar" type="application/json">
[{"title":"Source Code","icon":"fa-code","href":"","align":"right"}]
</script>
<script src="lib/header-attrs-2.21/header-attrs.js"></script>
<script src="lib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="lib/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="lib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="lib/stickytableheaders-0.1.19/jquery.stickytableheaders.min.js"></script>
<link href="lib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="lib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<link href="lib/value-box-accent-static-0.6.1/theme-cosmo-value-box.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/flexdashboard.min.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/theme-cosmo.css" rel="stylesheet" />
<script src="lib/htmlwidgets-1.6.2/htmlwidgets.js"></script>
<link href="lib/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="lib/datatables-binding-0.28/datatables.js"></script>
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="lib/dt-core-1.13.4/js/jquery.dataTables.min.js"></script>
<link href="lib/crosstalk-1.2.0/css/crosstalk.min.css" rel="stylesheet" />
<script src="lib/crosstalk-1.2.0/js/crosstalk.min.js"></script>
<style type="text/css">
/*
  CSS for flexdashboard.js' use of Sly(). The sizing/position of this CSS needs to be
  applied _before_ flexdashboard.js initializes, which is why this CSS has been pulled
  out from flexdashboard.scss and inlined in the document's head.
*/

.storyboard-nav button {
  background: transparent;
  border: 0;
  opacity: .3;
  outline: none;
  padding: 0;
}

.storyboard-nav button:hover,
.storyboard-nav button:hover {
  opacity: .5;
}

.storyboard-nav button:disabled,
.storyboard-nav button:disabled {
  opacity: .1;
}

.storyboard-nav .sbnext,
.storyboard-nav .sbprev {
  float: left;
  width: 2%;
  height: 120px;
}

.storyboard-nav .sbprev {
  text-align: left;
  width: 2%;
}

.storyboard-nav .sbnext {
  float: right;
  text-align: right;
  margin-right: 8px;
}

.storyboard-nav .sbframelist {
  margin: 0 auto;
  width: 94%;
  height: 120px;
  overflow: hidden;
  text-shadow: none;
  margin-bottom: 8px;
}

.storyboard-nav .sbframelist ul {
  list-style: none;
  margin: 0;
  padding: 0;
  height: 100%;
}

.storyboard-nav .sbframelist ul li {
  float: left;
  width: 270px;
  height: 100%;
  padding: 10px 10px 10px 10px;
  margin-right: 8px;
  text-align: left;
  cursor: pointer;
}

.storyboard-nav .sbframelist ul li:last-child {
  margin-right: 0px;
}

.sbframe-commentary {
  width: 300px;
}

.sbframe-commentary ul {
  padding-left: 22px;
}

.sbframe.active {
  display: flex;
}

.sbframe:not(.active) {
  display: none;
}
@media only screen and (min-width: 768px) {
html, body {
  height: 100%;
}

#dashboard-container {
  height: 100%;
}
}
</style>



</head>

<body>

<div class="navbar navbar-inverse navbar-fixed-top" role="navigation">
<div class="container-fluid">
<div class="navbar-header">

<span class="navbar-logo pull-left">
  
</span>
<span class="navbar-brand">
  PRECIS-2 Scores in PragMeta: Human Consensus vs LMM (Claude 2) - same prompt as for GPT 3.5
  <span class="navbar-author">
    Tim Woelfle &mdash; 2023-08-15
    </span>
</span>

<button id="navbar-button" type="button" class="navbar-toggle collapsed pull-right" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>

</div>
<div id="navbar" class="navbar-collapse collapse">
<ul class="nav navbar-nav navbar-left">
</ul>
<ul class="nav navbar-nav navbar-right">
</ul>
</div><!--/.nav-collapse-->
</div><!--/.container-->
</div><!--/.navbar-->

<script type="text/javascript">


var FlexDashboard = (function () {

  // initialize options
  var _options = {};

  var FlexDashboard = function() {

    // default options
    _options = $.extend(_options, {
      theme: "cosmo",
      fillPage: false,
      orientation: 'columns',
      storyboard: false,
      defaultFigWidth: 576,
      defaultFigHeight: 461,
      defaultFigWidthMobile: 360,
      defaultFigHeightMobile: 461,
      isMobile: false,
      isPortrait: false,
      resize_reload: true
    });
  };

  function init(options) {

    // extend default options
    $.extend(true, _options, options);

    // add ids to sections that don't have them (pandoc won't assign ids
    // to e.g. sections with titles consisting of only chinese characters)
    var nextId = 1;
    $('.level1:not([id]),.level2:not([id]),.level3:not([id])').each(function() {
      $(this).attr('id', 'dashboard-' + nextId++);
    });

    // find navbar items
    var navbarItems = $('#flexdashboard-navbar');
    if (navbarItems.length)
      navbarItems = JSON.parse(navbarItems.html());
    addNavbarItems(navbarItems);

    // find the main dashboard container
    var dashboardContainer = $('#dashboard-container');

    // resolve mobile classes
    resolveMobileClasses(dashboardContainer);

    // one time global initialization for components
    componentsInit(dashboardContainer);

    // look for a global sidebar
    var globalSidebar = dashboardContainer.find(".section.level1.sidebar");
    if (globalSidebar.length > 0) {

      // global layout for fullscreen displays
      if (!isMobilePhone()) {

         // hoist it up to the top level
         globalSidebar.insertBefore(dashboardContainer);

         // lay it out (set width/positions)
         layoutSidebar(globalSidebar, dashboardContainer);

      // tuck sidebar into first page for mobile phones
      } else {

        // convert it into a level3 section
        globalSidebar.removeClass('sidebar');
        globalSidebar.removeClass('level1');
        globalSidebar.addClass('level3');
        var h1 = globalSidebar.children('h1');
        var h3 = $('<h3></h3>');
        h3.append(h1.contents());
        h3.insertBefore(h1);
        h1.detach();

        // move it into the first page
        var page = dashboardContainer.find('.section.level1').first();
        if (page.length > 0)
          page.prepend(globalSidebar);
      }
    }

    // look for pages to layout
    var pages = $('div.section.level1');
    if (pages.length > 0) {

        // find the navbar and collapse on clicked
        var navbar = $('#navbar');
        navbar.on("click", "a[data-toggle!=dropdown]", null, function () {
           navbar.collapse('hide');
        });

        // envelop the dashboard container in a tab content div
        dashboardContainer.wrapInner('<div class="tab-content"></div>');

        pages.each(function(index) {

          // lay it out
          layoutDashboardPage($(this));

          // add it to the navbar
          addToNavbar($(this), index === 0);

        });

    } else {

      // remove the navbar and navbar button if we don't
      // have any navbuttons
      if (navbarItems.length === 0) {
        $('#navbar').remove();
        $('#navbar-button').remove();
      }

      // add the storyboard class if requested
      if (_options.storyboard)
        dashboardContainer.addClass('storyboard');

      // layout the entire page
      layoutDashboardPage(dashboardContainer);
    }

    // if we are in shiny we need to trigger a window resize event to
    // force correct layout of shiny-bound-output elements
    if (isShinyDoc())
      $(window).trigger('resize');

    // make main components visible
    $('.section.sidebar').css('visibility', 'visible');
    dashboardContainer.css('visibility', 'visible');

    // handle location hash
    handleLocationHash();

    // intialize prism highlighting
    initPrismHighlighting();

    // record mobile and orientation state then register a handler
    // to refresh if resize_reload is set to true and it changes
    _options.isMobile = isMobilePhone();
    _options.isPortrait = isPortrait();
    if (_options.resize_reload) {
      $(window).on('resize', function() {
        if (_options.isMobile !== isMobilePhone() ||
            _options.isPortrait !== isPortrait()) {
          window.location.reload();
        }
      });
    } else {
      // if in desktop mode and resizing to mobile, make sure the heights are 100%
      // This enforces what `fillpage.css` does for "wider" pages.
      // Since we are not reloading once the page becomes small, we need to force the height to 100%
      // This is a new situation introduced when `_options.resize_reload` is `false`
      if (! _options.isMobile) {
        // only add if `fillpage.css` was added in the first place
        if (_options.fillPage) {
          // fillpage.css
          $("html,body,#dashboard").css("height", "100%");
        }
      }
    }
    // trigger layoutcomplete event
    dashboardContainer.trigger('flexdashboard:layoutcomplete');
  }

  function resolveMobileClasses(dashboardContainer) {
     // add top level layout class
    dashboardContainer.addClass(isMobilePhone() ? 'mobile-layout' :
                                                  'desktop-layout');

    // look for .mobile sections and add .no-mobile to their peers
    var mobileSections = $('.section.mobile');
    mobileSections.each(function() {
       var id = $(this).attr('id');
       var nomobileId = id.replace(/-\d+$/, '');
       $('#' + nomobileId).addClass('no-mobile');
    });
  }

  function addNavbarItems(navbarItems) {

    var navbarLeft = $('ul.navbar-left');
    var navbarRight = $('ul.navbar-right');

    for (var i = 0; i<navbarItems.length; i++) {

      // get the item
      var item = navbarItems[i];

      // determine the container
      var container = null;
      if (item.align === "left")
        container = navbarLeft;
      else
        container = navbarRight;

      // navbar menu if we have multiple items
      if (item.items) {
        var menu = navbarMenu(null, item.icon, item.title, container);
        for (var j = 0; j<item.items.length; j++) {
          var subItem = item.items[j];
          var li = $('<li></li>');
          var a = navbarLink(subItem.icon, subItem.title, subItem.href, subItem.target);
          a.removeClass("nav-link").addClass("dropdown-item");
          li.append(a);
          menu.append(li);
        }
      } else {
        var li = $('<li class="nav-item"></li>');
        li.append(navbarLink(item.icon, item.title, item.href, item.target));
        container.append(li);
      }
    }
  }

  // create or get a reference to an existing dropdown menu
  function navbarMenu(id, icon, title, container) {
    var existingMenu = [];
    if (id)
      existingMenu = container.children('#' + id);
    if (existingMenu.length > 0) {
      return existingMenu.children('ul');
    } else {
      var li = $('<li class="nav-item"></li>');
      if (id)
        li.attr('id', id);
      li.addClass('dropdown');
      // auto add "Share" title on mobile if necessary
      if (!title && icon && (icon === "fa-share-alt") && isMobilePhone())
        title = "Share";
      if (title) {
        title = title + ' <span class="caret"></span>';
      }
      var a = navbarLink(icon, title, "#");
      a.addClass('dropdown-toggle');
      a.attr('data-toggle', 'dropdown');
      a.attr('data-bs-toggle', 'dropdown');
      a.attr('role', 'button');
      a.attr('aria-expanded', 'false');
      li.append(a);
      var ul = $('<ul class="dropdown-menu"></ul>');
      ul.attr('role', 'menu');
      li.append(ul);
      container.append(li);
      return ul;
    }
  }

  function addToNavbar(page, active) {

    // capture the id and data-icon attribute (if any)
    var id = page.attr('id');
    var icon = page.attr('data-icon');
    var navmenu = page.attr('data-navmenu');

    // get hidden state (transfer this to navbar)
    var hidden = page.hasClass('hidden');
    page.removeClass('hidden');

    // sanitize the id for use with bootstrap tabs
    id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
    page.attr('id', id);

    // get the wrapper
    var wrapper = page.closest('.dashboard-page-wrapper');

    // move the id to the wrapper
    page.removeAttr('id');
    wrapper.attr('id', id);

    // add the tab-pane class to the wrapper
    wrapper.addClass('tab-pane');
    if (active)
      wrapper.addClass('active');

    // get a reference to the h1, discover its inner contens, then detach it
    var h1 = wrapper.find('h1').first();
    var title = h1.contents();
    h1.detach();

    // create a navbar item
    var li = $('<li></li>');
    var a = navbarLink(icon, title, '#' + id);
    a.attr('data-toggle', 'tab');
    li.append(a);

    // add it to the navbar (or navbar menu if specified)
    var container = $('ul.navbar-left');
    if (navmenu) {
      var menuId = navmenu.replace(/\s+/g, '');
      var menu = navbarMenu(menuId, null, navmenu, container);
      li.find("> a").removeClass("nav-link").addClass("dropdown-item");
      menu.append(li);
    } else {
      li.addClass("nav-item")
      container.append(li);
    }

    // hide it if requested
    if (hidden)
      li.addClass('hidden');
  }

  function navbarLink(icon, title, href, target) {

    var a = $('<a class="nav-link"></a>');
    if (icon) {

      // get the name of the icon set and icon
      var dashPos = icon.indexOf("-");
      var iconSet = null;
      var iconSplit = icon.split(" ");
      if (iconSplit.length > 1) {
        iconSet = iconSplit[0];
        icon = iconSplit.slice(1).join(" ");
      } else {
        iconSet = icon.substring(0, dashPos);
      }
      var iconName = icon.substring(dashPos + 1);

      // create the icon
      var iconElement = $('<span class="' + iconSet + ' ' + icon + '"></span>');
      if (title)
        iconElement.css('margin-right', '7px');
      a.append(iconElement);
      // if href is null see if we can auto-generate based on icon (e.g. social)
      if (!href)
        maybeGenerateLinkFromIcon(iconName, a);
    }
    if (title)
      a.append(title);

    // add the href.
    if (href) {
      if (href === "source_embed") {
        a.attr('href', '#');
        a.attr('data-featherlight', "#flexdashboard-source-code");
        a.featherlight({
            beforeOpen: function(event){
              $('body').addClass('unselectable');
            },
            afterClose: function(event){
              $('body').removeClass('unselectable');
            }
        });
      } else {
        a.attr('href', href);
      }
    }

    // add the arget
    if (target)
      a.attr('target', target);

    return a;
  }

  // auto generate a link from an icon name (e.g. twitter) when possible
  function maybeGenerateLinkFromIcon(iconName, a) {

     var serviceLinks = {
      "twitter": "https://twitter.com/share?text=" + encodeURIComponent(document.title) + "&url="+encodeURIComponent(location.href),
      "facebook": "https://www.facebook.com/sharer/sharer.php?s=100&p[url]="+encodeURIComponent(location.href),
      "linkedin": "https://www.linkedin.com/shareArticle?mini=true&url="+encodeURIComponent(location.href) + "&title=" + encodeURIComponent(document.title),
      "pinterest": "https://pinterest.com/pin/create/link/?url="+encodeURIComponent(location.href) + "&description=" + encodeURIComponent(document.title)
    };

    var makeSocialLink = function(a, href) {
      a.attr('href', '#');
      a.on('click', function(e) {
        e.preventDefault();
        window.open(href);
      });
    };

    $.each(serviceLinks, function(key, value) {
      if (iconName.indexOf(key) !== -1)
        makeSocialLink(a, value);
    });
  }

  // layout a dashboard page
  function layoutDashboardPage(page) {

    // use a page wrapper so that free form content above the
    // dashboard appears at the top rather than the side (as it
    // would without the wrapper in a column orientation)
    var wrapper = $('<div class="dashboard-page-wrapper"></div>');
    page.wrap(wrapper);

    // if there are no level2 or level3 headers synthesize a level3
    // header to contain the (e.g. frame it, scroll container, etc.)
    var headers = page.find('h2,h3');
    if (headers.length === 0)
      page.wrapInner('<div class="section level3"></div>');

    // hoist up any content before level 2 or level 3 headers
    var children = page.children();
    children.each(function(index) {
      if ($(this).hasClass('level2') || $(this).hasClass('level3'))
        return false;
      $(this).insertBefore(page);
    });

    // determine orientation and fillPage behavior for distinct media
    var orientation, fillPage, storyboard;

    // media: mobile phone
    if (isMobilePhone()) {

      // if there is a sidebar we need to ensure it's content
      // is properly framed as an h3
      var sidebar = page.find('.section.sidebar');
      sidebar.removeClass('sidebar');
      sidebar.wrapInner('<div class="section level3"></div>');
      var h2 = sidebar.find('h2');
      var h3 = $('<h3></h3>');
      h3.append(h2.contents());
      h3.insertBefore(h2);
      h2.detach();

      // wipeout h2 elements then enclose them in a single h2
      var level2 = page.find('div.section.level2');
      level2.each(function() {
        level2.children('h2').remove();
        level2.children().unwrap();
      });
      page.wrapInner('<div class="section level2"></div>');

      // substitute mobile images
      if (isPortrait()) {
        var mobileFigures = $('img.mobile-figure');
        mobileFigures.each(function() {
          // get the src (might be base64 encoded)
          var src = $(this).attr('src');

          // find it's peer
          var id = $(this).attr('data-mobile-figure-id');
          var img = $('img[data-figure-id=' + id + "]");
          img.attr('src', src)
             .attr('width', _options.defaultFigWidthMobile)
             .attr('height', _options.defaultFigHeightMobile);
        });
      }

      // hoist storyboard commentary into it's own section
      if (page.hasClass('storyboard')) {
        var commentaryHR = page.find('div.section.level3 hr');
        commentaryHR.each(function() {
          var commentary = $(this).nextAll().detach();
          var commentarySection = $('<div class="section level3"></div>');
          commentarySection.append(commentary);
          commentarySection.insertAfter($(this).closest('div.section.level3'));
          $(this).remove();
        });
      }

      // force a non full screen layout by columns
      orientation = _options.orientation = 'columns';
      fillPage = _options.fillPage = false;
      storyboard = _options.storyboard = false;

    // media: desktop
    } else {

      // determine orientation
      orientation = page.attr('data-orientation');
      if (orientation !== 'rows' && orientation != 'columns')
        orientation = _options.orientation;

      // determine storyboard mode
      storyboard = page.hasClass('storyboard');

      // fillPage based on options (force for storyboard)
      fillPage = _options.fillPage || storyboard;

      // handle sidebar
      var sidebar = page.find('.section.level2.sidebar');
      if (sidebar.length > 0)
        layoutSidebar(sidebar, page);
    }

    // give it and it's parent divs height: 100% if we are in fillPage mode
    if (fillPage) {
      page.addClass('vertical-layout-fill');
      page.css('height', '100%');
      page.parents('div').css('height', '100%');
    } else {
      page.addClass('vertical-layout-scroll');
    }

    // perform the layout
    if (storyboard)
      layoutPageAsStoryboard(page);
    else if (orientation === 'rows')
      layoutPageByRows(page, fillPage);
    else if (orientation === 'columns')
      layoutPageByColumns(page, fillPage);
  }

  function layoutSidebar(sidebar, content) {

    // get it out of the header hierarchy
    sidebar = sidebar.first();
    if (sidebar.hasClass('level1')) {
      sidebar.removeClass('level1');
      sidebar.children('h1').remove();
    } else if (sidebar.hasClass('level2')) {
      sidebar.removeClass('level2');
      sidebar.children('h2').remove();
    }

    // determine width
    var sidebarWidth = isTablet() ? 220 : 250;
    var dataWidth = parseInt(sidebar.attr('data-width'));
    if (dataWidth)
      sidebarWidth = dataWidth;

    // set the width and shift the page right to accomodate the sidebar
    sidebar.css('width', sidebarWidth + 'px');
    content.css('padding-left', sidebarWidth + 'px');

    // wrap it's contents in a form
    sidebar.wrapInner($('<form></form>'));
  }

  function layoutPageAsStoryboard(page) {

    // create storyboard navigation
    var nav = $('<div class="storyboard-nav"></div>');

    // add navigation buttons
    var prev = $('<button class="sbprev"><i class="fa fa-angle-left"></i></button>');
    nav.append(prev);
    var next= $('<button class="sbnext"><i class="fa fa-angle-right"></i></button>');
    nav.append(next);

    // add navigation frame
    var frameList = $('<div class="sbframelist"></div>');
    nav.append(frameList);
    var ul = $('<ul></ul>');
    frameList.append(ul);

     // find all the level3 sections (those are the storyboard frames)
    var frames = page.find('div.section.level3');
    frames.each(function() {

      // mark it
      $(this).addClass('sbframe');

      // divide it into chart content and (optional) commentary
      $(this).addClass('dashboard-column-orientation');

      // stuff the chart into it's own div w/ flex
      $(this).wrapInner('<div class="sbframe-component"></div>');
      setFlex($(this), 1);
      var frame = $(this).children('.sbframe-component');

      // extract the title from the h3
      var li = $('<li></li>');
      var h3 = frame.children('h3');
      li.append(h3.contents());
      h3.detach();
      ul.append(li);

      // extract commentary
      var hr = frame.children('hr');
      if (hr.length) {
        var commentary = hr.nextAll().detach();
        hr.remove();
        var commentaryFrame = $('<div class="sbframe-commentary"></div>');
        commentaryFrame.addClass('flowing-content-shim');
        commentaryFrame.addClass('flowing-content-container');
        commentaryFrame.append(commentary);
        $(this).append(commentaryFrame);

        // look for a data-commentary-width attribute
        var commentaryWidth = $(this).attr('data-commentary-width');
        if (commentaryWidth)
          commentaryFrame.css('width', commentaryWidth + 'px');
      }

      // layout the chart (force flex)
      var result = layoutChart(frame, true);

      // ice the notes if there are none
      if (!result.notes)
        frame.find('.chart-notes').remove();

      // set flex on chart
      setFlex(frame, 1);
    });

    // create a div to hold all the frames
    var frameContent = $('<div class="sbframe-content"></div>');
    frameContent.addClass('dashboard-row-orientation');
    frameContent.append(frames.detach());

    // row orientation to stack nav and frame content
    page.addClass('dashboard-row-orientation');
    page.append(nav);
    page.append(frameContent);
    setFlex(frameContent, 1);

    // initialize sly
    var sly = new Sly(frameList, {
    		horizontal: true,
    		itemNav: 'basic',
    		smart: true,
    		activateOn: 'click',
    		startAt: 0,
    		scrollBy: 1,
    		activatePageOn: 'click',
    		speed: 200,
    		moveBy: 600,
    		dragHandle: true,
    		dynamicHandle: true,
    		clickBar: true,
    		keyboardNavBy: 'items',
    		next: next,
    		prev: prev
    	}).init();

    // make first frame active
    frames.removeClass('active');
    frames.first().addClass('active');

    // subscribe to frame changed events
    sly.on('active', function (eventName, itemIndex) {
      frames.removeClass('active');
      frames.eq(itemIndex).addClass('active')
                          .trigger('shown');
    });
  }

  function layoutPageByRows(page, fillPage) {

    // row orientation
    page.addClass('dashboard-row-orientation');

    // find all the level2 sections (those are the rows)
    var rows = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (rows.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      rows = page.find('div.section.level2');
    }

    rows.each(function () {

      // flags
      var haveNotes = false;
      var haveFlexHeight = true;

      // remove the h2
      $(this).children('h2').remove();

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // give it row layout semantics if it's not a tabset
      if (!isTabset)
        $(this).addClass('dashboard-row');

      // find all of the level 3 subheads
      var columns = $(this).find('div.section.level3');

      // determine figureSizes sizes
      var figureSizes = chartFigureSizes(columns);

      // fixup the columns
      columns.each(function(index) {

        // layout the chart (force flex if we are in a tabset)
        var result = layoutChart($(this), isTabset);

        // update flexHeight state
        if (!result.flex)
          haveFlexHeight = false;

        // update state
        if (result.notes)
          haveNotes = true;

        // set the column flex based on the figure width
        // (value boxes will just get the default figure width)
        var chartWidth = figureSizes[index].width;
        setFlex($(this), chartWidth + ' ' + chartWidth + ' 0px');

      });

      // remove empty chart note divs
      if (isTabset)
        $(this).find('.chart-notes').filter(function() {
            return $(this).html() === "&nbsp;";
        }).remove();
      if (!haveNotes)
        $(this).find('.chart-notes').remove();

       // make it a flexbox row
      if (haveFlexHeight)
        $(this).addClass('dashboard-row-flex');

      // now we can set the height on all the wrappers (based on maximum
      // figure height + room for title and notes, or data-height on the
      // container if specified). However, don't do this if there is
      // no flex on any of the constituent columns
      var flexHeight = null;
      var dataHeight = parseInt($(this).attr('data-height'));
      if (dataHeight)
        flexHeight = adjustedHeight(dataHeight, columns.first());
      else if (haveFlexHeight)
        flexHeight = maxChartHeight(figureSizes, columns);
      if (flexHeight) {
        if (fillPage)
          setFlex($(this), flexHeight + ' ' + flexHeight + ' 0px');
        else {
          $(this).css('height', flexHeight + 'px');
          setFlex($(this), '0 0 ' + flexHeight + 'px');
        }
      }

    });
  }

  function layoutPageByColumns(page, fillPage) {

    // column orientation
    page.addClass('dashboard-column-orientation');

    // find all the level2 sections (those are the columns)
    var columns = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (columns.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      columns = page.find('div.section.level2');
    }

    // layout each column
    columns.each(function (index) {

      // remove the h2
      $(this).children('h2').remove();

      // make it a flexbox column
      $(this).addClass('dashboard-column');

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // find all the h3 elements
      var rows = $(this).find('div.section.level3');

      // get the figure sizes for the rows
      var figureSizes = chartFigureSizes(rows);

      // column flex is the max row width (or data-width if specified)
      var flexWidth;
      var dataWidth = parseInt($(this).attr('data-width'));
      if (dataWidth)
        flexWidth = dataWidth;
      else
        flexWidth = maxChartWidth(figureSizes);
      setFlex($(this), flexWidth + ' ' + flexWidth + ' 0px');

      // layout each chart
      rows.each(function(index) {

        // perform the layout
        var result = layoutChart($(this), false);

        // ice the notes if there are none
        if (!result.notes)
          $(this).find('.chart-notes').remove();

        // set flex height based on figHeight, then adjust
        if (result.flex) {
          var chartHeight = figureSizes[index].height;
          chartHeight = adjustedHeight(chartHeight, $(this));
          if (fillPage)
            setFlex($(this), chartHeight + ' ' + chartHeight + ' 0px');
          else {
            $(this).css('height', chartHeight + 'px');
            setFlex($(this), chartHeight + ' ' + chartHeight + ' ' + chartHeight + 'px');
          }
        }
      });
    });
  }

  function chartFigureSizes(charts) {

    // sizes
    var figureSizes = new Array(charts.length);

    // check each chart
    charts.each(function(index) {

      // start with default
      figureSizes[index] = {
        width: _options.defaultFigWidth,
        height: _options.defaultFigHeight
      };

      // look for data-height or data-width then knit options
      var dataWidth = parseInt($(this).attr('data-width'));
      var dataHeight = parseInt($(this).attr('data-height'));
      var knitrOptions = $(this).find('.knitr-options:first');
      var knitrWidth, knitrHeight;
      if (knitrOptions) {
        knitrWidth = parseInt(knitrOptions.attr('data-fig-width'));
        knitrHeight =  parseInt(knitrOptions.attr('data-fig-height'));
      }

      // width
      if (dataWidth)
        figureSizes[index].width = dataWidth;
      else if (knitrWidth)
        figureSizes[index].width = knitrWidth;

      // height
      if (dataHeight)
        figureSizes[index].height = dataHeight;
      else if (knitrHeight)
        figureSizes[index].height = knitrHeight;
    });

    // return sizes
    return figureSizes;
  }

  function maxChartHeight(figureSizes, charts) {

    // first compute the maximum height
    var maxHeight = _options.defaultFigHeight;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].height > maxHeight)
        maxHeight = figureSizes[i].height;

    // now add offests for chart title and chart notes
    if (charts.length)
      maxHeight = adjustedHeight(maxHeight, charts.first());

    return maxHeight;
  }

  function adjustedHeight(height, chart) {
    if (chart.length > 0) {
      var chartTitle = chart.find('.chart-title');
      if (chartTitle.length)
        height += chartTitle.first().outerHeight();
      var chartNotes = chart.find('.chart-notes');
      if (chartNotes.length)
        height += chartNotes.first().outerHeight();
    }
    return height;
  }

  function maxChartWidth(figureSizes) {
    var maxWidth = _options.defaultFigWidth;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].width > maxWidth)
        maxWidth = figureSizes[i].width;
    return maxWidth;
  }

  // layout a chart
  function layoutChart(chart, forceFlex) {

    // state to return
    var result = {
      notes: false,
      flex: false
    };

    // extract the title
    var title = extractTitle(chart);

    // find components that apply to this container
    var components = componentsFind(chart);

    // if it's a custom component then call it and return
    var customComponents = componentsCustom(components);
    if (customComponents.length) {
      componentsLayout(customComponents, title, chart);
      result.notes = false;
      result.flex = forceFlex || componentsFlex(customComponents);
      return result;
    }

    // put all the content in a chart wrapper div
    chart.addClass('chart-wrapper');
    chart.wrapInner('<div class="chart-stage"></div>');
    var chartContent = chart.children('.chart-stage');

    // flex the content if appropriate
    result.flex = forceFlex || componentsFlex(components);
    if (result.flex) {
      // add flex classes
      chart.addClass('chart-wrapper-flex');
      chartContent.addClass('chart-stage-flex');

      // additional shim to break out of flexbox sizing
      chartContent.wrapInner('<div class="chart-shim"></div>');
      chartContent = chartContent.children('.chart-shim');
    }

    // set custom data-padding attribute
    var pad = chart.attr('data-padding');
    if (pad) {
      if (pad === "0")
        chart.addClass('no-padding');
      else {
        pad = pad + 'px';
        chartContent.css('left', pad)
                    .css('top', pad)
                    .css('right', pad)
                    .css('bottom', pad)
      }
    }

    // call compoents
    componentsLayout(components, title, chartContent);

    // also activate components on shiny output
    findShinyOutput(chartContent).on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {

          // see if we opted out of flex based on our output (for shiny
          // we can't tell what type of output we have until after the
          // value is bound)
          var components = componentsFind(element);
          var flex = forceFlex || componentsFlex(components);
          if (!flex) {
            chart.css('height', "");
            setFlex(chart, "");
            chart.removeClass('chart-wrapper-flex');
            chartContent.removeClass('chart-stage-flex');
            chartContent.children().unwrap();
          }

          // perform layout
          componentsLayout(components, title, element.parent());
        }, 10);
      });

    // add the title
    var chartTitle = $('<div class="chart-title"></div>');
    chartTitle.append(title);
    chart.prepend(chartTitle);

    // add the notes section
    var chartNotes = $('<div class="chart-notes"></div>');
    chartNotes.html('&nbsp;');
    chart.append(chartNotes);

    // attempt to extract notes if we have a component
    if (components.length)
      result.notes = extractChartNotes(chartContent, chartNotes);

    // return result
    return result;
  }

  // build a tabset from a section div with the .tabset class
  function layoutTabset(tabset) {

    // check for fade option
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it and grab it's text
      var heading = tab.find('h' + tabLevel + ':first');
      var headingDom = heading.contents();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab" class="nav-link"></a>');
      a.append(headingDom);
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation" class="nav-item"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      tab.addClass('no-title');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children()[activeTab]).tab("show");
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    // add nav-tabs-custom
    tabset.addClass('nav-tabs-custom');

    // internal layout is dashboard-column with tab-content flexing
    tabset.addClass('dashboard-column');
    setFlex(tabContent, 1);
  }

  // one time global initialization for components
  function componentsInit(dashboardContainer) {
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.init)
        component.init(dashboardContainer);
    }
  }

  // find components that apply within a container
  function componentsFind(container) {

    // look for components
    var components = [];
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.find(container).length)
        components.push(component);
    }

    // if there were none then use a special flowing content component
    // that just adds a scrollbar in fillPage mode
    if (components.length == 0) {
      components.push({
        find: function(container) {
          return container;
        },

        flex: function(fillPage) {
          return fillPage;
        },

        layout: function(title, container, element, fillPage) {
          if (fillPage) {
            container.addClass('flowing-content-shim');
            container.addClass('flowing-content-container');
          }
        }
      });
    }

    return components;
  }

  // if there is a custom component then pick it out
  function componentsCustom(components) {
    var customComponent = [];
    for (var i=0; i<components.length; i++)
      if (components[i].type === "custom") {
        customComponent.push(components[i]);
        break;
      }
    return customComponent;
  }

  // query all components for flex
  function componentsFlex(components) {

    // no components at all means no flex
    if (components.length === 0)
      return false;

    // otherwise query components (assume true unless we see false)
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++)
      if (components[i].flex && !components[i].flex(_options.fillPage))
        return false;
    return true;
  }

  // layout all components
  function componentsLayout(components, title, container) {
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++) {
      var element = components[i].find(container);
      if (components[i].layout) {
        // call layout (don't call other components if it returns false)
        var result = components[i].layout(title, container, element, _options.fillPage);
        if (result === false)
          return;
      }
    }
  }

  // get a reference to the h3, discover it's inner html, and remove it
  function extractTitle(container) {
    var h3 = container.children('h3').first();
    var title = '';
    if (!container.hasClass('no-title'))
      title = h3.contents();
    h3.detach();
    return title;
  }

  // extract chart notes
  function extractChartNotes(chartContent, chartNotes) {
    // look for a terminating blockquote or image caption
    var blockquote = chartContent.children('blockquote:last-child');
    var caption = chartContent.children('div.image-container')
                              .children('p.caption');
    if (blockquote.length) {
      chartNotes.empty().append(blockquote.children('p:first-child').contents());
      blockquote.remove();
      return true;
    } else if (caption.length) {
      chartNotes.empty().append(caption.contents());
      caption.remove();
      return true;
    } else {
      return false;
    }
  }

  function findShinyOutput(chartContent) {
    return chartContent.find('.shiny-text-output, .shiny-html-output');
  }

  // safely detect rendering on a mobile phone
  function isMobilePhone() {
    try
    {
      return ! window.matchMedia("only screen and (min-width: 768px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  function isFillPage() {
    return _options.fillPage;
  }

  // detect portrait mode
  function isPortrait() {
    return ($(window).width() < $(window).height());
  }

  // safely detect rendering on a tablet
  function isTablet() {
    try
    {
      return window.matchMedia("only screen and (min-width: 769px) and (max-width: 992px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  // test whether this is a shiny doc
  function isShinyDoc() {
    return (typeof(window.Shiny) !== "undefined" && !!window.Shiny.outputBindings);
  }

  // set flex using vendor specific prefixes
  function setFlex(el, flex) {
    el.css('-webkit-box-flex', flex)
      .css('-webkit-flex', flex)
      .css('-ms-flex', flex)
      .css('flex', flex);
  }

  // support bookmarking of pages
  function handleLocationHash() {

    // restore tab/page from bookmark
    var hash = window.decodeURIComponent(window.location.hash);
    if (hash.length > 0)
      $('ul.nav a[href="' + hash + '"]').tab('show');
    FlexDashboardUtils.manageActiveNavbarMenu();

    // navigate to a tab when the history changes
    window.addEventListener("popstate", function(e) {
      var hash = window.decodeURIComponent(window.location.hash);
      var activeTab = $('ul.nav a[href="' + hash + '"]');
      if (activeTab.length) {
        activeTab.tab('show');
      } else {
        $('ul.nav a:first').tab('show');
      }
      FlexDashboardUtils.manageActiveNavbarMenu();
    });

    // add a hash to the URL when the user clicks on a tab/page
    $('.navbar-nav a[data-toggle="tab"]').on('click', function(e) {
      var baseUrl = FlexDashboardUtils.urlWithoutHash(window.location.href);
      var hash = FlexDashboardUtils.urlHash($(this).attr('href'));
      var href = baseUrl + hash;
      FlexDashboardUtils.setLocation(href);
    });

    // handle clicks of other links that should activate pages
    var navPages = $('ul.navbar-nav li a[data-toggle=tab]');
    navPages.each(function() {
      var href =  $(this).attr('href');
      var links = $('a[href="' + href + '"][data-toggle!=tab]');
      links.each(function() {
        $(this).on('click', function(e) {
          window.FlexDashboardUtils.showPage(href);
        });
      });
    });
  }

  // tweak Prism highlighting
  function initPrismHighlighting() {

    if (window.Prism) {
      Prism.languages.insertBefore('r', 'comment', {
        'heading': [
          {
            // title 1
        	  // =======

        	  // title 2
        	  // -------
        	  pattern: /\w+.*(?:\r?\n|\r)(?:====+|----+)/,
            alias: 'operator'
          },
          {
            // ### title 3
            pattern: /(^\s*)###[^#].+/m,
            lookbehind: true,
            alias: 'operator'
          }
        ]
      });

      // prism highlight
      Prism.highlightAll();
    }
  }

  FlexDashboard.prototype = {
    constructor: FlexDashboard,
    init: init,
    isMobilePhone: isMobilePhone,
    isFillPage: isFillPage
  };

  return FlexDashboard;

})();

// utils
window.FlexDashboardUtils = {
  resizableImage: function(img) {
    var src = img.attr('src');
    var url = 'url("' + src + '")';
    img.parent().css('background', url)
                .css('background-size', 'contain')
                .css('background-repeat', 'no-repeat')
                .css('background-position', 'center')
                .addClass('image-container');
  },
  setLocation: function(href) {
    if (history && history.pushState) {
      history.pushState(null, null, href);
    } else {
      window.location.replace(href);
    }
    setTimeout(function() {
        window.scrollTo(0, 0);
    }, 10);
    this.manageActiveNavbarMenu();
  },
  showPage: function(href) {
    $('ul.navbar-nav li a[href="' + href + '"]').tab('show');
    var baseUrl = this.urlWithoutHash(window.location.href);
    var loc = baseUrl + href;
    this.setLocation(loc);
  },
  showLinkedValue: function(href) {
    // check for a page link
    if ($('ul.navbar-nav li a[data-toggle=tab][href="' + href + '"]').length > 0)
      this.showPage(href);
    else
      window.open(href);
  },
  urlWithoutHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(0, hashLoc);
    else
      return url;
  },
  urlHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(hashLoc);
    else
      return "";
  },
  manageActiveNavbarMenu: function () {
    // remove active from currently active tabs
    $('.navbar ul.nav .active').removeClass('active');
    // find the active tab
    var activeTab = $('.dashboard-page-wrapper.tab-pane.active');
    if (activeTab.length > 0) {
      var tabId = activeTab.attr('id');
      if (tabId)
        $(".navbar ul.nav a[href='#" + tabId + "']").tab("show");
    }
  }
};

window.FlexDashboard = new FlexDashboard();

// empty content
window.FlexDashboardComponents.push({
  find: function(container) {
    if (container.find('p').length == 0)
      return container;
    else
      return $();
  }
})

// plot image
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('p')
                    .children('img:only-child');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// plot image (figure style)
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.figure').children('img');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// htmlwidget
window.FlexDashboardComponents.push({

  init: function(dashboardContainer) {
    // trigger "shown" after initial layout to force static htmlwidgets
    // in runtime: shiny to be resized after the dom has been transformed
    dashboardContainer.on('flexdashboard:layoutcomplete', function(event) {
      setTimeout(function() {
        dashboardContainer.trigger('shown');
      }, 200);
    });
  },

  find: function(container) {
    return container.children('div[id^="htmlwidget-"],div.html-widget');
  }
});

// gauge
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.html-widget.gauge');
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {


  }

});

// shiny output
window.FlexDashboardComponents.push({
  find: function(container) {
    return container.children('div[class^="shiny-"]');
  }
});

// bootstrap table
window.FlexDashboardComponents.push({

  find: function(container) {
    var bsTable = container.find('table.table');
    if (bsTable.length !== 0)
      return bsTable;
    else
      return container.find('tr.header').parent('thead').parent('table');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var bsTable = element;

    // fixup xtable generated tables with a proper thead
    var headerRow = bsTable.find('tbody > tr:first-child > th').parent();
    if (headerRow.length > 0) {
      var thead = $('<thead></thead>');
      bsTable.prepend(thead);
      headerRow.detach().appendTo(thead);
    }

    // improve appearance
    container.addClass('bootstrap-table');

    // for fill page provide scrolling w/ sticky headers
    if (fillPage) {
      // force scrollbar on overflow
      container.addClass('flowing-content-shim');

      // stable table headers when scrolling
      bsTable.stickyTableHeaders({
        scrollableArea: container
      });
    }
  }
});

// embedded shiny app
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('iframe.shiny-frame');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage) {
      element.attr('height', '100%');
    } else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (!height)
        height = element.attr('height');
      if (!height)
        element.attr('height', 500);
    }
  }
});

// shiny fillRow or fillCol
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('.flexfill-container');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage)
      element.css('height', '100%');
    else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (height === "100%" || height === "auto" || height === "initial" ||
          height === "inherit" || !height) {
        element.css('height', 500);
      }
    }
  }
});

// valueBox
window.FlexDashboardComponents.push({

  type: "custom",

  find: function(container) {
    if (container.find('span.value-output, .shiny-valuebox-output').length)
      return container;
    else
      return $();
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var chartTitle = title;
    var valueBox = element;

    // add value-box class to container
    container.addClass('value-box');

    // value paragraph
    var value = $('<p class="value"></p>');

    // if we have shiny-text-output then just move it in
    var valueOutputSpan = [];
    var shinyOutput = valueBox.find('.shiny-valuebox-output').detach();
    if (shinyOutput.length) {
      valueBox.children().remove();
      shinyOutput.html("&mdash;");
      value.append(shinyOutput);
    } else {
      // extract the value (remove leading vector index)
      var chartValue = valueBox.text().trim();
      chartValue = chartValue.replace("[1] ", "");
      valueOutputSpan = valueBox.find('span.value-output').detach();
      valueBox.children().remove();
      value.text(chartValue);
    }

    // caption
    var caption = $('<p class="caption"></p>');
    caption.append(chartTitle);

    // build inner div for value box and add it
    var inner = $('<div class="inner"></div>');
    inner.append(value);
    inner.append(caption);
    valueBox.append(inner);

    // add icon if specified
    var icon = $('<div class="icon"><i></i></div>');
    valueBox.append(icon);
    function setIcon(chartIcon) {
      var iconLib = "";
      var iconSplit = chartIcon.split(" ");
      if (iconSplit.length > 1) {
        iconLib = iconSplit[0];
        chartIcon = iconSplit.slice(1).join(" ");
      } else {
        var components = chartIcon.split("-");
        if (components.length > 1)
          iconLib = components[0];
      }
      icon.children('i').attr('class', iconLib + ' ' + chartIcon);
    }
    var chartIcon = valueBox.attr('data-icon');
    if (chartIcon)
      setIcon(chartIcon);

    // handle data attributes in valueOutputSpan
    function handleValueOutput(valueOutput) {

      // caption
      var dataCaption = valueOutput.attr('data-caption');
      if (dataCaption)
        caption.html(dataCaption);

      // icon
      var dataIcon = valueOutput.attr('data-icon');
      if (dataIcon)
        setIcon(dataIcon);

      // If valueBox(color=) was an accent color, this attr should
      // be populated with the accent color and the relevant CSS comes
      // in through HTML dependencies
      var dataColorAccent = valueOutput.attr('data-color-accent');
      var valueBoxClasses = "value-box-" + (["primary", "info", "danger", "warning", "success"].join(" value-box-"));
      if (dataColorAccent) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.addClass('value-box-' + dataColorAccent);
      }

      // If valueBox(color=) was a CSS color, these other data-color-*
      // attrs will be populated
      var dataColor = valueOutput.attr('data-color');
      if (dataColor) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.css('background-color', dataColor);
      }
      var dataColorText = valueOutput.attr('data-color-text');
      if (dataColorText) {
        valueBox.find(".inner").css('color', dataColorText);
      }
      var dataColorIcon = valueOutput.attr('data-color-icon');
      if (dataColorIcon) {
        valueBox.find(".icon").css('color', dataColorIcon);
      }

      // url
      var dataHref = valueOutput.attr('data-href');
      if (dataHref) {
        valueBox.addClass('linked-value');
        valueBox.off('click.value-box');
        valueBox.on('click.value-box', function(e) {
          window.FlexDashboardUtils.showLinkedValue(dataHref);
        });
      }
    }

    // check for a valueOutputSpan
    if (valueOutputSpan.length > 0) {
      handleValueOutput(valueOutputSpan);
    }

    // if we have a shinyOutput then bind a listener to handle
    // new valueOutputSpan values
    shinyOutput.on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {
          var valueOutputSpan = element.find('span.value-output');
          if (valueOutputSpan.length > 0)
            handleValueOutput(valueOutputSpan);
        }, 10);
      }
    );
  }
});
</script>

<div id="dashboard-container">

<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<style type="text/css">
table {
  margin: auto;
  border-top: 1px solid #666;
  border-bottom: 1px solid #666;
}
table thead th { border-bottom: 1px solid #ddd; }
th, td { padding: 5px; }

pre {
  white-space: pre-wrap;
  word-break: keep-all;
}

/* Hack to make prompt-tab scrollable again */
div.level3.tab-pane .chart-stage {
  overflow: scroll;
}
</style>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div id="column" class="section level2" data-width="55">
<h2>Column</h2>
<div id="score-comparisons-of-56-publications" class="section level3">
<h3>Score comparisons of 56 publications</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-3b423dc1b5ee9f0a627f" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-3b423dc1b5ee9f0a627f">{"x":{"filter":"none","vertical":false,"fillContainer":true,"data":[["648","650","651","655","657","662","663","664","665","666","668","669","670","671","673","674","675","677","678","679","680","681","682","684","685","686","687","688","689","690","691","692","693","694","695","696","697","705","712","713","714","715","722","725","733","1528","1529","1567","1568","1569","1570","1769","1770","1771","1772","1773"],["<a href='#648' title='Jump to individual results on the right'>CORONIS Collaborative Group (2013)<\/a>","<a href='#650' title='Jump to individual results on the right'>van Dijk-de Vries. A, (2015)<\/a>","<a href='#651' title='Jump to individual results on the right'>Price. D, (2011)<\/a>","<a href='#655' title='Jump to individual results on the right'>Galdiz, J. B.  (2020)<\/a>","<a href='#657' title='Jump to individual results on the right'>Arntzen E. (2019)<\/a>","<a href='#662' title='Jump to individual results on the right'>Bogosian A. (2015)<\/a>","<a href='#663' title='Jump to individual results on the right'>Callesen J. (2020)<\/a>","<a href='#664' title='Jump to individual results on the right'>Carter A. (2014)<\/a>","<a href='#665' title='Jump to individual results on the right'>Cooper C. (2011)<\/a>","<a href='#666' title='Jump to individual results on the right'>Cutter G. (2019)<\/a>","<a href='#668' title='Jump to individual results on the right'>Dodd K. J. (2011)<\/a>","<a href='#669' title='Jump to individual results on the right'>Feys P. (2019)<\/a>","<a href='#670' title='Jump to individual results on the right'>Finch P. (2014)<\/a>","<a href='#671' title='Jump to individual results on the right'>Freeman J. (2019)<\/a>","<a href='#673' title='Jump to individual results on the right'>Garrett M. (2013)<\/a>","<a href='#674' title='Jump to individual results on the right'>Giovannoni G. (2016)<\/a>","<a href='#675' title='Jump to individual results on the right'>Grossman P. (2010)<\/a>","<a href='#677' title='Jump to individual results on the right'>Hermens H. (2008)<\/a>","<a href='#678' title='Jump to individual results on the right'>Higginson I. J. (2009)<\/a>","<a href='#679' title='Jump to individual results on the right'>Jongen P. J. (2019)<\/a>","<a href='#680' title='Jump to individual results on the right'>Kiropoulos L. A. (2016)<\/a>","<a href='#681' title='Jump to individual results on the right'>Learmonth Y. C. (2012)<\/a>","<a href='#682' title='Jump to individual results on the right'>Mayo N. E. (2020)<\/a>","<a href='#684' title='Jump to individual results on the right'>Miller L. (2011)<\/a>","<a href='#685' title='Jump to individual results on the right'>O'Hara L. (2002)<\/a>","<a href='#686' title='Jump to individual results on the right'>Papeix C. (2015)<\/a>","<a href='#687' title='Jump to individual results on the right'>Paul L. (2014)<\/a>","<a href='#688' title='Jump to individual results on the right'>Pozzilli C. (2002)<\/a>","<a href='#689' title='Jump to individual results on the right'>Renfrew L. M. (2019)<\/a>","<a href='#690' title='Jump to individual results on the right'>Solari A. (2018)<\/a>","<a href='#691' title='Jump to individual results on the right'>Thomas S. (2013)<\/a>","<a href='#692' title='Jump to individual results on the right'>Torkhani E. (2021)<\/a>","<a href='#693' title='Jump to individual results on the right'>Velikonja O. (2010)<\/a>","<a href='#694' title='Jump to individual results on the right'>Vermöhlen V. (2018)<\/a>","<a href='#695' title='Jump to individual results on the right'>Ward C. D. (2004)<\/a>","<a href='#696' title='Jump to individual results on the right'>Weinstock-Guttman B. (2016)<\/a>","<a href='#697' title='Jump to individual results on the right'>Williams K. L. (2021)<\/a>","<a href='#705' title='Jump to individual results on the right'>Petrella, R. J.  (2017)<\/a>","<a href='#712' title='Jump to individual results on the right'>Mafetoni, R. R.  (2016)<\/a>","<a href='#713' title='Jump to individual results on the right'>Jonsdottir, H. (2015)<\/a>","<a href='#714' title='Jump to individual results on the right'>Pinnock, H. (2003)<\/a>","<a href='#715' title='Jump to individual results on the right'>Ndosi, M. (2014)<\/a>","<a href='#722' title='Jump to individual results on the right'>Patel. A. (2015)<\/a>","<a href='#725' title='Jump to individual results on the right'>Rangan, A. (2015)<\/a>","<a href='#733' title='Jump to individual results on the right'>Iliffe, S. (2015)<\/a>","<a href='#1528' title='Jump to individual results on the right'>Humphreys I. (2013)<\/a>","<a href='#1529' title='Jump to individual results on the right'>Khayeri F. (2016)<\/a>","<a href='#1567' title='Jump to individual results on the right'>Stuifbergen A.K. (2018)<\/a>","<a href='#1568' title='Jump to individual results on the right'>Riemenschneider M. (2022)<\/a>","<a href='#1569' title='Jump to individual results on the right'>Straudi S. (2022)<\/a>","<a href='#1570' title='Jump to individual results on the right'>Mazdeh M. (2010)<\/a>","<a href='#1769' title='Jump to individual results on the right'>Millar J.H. (1967)<\/a>","<a href='#1770' title='Jump to individual results on the right'>Hoogstraten M.C. (1990)<\/a>","<a href='#1771' title='Jump to individual results on the right'>Langeskov-Christensen M. (2021)<\/a>","<a href='#1772' title='Jump to individual results on the right'>Calkwood J. (2014)<\/a>","<a href='#1773' title='Jump to individual results on the right'>Medina-Perez C. (2014)<\/a>"],[0.0228571428571426,0.446153846153846,0.0357142857142857,-0.141791044776119,0.266666666666667,0.357142857142857,-0.0879120879120878,-0.0327868852459017,-0.140845070422535,0.244274809160305,0.196428571428572,-0.309090909090909,0.334975369458128,0.0727272727272726,-0.155080213903743,0.171428571428571,0.214953271028037,0.347328244274809,0.467105263157895,-0.041044776119403,0.0560975609756098,-0.214285714285714,-0.320819112627986,0.257731958762887,-0.108695652173913,0.531791907514451,0.191011235955056,0.508403361344538,0.282208588957055,0.397887323943662,0.429577464788732,-0.0426829268292683,0.0571428571428572,0.348684210526316,0.196428571428572,0.131034482758621,0.0943396226415093,-0.00544959128065381,0.479338842975207,0.0198019801980199,0.131578947368421,0.0526315789473683,0.147368421052631,0.0869565217391306,-0.0305343511450382,-0.017857142857143,0.347826086956522,0.274193548387097,0.0454545454545454,0.121951219512195,0.00847457627118631,0.028169014084507,-0.0662020905923346,0.211678832116788,0.0145985401459855,0.0935251798561152],[0.222222222222222,0.666666666666667,0.333333333333333,0.444444444444444,0.111111111111111,0.333333333333333,0.444444444444444,0.222222222222222,0.333333333333333,0.444444444444444,0.333333333333333,0,0.333333333333333,0.333333333333333,0.222222222222222,0.111111111111111,0.333333333333333,0.222222222222222,0.666666666666667,0.333333333333333,0.111111111111111,0,0.333333333333333,0.222222222222222,0.111111111111111,0.666666666666667,0.222222222222222,0.555555555555556,0.555555555555556,0.444444444444444,0.333333333333333,0.222222222222222,0.222222222222222,0.444444444444444,0.444444444444444,0.111111111111111,0.222222222222222,0.111111111111111,0.111111111111111,0.222222222222222,0.444444444444444,0.333333333333333,0.666666666666667,0.444444444444444,0.333333333333333,0.222222222222222,0.333333333333333,0.222222222222222,0.111111111111111,0.222222222222222,0.333333333333333,0.111111111111111,0.111111111111111,0.222222222222222,0.333333333333333,0.444444444444444],[0,0.217391304347826,-0.125,-2.22044604925031e-16,0.11764705882353,0.28,-0.173913043478261,-0.148936170212766,0,0.217391304347826,0.166666666666667,-0.363636363636364,0.526315789473684,0,-0.142857142857143,0.146551724137931,0.272058823529412,0.307692307692308,0.196428571428571,-0.125,0,-0.263157894736842,-0.255813953488372,0.169230769230769,-0.125,0.181818181818182,0.142857142857143,0.25,-0.235294117647059,0.257731958762887,0.63265306122449,0,-0.0687500000000001,0.307692307692308,-0.0227272727272729,0.1,-0.11340206185567,0.0581395348837208,0.294117647058823,-0.0112359550561798,0,-0.161290322580645,0,-0.125,0.0689655172413793,-0.235294117647059,0.1,0,-0.0263157894736841,-0.134453781512605,-0.051948051948052,-0.0384615384615385,-0.231578947368421,0.0168067226890756,-0.161290322580645,0.318181818181818],[0.444444444444444,0.666666666666667,0.666666666666667,0.444444444444444,0.444444444444444,0.333333333333333,0.666666666666667,0.333333333333333,0.777777777777778,0.444444444444444,0.444444444444444,0,0.666666666666667,0.555555555555556,0.444444444444444,0.111111111111111,0.444444444444444,0.444444444444444,0.777777777777778,0.333333333333333,0.222222222222222,0.222222222222222,0.333333333333333,0.333333333333333,0.555555555555556,0.777777777777778,0.333333333333333,0.555555555555556,0.555555555555556,0.444444444444444,0.777777777777778,0.555555555555556,0.222222222222222,0.666666666666667,0.444444444444444,0.222222222222222,0.333333333333333,0.333333333333333,0.444444444444444,0.222222222222222,0.666666666666667,0.444444444444444,0.777777777777778,0.555555555555556,0.333333333333333,0.555555555555556,0.666666666666667,0.444444444444444,0.222222222222222,0.333333333333333,0.333333333333333,0.333333333333333,0.222222222222222,0.222222222222222,0.555555555555556,0.444444444444444]],"container":"<table class=\"display fill-container\">\n  <thead>\n    <tr>\n      <th>Ref.<\/th>\n      <th>Author & Year<\/th>\n      <th>weighted κ<\/th>\n      <th>agreement<\/th>\n      <th>pooled weighted κ<\/th>\n      <th>pooled agreement<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"t","order":[[0,"asc"]],"columnDefs":[{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":4,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":5,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"className":"dt-right","targets":[2,3,4,5]}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render","options.columnDefs.1.render","options.columnDefs.2.render","options.columnDefs.3.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
<div id="score-heatmaps-unpooled-pooled" class="section level3"
data-height="720">
<h3>Score heatmaps
(<a onclick="data = 'data:image/png;base64,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'; $('#score-heatmaps-unpooled-pooled p.image-container')[0].style = 'background: url(&quot;' + data + '&quot;) center center / contain no-repeat;'; $('p.image-container img')[0].src = data;" style="cursor: pointer">unpooled</a>
/
<a onclick="data = 'data:image/png;base64,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'; $('#score-heatmaps-unpooled-pooled p.image-container')[0].style = 'background: url(&quot;' + data + '&quot;) center center / contain no-repeat;'; $('p.image-container img')[0].src = data;" style="cursor: pointer">pooled</a>)</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><img data-figure-id="fig1" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAB4AAAAQ4CAIAAABnsVYUAAAACXBIWXMAABMRAAATEQE5YH/wAAAgAElEQVR4nOzdd2ATZR8H8Oe5y2i6994ptOy9h4CCspcgIIKAAwEVQcWBiIq+qIAoOFBEEAcqe6ooKENFQPam0KZ77zTr7nn/KKMjba9tQpLy/fzXNHf53XN5xv1y9zyUMUYAAAAAAAAAAAAAACyNs3UAAAAAAAAAAAAAANA4IQENAAAAAAAAAAAAAFaBBDQAAAAAAAAAAAAAWAUS0AAAAAAAAAAAAABgFUhAAwAAAAAAAAAAAIBVIAENAAAAAAAAAAAAAFaBBDQAAAAAAAAAAAAAWAUS0AAAAAAAAAAAAABgFUhAAwAAAAAAAAAAAIBVIAENAAAAAAAAAAAAAFaBBDQAAAAAAAAAAAAAWAUS0AAAAAAAAAAAAABgFUhAAwAAAAAAAAAAAIBVIAENAAAAAAAAAAAAAFaBBDQAAAAAAAAAAAAAWAUS0AAAAAAAAAAAAABgFUhAAwAAAAAAAAAAAIBVIAENAAAAAAAAAAAAAFZx1yWgxatLuisoVY3dqDf7f+H82x0VlPN4ZLv5/zsuU8aRdQsfG9olNtTX1Unp4hnUtMvgx97acCJHtHVkjQpL3zQxInTCxixGCBGvfdBTSZW9lifUXMjC5Xe7KKiyx9J4y58M3dFX2/j2XnrOYPE9S2P6b34LOeVDZ+yrMQIpb9PvfNSbo5Ryyu5LrgrVvEm49G4XBaWUct6P7qy9Elc4X1ah3/6IB8eHzdpvJMT2pwMAHIx+xyQvjtZE3vK1EyZCqnQlwuk32sqp04BV6XVp3ypuJbkXq/hZFomkDqzfkoPdQDfaEMbDc9Syqo0Ix8lVHoFNuwybtXxvot1d/1i9AbEJtFqOBM1ONVjxpZ3Lnhndu2W4r7vKydU3NKZNr5Gz3t92odBK32ubtQaosI5OTD+w5oPlP50svv0S6rWN3HUJ6LuTMXHzrM6x3ae88eXOo/E5gquPt9KQdfXf3V8umNCl9eBlx4tsHWBjwbK3vfjs1vA5b4z0o7aO5QanjnNff+DKmzM/vVxdytbhMOPxzduum8+GCNe2bz1pkrynO36+GuHpAADro0qvkMjqhHgq7KXHkciQcmL/7/uPJmotsjcb9bzaq9venty3WZCHs4tPZIdhs1f9nSWtXZe6oT7hl6VPDWwX6evm6hvdrt/DCzZdLLHoEdRTfQ/ckLzvo2dGdm0S7OXs5OwZ0qLPxAUbThdUvJg3/vlMhJn8KKWKTv+7UPYp6EYbjso9giq0IeGhvipD1tV/d3w854GOQz48a3c56Ios24BYkPTArNxqWbOSEmJI3v/RrGGd1f7uKqWzZ0jze8a/vO6YfdzPVM8Dr/WI0OyYY7iybmK7dsPmrthy+EqhIqBpi6YB8rxLf237+MWR7dqO/eK8ro67M1d97KSyO2iFre0Ohtsdq41Yq8JWJVxf89jox+fM+/Rw/u33oV7bCrvLCFfe7yYnxGnMTzqz/zedW9RBTqj7xG3m/++AxJxfZsYqKOV9uz712b6rBSbGGGPGgvgDa2b3DpBRyodP2Z4l2jjKRkH394vNFIGTtuXfKE0hflkPBVH0/OC6UON2pkuLO8uJovuSqzW/r54MJxa0Vvg/9EOmLU6y8firzWWEC3nqd31D36bbMdmLEsrzPFV0X3LFXFkJV5d0V1Ce5ymhXpN31FKJK58vq9Btm+hOudCZ+ww3XrDp6QAAB6Pb/ognJfJ2b5011fbWSl2JmPvfljWrv9pzUVuXz6u4ldRerNJn1RKJmPrpvUoi7/jO+VqPSYI70pJXIuYffr2bJ0co5xIY17plpJeCEiqPnvB9Qi1HJHVDMffP+V29OEo516C41i0ivZWUEM6r1/+Ol1jxsGpX7wPXnljSz5enhHIuQXHt2jQNdJFRQqhz3ONbUm5/t8TsNYOcKKWcrDJVl/9duPUR6EbrzXDouWie8Oq5hw2V/6XP+OvDEeEySqj7oNXJVhmO1pN1GxALkh6YNVstK1dSw8XPhgTKbr6rfctIbydKCVWqJ/1k429NfQ9c4hGh2anEcOqtjipKZaED39oTX3SzVMSi+F/eHR6poFTR4sW/6tJfma0+VV6s38CmoRy1wup2POojr9KdymQymYznKKHKnsvibVZrrVxhK23zYT9PjhCi6LsyqcKbUK9tAQnoShpdAlrM2zk1lCecb/8PTldtq7X/vdXFmVJ5uzfPGG0QXOMipn8z0lsWM+fQra+OnSSgmXD9oz4qZYdFZ21wki2egFZ0uqe7czUZaCH+g55K6tztnk6K2hPQVc+XVVRJQNv0dACAg6l/AtoSpPZidYvEkvmjO9SSV1Ry6Plmcsr59n37cLaJMca0l7+d1ERBOd/h62rMwUjcUEz/YVwgRxUx41efyhcYY6z0+pYZrVWUqrq+d8GGSbf6HnjpkZdbKihVNn34yxsHxEoub57b3ZsjnO/I9ak3r/yMR1+Ok1HVsPV5NceBbrS+akhAM8bE7A1jvDlCXUd/X3DHQ5PO4RPQVm21rFtJheTVA90pVcRO+vpcYdlL+pTfX+/jwxEueOrOQisckFT1PHDpR4RmpwLDgWcjecKHTttdtbEoPfZqazmlHqO/z5Ge1pOWgLYFB66w1RBz9jyplimbP/dHgc3yrlavsLfpTv2vu2vZnetVEtCo17aAKTiswKTT6q16J7/JoDdJnIFIuPrV4u9TRNc+Cz97upWqyr9VbZ986l4XYjzz00/nJM9b0JB4LOEOf5xUYsKGVXsK1aMf6qy0dSiVceGjxvXkTq5Z/bedP1UpBec/eFRvZ+MxM7NwiJodW44anHuPHuRfe8sm6XwJRYUlFv+uNarTAQBgQ7boeVnejuWrL5pUvV5b/VJ3H54QQlRNJqz8aHIozd79wZrz1Q4ApW5oPLZ84cYMrumsr76Y1tqDI4QQp8gRS5dPDedKj3/3Y/UfYGX1PnD9wS/Xnjdw6ulffD71xgER5yYj39vwzn2uLGf3l5uSbnTnumtXkgQupGmMS82RoBu1DurVpXtzGWGGzPRcq06oYJXB1U32dBVmljVbLStXUpa5+8f9RdRv3HsrH2nudiOjE9xv/tKnmsnE9F92HbXZXKr1PfA6HBGanfJYweVLaQKRNevUzq3KP53ajBzShGclly8k3dnuyiopAgeusNV8aPauF576MqXVC18tusfdRhO43YEKe5P237envHlEdf+kIcG8mT2iXtsAEtA1Mx19uZmcqkZ8W3GWZMOvTwTyvO/UPTe+5WLyx/2UnMtDPyb8/tbwWF83V5VC6RHSetDc7y5oCSs+v+GlkR0jvV2cVF7hHUa8svlqxUmR9En7Vj47qkdcsJezUunsGdKs15gXVh/JKtdw3Nj/uI35VzfOuTfK21mlkCndgpr1m7p0f2pNiWMhfssPR0qp1+DpE6LMVTpCfUct2bFt66Z3htye04gVnvvxjUn3tgr1dnFy9gppfs+4l9cdyy7fEkiPhxWd3/jm5HtbhXk5K5QuPpHtB01fvi/FWLGQM/9Z/cKYHrFBHs4uPuHNe4x5ac1faUYrfJzEsykx7CpFvXHDEWPowCHt5FX/KRacXDt3WIdIHxeVq29Uh6FPf3wgrfq9SY9TSukRQggX9MCQTnzixg2Hq21ctb88EcJTeYtXj1f6QpXunR5a9g8jqVfJWBrnP3h0L3MZaDF559Z/DaqeowYF1N6wmT1fYuKHvZWc+8RtekP8pufvj/NxjXxmf1lxSypnor2y/Z1H+7UI8XRWeQQ16zP5f7sTdFVHQhJOBwBAA5UtqlxxrR4x5+jq2UPahXs5O3uGtR3y/PcXCs+81U5RbgFYc1uRWnuxarYy89/i70epuOCnftcT47FXmsuoss8KjcgyvhrixvEBj+4orrAhy1o/woPjvMZsyDV/TWmuJWc5Xw1yovK4l/691ZsJqdunt3DmeI8uL+3PafDVqfaPbb8VEGXPCWOjyvU1bv0mDAvmjed27qp2kVyJGxqP/bDxsknWYeqT3crnYZ3ueffotYSr22fGmB3OVa/2QaZE9T1wMenUmWyR8793SFfn8q9zwff0bSZjpqsXr5VtKWiuXDcwmTo2WlZLKOhGrUQQREII5+HtefsUSxv/iHknv3llXK+4IA+VyiMorte4V9afyLvxJatucCVxuFtrA9KwqzDLXIaYDcx8GVuz1bJyJTXFX7hqZLLY9q0r/EbEh0WG8YQVFtR55Tmbt051OSI0O+VQhbOzjBLj2YOHs6uedVn7N44XFBccebVVuba8hopmtvqYfbHSYKMuGZLaxz9mOXKFNYfl7n5p1rq0FnM+faWzczXvqZZDVVhCCCFFBxZMfe+U58jln0yOND92Qr22AVvfgn2n1XEKDuO/L8XJiNPwbyre0a//5fEAjvOZsvvGdAFC0sq+CiqP69DGjVP4NO3Wf0CPJt4ySggf9uD853p4caqAFr0G3Nsx3JUjhCqavXC49OaudKc/7O/PU0LlHmHN23dq3yLCS0EJoapW8w4W34o6aWVfBXXqO+WRGDlV+sR0vu/+vm1DnCkh1Knli7ffV5mYtWawilLlvZ/W/CRG+QJK2zGjlQslhCp91G07to8NUHGUUEX0uPVXbz2bIDWewkOvdnCjhHLO/k3adGzfLNiVp4TKo6ZuuzXTTunZT4eFyiihvEtAk9atY/yceUqoLHTIh/8VWfrjJJ5NKWFXLTfNyr5KzuvhLeVPRtnDy/LWD05o70op5xzQpFmkl4JSQqg8bMTqSzcfgKz0tLLUOKWVXhnj8VdbyHj13L/MPXRZtq/fngrjiazF/OMVnkEp2fNYEEcVnd65YKpXyVh8Cg6noV/npn7xgDNVdF9a4eluQfNxPyfqPGBVcs7XQ51qmYLD7PliQsLyXgrqNv6zDVOiFEq/Zj0eGP/hMaPEchbzD73e3YsjhFCZW0hsbIgrTykf2H9oV+eKU3AwKacDAICxhkzBUTaeUfb/LO3msgSp2x6Pc6KEcir/pm3bxvgqKefdeUS/cL5c21txK8m9WMXPqiES/Ym1Lz8/vX8ET/jAXlPnPv/SJ4fyRCamrxnkQrmAKTvLt8li+peDXCnn9/CWauYDMNuSi9lrBiqJLHbeEeONw94xo6Uz5Tw6v7Q/2wJPmxpPvt5aRmTNXj5a8YFNMXftECdKPSZsrmbaS4kbCteW9VQQXj3H7CQJdSVpkClNvQ9cSNq1eM7suUt+Sav0WK3+z2cieSJr/sqxsj3qdk72pnzYzG0nNr/33JQxA+8bMGzCrLfWHko205mjG62XWqbgSFs71INSRftFt5obaeNMk2bjlFgnSijvHtayQ7u4IFeeEqqMnVY2F2l1gyuJw91aG5AGXIVZ7DLEfMtmhlVbLatXUpO+pKS4RFfpYfX83Y+F8VTReXHdJgiyh9apbkeEZuc2IWXNEE9KCHWOGfzCZ7tPpZXW+EWtuaKZrT5mX6w02JCcIZE0/jF7nA5dYasQ8/fOiJHJms7+s45VjDlihRVzfp4eI+dDH96YJhr2zwrjzUzBwVCv77y7NQHNuQapY8wK91HS+iWgCaF8yLAPj5UNOExpmydH8IQQKldPWHu+rF6WXlx5vxdH+KjnDt34ihdvedibUkXsYz9duzlDsz517wsdVJTznrzj5gDpxv4JVcZN++HqjTdqL38xMpAjnM/knbcHUhUZT73eWka4wCd+rTH5d5uY9v0Yf45wAQPe/jOtLEQh5+iKkeEySt37rbiZ75MWj5C4oq8T5bz7/e+fnLLmQMg/8lYvd0pvXZXqji5o60Q5nx7Pb7p8o6XRXt/xYjcvjsqbzv6j2LIfJ+1sSgjbjKJN4zyoolvFN5RduhNCOP/+b/+RqmeMMbHk2s55Pbw5Qt36fHil7APqmYCWVno3FG8a514lZ1uBbv/TETyRtXrtRLlWvXjX1ECOqvqsSBDqVzLWSEDnCamf3+9MlT2Wlls6QUj+9D4VVfX/LFnIqz0BbfZ83bhGkvsHhbWbufX6zWolrZyLfp+lllHqFPvIlydyTYwxZsz6d8XIcBklhFROQN8+HTUVCgBAWQKaKn3CzQ9aYuIGf3jBbFdS6TpNzPhxXCBHlXFTvrtcIjLGmCH55xe6uFNCSC0JaAm9mOQENGNmZ3W8kYEOnLb79lWHkLJqgDPlgqbtru7SxmxLXuHKUEjbNauVM+U8urxskewzY0y/a4oPR5T3fpJSaX/6vdODOKLotbyaCbMlbqj/bXowRxT9Pr6W8Ov7U+9tEeyhcnL1i+n64ItfHcuu6+ze0gaZ0tT7wKthSvp6pD9HePXsAzeGcdeX91IQqnRxllV4Kpi6tX78x2uVr6ZrH9VAVdUloAVdXsKR717o7cdRVYtn996cuFXiKP365wO9OOoUN3n9hbK1yIS8EytHhPCUD3t8T0F1g6t6JaAZM9OA1P8qzJKXIRLnq7Vqq2X1Slo+5vzr//1zcO+WNYse7ejDUZe2c3+vw4S/zA5bJwlHhGanHFPipqfa3pj9gVBOFdiq37hnFn2+9a+reZUTeVIqmrQ5oM0loGuvmxLHP+Y0mgrLGGNMd3R+GwUfNGFjPdbcc7gKK2ZsmRTO85FTtmeJjNWQgEa9vtPu1ik4xOK0+KtmaXL09X08k7o+8Naqpzt4UkII4QOHTBkWwhPOZ/TilZOalT0n4BQ7eep9zlTMycwue1hBzDP59x48fMZbC0ZF3ZyhWRHUZ+KQJrxYkplVaYY0PuqJTz8aq77xRlWTyXMnRPJicXpaUTUhs/y8Akaoi5uLtBl+hKvffLQ9i/g9+OH6l3sHlj1pwnl3nPnVZ4+GcoUHPvnyvwpPs9QSjxB/8YqRydqMfqSTd9lDD5xHp5nvLl3w6rzhTSkjhBTsXv7JaYP38OUb3xvV5MZjIKrIIf/7/u1+Lqar67/8vcSiHydNvfYjXD97UUtU0TEhZqoU5zf6w29evidIQQgh1Dlq8Ds/LBviTYsOrfrqZP1n3q5j6SmjmoTzxounL1Y7XYay+9hREbzpwratt+cDL973485M5nrv5DHhnMVKuOG4wMGjeqoMxzZvS7j51A9L37XlL51T95GDgyS0ajWdL2bMdRu7cunwSKeyvyWVM8veuuLra4K87bzvv5ja1osnhBCZb6dZa7+YFm7uiZ9bp6PuBw8Adx+mz9GYH7RcvZqUK2XYIl779qMtGTRi2sqPxjdxpoQQIg+5/50vnm8rr32AYKVerBzqP2j0Pc4sc8+Wg6U3I07esuFgKRc6akLfamYErrHnJYQIGXtm3z/243PyLi9t2/12Hx/LzHVoKi7Smh1ZURcXF0pYSbHW/PmQuCErLChghGVteaz7wBe/OpjMBanD3UoTjmx8b2rPLpN/0NRlSs26DTJrUe8DN4MVnFw99YGntmZxERPem9ezrLs1Xb98zUSYURb32Jq/E/J0Bm3mxd8+ntrOveT06kcfWnyy4lPStY9qoDpC/NIeCloe7+QV2WXCkn9chy3Zu3/Zfd5lp1jaONN04ovle/O4pjNXfzoxrmylJ86z7VMr5/d1ElN/3vXfjRNUeXBlcfW4CrPoZYg01m21rF5JyzHse6V3t179R06dv/a4tumjazb/r593XaK1v9ZJwhGh2SmHDx/1yb+Xjvy07IVJ97cPcTZknNm34aP5T4zo3iQguPWIl384V3yzzOtW0eoTSs11swHjn8ZTYQkh4vUvX/rwDN9lzoIRfnUeDzlahRVTNsya8W1q1OOfLR3iW8vRol7fYXdrArqWKTjqh49o367cN5zz8vGiRNaiexeP2y8qfHzcKLlVp7jQB5dt2bHlgzFht86EqeDq7z/8dt3MFQbn339Y9/Kz9XAenu4cIYRUV0epm7sbJaykWFqrwPL/+vOkgXoNnDjUv3xNpR73PjwsmDfFHzqUXG6Wn9ri4aPjmiip8eA7j766/uDVPCMhhFCvbo8tfOvNF4dG84QYju3dn8uc+zw0LLBCw8CFPTCojVwsOHK4/MqIDf44ieq1HyElMVng/IL8zfyf8x40aViFAuVCHpw22IszXT38V2q9l3mpW+kRPiDIn2MlyZrqJ6ZSdBk7Opo3Xdi27cKNr1/hbz/uyibegyYP96eWK2ELoEFDRvdUGY5tupmBZhm7txwqVXYbNSRYSqNW0/kinH+/gR1vLTQhrZwNR/cfKmbyro9OaVNhiQr3vpPHmJt+/dbpkBAsANz1apiCw3hqYZvaZswlhOUe+O24gQY8MKqna7mXZc2HD29ea+ttpV6sAuo/ePQ9zix995ZDZRloMXHzD3/puKgHJ5i9kCKklpZcyPhl7gNjVp4uIS6dJj/Rq9xlienIi01ltAaKzosv1pDmZTd60WquaESh2qkXJW1o1OkERoxnfj/i99j6M5m5SRfOXErNSz7w7gOBxvhvpz+1toa1hSqTNsiUWiD1PvAKhOxja565p3mXJ74+z5pO+HzPqlE3O1caPPDlZR9+uvnQn5882jXCUylX+cXeO2P1z2vGh3Da4x8u3V1hpmAJoxqoBpV7BEVWEBHq6yKjzKj585v1+xNvXIRLG/8I1/ftu2KSNRk1rkv5tc65kEc3XLx66c/5HW82TxUHV5ZX96swy16GSGPlVsvalbQceYfpq776ctXyRc+ObuNyde2ETn1e+6OayfrNsr/WScIRodmpRB7Q8cHn3lv38/GknMyLBzd9+sbM0d0iXUw5Z7YtntDjvjf+LiakzlesdVdL3WzI+KfxVFhCin5/770/SgIfevnxpvW4aHesCitcX/PkM5uym8z8fPEAr1qT7ajXd1jtFy0gHc9zVb7iVKGo5dc1Mf/szm9/2nvk1IUr165fT0jKLDYyRgipMkjjfAP86vaLAR8YEsDTc3nx13IYCTIfBsv6+9sN/+Zw6geeGCgkp5oYHxkbU/mzZeo4NU9SU5NSBRJ5M4ba4uEipq346MjYOd/9vnjSb+/yLoFxHbp273Xv4DFjB7fxkxHCijSJOSLTbxrnQceZ2Z5mZWQJt7+jDf04qeq1H7GkWMtokEplppD5qLgqBeoU10LNk/8yUjNEEl6vn4HqWHqEqJxVlIjFRcUiIdX0O/KOY0Y3+WDxua3bLrzaqiVPCn77cU8uCZwyeaAXJZYrYUuggYNHdnfae3DztoRnn4vmWOaerQdLld1GDqnmF+pKajpfhA8MCbxVQtLKmRWmphaJnHez5pXvv5Y3b91cTq5V2e7m6ZASLQBAAwnJCUlGxodHh1dsrPkIdYSMnKl5Y+v0YpWU3QO955ddW/7S9b/XSYjf9MMRAx87dkJnRXWb1NSSC/HrXv+EukdG+SZe3/fGiz+O2DDu5hUZF9Bt/JPTM6tP4/IR7bwo0e+YFDh8ff6tyxFF9yXnD85Vc7yrqxMhWm2JlpEKC8gzbUkJI9TFtZqHziRuKFMqeUqoostrG1Y+HHfjdMkCer6w9n+HY6ds/+3LH69PmauWXuS1DzIlFki9D/wWIeufz19+ZsG6Y9mCS5Mh8//3/rxRsa63t5HHDpkZW2Uj6j90xkORG5YlHP7zlHFEz9v3iEgY1YB5XPhjGy8s6V7xfhtT9tFPHxv53LbPn5jTq9/mh32pxHEmTUpIEgivjlVXGgg6+YRH+xBCCCn7alUYXFlDXa/CLHwZIo11Wy2rV9JyuPDeEyb3JoSQZ+c9u3pk5yd3Ln7y3SFn3+1Sh/u47Kh1knhEaHaqo/Bu2nNU056jpi/4KP/0dy9NnvH5yX8XP/fJ+MMvNpVW0RpQnLXUzYaMfxpPhRU137y3XkObvTLrfo/aK4N5jlJhTZc/eeyFPUUtnt+6qK+kg0W9vrOQgK4vy/xCwgr+fmfEiIV/ZjG3iI49u3cfef8j6iYt2nofmDH83QtV3s1xtG4tBvXr3jOW//3M8d/+zHtinPkno4r2fzDj2Z+0UXM6PTHQo2wrM+/jOI4QIohixRdriUfVYtr6UyNf2bdt68/7Dh7++8iRrasPbFn9v1fbTF+3c8XwYEEQCOHc2499rF+omX6DKttFlG8EGvhxNWUmK57NeuyHyhVyQoxGyY9ucDxHCJHJ63a7ffk461h6xGg0EUIVCkUNhShrN/bBuCWLzm7ddunlls2Kfv3x5zwa8fSkfjcff65/CVscFzR0dI85vx/cvD3x2dmROT9v/lOr7DJyqLmiMKPm81XhtEgr57IKYo7SWVX1iuj26ZAULgBAAwkmEyFmOvi6jitub1ivXqwGNGDQ6N7Oe37dueXvD+7tfW3jD8eNspbjxretfqBaU0vOGPXquWDH1mnXHm//6JZN817Z1f/LIWVPx3KRI9/4eGSt8ZhCe4ydyG4/Bipr0tyNEkL4kPBQnlxIS04VSGD54ErTUvMYVYaE+ZvvDyRuyHv5eFGibzrggZgKh0797unXWr798OVzl0xELa3zkDbIlFog9T3wslByDy8e/9Dre1OZX+fHVr73+uO9Q6R2gLLImEgZuZaXm1dhDCplVAPSyXw7zVgy+7vdLxz589d/DA8PUUoc/4iCSSCE8nytl+11aC3uzG1olr4MkcLKrZaVK6loMpgEwskVsgq7kUU9/OTgl3avS/j3WIbYReJI3D5ap7oeEZqdMsKFNTPm78ht9tinbw2uPL8B59l64sr11/9tv+Dkyf2Hcl9oyup4xVp3tdTNBox/HLvClv+o019++qdW0XXa1Hb1G7U5UoUt+vvXw/lE4bH3+f4HbsVfmJAhEtN/S4f3+EYhi5u+/svJt+6pRL2+w5CArhd9bm4JIw2fxUw4v/LpN//M8R/+8c/rpre69QuQcPY/C33/Zc1HjGz+zpkzu1d+dfnBubFVTzfL/23bHyWM8+nRu5Wc04cEyejJxMvXDKRZ+QfpiHD9yjWB8EH1uHlB5t1swJRmA6a8TAjTph7f+dHzs97/87OZi0be/2mv4CBXjhmaPPjW+6Oda99TQz/uvmq+7WbPZk37MXPiOd8AX0ke6FYAACAASURBVE7Mz80385OfcP3iVT2Jq3CEhkvn4wUqD4sMkV6gFeOkHnUrPTE/N1+kMl9/75oGhrLWY8e0ePf101u3XZ4XeOqHX/K5uBmTule4862OJWM1XNCQUd3n/H5o87bEWRMPbfmzRNF51NAwiTnwms5XRRLL2S001IsTcy9eSBfvq3AzoJh8XWOqeiV163RIixcAoEG4gOBAjlxKuq4RSEy5fkdITkyu9UlHS/VitSjLQP/8684tf7/re+DHUyZ5hwkPNath9zW15FzwxK+2LejhTbsuefOb/TP3rp+zcGLvFf3cpYcja/fkqq+fNPO6unVzF3r2+onT+ax9uStv49kTZ41M1qJ1C1XVjeqwoSy2RaycppuqXvCKokgIUSglz2Jg2UFmvQ+cEKI9/s6QQa/9o48cvuSbz5/t7mfmrLL8s7/uPVfo1vy++1tVfGJWLMjLFwnnV/EeN2mjGqgLPiy2iQv9R5udXcKIUuL4RwgKDeRJTuK1RIG0KndiWeHZ3duO53q3HzaoRd3CsNRFVm3qOpC2CCu3WtatpKbj81t3f/d6pyXnD1V6CkPm4qqipLBUWyr1twP7aJ3qekRodm7iMk/s2PrfsZAZ8wf3NVNX+eCwYI6cIJRSQt0lVTTr/erUkPGPQ1fYcgxHvv72vEnZ+6HRkfX76jpehRWLEk/8k1h5DwXX//vnOpGbhpWv2KjXdxiKWQpWXFRc7lvK8vftPiy5h61J6Zn/zhuJe//HprYq//xBaVJiRl1WmamBrM1T84b6UO3fb01750hhlZiL/373zc3ZIh82etJ9boR6devdWs5y9ny7K7vCW4v++HZrkiCL7NWrDq2WcHbpgCZRMfe+e+rmxE7UObjj2DdfGx3IidnXE4qYomOf7i6k5MCWnyt+nJjy9bgmwSFtnv9DL/1Ia/+4Gy/XcjYl76cCWXTTaBnLS0qqWsZEzN2zfkdm+ddZ2qYvt+cwRfv7ele/WkFt37o6lp6QnJgs8GFNY2oeY/PNHxzTWm48tWXrkZ0//lYgbzdx4s3ZRetXMtbDBQ8Z1U1p+HfztpN7tuwvVnQeOVTyc+A1na9KpJWzvH2fHu7U+PfatWcqLJNkOPPd98fN/Gx+63RIDBgAoCG4oN59mstZ+s9b/9KWe1m4sm3bmVonX6xnL1ZnNGDw6N7OYvKOn1av/+msSdlt/JiYmq6pamrJObegIHdKCOGjp33wajdn4erns//3j5aQhs8B7dpn0D2upPTgxh3p5T5X/+/mHYmCrMkDA6udXVHahjTw/sEdFcLVnVtPVujFRc3Pu04aqap9l1ZS71+SOMiUWiD1PnDh4spZb/9T7Dvkk99/mlPddTKVXVk/fcJDIx5bdbHiN9J0adv2sybOr1ff1uUPXOKoBuqCOqmcKGFFBYWMSB3/8E179wrmTec2/XS6/PiHZW+bP2HylJlrzrFamgirXWTVyqKXIRJZudWybiXlY9q0cKbGM7//kV4xetOlQ39lCJxnXLNgqb9I2kfrVNcjQrNzAx/dp08kLyR/v/jLy4aq/xZTt236y0jkzbp19qI2qWjlNWT849AV9jbD3z9sThAVXUYOk/iAQhUOVWG9Ju+ostabYf+sMJ4o+q5MEhgzHH25WeWfIlCv7xzcAV0zzi/QjyOXDq/64MDYxfd4c4SQkgtrpz/3fYZY3bTpdaHwD/SmLOOfPQdzB91Yc7r02u6lTz+1Lk0kCpPBAmtx0oBxKz7dfWz8d4ffuL/X1df+99KU/s295YQwrebQd+8+P++z0zoaOGrRK/1cCCF8k4mzBr8/eeuPz0xuH7L2uW5+PCFi/onPn3jiy0TR7Z5Zj3eswxeGD4/2z9Psvf7x2+uGrpna3JUSQsSCM+u/2JMhytRtWnlSKh/19MMLd6/6fvpYtdu6V/qHKQkh+tTfF0+c+1N8QdO5o7rUYbGS2j9O2tmUsB9zxezboZOa33fh9AUT6VX50lDM2jR78vuh6+b08JcRotP8/NbE2dtySOD42RPNTuMo7VtH/etSemLG+fNZzLV35+a1nEI+9sEx7d7878TaWe+nFDr1mDz+VhdQv5KxIi5k6Kjuc/cfWvNMaUKRotPIYRGSO9Uaz1elt0oqZ+ozbOYj0dtWnlg8YXrkD8sntnTnCCu+uOG5ie+eMFZ96Ov26aj7YQMA1B3f4rG5Qz+evGX1rDl9dn44KlJJiCl9/8LH3jtmJITWMqKpay8mCdPr9JWu6Moy0D//snb+xzpBdd+E0TX/qiixJZc3f/qjF77v8caJD59ZNu7Q/DYyaXMU1vCxo56dtHDXxz8vnP1N7/WPqBWEsJyDC59bdVV0H/DsE7fnDDEm/LnpcLIoi+g1pmcYJ3lDLmrySxM+GLF2yYRJges/mdHFhyNEe2XTKxNf3a/lIp98ZtTN9SDL9i/wYT0e7B1prm+XOMiUOGljvQ/cdOrbr4+V8i2ef3NSVA1DENf7pk6I/uHjo4sefq7pj4tHxbgQQsTC8xteHL/oX4Nzl9nP9S9/bSh5VAN1wfMcIWJhfqFICCdxnKnoOX1m5zXz/ln66LOtNy97UK0ihBWd+3Lm/J1F1G/c+P4ehBSY/7QGXWSZaUDqqm4DaalqDszKrZZ1Kyn1GvToqKCt63597fFlLdY+29VPRghhJfFbX53y/kmTrMnEabfm7HOQ1qkOR0QImp1y5J2fWTjym0mb9j5337C09xfNGNo+2JkjhBCxRPPX928/O3d3HvEf/fy05jwhpA4VzWz1aWhlb8D4x6Er7C2ms3t/TxFkrfv3q266zMZZYSVCvb7jzC+q3ngJV97vJifEacxPVX4ZYYwxZjq3qIOcUPeJ28r+LyStHxXAEULlvnG9Bw3p30ntraCcZ8vWETLOZ8pu/Y29Jq3sqyCyNgtPlVul3nRqYRsZUfb/LE28/aL+t+lBHHV7eGvZ7vUnF3d3p4TKfOJ6DRo+pF/HGF8l59Fu0vjOKkoV4b0nvbUrRahm/4yZzrzZVk6U93+RIbIalZxb83CsMyWEEMqrvILCQnxd5JQSQqg85P53/86/vb2QsvWJ5s6UUE4V2LxzlzaRngpKCFVGj1t/1XjrTdLi0Z9eco8XRwjlXUNadO7RrUNcoAtHCVU1n7HrxlvE/IOvd/fiCKFyr6h2Xbu2i/F1ooRwPr3e/qfQ4h8n7WxKCNsM3b6ZYby863uXy8UoxC/roaCuTVpGqyihMreQ5q2a+Kk4Sgh1af307vSbOzNdWtxZThTdl1wVmPQ4JZZemcJN4z05l0FravuqMMaEK0u6KyghhLoNXZte/v31KRnj8VebywiVeYTEmNNs3FdJgsS36XZM9qLEaejXebdCTVzR14kSQqii+9IbhccYy/t6qBOh5n7+vM3c+WJCwvJeCiLvvPhShW+atHIW8w7M7+LBEUKo3DOiZSu1j5JSzq//3Cc6K7jQmfsM5fZYh9MBAHc13fZHPCmhSp9ws41jTExMTNMeC/4ysCpdSdl4ptwgREzfNbOlMyWUdw1u0b5VuIecc+kw59kBSsJHzzl0o4mquJXkXqziZ9UWSeEPY9wo5XxaPTD6oVd3lG8IxbTVD7hQQgh1H7au9hbSXEsuZq8ZqCSy2HlHjLdfLD74fHM5pa69l100Vt1NnYm5++a2caGUc4nsOmjE0HvivGWUykJHfRVffu8F64c5EUKdH9qoq9uGTMz5fW5bF0ooVXpFtmwTG+jCU0J5vz7v/F0oVto/cRr+TaUe/xaJg0zrHriY9ll/JSFU5uRqlme3d86WnT+x4J+37/HhKKFy99Bm7Tt3iAt05iihqqaPfBtf6byhG60Xw6HnonnCq+ceNpj7t/HkglYyQt2Grq3LKJ0x/cXVI8Pl9Ma7OreK8JRTQhVRD29INLFqB1dSh7u1NiD1vgqz7GVITS1bOdZutaxcSTN2PtXMmRJKnXxj2nbp2qlFqJuMEsoH3Pve0aLK+7f71qkOR8QYmp1Kio4vHxKuLEsvyF39QiKjIkN9nWWUEEJ5357z92ffKicpFc1s9an8YqXWQHLdlDT+McuxK2xZcVx+r6uc8OFP/1HtgTbOCltehTugK0K9vtOQgK6kcgKaMVZ8/oeXR3WK9HLiKSWEKsMfWLTv5Mp+CkskoBkTc49+/vSgNqEeSoWTR0jrAY+/v+eaVsjbv6BvuKtC6TtgxRVTwxPQjDGmvb535dxxfVuF+7o7yRUuXkFNuw594u0fT+aYKr9TzDv9/YKH+zQP9lQpnNwDY3uOnbf2aFaFPJ3k5r7o/E8LH+nXKszLWS6TO/tEtO3/6Bs/nM6vEK82fvf7Tw5sF+HjolCovCPaDZq+7NeE8qfHkh8n4WxKDLtKAf/2VBiv6v9ZSrlsfvyyHgou5Km9Gae+fXVcz9gAdyelq3+THg+9+t3pgnI7q5yAlhqnpNIre9evT4bwrgNXp0ppWoVry3srKeF8xv2UV+n9dS+ZssxytRQ9P7guSHxb1QQ0ExJX9HGihCq6Lblyuz+RkoA2d76qv0aSWs7Flza/NalP8yAPJ6WLr7rbuIVbrxZfX96rcgK6TqcDAO5mZQnoGnEhT/2uZ7WnfRljQva/X8x58J4WgW4uvk37PPHJkZysrwYpiaz16ydvjPjNJKCl9GJ1S0CzkhOfjG8f7KaQqfxHflXhmuVGBpp6jdmQK2VoU7UlN3tlyMT8X5+KllHO64FV1+t0jVQdseDk1y+O7hLt66JUeYa0GvDEB/tSKl10mklAS9uQMcbEwrMb5o/v2TTA3Unp4hPZcejTK/ZpKnY6tV8xShxkWvfAjcdeqfG2ooqjO0PKn5/MebBHbJCnSqHyCm117+Q3fjhTdZCBbrR+aklAM+3uaQEcoXzoo9tv1T9p4x9j+uHPZo/oHO3rolA4+0R3Gj571V8ZN85rDYMrKcPdWhuQBlyFSTpA6Vdh1bds5T/P6q2WdSupWHB6w8JH72sd4e/upFB5BDXrNfb5VYdSDWb2b/etUx2OiKHZMUMsurh92XPj+rSMCPB0lsud3HzDW/YcMf3t745mVunWaq1oZqtPpRfrm4BmUsY/5jl6hWVi6mf9nSh1Hroup9pvbqOssBVUn4BGvb7jKGN3eOJWByaUZGoyBL+IIFeLLbkDNmP5s2k88lKrnivCV17++cnqHnCpB4vEqd07PXbQxh7fXf5+jDfWd73BOudLCpwOALjjTMVZmQVGuUeAX/nexHTitbad344fuDZ1+yQv2wV3G8v+ZlTMpO2KhzdfXT9cwlo+tmvJ7UPJhtHhm8cl/Tjm7pq6EN1o43MXXWTdLa1WY2ud0Ow4rIaNf1BhGzXU6zuvMVcji+Nd/KOi74KB0d3B8mdT3umpZ/twB9Z+d9VCK0gSQiwSJ8vb89WmjJhpzw1Dw1qOdc5X7XA6AODOY3k/PRoTFtZ69q/lF+Exnt++87Igb9e7ex3WbbcmMWXT13sLaeCIif2lRWSrltxOCKlJGSExUQpbx3FnoRttjO6ii6y7pNVqZK0Tmh3H1cDxDypsI4Z6bQtIQANYChcxeeH06BOfrThQYutQyhPi1y7fzo1Y8Fzn+iym0ojZ5nzhdACADVDfgQ8P8iEZ386d/sXhhHydSZ937cCqxye8d0rwHTJjQrRdpH1Y7t5F7+/XcpFjHukj9RYcO+157wT98c8mT1zn++y0dnfXwjnoRsHB3QWtVqNrndDsOLCGjn9QYRst1GubwBQcABbEcn9+qvP4y7OP7Z2ltovLecLydk5rOyXtlSM7n7SPBINduePnC6cDAGxFTP953siJHxzJEW4N/Kg8oPeL3/z45n3+Nr4fQby+ckif90/kpWYUiR4DPv5vz/Qo6RHZX897Z5iS//u7MLxbc9+76oIR3Sg0Bo291WpkrROaHUfX0PEPKmxjhHptI0hAA1gUKzy9/acrYaNGtfeyi0c5DFd++fZfl/vH9wzG4w7m3OHzhdMBALZkyj23d8vOw+dTi4iLX1Sb3oMG9Yp2s4POSkz9ZnyXJ3cU+bYeMnvph7N7+NQtJnvrecF60I1C44BWy4Gg2WkMGjb+QYVtfFCvbQQJaAAAAAAAAAAAAACwCuT7AQAAAAAAAAAAAMAqkIAGAAAAAAAAAAAAAKtAAhoAAAAAAAAAAAAArAIJaAAAAAAAAAAAAACwCiSgAQAAAAAAAAAAAMAqkIAGAAAAAAAAAAAAAKtAAhoAAAAAAAAAAAAArAIJaAAAAAAAAAAAAACwCpmtA7ijFi1aVFxcbOsoLIMxJggCpZTneVvH0tigbK0HZWs9KFurMplMKFsraXxlO3DgwHvuuafh+1m4cKFOp2v4fqojCAJjjOd5Sqn1PqXhHOIb4hCF6SjdBAqzjCAIer3+gw8+aPhHHD16dNOmTRaJqjomk4kQIpPZ9aWlKIqiKNr5V4ug0bMoFGYZvV7fuXPn8ePHN3xXy5Yty8zMbPh+qlNWTzmO4zi7vlcSjZ4FoTAtyNqNniiKer1+/vz5fn5+9djcrs+xxR04cGD58uV2/o2RSBCEoqIihULh7Oxs61gaG5St9YiiWFhYKJfLXVxcbB1LY4OytZ6yspXJZK6urraOpbFhjBUUFDSmst2zZ09CQoJFEtCHDh1asWJFw/dTndLSUr1e7+rqas8jfkepfVqt1mAwuLm52XOaw1G6ibLCdHd3t+fsg7XHiiUlJRkZGcuWLWOMNXxvKSkpKpVq7NixDd9VdfLz83med3Nzs95HNFxZo+fi4iKXy20dS7UcpVssq6foQSzCqj2IKIqZmZlHjx7VaDQW2eE///zz/PPPW6+y6/X60tJSZ2dnhUJhpY+wiPz8fI7j3N3dbR1ITXQ6nU6ns/PCLGv00INYhLUbPZ1Ol56e/sUXXxgMhvrtwX47DCtp1qxZ40hAm0ym/Px8JycnO+9QHVFZ2SqVSjtvBB2RIAh5eXkKhcLOe2tHhLK1HlEUc3Nz5XK5h4eHrWNpbBhjOTk5jalsjx07JoqiRXZFKW3WrJlFdmVWSUlJaWmph4eHnY+kHaL2FRcX63Q6T09Pe87FOEo3UVRUpNfrvby87Dmbb9WxYlZWFmOsV69eK1eutNQ+fX19rdqeZGdny2QyT09P631Ew5U1eu7u7naei3GIbrGs0UMPYhFljZ41ehCj0ajRaKKionQ63blz5yy12yZNmnh5eVlqb5WUlpaWlJS4ubkplUorfYRFZGdn8zxvvXKwCK1Wq9Vq7bwwyxo99CAWYdVGLy8vLy0trWvXrt9//329c6p2N0pmpQn7vlm79dCFtFKFT2Sb/uMfHdHOV0YIEXNPbVq74Y+TiUWuEW37jZsyuo0XJTW8DgAAAAAA4CAYYykpKVqtVq1W23O+AADsn1ar1Wg07u7uQUFBly5dsnU4AOCoGGOZmZm5ubkRERENfIrOzh5tYwV/ffz6ysNCx0deeOP1Z4aFJW9c9PrX53SECImb33l7Y1Lo0GfmPT00OPHHtxdvTRJI9a8DAAAAAAA4BpPJdO3aNYPBEB0djewzADREfn5+QkKCn59fcHBw43j+GwBsQhCExMTEoqIitVrd8Dnc7OsOaJb39y9HTF2feXFSLzdKSIu4QO31Z7fuPTOxiWznzuuho5dPfyCMJ6Slb/7V53fsOjd4etw586+3tt+74gEAAABszsXFxc7nAiaEcBzn6+tr6yhq5+rqav9TovE87xCF6ebmZv9zoMlkMssWZvl7FR0xW+QQXy2HaPQopQ5RmNZq9HJSLbgzjhBfSojJQHJKLLhbQgj5a6cFd+ZGiAWbPEZIpndErqt/RExT+//CV6VSqVQqla2jqJ1D1FNnZ2erLFSQmWjBnVFCfAkhBkIyCyy4W4tzIcSFEJJv6cbEP8KCO7P4sNlgMCQmJioUiujoaIuszGFfd0CzIqMyomOnONcbwy7eLyhAZijV6pPOXSgObN8huGwqOD68Qzv/wgvn04zVvG6ZyRcBAAAAAACsqaCgICEhwcfHB/cqAkBDiByvCYgrcvZSp552xOwzANiP4uLi+Ph4d3f3iIgIS60LbV93QHMRQ19dcvtPIfPAvtMk5qFYZfbxbObj533zmDlvP2+WnZllys40+7pIIspeunbtWnZ29q0dMsaMRmPjGNgJgkAIEUXRaDTaOpbGBmVrPWVrc6FsraGsbMtaOVvH0tigbK2HMUYaV9kKglB2UAAAUmRmZubk5ISHh9v/TfQAYM8McqdE/ziFYIhKPcOLmJYUAOovNzc3PT09ODjYsotD2lcCuhx9+r+bPlu1OT564pv3B4r/6k1UpVLdTBxTlcqJGvQGk8H867eu/NatW7dr165bO3V3dy8oKGgcCegyBoPBYDDYOorGyWg0FhTY9WMgjstkMqFsrQTfW+vB99Z6GlPZ6nQ6i69iDwCNkiiKycnJOp0Okz4DQAOVKN2SApt5FGcF5SYQ/BAOAPXFGEtNTS0qKoqKirL4fDj2eI1kzDj642efbz1LWo2Yt3RsJ385MSqUPCso1THiRAkhhJWW6pjcTcFX8/qtXXXo0KH8eG7//v1OTk6NIwHNGNPr9TzPy+VyW8fS2IiiaDAYULbWUPa95ThOocBE7RaGsrUelK1V6XS6xlS2MpnMUg+pAUAjZjQaExMTZTKZWq3med7W4QCAA8t1C0j3jgzOve5ZlGnrWADAgQmCoNFoBEFQq9XWyIbZWwKaaS/++NaijVlNR89bOapjwI3LUc7Hz5dez8kTiSdPCCFifk4+9WnhI6vm9VtXfsOGDRs2bNitvf/xxx+urq6NIwFtMpn0er1cLsfzehZnMpkMBoNMJkPZWpwgCHq9HmVrDShb6xFFsewHP5StxTHGdDpdYypbpVJZNmcLAEB1HH3JQQCwE4zQdJ/IAle/iPTzLvoiW4cDAA5Mp9NpNBqVSmXBSZ8rsbObdHRn1i/7qbDHy0teG3cr+0wI4cNbNHNJO3kqq+xhEjH91Ol0t+YtQhTVvI67CAAAAAAAwN7k5eUlJCQEBARgyUEAaAiBkyUENi9xclennEL2GQAaoqio6Pr1656enmFhYdZ7mtO+7oA2nv/zUHZQ1ybC1ePHbr3IeavbRbceNCj8pZ9WfBc8tbd35v4vNyepRz3dUkH4al4HAAAHFPdGsq1DqNaR2ZiTBwAA6o8xlpmZmZubGxER4eLiYutwAMCB6WVOmsBmSkNJRMYFjuHRKwCov5ycnIyMjNDQUHd3d6t+kF0loFl+SmqJKfGXj9765faL1KnXS9++0C36wZdfNK5at/KlzTrnkLZD5j05MoInhMiqeR0AAAAAAMAuiKKYlJRkNBrVanWjmfUeAGyi2Nkrya+pd1F6QJ4GSw4CQL0xxlJSUkpKSqyx5GBVdpWApn5D/7d5aDX/5P06TpzfcaLk1wEAAAAAAGzNYDAkJiYqFIro6GisUwoADZHjEZThFRGcddWzJNvWsQCAAzOZTImJiZRStVotk92J5LBdJaABAAAAAAAaj+Li4qSkJG9v74CAAFvHAgAOjFEu1VddrPKISjur0hfbOhwAcGA6nS4xMdHV1fVOrkiBBDQAAAAAAIDl5ebmpqenBwcHe3p62joWAHBgAi/X+McyyqlTTssEg63DAQAHVlBQkJKS4ufn5+fndyc/FwloAAAAAAAAS2KMpaWlFRYW3pl5FQGgEdMpnBMDmjnrCkOy47HkIAA0RFZWVnZ2dlhYmJub2x3+aCSgAQAAAAAALEYQBI1GIwiCWq2Wy+W2DgcAHFihi0+yb4xvYap/XpKtYwEAByaKYnJysk6ni46OViqVdz4AJKABAAAAAAAsQ6fTaTQalUoVERGBJQcBoCGyPEKyPENCs664a3NtHQsAODCj0ajRaHieV6vVPM/bJAYkoAEAAAAAACygqKgoOTkZSw4CQAMxyqX4qrVObuq0s0qD1tbhAIAD02q1Go3G3d09KCjoji05WBV+kwcAAAAAAGionJycpKSkkJAQZJ8B7ID+rw+fGLfqrMnWcdSOFW75+M3wF3f9J9x4wSRTXAtqaZApo1PPIPsMjZL22q9vzhjbrHUrVVicb6fhoxdtP1vCbB2UGY4SZw3y8/MTEhL8/PyCg4NtmH0muAMaAAAAAACgIRhjKSkpJSUlWHIQwE6wnN9WrvrlwKBJdr9mH0v+8/sZv6ZkBbUwEkII0SldE/1jXbX5wbnXKHOwVBeAFMar34wetuCXooDuw8Y9GGKKP7xn08rZ+/5N/WPj9DYKWwdXjqPEWR3GWGZmZm5ubkREhIuLi63DQQIaAAAAAACgvkwmU2JiIqVUrVbLZLi8ArAtoTQn+dyJg98sf++HTNH+H0YQ0g89ufpEBqFlD6cXuPim+Kr98pP9ClJsHBmAlbDCbe8v/bUgdMpXm78Y4MsRQsSnf3vtoUFfrpy/efT2cX62vEe3PEeJsxqiKCYlJRkMBlstOVgVpuAAAAAAAACoD51OFx8fr1Qqo6KikH0GsDmW/cPIVt07jZv34T85dn/vMyFC+soVmw8EdB0XyRFC8rzCUn2jwzMvIvsMjZnpwoGjhXyLh+be63sjI8l595v5cHdZycGDJ/W2ja08R4nTHIPBEB8fTwixn+wzQQIaAAAAAACgHgoKCq5du+bt7R0aGmrbeRUBoAz1vP/DXTv/+WXn39/P6CS3dTS1MJ3asu61+JCFzwxooyCE9yly8Y1OPeNaWmDrwACsyaQlXlGturVW87dfo04qFSUmg9GOfjdylDirKCkpuXbtmqura0REBM/ztW9wp+BXegAAAAB7xCrO/Ij0FoBdycrKys7ODgsLc3Nzs8gOmXUmey3bbfmdozGBxkzmE9vOhxDCMs662/c3XXt599Qf0rs8+vKMKMUbckoICU09raRCrRtKUb7KW7ZtYYyhPYEGUfX96Pe+FV8Sk3fv+dskb9uhhZNtYjLHUeKsKDc3Nz09PSgoyMvLy1L7tFQbJd0uHwAAIABJREFUggQ0AAAAgN0RRTEnJ6f8K76+vrYKBgDKK1tyUKvVWvbJ1kpVXhQtc3+VyWQqLS0tv3M0JgC2V3plwUe/alqNWz8yJtFfJWeECLmcKBAL3a1YvsoXFxcbjUaL7FYQhLy8vPKtE9oTaDBDwi+Lxy48UBI2bv64cDuepcHe42SMpaen5+fnW3zJwfLticlkEoR6/k6GBDQAAACA3aGUyuX2/vAwwF3IaDRqNBqO46Kjoy076bOVqjyllOM4tCcAdoRpf1n79YrClh++P4oERQVk/+VuZIRY8j7l8lWe53mOs0y6jFIqk8nQnoClGFIPf/jGG4u2XzFEDP7s6wUPeNrpDfX2H6cgCElJSSaTKSYmxuI1tPwOKaX1fu4BCWgAAAAAu0Mp9fDwsHUUAFCBVqvVaDTu7u5BQUEWf/C8UpW3VMJIJpMplUq0JwB2g+X/t/nJXw0DX3+hV2xERMZFF21O7RvVUfkq7+zsbKl5YDmOc3d3R3sCFsAKjq5747G3t57RB907ffkHc4a1dLO7rC4hjhGnXq/XaDRKpTI6OtpSg4fyylf5hvyghQQ0AAAAAABALQoKClJSUgICAnx8fGwdCwA4LpaemJwi5CcumLBtQfnXf+068lc+eMDhj0d3saNlwwCsQEjd+Pwjk75P8us7a+s7Tw2LUtk6oGo4QpzFxcVJSUne3t4BAQG2jqUWSEADAAAAAADUJDMzMycnx+LzKgLA3cYgVxX2emgWl+qizaVMJIQQpv379wP7DZGTH4gL84gJscPJZQEsyXTh82enbkhvMWPNrvk9/e33C+8Acebk5GRkZAQHB3t6eto6ltohAQ0AAAAAAGCeKIrJycl6vd6ySw4CwF2oWOWZ5N80zD34A/8Ewm5O+ixmvn/y4B/FMU9OGI57n6Hx0//z0ef/6dvM/foVO83q3mDfcTLGUlNTi4uLo6KiVCp7vDW7KiSgAQAAAAAAzDAYDImJiXK5PDo62lKTqALA3SnXLSDdOzI457pncaatYwGwGeHa8X+yRIXrv4vnXquY16XuXR9bOj7WTtKU9hynIAgajYYxplarLbseslU5TKAAAAAAAAB3TNmSgx4eHoGBgRZfchAA7h6M0HSfqAJn76j08yp9ka3DAbAlU3KSxsSKL//x9eVK/+H8+aHvj4+1SVRV2W2cOp1Oo9GoVKqQkBBrLDloPUhAAwAAAAAAVJCbm5uenh4UFOTl5WXrWACgzmjAI7+lPmLrKAghRODlGr+mAi9Tp52Rm/Rm3sH5v7DkkxfueGAANqHsvyQnfYmto6idfcZZVFSUnJzs4+Pj7+9v61jqDAloAAAAAACAGxhjmZmZubm5WHIQABpIJ3fWBDZT6YsjMi5wZUsOAgDUS1ZWVlZWVmhoqLu7u61jqQ8koAEAAAAAAAghRBCEpKQkk8kUExMjl8ttHQ4AOLAilWeyf6x3UXpAbqKtYwEAB8YYS0lJ0Wq1arXacddDvrsS0IwxvV7fOGZwE0WRECIIgl5v7ikeaABBEAghoiiibC2u7HuLsrUGlK21oWytgTFGGlfZmkwmW4cAAPVXtuSgUqmMjo52rHkVAcDe5HgEZXiGhWZfdS/JsXUsAODATCZTYmIipTQ6OtqBlhysyoFDrx+j0dg4EtC3LtqNRqOtY2lsbiXyULYWh++t9aBsrY0xhrK1ksZUtoIgIGkF4KCKi4uTkpK8vb0DAgJsHQsAODBGuRSf6BJnz6i0cypDia3DAQAHptPpEhMTXV1dg4ODHT2ZeXcloCmlrq6ujn7OyphMJr1eL5fLXV1dbR1LY2MymQwGg0wmQ9laXNk9+yhba2gsZZtv6wCqxfO8g5etPWKM6XS6xlS2SqWy7FdMAHAsZUsOBgcHe3p62joWAHBgJpki0S+WEqJOOSUTGsnv6wBgEwUFBSkpKX5+fn5+fraOxQLurgQ0AAAAAADALYyx1NTUoqKiqKgolUpl63AAwIHpFC6JAXEu+qKQrKsUSw4CQANkZmbm5OSEh4c3mjt1kIAGAAAAAIC7kSAIGo1GEAS1Wo0lBwGgIQpdfJN91X75yX4FKbaOBQAcmCiKycnJOp0uOjracZccrAoJaAAAAAAAuOvodDqNRqNSqSIiIjB7OwA0RJZHSLZnaFjWFTdtrq1jAQAHZjQaNRoNz/NqtZrneVuHY0lIQAMAAAAAwN2lqKgoOTnZx8fH39/f1rEAgANjlEvxi9EqXKPTzigNWluHAwAOTKvVajQad3f3oKCgxrF8XXlIQAMAAAAAwF0kKysrKysrNDTU3d3d1rEAgAMz8gpNQBxHWHTqaZlosnU4AODA8vLy0tLSAgMDvb29bR2LVSABDQAAAAAAdwXGWEpKSklJCZYcBIAG0ipdNQFx7tq8oJxrlDFbhwMAjooxlpmZmZubGxER4eLiYutwrAUJaAAAAAAAaPxMJlNiYiKlVK1Wy2S4DgKA+itw9UvxiQ7I0/gUptk6FgBwYKIoJiUlGY1GtVqtUChsHY4VYeAFAAAAAACNnE6nS0xMdHV1DQ4ObnzzKgLAnZTpFZbjFhiecdFVV2DrWADAgRkMhsTERIVCER0d3ejXQ0YCGgAAAAAAGrOCgoKUlBQ/Pz8/Pz9bxwIADkxkLDkgTq9wjk47qzSW2jocAHBgxcXFSUlJnp6eQUFBto7lTkACGgAAAAAAGq2srKzs7OywsDA3NzdbxwIADswgCIm5xXJCo1NO8aJg63AAwIHllhrSszXBwcGenp62juUOQQIaAAAAAO4yOam2jqARsePCFAlJNsl1jIuOaapUKm0dDjRGdvz9r8Ah4rz0n60jqInWyV3jH+tRkh146W9M4gN3r9OHbR2BNP0ftnUE1WI8nz5vXsF990V17XpXrYeMBDQAAAAAADQ2RkY1JgVPmVqu55F9BoAGyHMLSPOODMq57lWcaetYAMCBCZ6emqVLBXd39cMPy1Md4adBy2nkU1wDAAAAAMDdRsu4eJNCxYkRMgNv62AAwHExQjK8I9K9wiMyLiD7DAANoYuJid+wQZafH/3II/K0NFuHc6fhDmgAAAAAAGg88gUuVVAE8EYfHpO0AkD9CZwsyT/WxMvVqacVJr2twwEAB1bUs2fye+95//RTwPLlhDFbh2MDSEADAAAAAEBjwBjJFOW5AhchN7hQ0dbhAIADM8hViQFxCqMuOu0sJ5psHQ4AOLCciRMzZs4Mfe01999+s3UsNoMENAAAAAAAODyR0CRBZmScWm5Q0Lvx3iIAsJRilWeSf1PvooyAPM3dea8iAFgEUyhSFiwo6do1ato01fnztg7HlpCABgAAAAAAx2ZgNNEkV1ASJdPz1NbRAIAjy3ULSPeODM655lmcZetYAMCBmby8kj74gMlk6ocekuXk2DocG8MihAAAAAAA4MBKRHrNpHTlWITMgOwzANQbozTFNybTMywq/RyyzwDQELrY2PgNG+QZGZHTpiH7THAHNAAAAAAAOK5cgU8X5MEyoyeHJQcBoP4EXq7xbypQXp12Ro4lBwGgAQoHDEh+802/zz/3W7PG1rHYCySgAQAAAADA8TBC0gV5gcBFyQ0qLDkIAA2gUzhrApqp9EURWRc4hvYEAOqL0qwpU7Iffzzs5Zfd9u+3dTR2BAloAAAAAABwMAKhGqNcIEQtN8ix5CAANECRyivZv6lPYap/XpKtYwEAB8aUypQ33tC2bh09caIyPv7/7N1nfBTV/gbw38xsyWY3yaZsKiFkl95FLohwQVBQUVAErzQLYveKiv1KsXdERP/oFa8ooILSpEgXaQqICoKAUrKb3ttm68yc/4tQAoJismFmNs/34wszWTZPzu45mf3NmXOUjqMuKEADAAAAAICW+BnnEg0RHMsQAjwWfQaABiiOSSu2pjUr/j3aU6Z0FgDQsGBiouvtt3m/3z5mjK68XOk4qoNNCAEAAAAAQDPcTDgqGqN5OV2H6jMA1B/j+Bxby7KYlMz8/ag+A0BDeDp3PrJggenAgRbjx6P6fFZqnQHNCpZPeaF45IzbOwi1X5d/PeWOWXuCJx8gpA1/9Z1bWwskl+1ZNOfzTT87qy0ZXQeMHDe8SyzOQwEAAAAAwlCprCsUdalCwCpgkVYAqD9RZ3AmtuEYc+Tu0UnBv/4HAADnUHn11blTpybNnBk/f77SWdRLlQVo5sv9Zu7SfZ4ep84q5aKCIq71kIk3dDDUHuBMaak8keRc/NKLX0r9xk0YGV+8ed5HL74iTHtpWLqgUHIAAAAAAGgEjChP0rtlbDkIAA3lM5idSW0t3orU0qMcwyLyAFBfHFd0772lo0c3f/BBy44dSqdRNbUVoFnxxjenfvRdblWAUUKd48GiwvLoVpf889JOp9WWA3tXrDjWbPhb91yVLhB1TKg4/Ojylfuvuaez4QLnBgAAAACARiIR5xL1jMihD+gI1SIAqL9Kc3xuQktbRY6tMlfpLACgYXJkZM4rr/jtdvvYscasLKXjqJ3a1oDmrN1uemTqK9OmjmhdtzYuFxcWscSURNlbXlRSHTxxzill7z/gTu52cWptVVpofvFFiVUHfs3HjAgAAAAAuFD822fcNfL9faLSOf6U2kN6nJuee/Sudn36mzr1Sbj8tuFvrNnnOX7S72Pc4YBBR6yFgOozhDcN91M1YlVL3n2u+eMrf5ROHSuOSctLaJle/JvC1efAgVH3PcPdPvW0/+6aP6dGxe0JEELMvevruUPunRA75I6U258d89merIDSkerYTjSSqO5QLBH1IOJO/0/weDImTGg39IafUX0+D2qbAU16azOHlVj576a6KznLxfnFYvHGl2//6FilRLqoFr1HP3Dv4Jb6kqISFm+LO1FG5+NscaykqFimjNpD+/fvz8/PP/U0suz3+zkuHBaJlmWZiCRJ8vv9SmcJN5Ik0Yl3i9JZwk3t+xZt2xjQto0NbdsYGGMUXm0riqotGkAjYqXr33l/zebBt6h5DoTKQwaPfTl89Otr3AmXXnX9iFTxyI4Ni2ZP2fhj4aY5t2TqhBxRnyCIiQL6F4Q57fbTLmq8A5nlfPvZfWtzi1M61C7wLHN8TmJrnz7SnrfXGPQqG04qL8sKckkt2vRP0p86KiRn6sKhWAHwF1jV6ndeGLa8JLnDRaOHxvsO7/r8ozc2H7t/x1OXpKqgBzCid4g2E9UdijmiQUSOE19KsbE13brp8w//8quzUA7YFIipPaorQJ8Vqy4pD5osjiEPPvvPNCrcs+K9mbNfmm17+86AX+RMppO1as5kiuAC/sDJi4YLFy5cuXLlyeeJjo6urq4OjwJ0rWAwGAxiw4RGgbZtPKIoVldXK50iPKFtG48kSWjbRhJObev3+3U6bZxcQShI3tKc/T9tmffWawuK5CSl05yDFkKy6mUz31tbmTLunf99MCCOJyJ5/PqX7ho873+PfzX0zaFJ6bpANK/OihxASGi7n05acc1XN8Sr7TO2VLD17tk/FRJXOzUtKBhcye0EKejI2yvIyl/NkkrKspjh8mtHzO+m/+tHA4QVVvnDwrtXFLX911ObxreJ4YjYtUNenzRi46KZw//xchslt3TzEu0nmke0gOiMoZgneuHE/5ePGJH/2GMpL79UucHZnWgSkf1CJ9UkbXxG4mIHTfl80Imv0nuM+vcNP9+/4Ns9t/U1CqzS62MUwRERMa/Xx/RRpy6/9unTJyHh1FrSy5YtM5lM4VGArp0vptPp9Hr8xQqx2rYVBMFgUOOlfE1jjPl8Pp7njUaj0lnCTbi8b31KBzgnvG8bidfrDae21ev14XGaAeeDlSwY1vmxNcfvGFXbunbHaSIkSb9v/qlaaDvmkX4nbmzkrf3Hj7j48ze+++5As+Fx0dhyEMKadvvpgPHDL/182pbv9vtv6BuhbLwzSAXvzFy8OemSkfE7F/rJFxF1JKVttKcsRS1bDrLykvJyimllU7LWBqAM5l62/LscS/dpI1vH1J41c9FDbrnz3Vb5iUaJSLFOwYiGEa3588fwfNGDD5YNG5Zx//2mH34YR2QnmniBAmqeNgrQZ+IT0lKNwfLqQJwtgTtWWi6TVSAikitKK7j4DvEn/2gPHDhw4MCBJ//d8uXLzWZzeHwyFEWxtgBtNpuVzhJu0LaNR5Ikn8+Htm0MtQvyCIKg8bYtVzrAOWm/bdWIMeb1esOpbQ0GQ+16ONAUcNYrZ6xsVyETK1s14Zb3cpTOc1aaCElBL8VkdOrRznHiU6dIXJZgNnAkix49qs8Q7jTaT4mIi4gwcSQGgirrpeKeJR9PPpL2zKuDpJk7FwZM+UntO1Y446sKlA52EssqqpB0Noe5/NsfXPsqgpFxKQM6NMswhkOlAuAviIe/2e83tO3c33zqDS8kd7p7WCcFQxERRzSDqIKIEU0g+uNQLEVHZ0+bJsbFOUaONOTlLSFaTfQNkabnf11I2ihAe75755G54piXH+xTe31Eyj3iDMR2SLdmJLYzL/t5T/GozGSOSC7Ys7cgqn2HNFxGBAAAAK07Y0VpLO6hOrr4NhfFExEr3Bet2qKBJkKaer+9tPfJr3yMd4pC9cb1e0R9165t1DWtsjE10iLyjDFZlus+OQYT1dFgPyUiIjln3cbv1NdPPb+tun1BQc/bnpqQTi/oOBKsyUUH4wOVSueqS8wqqpZk35PPvJvvlhgREWeIafHkXTc+084ckrdA3S4vSRIL3bxvURQxnkBDyGVFRz1cYor5yJpPxi7esS0vEJPSvFfPAZNHX9opUuERsA0RETGi6D98K5CR4Zw505Cdbb/1Vt7t9hA9RTSc6JILnVEBdbt8QwYTbQwWpk6XdAy+/MHrceK/LkkTSvevmb+0uMOt17TTGeTBg5s/+cXMT1Nv7xtX9M2Hi7MdNzzQEZcfAAAAQNtkWa6oqKh7pO6qYgDhqlIWckXZt/m1+17fXpN2/aThaWpdjyD0zujyobqdovbevrpPjsEEQiGQtfGdf736ver6qff3KW+vdXUaufCalDybyc8TiUUmb6Vyt/WfjVx5pFRiki6z77/WXeVoQdW7f9w6YcGPL8xamjF19O2hWE+7bpf3eDyhur4lSVJVVVXde8oxnsDfxbyeamKV2+cMWim27PmPu3vo8n/9YdHCWet+Ld/0yrWq3NGU3Jdemv3663Fffpk0YwbJMhF9SOQkWkyk2ouGIVR3PJEkSZKk+j2PNgrQnKX7Xc8/bv144byXv6oS4pq17n7n82MvT+WJePuIpx4Pvv/xO08u9kWmdb32ibuHZajqTwsAAADA38dxXNgsjQ1wnookXUHeD8vffOW11UcD6Ve8938Tr1LvdNDQO6PLh2rZQJ7nBUHAeAIhFCjYNeO1N174+pjq+inzrJnzycyqju+9cLmc1o6CR2ODjKietZJGxFmuv3HURYaEfo7YSCKiuH/2HbKcq+o45/DbW4tuvS6p4SWNul1er9fzfGiuEXAcZzAYMJ5AQzBJFhmrKjfe9czz7/a0CkTEbrj57anXrlw6aVOfrwZZVTOgHFc2YkTBY4+lPv+8dcWK2iM1RNOJhhK1UzbZhVK3y3McV+/zE5UWoLnYq5//8uq6R/TJPcc80XPMHx8q2LqPndR97IVKBgAAAND4OI6LiopSOgXABSIT5QR9uz5/9dkZq/YFki4f99z0+67saFHbh9DGdUaXD1UBunaDYownEBqsatfn0+6YtvoXNfZTVvHj4rvXBoY8eWfPLl0s7uKUkiO8GnYc/CPO1L5dq/anH0rr2r6XcHiTs8BNSTEN/gl1u3xERIQghGaaHs/zFosF4wk0BGcwmDjO0PHKyT2sx9+XnGXgyIG9Vs/b/MNvnkE91LMzDNPrcydPru7dO3P8eNO+fSePLyHKJvqgaUx/ptPHE0EQ6n1BS6UFaAAAAAAAaAqCjHMGStY9c+8jS3JtfW5fOvnWoRmqWlEWAIiISCr4cvIDtyzOU2s/ZUVZ2XlSxaIX71v0Yt3jay8ZtlZIHbTt3eE9VXy3NGcyWQVisiyxJlPWgiZJiItLFej3xISEOu9zPi4hTUc73R4Po9Csg95wRotz1tu8xeIYM0ZfcGoLU5noQ6IWRH2Vi6ZRKEADAAAAAIAyPIx3iULh3KeeWFrYYfz0lY/0SFTRarIAcJJ04OPJty8pUm0/ZcQHe153l9FjcZfoJT8REfN8t2HzN4EWt17VNj2mpXpWqhad24Z98mts/xFz+sSeDCUVlxwWuZSkuCiVVN8AGokpo3tzflVOXja7qOWJd7tUVJAlUkxCnEpW9JE5Eq+YpCstbXHffbzPV/dbWUTfEd1HpFcom3ahAA0AAAAAAAool4V8UZ8ibZ0xd4+/472fTFRjVQsAiIj8u9/+eK9q+6nE61yJbYxpXaa3OKgX/cePykWv/7xlk7vl3aOvU9XcZ11ifGxp7qfLN/+r89Bra+ttYsUXy3/4icVN7JGGqhaEOT51+GWZL3y4duqmnnP6J+iJSCpf9un6XbL1tj6t1LC+eHXPlt4fj/JZ25s9vpxnZ67js4EoSDRIkWQahwI0AAAAAABcUIxRkawvk/gMfSAi6+fvS5jB8tMrk5yn17W46O5jpg134BMLgOIk517V9lO/LsKV3M4YqMkoPMAzWbkg583UetKwVuvm/jTi2ZIbe2RmcjV79+9fkSN1unL0f+wY8CDs8W2vHfPwNy+/8srkg1t6DmrGH/tpx+JD7uaX3//sP0xKZ6PSsWMLbko1Xvc6v/+rsz5gA1EEUY8LHCssYHQDAAAAAIALRyYuW9IFGe/QBwwc8+fluiTmPrz9k8NnPJBPFAa+PtyhSEgAqEtUaz91R8Zm21rFVRcmlbvoD3MV1Ypv3e+m7+J2vLh2z9dbti8UdWlpmY+O7/dkr2SrOtYfAGhcka2ff+WptDmLZm3fMv17ik1rOe7e658Z2i5F0fc/Mxhyp06t6dkz896xOvnsg4mfaCtRS6LoCxwuLKAADQAAAABQf1zSzevzblY6xV9QT8gA45yiwcAxuz7AEyMi42VTSw9OVToXgPLU00//SJ39tDQmpTA2I7X4sLWm5Czf5hMfe+P/Hrvgqc6PrkWn3h906q10DABlCDGt73/wqfsfVDrHCaLN5pwxgxNFx0036UpL15/jYUainAuaK6yob/UmAAAAAAAIR26ZPxI0RvNyhu549RkAoB4Yx+faWpbEpGXm7zt79RkA4Pz42rY9Mn9+xO+/Z44frystVTpO2MIMaAAAgL8Ws3iG0hHObdwUpRMAAPy1MkkokPSpuqCVl5TOAgAaJgl6V2IbxvGO3L06KaB0HADQsMpBg3Kfe8723//a/vc/pbOEORSgAQAAAACgETGiAklfKfGZ+oCJ08IWYQCgVj5DpCupnclXnVZyWBtbDgKAOnFc8bhxJXfemf7EE1Hffqt0mvCHAjQAwN/T9ln1rvu082GD0hEAAABOIxHnCuolIoc+oOew7AYA1F91ZGyOrXV8VV5iebbSWQBAw2STKeell3ytW9vHjDEePap0nCYBBWgAAAAAAGgUPsa5RIOJkzOEIK/o7vYAoHXFMWnF1rRmxb9He8qUzgIAGhZMSnK9/bZQWekYNUqoqlI6TlOBTQgBAAAAACD0qmX+mGiM4eV0HarPAFB/jONzbK3Ko5Mc+ftQfQaAhvB06XJkwQLTr79m3Hcfqs8XEmZAAwAAAABAiJXKukJRaKYLRmPLQQBoAFFncCa25Zhsz/tFJwWVjgMAGlYxeHDe1KlJb70V/9lnSmdpclCABgAAAACAkGFEuaK+htVuOYhFnwGg/nxGizOxjcVTkVp2lGMYTwCgnhjPFz34YNkNN2RMmGDesUPpOE0RCtAAAAAAABAaInHOoJ4jcugCOlSfAaABKs0JuQkOW0WOrTJX6SwAoGGy2Zz98ssBu90+dqzR6VQ6ThOFAjQAAAAAAISAj/FOUW/mWZoQ5AjVZwCov6LY9NLolOZFBy3eSqWzAICGBdLTnTNnGvLz7SNHCm630nGaLmxCCAAAAAAADVUp80eD+jhebCYEUH0GgHqTecGV1LbCnGDP+wXVZwBoiJpu3Y7On2/5/vuM++9H9VlZmAENABA+ohe9pXSEcxs3RekEAADQWIoloUTWp+uCUdhyEAAaICgYXMntBCnoyNsryBhPAKD+ykaMKHjssZSXXopdtkzpLIACNAAAAAAA1BcjLlfSe2TOrgsYOVnpOACgYZ6IaFdim2hPWUrJUdxIAQD1xgSh4LHHKgYPzrjvPvPu3UrHASIUoAEAAAAAoH6CkuwK6nmOs+v8Ok7pNACgZeVRSflxLVLKjsVWFymdBQA0TOKF7PffF63WliNH6vPylI4Dx2ENaAAAAAAA+Ns8AfFISZWJZy1QfQaABmCMCiV9QWzzjMKDqD4DQEP4BcPR+JZ8ZaV97FhUn1UFM6ABAAAAoIl5+QGlE5yHXT8rneDPVHbvmzv6/qSv5sYf+UHpLOdh3jalEwAo6r8vK53gnGS9Mbvv8KDF6vh5rcFbrXQcAPhTnXsrneDPuANSdpU3zmRIammmz6crHQdOgwI0AAAAAACcN44rGjyytN81Ge+/aD60l9KTlQ4EAFoViI5zDhhtcFfYv/6Qt1qVjgMAGlbqDRS6A6lRRmuEnhgWkVedplWAZoz5fD6OC4dbBGVZJiJJknw+n9JZwg3atvGgbZsyvOiNR+ttK8uy1n+Fk0RRVDoCQOOSjRE5tz3iT25mn/aEsTBX6TgAoGHuVEf2ZTdaj+xJ2bka1SIAqDdGlFftcwekTKvJpBeUjgNn17QK0EQkSVI4FaAZY5IkKZ0l3KBtGw9jjNC2TRVe9Maj9bYNpzFBluXwOM0AOKtAQpLz7kn6ihL7q48IPo/ScQBAw8paX1zwj6tSd6y0Hlb1ckMAoHISY65KL2PkiI3U8TgPV6+mVYDmOM5sNofHJ0NRFP1+v06nM5vNSmcJN2hPGvHzAAAgAElEQVTbxlM791n7bVuudABNOr8XHW1bH9rtUIwxr9crCIJ2f4UzGAyG2quYAOHH42jvuvPJmN1bkr/8kGN4nwNAPTGOL+h5dWXzdplrPzYV5ygdBwA0zCfKrkqvScenxUTwYVHrC2NNqwANAAAAAAB/V1nvQQXDx6csfD/2+41KZwEADZOMka7L/iUZIxwrP9DXVCodBwA0rNov5lT74k2GRLNB6Szw11CABgAAAACAs2McX3TdzWW9rsiY9bz5931KxwEADfNZE11XjDGV5Gasn89LQaXjAICGFdf4iz2BZtGmaCMKm9qA1wkAAAAAAM5CMkdlj39MtMS0fPURfVmR0nEAQMOq01rl9BsR99sPSbvXY8tBAKg3RpRb5fMEJUec2SjwSseB84UCNAAAAAAAnCmQmOq852ljnsv+3kt8wKd0HADQsNL2lxR27d9s27Jo569KZwEADRNl5qzwchzZseWg1qAADQAAAAAAp3G375Y97pG4bWuTvppL2FoTAOqLCbrcXkNqUu2Zaz42leYpHQcANMwnys4Kj8WgS42OQO1Zc1CABgAAAACAU2q3HEz9fJZ15yalswCAhokRkdkDRjHiHMvf13ndSscBAA2r9Iu5VV5bpMFmNiqdBeoDBWgAAAAAACAiYjpd3sh7q9tdlDljksn5u9JxAEDDfHHJzgGjzMXZaVuXcpKodBwA0LCimkCpJ9A8xmQxoIypVXjlAAAAAACAJHOU684npYhIxxuP68tLlI4DABpW1aJDTu/rbHs22/ZtVToLAGiYzFhOlc8nSvbYSKMOWw5qGArQAAAAAABNnS81w3XvJNOx3zLefZYPBpSOAwCaxXHFHXqXdOmbvnlRVPYhpdMAgIYFJdlV5RM4csSaBWw5qHEoQAMAAAAANGnVHS7Ouf3R+I1fJa76nBhTOg4AaBUTdLl9rvckpNlXfmCsKFY6DgBomCcouSq90UZ9isXAcag+ax4K0AAAAAAATRXHFV8xrPjKG5t98lb0nh1KpwEADQtGRrkGjOZl0b7yA53Po3QcANCwcl8wv9qfbDHGmfRKZ4HQQAEaAAAAAODvkcoO9fp4/y75LN8SYltvu61jT9WsUlhV437ZWbmgIpDP+HSL6bb0uEfidLX7xzOdPnfM/TWtOmXOeNqUfVTZnO7Kkpd/KVhR4jka4NNjLFc40qY4ohIw4QmaFv/2GQ+8HTFh3t0d1fZB/S8HvU5JzVwDRkVnH0r5fgUnn+1xFwzz7/rhh+e2H91aEoiIiRvQ7eIX+zZvobYGJe3kBGgEnqNr33hj9mdbD2SVB83JbfpdN/7Zh4d0NHNExBgr8gTLPIEMq8msF5RKKOWs6fXg0l3SWb4lpA7cNvOGnopF06pQDG+ya+vCLc6zvSpnEtJ7j+iLIRUAAAAANI0zRA9q08xxxmIVsm/nkdJCi8mmmrKpu6p80L7yXWS42hZzEy9uL62ZtN+3r23qPJtOtsY773ySkyTHqxN11ZXK5gxU5A1Zl7WZmQY1T7zGKB/ML5m1o2JTVfut3aKjlU0GcAGx0vXvvL9m8+BbFC3fnt2fD3oRjk5Zlw5J+nFj/IHvlcl3EvOuXrZs2Pfu5Izmo3tF+fKOfr521eaCgTtGOVJVMzITaScnQCMIHp43fOiUNdVJlw4dOSJNPLLt60XvPLRxZ96mL+/ppKfsSl9QZo64SIOg5MV8LjJlUJ/ujjOGY7ly587DhXGxNtXMM9CQUBSDgzvfHjf2C995/LC2T24f0bdFCH4kAAAAAIBieEvKC4NTTj/GsvZu754VN2lApl0l5QMWmHmkYheZ3uya/GAkR0Ryc+/jvxS8daxibKcejvv/YznwU+rC9zlRVDqotOrX3M3ByEcHdXo1QSAi6pIyfcPeR37Lnt+2w72RSqcDaHSStzRn/09b5r312oIiOUnpNGf1J4PeQ/eOM1zSK33jZ5b8Y8qEq6Pyt51376hq23fIpqtTYjgi1nXIF1+O+GnnzL6ZLzdTUcVIKzkBQo9VLXt92trKZuM+WvzBoASeiOQH1k++afCH7/zny2HTr7QYdbw9NlLxHQf5uM4vPNz59GMsa+273X/MnHTnP9VypqcpoShAG2/45Md3q/tO+NYy4M4Hbrvq4hZRYnHW3k3z3/nvt7phb8566B8xx18ZPqZFJ0x/BgAAAICwI1e7Htpaau/Rb2KCWmoHktezxM2apVjviTxxNq43PZ0e+cHBwOxLp7y/+SvbusXKJjyOBQ5ViRQRPyjuxO2sfMRVqaYnin0H3Iwi8SEPwhwrWTCs82NrArVfqWUA+UtytevBraXNRr48ul9X+8rZxqpSpRMRMd+y73/Picic1j/leBGCMw254rJ30yoTdbKK2lYrOQEag3hg864qocMdj1x+4oSJjxtw/5ieHz+7ZeNOw9BBGRajsgHPRS7d8dC8w/YbHp2YgcpmfYSk1WrWv/b8BvPYL77/33VJx98/fS6/bvSYAXdeMuK1JeP3zeyPiQsAAAAAEL4Cy7b8ujrS/k23GIPSUU6SAmIu4xwm/antezjO179z0m+7Dn/6UlzEbwpmOw1naBUlULl7exW73MoREbHgjmKfxJtbm1F9hvDHWa+csbJdhUysbNWEW97LUTrP+Qks+v7A6qThn93gaLPiv0LgPG6IvgCkwm+yREPz9P4Rp44Jcel3905XLtPZaCUnQGMQPRSb2alXZ0edNZTLmZ44kmRKVGv1mZh72SfLVsf0/WZoM/Wc6WlLKArQgR++XlfafOTdg5NOu1LHJ159978y5326eOeb/S/DrpUAAAAAf0cwGKz7pV6P0yn18uQeeuo3Nvya1peo6VXiBT6GY3l+USSdgUg2RuTc+nC564sKWWSun6XWkarZPkcY2tV+S9nhFzbuO2yP62qUD+UVzS3ir+7W4naz0tEuoDO6PGPsXI/8WxhjsizXfXIMJqqji29zUTwRscJ90Rq55lLizX/igOmaCZdcv3U+H6L3asPJ1VVH/ZQYZzzyw9axW49sKxVj4hN6tWk/+fJWndRU1LoAOet2eUmSQjieBINBjCfQIKb+b2/of/IrxlhBje/Q8tV7Rf1FPTpH/Mk/VJTn4JqntsnDHxl0iZoGkwujbpdnjNV7PAlFAZrVuGsYO8tGt0yWZbmqskqFeygAAAAAqJgsy5WVp+0Ll5CQoFQY+Aus5sNtx5y2NotbGlRVO9KZTQOMFbMKKz9NNY5JTnDd/bRQtm/lGxtKGEVKqqkYERGRLjLmLnv0qj0Vn+yv/oSIiKLiU/+dHtmkbqM8o8uHqmAkiqLf76/75BhMoIHKW9mnz16dl9p7BduiqtUimD9QTVT569ZBO6SW7TLvbiPku44t2rxhnatm0x1du6jmpvkLkLNul/d4PGKI1vqXZbm6uprnT73sGE+gISTGXBWVrg1vPvbGNk/6yEkjm6tqSDmFFX84f4sz8+rFPS2qOtO7MOqOJ5IkyWcp/56XUIxt+nZd2vPzF8/++qlLh9bZ85uVrJ395VGu5a0tVTPQAwAAAGgCx3Emk0npFHBearJ/n57LDx2c2U5tH0p405MtLMsOue/8pWxhRp9W01/cv233LhKSOMnDqSqrtHXPr1f96u/cutWydrEdDfLvBYVP/pAzdJ34+aCWNzSZfnBGl+dC9BoJgqDT6TCeQEgwjiu6+Irc8g2f/ihfN9iotkGPybLIWFW17q5bhr/bNlIgItb95qWLr92xe9LPrb/qrpYV5S9Azrpd3mAw1C0ZNwTP8xERERhPICR8onTkt02fTnv5nVVHAhnXvPfJlKusKumjZ6r5ZcP0A7qhD/dpp9ICeeOq2+V5nq/3eBKK2jBvv+Xx0TNGfDz6n5UTH7994EWOBCo9umf9R69NW+y0XjPp5raqubsPAAAAQBM4jjObm9LqAxrmX/JTdrYl/QOHuqY/12qWaFvZrtXTR4u3L/l0E/HdEuI2prIJP5U6dSqqQMue4ucO1RjSWi3pbksiIqKL0tO/1AU7fVM4+bfkoV0sTWQ2yxldPlQFaJ7n9Xo9xhNoOMlgyu7/L9EY3PvsVzmWZrPVN+hxep2JI0OLTpPbnFhiiIsYeFnHXru2bf6twNPdrpJucAFy1u3yRqNREEJTlOE4LjIyEuMJNFy1r3T17GeeeWvlgUDK5fe8NX3i0I5RahtRTmDVS1buzI77xwc9mujGFHW7PM/z9T4/CcnpHJdw3btff6i7+eE5L4xf8vzJoxEtBr84d844tU6hBwAAAABoGLkq58MssUXX5n3VVyVlHF903c36Swd+PvtVc8wvtQcDFSUuxmWa9OrJK1Z59klcx6RoW52DUbaYHkLBV+WeKrLEKRYNAI4LRMc7Lx9tqC5rseDlOw8H1TnoCVGWVJ773RqVUKc8wkdFpQm00+f3MFJJ9UgrOQEaSak7a+6j4/6zNNfW/99LX7p3aKaq59TLJbs//MnfYnDPvth8sGFC9Ucjsv0tH/wwfNL36zbsPJhbKRrjW3TuM3BAlyS8PgAAAAAQrljW7znfSZH3tbSqbRsmOcKUfettW392VT983y36qhOH2S8VvgJOf0uMoJ45IpxOsBCVB0SZjCdTsWCwXCaDTmh6m/0AqI471ZF92Y1xv+1O2r3u6K9Z6hz0iIgM8d0TuVUl5dkso+WJGq5UUZklcTExFhVt8KiVnAChxohyq9x7/ztxyrKiDvf9b+WkPonqOR05O5b1/e7vxPj7ejZX46CnKaG8asmZM3pdf3uvED4jAAAAAIB6+TdkVQRN6YOS1PX5KZCQ7LxnkqHsYPmH7z5YZaRuKfdEEBEFve5n8gPG6Pjb1DS/Th9rHRSZ996R3C8drUbWBmPipl8LtjDdVWnRTWofQgAVKmt9ccE/rkr9frn1yF4inzoHveP42OFdbC+s3jd1r2NOlyg9Eck1yzbu38Uib+uQpKKrWVrJCRBSosyyq7zMt2PZvD3+Lo988h/1V5+JWPWG3c5gdI9BDvXd9KE1oWtB5j644sNPvv7xaJHU64mP7o/9bl1Nuyu62Op5iYAVLJ/yQvHIGbd3OLFWkVy2Z9Gczzf97Ky2ZHQdMHLc8C6x3J8dBwAAAABoVIHSDflyRLOEHmr6VFLjaJ9911MxP2xOWfThLelR7/1S+dCevO9sEUliYG2pdx+Z3moV3UpV58tCzNMX29ZsLRq7yvt5hrWzQf6tsHRJSTA2LfPVDL2qkgI0KYwX8noNqU5zZK6ZYyrJJVLpoFcH1/aSSx/+efkrny86+ItjUAJ37PCRxTm+5hdd8WwbVd2crZWcACHjE2VnhSdSLySX7dtZIhuidr7yyNHT689c9CV3TBvVRl2ji/fwht/FiPYte2D+c4OF6JUVj82/bdCdnx72MiIuNuI2OXD07RtGrW5x8/vLPxjT8u8OocyX+83cpfs8PeSThyTn4pde/FLqN27CyPjizfM+evEVYdpLw9KFcx0Pza8FAAAAAHAu/oLirQFqmRgTrXSSk8p6DyoYPj514fvW7zcSUXRM/MbO+slZVasKKis43UWx1qUtrNdGqK6om5Lu2HaF5cX9hUud+atEzhZlufmilpPbWjPUPzcKIExJxkhX/5skvdGxcra+prL2oAoHvTMZk5+/Y0ja2l2z9h+afoBi45PGXXvxM5empqht2NNKToBQqPKLOVVeW6TBZjb6d2a7ROb+bdMnv53xKD5RGPL6qDaKJDwX/+FDWz1cS0c61sZpuJAUoOWj742/5/PyiyYuePd+z/MdJhKR6crJH9zn+vesu2/r3P3bR9qcd0GYFW98c+pH3+VWBRglnDoc2LtixbFmw9+656p0gahjQsXhR5ev3H/NPW33n/14Z1w2BAAAAIDGZWzeNWdiV6VTHMd4vmD4HZUX9cqcOcV07NDJ44nR0e93Vm+x6AQu0ZY847LkGUrnAFAQl3Tz+ryblU5BROSLTXJdPtpUnJOxbi4viSePq2rQOxfBnHz/sCH3D1M6x1/RSk6ABiqu8Rd7AukxpiiDjoiMA98oLXhD6VDny9h5VM6SUUqnCBOhmFQg7Z/34VbW79n5r/2ra6qlttbMWbuMfXvRawP5nZ98tk/8iyeog7N2u+mRqa9MmzqidZ3auJS9/4A7udvFqbVPLjS/+KLEqgO/5gfPcVw+21MDAAAAAIQlyRyV9e9na1q2d7zxRN3qMwDA31XdrNWxweOth39O3/xl3eozAMDfwohyqnzlPtERZ66tPkNTFop3gHjk0BFqdUO/9DOq2Xzqpb1b0huHsyTqct4/R29t5rASK//dVGd+u1xSVMLibXEnfgAfZ4tjJUXF4jmOy3T8dr0ffvjB5XKdfB7GmM/n47hwmDovyzIRSZLk8/mUzhJu0LaNB23blOFFbzxab1tZlrX+K5wkivigDgrwJ6a67plkzM3KeO8FPuBXOg4AaFhp+0sKu/ZvtmVxtOug0lkAQMOCkuyq8vEcZ4+N1PHhUIWDBgpFAZqLsUZTWVGJRHT6UhvBwvxiZomyNPidJgX8ImcynaxJcyZTBBfwB8RzHGcn/uHy5ctXrlx58nmio6Pdbnd4FKBrBYPBYDCodIrwJIqi2+1WOkV4kiQJbdsE4UVvPFpv23AaE/x+v06H+R1wQbnbd8u+/dG4rWuSvppLMu4DBIB6YoIut9eQmlR75uo5prJ8peMAgIZ5gpKr0htt1KdYjGFUgYMGCcVnJEO3gf2t73/66uwJve5rfuqwd9+sVz7Pjx44oFuDN4sUDEaBVXp9jGq3TGFer4/powznOn7yHw4cONBut5/8cu7cuWazOTwK0LIse71evV5vMGDB6xCrbVudTmc0GpXOEm5q21YQhIiICKWzNESYTNW8wMxm83k8Cm1bH+fXtipVU1Oj/THhFIPBEB6nGaAVpf2HFA4dmzr/XesPm5XOAgAaJkZGO/vfxDHZsfx9nTdMrgoDgCIq/WJulTfJbIyPRLUKTgnJJJ2Yayc/N3DN/RN6XbLxpsxDoj9q1TsvrNk0/5NVv+n6TZtyfWyDP4jx8bYE7lhpuUxWgYhIriit4OI7xOvOcfzkWiB9+vTp06fPyeeZP3++yWQKj0+GoijWFvJMJpPSWcIN2rbxSJKEtm2y8KI3Hu22LWOspqaG53nt/gpn0Ov1MqagwgXBdPq8Ufe523XNnP60yXVY6TgAoGG+uBTn5aMsuYdTv1/JyZLScQBAw4pqAqWeQPMYkwWLPsPpQrEJIZGu9T1ffvPJA10rV7+3dF/Q892sR6fM+jbYc8JHm5Y92KHB85+JhOYd2pnzf95TXLu2hlywZ29BVPsOaYZzHBf+7MkAAAAAADRMskRn/fsZf3Ka45WJqD4DQENUtuhw9OpxcQd2pm3/CtVnAKg3mTFXpbfCF7DHRqL6DH8UiveE5Kmo9AktR09fP/rl4iMHjxZ5hegUR5sWsSEoPR9n6Dx4cPMnv5j5aertfeOKvvlwcbbjhgc6Gkg4x3EAAAAAgHDkS2vhvOfpyKMH0+bN5IMBpeMAgGZxXHGH3iVd+qZvXhSVfUjpNACgYQFJdlZ49QLniDUL2HIQziYUBWjvirsybi588bdvJmRE2Fp2tbUMwXOeSWcf8dTjwfc/fufJxb7ItK7XPnH3sAzhT44DAAAAAISbqosuzbn5wYQNSxNXfqZ0FgDQMFmnz/nnDb7YZPvKD4wVxUrHAQANq7PlIHZDgXMKRQE6sufll5omfber8oGMhi/3XIuLvfr5L68+7ZBg6z52Uvexf3jouY4DAAAAAIQNjiu+YljxlTc2mzMteu9OpdMAgIYFI6Ndl48S/F7Hiv8KAa/ScQBAw8p9wfxqf4rFGGsK3SoIEI5CsQY0n3HH/+aOOfbcra+tPVKFRaMAAAAAAEKJ6Q05tzxU3ucqx5tPoPoMAA3hSUw/MuRuU2l+xvp5qD4DQL0xxgprAgXV/owYE6rP8JdCMQM6+O0Lt7+5h/f9/J+rWj0dEZMQa9HXqWtHXPvevlnXGEPwcwAAAAAAmhrRGu+86ylODNrfeExXXal0HADQsIrMTnmXDk3avS7+IC5lAUD9STLLrvKJsuyIizQIoZjbCuEuJBtT6iIsFouhTZ/Bbc7yTUMLK96KAAAAAAB/ny/d7rz7acuvu1MXvM9JuNcQAOqJcVzRxVeUteqWsfFTc/4xpeMAgIYFJNlZ6TUIvD3WjB0H4TyFogCt7/3EouVPhOCJAAAAAADguMqL++SO/rdt9ULbusVKZwEADZP1xuy+w4NRsY7l7xvcFUrHAQANcwek7CpvnMmQZDYonQW0pP4F6Fts1h/Hf/3TK71OLPQi+T1+WRdhMmDCMwD8mehFbykd4dzGTVE6AQAAABHHFV0zqrTfNc3/+7Ll0B6l0wCAhgUk2XnNnYaaisyVs4WgX+k4AKBhZd5AgTuQGmW0RmDRZ/h76l8s9rndHn+d2wD9S26Oj+7wxPZgCFIBAAAAADRRst7g6j+yontf+7QnUX0GgIaoCQSPllRZ8o9krJ+P6jMA1BtjLC8vr6gmkBlrQvUZ6iEka0ADAAAAABCV5imd4PwMv03pBOcU5HSuyCRBlhx9Lxeqq5WOcx4e6ap0AgDlqHvQK5OEAkmfqgtad3ytdJbzYEtWOsH5wR2T0PRIkuRyuSRJchzbqRe1cCmr06VKJ4AzYbkMAAAAAABV8AgRR8ypJsmf4S3QRvUZAFSJEeVL+iJZn6ELWHnsXwoA9efz+Y4cOaLT6ex2uzaqz6BKmAENAAAAAKC8cn1UvjEuxV8WG0TpGQDqTyIuW9SLjBx6v56Y0nEAQMOqq6tzcnLi4+MTExOVzgLahgI0AAAAAICSGFGRMa5Mb8nwFpoln9JxAEDD/IxziQYjyXZdEPc7A0BDlJaWFhYWNmvWLDo6WuksoHkoQAMAAAAAKEbm+OwIW5DXOWryDExUOg4AaJibCdlBfZwgJQlBpbMAgIYxxnJzc2tqajIzM00mk9JxIBw0pADNKnd/Pn3aDqH2K3Hvb9LpR47/hDZD/n1ta+FsTwCgYlFfTlc6wrlh4wsAAICwEOD1TlOSQRbtnnyeyUrHAQANK5V1haIuVRfEos8A0BCiKDqdTo7jHA6HTod5qxAaDXknyWVb3n1iy+nH/ngk4saMe1CABgAAAAA4jVswZZsS44LVSf5ywjqtAFBfjChP0rtlPlMfMHG4lAUA9efz+ZxOp8ViSU1N5ThO6TgQPupfgH5yyYpbz+fCqpBysb7ePwQAAAAAIAyV6aMKjHGp/lJr0K10FgDQMIk4l6hnxDn0AR0uZQFAA1RWVubm5tpsNpvNpnQWCDf1L0B3u+qaEOYAAAAAAGgKGFFBRHylEJnpLTBJfqXjAICG+RjnEg0mTk4TAthyEAAaori4uKSkJD09PSoqSuksEIawmAsAAAAAwAUicYIrwiZxgsObr5ex5SAA1F+1zOdIhnheTBQwmABA/cmynJOT4/P57Ha70WhUOg6EJxSgAQAAAAAuBB+vd0UmmyR/hqeQx53yANAAxZJQLOma6QLRPBZ9BoD6CwaDLpdLEASHwyEI2MANGgsK0AAAAOGv7bM5Skc4px0PYbMIaBKqBVPO8S0Hy5TOAgAaxojLFXUexjv0QSO2HASABvB4PC6XKzo6OiUlBVsOQqNCARoAAAAAoHGVGmIKDdZmvuJo0aN0FgDQMJE4Z1DPEdl1fh2KRQDQABUVFXl5eUlJSfHx8UpngfCHAjQAAAAAQGNhHJdrjK/RRWZ68k1yQOk4AKBhPsY7Rb2Fk1J1IorPAFBvjLGioqKysrKMjAyz2ax0HGgSUIAGAAAAAGgUIq9zRtg4IkdNro5JSscBAA2rlIVcUWcTRJuAwQQA6k+W5ezs7EAggC0H4UJCARoAAAAAIPR8gsEZkWSW/Wm+Yo5hy0EAqL8iSVcqCc11QQu2HASABggEAk6n02Aw2O12bDkIFxIK0ADhSc0bjh1srnQCAADQBv/2GQ+8HTFh3t0dVXnOKuXsXDb5kw1rDhWWiobkjLZDrx/5zNDW8TwRUaXOnBuRYAtU2AKVSuXbTvQ20bw/nPEzoo+I5hLtJkomupPoISIFNwOVyg71+nj/rrNV1YTY1ttu69iTv+CZAC4sj3PTGzM//ez737Mqg+bElv2uHvXsfYM6RnJEJBPliAafTHZ9wMgpdilLM/00cGDUQws+953eULrWH00ffZsZy5ZAU1dTU5OdnR0TE5OSkqJUBilnTa8Hl+46240cQurAbTNv6KmiqriYs3Xu5FlfrdmXWyoak+1dho6++5mbOsWrZLjTGlWezDcaxpjX6w2PnT1lWSYiSZK8Xq/SWcJNbduqGV70xoO2bTxo28aj9baVZVnrv8JJwWAwPE4zVIKVrn/n/TWbB9+iyj/MrPS79/s/scYV03r4tcNa6St3b/n2/15/elvRi1vval1jiCkxWtO9xVHKbTnIiN4h2kz0x9Z7gegZoh5EDxDtIHqS6BjRu0RKvXc5Q/SgNs0cZxTWZN/OI6WFFpMNXQrCXfDYl8NHv77GnXDpVdePSBWP7NiwaPaUjT8WbppzS3s955IMAjGHPiAo2he00k+l8rKsIJfUok3/pDqX1YTkTOzYCE1eWVlZQUFBSkpKbGysgjG4yJRBfbo7zjg7kSt37jxcGBdrU1Ftl5V++3L/uxa54joNv/HWVoay3eu//r/Jd2zLn711YqdIpcNpUdMqQAMAAACA6kne0pz9P22Z99ZrC4rkJKXTnJ1cMGfOhqPRl8z58ImbE3kionEDHrvjqWlfLP7fbdMGmY32mnyjQlsOeon2E80jWkD0x9ZzEr1G1I9oNZGBSCa6mWg20XiiixUIS0TEW1JeGHzGVCyWtXd796y4SQMy7agaQXhj1ctmvre2MmXcO//7YEAcT0Ty+PUv3TV43v+eWjFk2pDkGF5OEYKK9wOt9FOppCyLGS6/dsT8bkN6D1gAACAASURBVAre1wGgLoyxgoKCiooKNWw5yMd1fuHhzqcfY1lr3+3+Y+akO/+pnsGEpOw573x11DpgzpI3bk7miYj+PeSxYeOnffzR0tunjbaqJ6hmNK0CNMdxJpMpPKYmiaLo9XoFQTCZTEpnCTe1bat0ij+DF73xoG0bD9q28Wi9bXme1/qvcJJer1f/bTTqx0oWDOv82JrjxVsVzYQ5jefQlt/EqH79hyeeSGhqdW1P2/QvCg7k8fcY83RMmXcCIxpGtObcD1hG5CF6hMhAREQ80aNEC4kWKFeA/iO52vXQ1lJ7j34TE9T6BgAIFen3zT9VC23HPNIv7vjbnbcOGD+8x+fTtm47GHt9QjKv0i0HVdlPWXlJeTnFtLKp6B5+AGVJkpSdnS2KYsuWLfV6NV6YkUt3PDTvsP2GRydmqKlE6flly6/BqEHXDk8+McRFdry+b/L0j4/tz5HJikHmb1PTqwsAAAAATR5nvXLGynYVMrGyVRNueU+lexoIjrsefWBkRpuIEwc8gvBbQGR8VEtDoU65HQc5ohlEFUSMaALRH1tvJ5GB6JI6R9oTxRPtJpLVUu8PLNvy6+pI+zfdYgxKRwFodEEvxWR06tHOcaKawRgV6c0cR7LojVZr9Vmt/ZRlFVVIOpvDXP7tD659FcHIuJQBHZplGMNhChpAPfj9fpfLZTQa7XY7z6vjj/wZmHvZJ8tWx/T9ZmgzNQ0mREK7u557ZqS9c8SpQ1J1jY/xNlsMhpT6QAEaAAAAQHUYYz6fr+6RiIiIcz043Oji21wUT0SscF+0as/wTemDr0knIiLmq6l2ums271rx5qry1MtuvylZ4WhtamMRRf/hWzJRFlE8UVSdgzqidCIXkaSOArQn99BTv7Hh17S+RI3ztBrRGV2esdBcx5BlWRTFuk/ehAYTTTD1fntp75NfycRlS7xr3YZfRH3Xrq1V+1KptZ+KWUXVkux78pl3890SIyLiDDEtnrzrxmfaNa0tCOt2+WAwGKrbsxhjfr8f44lWuN3u7OzsuLi4pCSVrmdGRJ6Da57aJg9/ZNAlRqWjnCHSPni4nYiIZJ+7qqys4Jdv5z36VXnqVU/8K00Np0sXTt0uL8tyvc9PUIAGAAAAUB3GmNvtrnsEn/FUSs55/sEHX/pVJOJiu4xe9UTvVBV/KmFENUSW0wvNHJGFKIdIuXnbdbCaD7cdc9raLG5paFLVIiI6o8uHqgAtSVIwGKz75BhMVCvAOKdIRZvefOSN7TVp108artYih2r7qVx5pFRiki6z77/WXeVoQdW7f9w6YcGPL8xamjF19O3x6grbqOp2eZ/PJ0mhmUovy3JNTY1Od6qOhPFEtWq3HExNTbVarUpnOTdW/OH8Lc7Mqxf3tKi3f0pZ08fe+J9fRCI+tvu9q14cqOYzvcZQdzyRZbneF7RQgAYAAABQHY7jLBaL0ingL8gcnxPZvt/EV9pkHXH9un32is+ufUxY9caIHipe1ZwRnfUznkoWL6/J/n16Lj90cGY79X4SbSxndPlQ7VsjCIJer8d4on5umT+a+9MXb7789uqjgfQr3vu/iVep9R4Q9fZTznL9jaMuMiT0c8RGEhHF/bPvkOVcVcc5h9/eWnTrdUlNZ9HWul0+IiJCEELzq/M8bzabMZ6oHGMsLy/P7XZnZmaqfJ+Vml82TD+gG/pwn3ZqLunySTc88VqL3KIje7+Z/eWsa+8UVs0e3yNS6VQXUN0uz/N8vddyQQEaAAAAQHU4jsOsIpUL8DpnRJKeiZe3byu0b02DrxydObXL9IWT1/b/+rp4dX6Sqp3sXHb6ZGdG5CaynKMwfWH5l/yUnW1J/8ChsmmVF8QZXT5UBWie53U6HcYTlSsTa9Z/Nu25GSt/DSRdPu656fdd2VG90wFV3E85U/t2rdqffiita/tewuFNzgI3JcUolOvCq9vl9Xp9qBb/5TjOaDRiPFEzSZJcLhdjzOFw1J2rrkasesnKndlx//igh7pXyOHMbXpd3oaIRtw0utU9XZ77YPJXQ74emajOM73GULfL8zxf7/OTptNiAAAAAAChUZF/4K0Ne/bnejK8hcLx2cN8Rs9uHfnAwaP5qt01jCdqTlRMVFXnoESUS9ScSPG5gXJVzodZYovWzfuq+yMzQAgxovxA6dxJ4257cU1119uXLl+47vGrVFx91l4/5Uwmq0BMliVVLDME0Ih8Pt+RI0d0Ol2LFi3UXn0mkkt2f/iTv0Xvnn3VtfngcQHXjnlLVm3Jq3uHGJ/Rt3dH3n/wkEu1Z3pqhgI0AAAAAMDfUKaPchbveH3y5DfXHTptKnGNp5pxJqP6ZgXWcQlRgGhLnSO/E5UQdVf+gwHL+j3nOylySEurunY1A2g0EnFZQWHvx09NXlbYYfz0Xf+9e2iGyueWqrqfis5tQ57/4Jat5XUrRlJxyWGRS0mKi1Lz0AzQYNXV1ceOHbNarenp6aGa896YWNb3u78T44f0bK7CwYSIKGv1xMenPL22oO54wtzuasaZTBEYTupB/W9KAAAAAABVYESFxrhCY6zD3vYys7Rj+eqd3hPfkyu+XvTtQRZ7WfcMNU86GkpkIvo/oiARETGiWUREdJOSoWr5N2RVBE22QUn4hAJNgo9xR4IGXWDXknl7/B3HfTKxhxbu6FZ1P9UlxseW5n66fPOqqhMXB8WKL5b/8BOLu7FHmkqLXAChUFxcnJ2dnZaWlpiYqHSW88OqN+x2BqNbD3Ko9KRJ37lnvyhpx8IvdnpOHJJKv5676iAlXHZpS5WGVjc0GgAAAADAX5M4PtuUKHJCS0+e3nLx1Fvbr/u/RVff4Rz5z9YprPyXXduWHnI3u2Li092NSif9My2IHiV6nuhaomuIdhPNI7qT6GKlg1GgdEO+HNEsoQc+oEATUC3zOZIhjpcScn/cUcIMlp9emeQ8vabLRXcfM224ymozKu+nptaThrVaN/enEc+W3NgjM5Or2bt//4ocqdOVo/9jV2digIZijOXm5no8HofDYTSq+gzkNN7DG34XI9q37KHWS0OcdcDUey9a99qcq4cdHjmwUwor+WXbuqX7qppd++LTl6r8VhWVwigMAAAAAPAXArzeaUoySgG7r5AnRqTvOGrqVtvC577YtnjRngrRkJzR9q6Hh08a1iFFjfMCTzOFyEY0k+hxojSiF4geVcEOhP6C4q0BapkYE610EoDGVirrCkWhmS4YzUv+vFyXxNyHt39y+IxH8YnCwNeHOxRJeC6q76d86343fRe348W1e77esn2hqEtLy3x0fL8neyVbFR/jABqBKIpOp5PjOLvdrv5Fn+vyHz601cO1dKRHq7dvGjre8c7W5A+e+3j94rk7KkRjsr3LXVPGTRpzsfrP9NRJS29QAAAAAGg6uKSb1+fdrHQKIiK3zpQdkRgXrE7ylxOduLObi+g48JaFA29RNNo5cUTrz/Etnuh+ovsvaJy/ZmzeNWdiV6VTADQuRpQr6msYn6kPmDhGRMbLppYenKp0rvOlhX6qa9Gp9wedeisdA6DR+Xw+p9NpsVhSU1M5Tr113LMydh6Vs2SU0in+ChfZcciDC4c8qHSOMIECNAAAAADAOZXpowqMcan+UmvQrXQWANAwkVG2ZGTEHLqAjmN//Q8AAM6hsrIyNzfXZrPZbDalswCcFxSgAQAAAADOghGXFxFfLZgyvQUmya90HADQMB/jnUG9WWCpfIDX2FRFAFCXoqKi0tLS5s2bWywWpbMAnC8UoAEAAAAAziRxgsuUKBHn8OTrmah0HADQsCom5AR1NkG0CZLSWQBAw2RZzsnJ8fl8drtdS1sOAqAADQAAAABwBh9vcEUmmSR/hreYJ9wpDwD1VywJJbI+XR+M4lB9BoD6CwaDLpdLEASHwyEIgtJxAP4eFKABAAAAAE6p1plyTInxgapEf7nSWQBAwxhxuZLeI3N2XcDIyUrHAQAN83g8LpcrOjo6JSVFc1sOAhAK0AAAAAAAJxUbYooN1mbe4mjRo3QWANCwIONcop7nOLvOr0OxCAAaoLy8PD8/Pzk5OS4uTuksAPWEAjQAAAAAADGOyzUm1OhMmZ58kxxQOg4AaJhH5lyiIVqQU4QAis8AUG+MsaKiorKysoyMDLPZrHQcgPpDARoAAAAAmjqR1zkjEjlijppcHcM6rQBQf5WykCvqkgQxHlsOAkADyLKcnZ0dDAYdDofBYFA6DkCDoAANAAAAAE2aTzA4I5IskjfVV8phy0EAaIAiSVcqCc11QQuPRZ8BoP4CgYDT6TQYDHa7ned5peMANBQK0AAAAADQdFXqzLkRCbZAhS1QqXQWANAwmShHNPgZZ9cHjBwuZQFA/bnd7uzsbKvVmpKSonQWgNBAARoAAAAAmqhiQ0yJ0ZruLY7CloMA0AABxjlFvZ7IrvMLWPUZABqgrKysoKAgNTXVarUqnQUgZFCABgAAACXFLJ6hdIRzGzdF6QTQWGTickyJPl5vr8kzykGl4wCAhnkY7xINMbyUzAc5VJ8BoL4YYwUFBZWVlZmZmSaTSek4AKGklQI0K/96yh2z9pz6cCCkDX/1nVtbCySX7Vk05/NNPzurLRldB4wcN7xLLP7mAwAAAMA5BTnBFZksMMnhyRMY1mkFgPorl3X5oi5FCMZiy0EAaABJklwulyRJDodDr9crHQcgxLRSgJaLCoq41kMm3tDh+MafnCktlSeSnItfevFLqd+4CSPjizfP++jFV4RpLw1LF5RNCwAAAAAq5QmILnNatOhJwZaDANAAjLEiSV8m8Rm6gBlbDgJAA/j9fpfLFRERkZGRgS0HISxppQAdLCosj251yT8v7XRabTmwd8WKY82Gv3XPVekCUceEisOPLl+5/5p7OhuUCgoAAADQdMWnKp3gL1RUVOSV5yXFRMWbbUQZSsf5U4d2KZ3g/Bz6UekE8DeV5imd4PyoezyRJCk7O1vUmx2O5gaD6j9+vrFI6QTnQSvvzO+WK53gPPQaonQC+Buqq6tzcnLiInRJRplKspWO86fM0UonOD+WGKUTwJk0cl1FLi4sYokpibK3vKikOnhiqoqUvf+AO7nbxam1VWmh+cUXJVYd+DUfV58BAAAAoC7GWGFhYX5+fkZGRrw5Quk4AKBhgUDg6NGjHMfZ7XYNVJ8BQMVKS0uzs7PT0tKSzBhMIJxpZAa0XJxfLBZvfPn2j45VSqSLatF79AP3Dm6pLykqYfG2uBNldD7OFsdKioplyqg9tHXr1iNHjpx6Gln2er1cWGwMIcsyEUmS5PV6lc4SbmrbVs3wojcetG3jQds2HrRt4/m7bRsMBsPjNCP8yLKcnZ0dDAYdDofBYCBfpdKJAECr3G53dnZ2XFxcUlKS0lkAQMMYY3l5eW63+/iWg75ypRMBNCJtFKBZdUl50GRxDHnw2X+mUeGeFe/NnP3SbNvbdwb8ImcymU580uNMpggu4A+cXMxv3bp1K1euPPk80dHRNTU14fTJMBgMBoPYt73JqampUTpC2ELbNh60beNB2zaev9u2gUBAp9PGyVWTEggEnE6nwWDIzMwUBGwVAgD1V1ZWVlBQkJqaarValc4CABpWu+UgY8zhcODsEZoCbbzLudhBUz4fdOKr9B6j/n3Dz/cv+HbPbX2NAqv0+hhFcEREzOv1MX3UqdsWhgwZ0qVLl5Nfzpo1y2KxhEcBWpZlj8ej1+uNRqPSWcJNbdsqneLPWCyW83iUr9Fz/D979x3YRPnGAfy9u4ymTdOZtklHIGGXqeyhDEFFHIAiQ0FwgDh/igMXblHBgbhRURzsJUNFQBkioqIIisjK6Ep3M5omubvfH4GSlo60SbhL+/38R2guz725e+7uuSfvtUQY2/DB2IYPxjZ8Ahvbc3BQFiGHw2E2m+Pi4jQajdCxAEAE8/Uq2my2M72KAADN5XK5jEZjdHR0eno6HjkIrURkFKBro5PTtXJPqc2dqE6mThWXciSeIYQQrqy4jErKTqrefXv37t27d+/q97333ntRUVEtowDt9XqdTifDMFFRmMQwxHxjK3QUDcGXHj4Y2/DB2IYPxjZ8mjq2EolE/PM4tSroVQSAkPD1KrIsazAYpFKp0OEAQASrqKiwWCxqtVqtVgsdC8CFExl3Wpz7Ft85+4095dUPH8w5YXQnZGbG67I7x+T98Weh7z+4/D8P5cd2yU7HTysBAAAAWjOe5/Py8qxWq06nQ/UZAILhcrlOnDghkUj0ej2qzwAQjMLCQovFkpmZieoztDaR0QGt6Na/q+elD19N9E7on84UH/n2i/WF2dOu6iyRcaNHZz266q0vtTMuSbTu/Git2TDunq54cigAAABA64VeRQAIFZvNZrFYkpKSUlJShI4FACIYz/M5OTlOp9NgMGDSNmiFIqMATSl73/Hcw/Gfrvz8pY0VTGJGh963P3fTCC1NCK2/fu7Dnvc/XfzoWld0es8xj8wcq0P/MwAAAEBrVVVVZTKZ5HK5TqfDvIoAEIzi4uKCgoKMjAyVSiV0LAAQwTwej8lkomlar9fjkYPQOkXMdi9N6zflkX5Tzv8PRt37pid633ThIwIAAAAAcbHb7WazOTExMTU1VehYACCC+XoVHQ4HHjkIAEFyOp0mk0mlUmk0mpbxTDKAZoiYAjQAAAAAQAN8vYp45CAABMnr9RqNRoqiDAYDehUBIBjl5eU5OTmpqalJSUlCxwIgJBxNAQAAACCy8Tyfm5trt9vRqwgAQXK5XEajUalUarVa9CoCQDCsVmtxcXFWVpZSqRQ6FgCBoQANAAAAABHM98hBnufRqwgAQfL1KqrVarVaLXQsABDBOI6zWCwul0uv1+ORgwAEBWgAAAAAiFy+XsXo6Oj09HQ8chAAglFYWFhUVJSZmRkbGyt0LAAQwdxut9FolEqlBoOBYRihwwEQBRSgAQAAACAiVVRUWCyW5OTklJQUoWMBgAiGXkUACBU8chCgTihAAwAAAEDkKSwsLCwszMjIUKlUQscCABHM4/GYTCaGYdCrCABBKi0tzcvL02g0CQkJQscCIC74oSIAAAAARBKe5y0WS2lpqcFgEEf1ueqnN++Y+P5hr9Bx1Mlp/OHZOXd0HjxM0W1w8ohbxi/49rCTFzqoBvEV695+Nuvhzb+zQkcCARH19t8op9N54sQJhUKh0+lQfW5ZRL5lspZf1k6/+y7tyOvlwybrbnn2nvXHijmhg4Ig8DxfUFCQn5+v0+mErT47T3737OwJnbt3U2R2Su5z7fjnNx52iO+4z9sPbF129Z33Jlx9m2bGM1O++vO0W+iQ6hIZgxkhUIAGAAAAgIjh9XpPnjzpdrvF80t5vvj7xe9/u+u/MhGWDjynVo+f+MjT3+YkDbhuzoyxo9TWTUueGnLbsj9FeZlHCCGEt/z41ezvcnIrXB6hQ4FAiHn7b1RZWdnp06fVarVWq8Uv5VsYcW+ZfPG+94fN+fRLY/TQMWMfvWFwt6oj77z6+Mglx5xCRwbNw7Ks0Wi02WwGgyEmJkbASDzHPx8/ZtbTX5uThkycc+ekUSkFmxbfP2TS++I67vMV3yx+9pLXdx6Oaj/5muGj1WXrP1kwZMHPuSIr7UbGYEYOTMEBAAAAAJHB98hBpVIpjmoRW1lsOXJw9+dvvLLCyqUKHU0deNuGt977rlwzffHHHw5PpAkh3K3fv3jH6M8/fmLTVRvHJQk+gudj8/fMXHKwgFBokxE90W//DeJ53mq1lpSU6HQ6YatFEGqRsGVy+UuXbj+p6r/0o0duTqEJIWT68Idum7tw1Zr1Ex+drBJhboaG+B45KJPJ9Hq9wM9D5is2vLrwu/KM6Z+s/XBUMk0I4e75/skbR3+0+Im14zdOVItj2+LLf105c5O104S5P9zaMY4ihB9z9atPXL9jzVvj+7zUUTS/RImMwYwkOLUDAAAAgAhQXl5+8uTJxMTE9PR0EVSfCV+0Ymy3gX0mPvLmz2L92TT7366DNqbTtQ9emnjmpJ+OH37r+IES5+59R6qEja1ObP7it9buSu0/sQ0uUsQuArb/+nEcZzKZxNCrCCEXGVum89/dx7yxvYeNTzmb6xTtr+unpl2WI7nijRrqZLfbT5w4oVKpdDqdwNVnQoj3n10HKpjsGx8ckXz2uJ84/K4pAyWO3bv/EMtxn7dv+HqfRdn78Ykd4nxnc5Tq6qm3vz1zZF+5mObeiojBjCjogAYAAAAAsbNarcXFxVlZWUqlUuhYzqDiL39zc+cyjvAlW+6d+p5F6Hjq4KkkcbpufTsb/NqJqKgoBUW8bo/4ihzeP9d9+uSJ9KdfHsW+9ctKXNuJWwRs//Wo7lVs27YtJn1ueSJjy2QMd8y5Z6KuY9S5l1ibs4qnE9UqoSuY0BQlJSX5+flarTY+Pl7oWAghhHidJKFttwHdax73FeI67nuP7zxSJevUfVjMuWYCJq3bzLHdBAyqDhExmBEFBWgAAAAAEC+O4ywWi8vlEs+kz2dIkjr2SiKE8AWHRfqDacWgResH1XyJs2zbsc8r7dnTv/AhCs5jW2asyO93y9z7MsnrQgcDjRP/9l8Xh8NhNpvj4uI0Go3QsUB4RMSWqcgcfVUmIYQQ3uWwlZQV/fXzxjnfVWiH3j4hTbRBQw08z+fl5VVUVLRt21ahUAgdzlmKYYu2D6v5EmfZsnWfV9rz4myRHPe5EutJJ5WiiTnx7Wc3rd2/N9cdp8ka0G/4k5MHdosW0/YfCYMZWVCABgAAABAdnucdDof/K63zd+Iej8dkMjEMYzAY0KsYNPfpHYsnvPyzI/26J8ani6vLrvK/pxZ9Z+o2cfWVKRJiFToaYdTa5Xk+NA9j4jjO4/H4L7w1phJCiAh7FQE4y+v33PvYUZYQKqHH5C2PDNKGKDX77/JVVVUsG5qZDXiedzqdMpms+pXWeXLCsqzJZGJZ1mAwSKVSocNpgPv0t/MnPL3LkTnxiYlZIjnu85VOG+HLf1o6arO3Xb8+M/tK8v7+dc3Kd7f9XfrD/DE9ZI0vQSBiHMwLwz+fcBzX7PMTFKABAAAARIfn+crKSv9XWuE1ntPpNJlMKpVKo9GIYdLniObOP/DmKwue33rKnXnZe+88cIWoOgN557dLP3urouuSpwe1pQlprb9rrbXLh6oAzbKs1+v1X3iMmL78C4Pn+fz8/PLycjxyEMSFSh5318Nt8ktO/PPzkk1fjXmI2bLg+r6h6Kb13+XdbjfHhSaxchzncrlq5JPWt0O5XC6TyaRQKEQx6XP93Ll733zmmec3/ufWXfXeZ09dES+W1M+znJfnK0rldzz93Nv94hlCCD/u5kXzxmxe/8QPgzeOEk2gfkQ7mBeG/y7PcVyz8wkK0AAAAACiQ9N0bGys0FEIqbS0NC8vT6PRJCQkCB1LhOMrDixfeNvCb/5yp46Y/uzrsy/vqhTVhRNf9vvamd+5xz44aUqyqAK70Grt8qG66cIwjEwmq7Fwe3FIlhwpWJY1m81er1f0vYrQ+lCKjhcP6EgIuerKyW3n9Xh95ZPfDdt6bVLwRU3/XT4qKipUPyGiaVqpVLbm8xObzWaxWJKSklJSUoSOpX58+YFPn7nthfV/VWlGzHrj9Qeu6RorosMrJZMpKErW9fIn+8af2S4p5ciJIwd88/muX485R/UV1z0NcQ/mheG/yzMM0+z7LihAAwAAAIiRuOY7voB4nrdarSUlJehVDAE2f/WT90xdm6sePGP9k9Ou0Ylw0kLeetqcy5ateOXhFa/4v/5d/7HfMdpRe98e3691TL5Sa5cPVQGapmmGYWos3B6SBUeGqqoqk8kkl8v1er2YexWhVXHn/LnyUJnuokuGpFbv5rSu30Vd6b+OnsxjSQgK0P67vFQqDdXGT1GUTCZrtecnxcXFBQUFGRkZKpVK6Fjqx+aunnPz1K/M6mF3r3/xzmvaimZ+6rOYxEQtQ/5LSfa/6UwnJqdLyC92p5MX0890RD+YF4b/Lk9RVLPPT1CABgAAAACx4DjObDZ7PB6DweA/yyQ0C/vPp0/OWGfNvvX1zQ/2TRFp8Y1K7DTosRu7nJuglHfu275rp7vNtCs6Zca1E9lk1RBJ7Ha72WxOTExMTU0VOhYAP5bdD7ywo9O9nX+YcC4x8w6njacUcpl4im9Qjef5nJwch8MhrkcO1sH7zwf3zVienz37481PDBbpcV+h651Fb7Hkmvle7c5u7qw1/7SXxCUnimmGsEgYzIiCAjQAAAAAiILb7TYajTKZDL2KoVH126JPD1V1vfOzB0RbfSaEUMnZlzyd7fcCZ331j90/2NvNnHxtK+l9hnDw9SrikYMgQtJOPS6N2bbx629+uXpqf18xkyvbuubHo3zCbb11qNGIjdfrNRqNFEUZDAaJRNzfT9XPiz74varHg589JuKCKa0dP7Tt8x99N++HfkuHJUsJIWzphi+/P8DF3zK4vYi66yNiMCOKuHceAAAAAGgdfL2K8fHxGo1G6FhaCNZ46OciXqY8OP8JY81LJ0rVe8rC8QZcCUCLxPN8bm6u3W4Xfa8itFJUXP9507pse2fNlbcZJw7poOFL/zqwd/2/9ozLHni8t4jqb0AIcblcRqNRqVRqtVrxPw+ZPfnbz4WcTPnL/AdP1j7u979t4aSO4jju053GTPnfzpfmz3/y6O5+ozLoUwf3r/3XnjXirmf6iChjR8hgRhKMGAAAAAAIrKSkJD8/H72KoeXNzTGxvP34T58dr/U/dAoz8tXxBkGiAggrlmVNJhPP8xHQqwitl7TrpHl71CufXbV37Zo/y7yyNF2nO/43/omx2Ro0WopJeXl5Tk6OWq1Wq9VCxxIQr8Vs8vL2Yz98dqzW/9ApzNWvTuooSFR1iO7w3Py56UvXvPvT7td/Jgnp7abfed3T13TWiKnCHzGDGTlwSAYAAAAAwfA8n5+fX15eHrm9ilTqzd/n3ix0FHWQD51XfHSe0FE0HZ3yJ9rDfgAAIABJREFU0IJ3HhI6CgiQqLZ/l8tlMpkUCkV6ejqm8WnlRLVl1oGK6jpy6sqRU4WOA+pVWFhYVFSUmZkZGxsrdCyBko9cUJy/QOgoAsLEdbjrvrl33Sd0HPWLoMGMFChAAwAAAIAwfL2KLMsaDAapVCp0OAAQwWw2m8ViSUpKSklJEToWAIhgHMdZLBaXy6XX6+VyTIoCEBooQAMAAACAAKp7FXU6HXoVASAYhYWFhYWFGRkZKpVK6FgAIIJ5PB6TycQwjMFgYBg8CRcgZFpXAZrneYfDIf6Z4wPBcRwhxOv1OhwOoWNpaXxjK2b40sMHYxs+GNvwwdiGT1PH1u12t4zTjAvA16uYmJiYmpoqdCwAEMF4ns/JyXE6nQaDAb2KABAMp9NpMplUKpVGo8EZHUBota4CNCGEYZiWkUd8a0FRFG7KhZz4txB86eGDsQ0fjG34YGzDp6ljizbeABUXFxcUFKBXEQCC5PV6jUYjRVF6vR6PHASAYJSVleXm5qampiYlJQkdC0AL1LoO0hRFRUVFib+8GAiv1+t0OhmGiYqKEjqWlsY3tkJH0RB86eGDsQ0fjG34YGzDp6ljK5FIxP8zGmH5ehUdDkfkPnIQAETC5XIZjUalUqnValvGJR4ACILneavVWlJSotPpYmJihA4HoGVqXQVoAAAAABBKda+iwWBAryIABKO8vDwnJ0etVqvVaqFjAYAIxnGc2Wx2u9145CBAWOHUHwAAAADCzterGBMTk56ejl5FAAiG1WotLi7OyspSKpVCxwIAEcztdhuNRqlUqtfrMakdQFihAA0AAAAA4YVeRQAICY7jLBaLy+VCryIABMnhcJjN5ri4uLS0NNwaBwg3FKABAAAAIIwKCwsLCwszMzNjY2OFjgUAIpjH4zGZTAzDGAwG9CoCQDBKSkry8/M1Gk1CQoLQsQC0CihAAwAAAEBY+B456HQ6DQYDehUBIBhOp9NkMqlUKo1Gg15FAGg2nufz8/PLysrwyEGACwkFaAAAAAAIPV+vIk3Ter0ejxwEgGCUlpbm5eWhVxEAgsSyrNls9nq97dq1k0qlQocD0IrgYgAAAAAAQgy9igAQEjzPW63WkpIS9CoCQJB8jxyUy+V6vZ6maaHDAWhdUIAGAAAAgFDyPXIwNTU1KSlJ6FgAIIJxHGc2mz0ej8FgkMlkQocDABHMbrebzebExMTU1FShYwFojVCABgAAAICQsVqtxcXFWVlZSqVS6FgAIIL5ehVlMhl6FQEgSL5HDmq12vj4eKFjAWilUIAGAAAAgBDgOM5isVRVVen1ejxyEACCYa/ymK0n4uPjNRqN0LEAQATjeT43N9dut7dt21ahUAgdDkDrhQI0AAAAAATL16solUr1ej3DMEKH05gkrdARBCAigiSEdOgtdATQRKLftEpKSvLLytCr2OqIfss8Y0CExAmEsCxrMpl4njcYDBHwPOQUndARBOCySAgSREn0eyAAAAAAiJvvkYNxcXFpaWl45CAANBvP8/n5+eXl5ehVBIAguVwuk8mkUCjS09MxjQ+A4FCABgAAAIDmKy0tzcvL02g0CQkJQscCABHM16vIsqzBYJBKpUKHAwARzGazWSyWpKSklJQUoWMBAEJQgAYAAACA5uF53mq1lpSU6HS6mJgYocMBgAhW3auo0+nQqwgAwSgsLCwsLMzIyFCpVELHAgBnoAANAAAAAE3GsqzZbPZ6vQaDQSaTCR0OAEQwX69iYmJiamqq0LEAQATjeT4nJ8fpdOr1+qioKKHDAYBzUIAGAAAAgKbxPXJQJpPp9Xr0KgJAMIqLiwsKCtCrCABB8nq9RqORoii9Xh8BjxwEaGWwTwIAAABAE9jtdrPZjF5FAAiSr1fR4XDgkYMAECSXy2U0GpVKpVarxfOQAUQIBWgAAAAACFRJSUl+fr5Wq42Pjxc6FgCIYF6v12w28zxvMBjQqwgAwSgvL8/JyVGr1Wq1WuhYAKBuONIDAAAAQON4ns/NzbXZbOhVBIAg+XoVY2JitFotpvEBgGBYrdbi4uKsrCylUil0LABQLxSgQUidnrEIHUK9jmYJHQEAAIBosCxrMplYljUYDFKpVOhwACCCVVRUWCwW9CoCQJA4jrNYLC6XS6/Xy+VyocMBgIagAA0AAAAADXG5XCaTSaFQ6HQ69CoCQDAKCwuLiooyMzNjY2OFjgUAIpjH4zGZTAzDGAwGhmGEDgcAGoECNAAAAADUy2azWSyWpKSklJQUoWMBgAjme+Sg0+lEryIABMnpdJpMJpVKpdFo8MhBgIiAAjQAAAAA1K2wsLCwsDAjI0OlUgkdCwBEMF+vIk3Ter0ejxwEgGCUlpbm5eWlpaUlJiYKHQsABCryj/1cyZ9rli7/4Q+jTanrOXzi9PE9EnD7CwAAACAovl5Fh8OBRw4CQJDQqwgAIcHzvNVqLSkp0el0MTExQocDAE0Q6QVo1rj2xRdWs5dOv3diUuGuzz95YT6z8MWxmaGb/0fMT8kjhPz6YJTQIQAAAEBL4/V6jUYjRVEGgwG9igAQjPLy8pycnNTU1KSkJKFjAYAIxnGc2Wz2eDwGg0EmkwkdDgA0TYRfUbgPbdp0KmP8G7OuyGQI6ZpcdnzO15uPXDWrO5IRAAAAQHO4XC6j0ahUKrVaLXoVASAYVqu1uLg4KytLqVQKHQsARDC32200GmUymV6vx/OQASJRZBegWfORf+xp/S/W+jqemayLe6WsOfh3Htdd10oSknLVa0KHUL/pTwkdAQAAADSNr1dRrVar1WqhYwGACMZxnMViqaqqwiMHASBIdrvdbDbHx8drNBqhYwGAZorsAjRXZC3ik9SJZ6vNdKI6kS+yFnLkTAF627ZtR48ePff3HOdwONDLc2E4HA6hQ2ixMLbhg7ENH4xt+GBsw6epY+t2uyP6NKOwsLCoqCgzMzM2NlboWAAggvl6FaVSqV6vZ5jQTY8IAK1PSUlJfn6+VquNj48XOhYAaL7ILkCz7iovpVAozl7pUQpFFOWucvNn/2DPnj2bN2+u/nuVSlVZWdmkK8M9d4l6kuUiMlvoEOpXWdnon4h5eDG24YOxDR+MbfhgbMMn0sfWn8fjidAZk329ii6XC72KABAkPHIQAEKC5/n8/Pzy8nI8DxmgBYjIa6RqjEzO8OWVLp5EUYQQwldWunhp7LkJoCdMmDBkyJDqf86fPz82NrZlnAb5urmlUmlUlHhrChGKZVmn04mxDQffdiuRSHACEXIY2/Dhed5utzMMEx0dLXQsLU3LG9sILd16PB6TycQwjMFgQK8iAASjtLQ0Ly9Po9EkJCQIHQsARDCWZU0mE8uyBoNBKpUKHQ4ABCuyC9B0kjqZOlVcypF4hhBCuLLiMiopO6l6Aujs7Ozs7Ozqv3/llVfkcnnLKEB7vV5CCMMwEXqtK2Zer9fpdNI0jbENOZZlHQ4HxjYcMLbhw3EcIQRjGw6+AnRLGluJROLbYCIIehUBICR4nrdarSUlJTqdLiYmRuhwACCCVVVVmUymqKgonU6HRw4CtAyRvSczWdmdY/L++LPQN+cGl//nofzYLtnpaN0BAAAAaFRZWdnp06fVarVWq0X1GQCajWVZo9Fos9kMBgOqzwAQDJvNdvLkSZVKlZmZieozQIsR2R3QRNZ99OisR1e99aV2xiWJ1p0frTUbxt3TVdb4GwEAAABEzNce7v+KUqkM7fLRqwggKrV2eZ7n6/vLJmFZ1u12+y88tMmEnH3koEwm0+v1qBYBiIH/Lu9yuViWDcliqycCrX4l5PmkuLi4oKAgIyNDpVKFdskA0Dz++YTjuGafn0R4AZpI9NfPfdjz/qeLH13rik7vOeaRmWN16H8GAACACMfzvMvl8n8lhNd4HMeZzWaPx2MwGGQy3LkHEIVau3yoCtAcx7Es67/w0BaM7Ha72WxOTExMTU0N4WIBIBj+u7zH4wnV/GA8z1dVVYUpn/A8n5uba7fb8chBAFHx3+U5jmt2Pon0AjQhjLr3TU/0vknoMAAAAABCh6bp+Pj4cCy5ulexbdu2eOQggHjU2uVD1UoskUjkcnmY8klJSUl+fr5Wqw3T8gGgefx3yejoaIkkNJUfhmFUKlU49nffIwd5njcYDKGKFgBCwn+XZxim2ZcP2LEBAAAAxCgcF2AOh8NsNsfFxWk0mpAvHACCEaaaC0VRNE2HfOG+XkWbzYZeRQAR8t/lGYYJ4WMeJBJJyPOJy+UyGo3R0dHp6emYxgdAbPx3+WCSCQrQAAAAAK0CehUBICR8vYosyxoMBv/ZYAEAmqqiosJisajVarVaLXQsABBGKEADAAAAtHA8z+fn55eXl+ORgwAQJJfLZTKZFAqFTqdDryIABKOwsLCwsDAzMzM2NlboWAAgvFCABgAAAGjJ0KsIAKFis9ksFktSUlJKSorQsQBABON5Picnx+l0GgwGuVwudDgAEHatrgC9ePFioUMIDY7jqqqqGIbBw+tDDmMbPjzPu1wumqZxkhFyGNvwwdiGVWVlZUsa2yNHjgwYMEDoKGqoqqoymUxyuRy9igAQpOLi4oKCgoyMDJVKJXQsABDBPB6PyWSiaVqv1+ORgwCtROva1e+//36XyyV0FKFRVlZ26NChjIyMHj16CB1LS1NeXr5nzx6tVturVy+hY2lp7Hb7jz/+mJaWdvHFFwsdS0vjdDp37typVqv79u0rdCwtjcvl2r59e1JSUv/+/YWOpaVxu93btm2Lj48fNGiQ0LGERnp6eteuXYWO4hy73W42mxMTE1NTU4WOBQAimK9X0eFw4JGDABAkp9NpMplUKpVGownh0xEBQORaVwF69OjRQocQMocPH37nnXd0Ot24ceOEjqWlOXbs2Ntvv63RaDC2IXf69OlFixYlJSVhbEMuNzf3jTfeGDx4MMY25IqKil577bW+fftibEOuoqJiwYIFPXv2xNiGg69XEY8cBIAgeb1eo9FIUZTBYECvIgAEo7y8PCcnJzU1NSkpSehYAOCCwgkEAAAAQIvC83xubq7dbkevIgAEyeVyGY1GpVKp1WrRqwgAwbBarcXFxVlZWUqlUuhYAOBCQwEaAAAAoOXwPXKQ53n0KgJAkHy9imq1Wq1WCx0LAEQwjuMsFovL5dLr9S3myR8A0CS4LAEAAABoIXy9itHR0enp6XjkIAAEo7CwsKioKDMzMzY2VuhYACCCud1uo9EolUoNBgPDMEKHAwDCQAE6UnXo0GHDhg3R0dFCB9ICtW3bdsOGDfjNcjhkZGRgbMMkNTV1w4YNUVFRQgfSAiUmJm7YsAHNGuGgVCo3bNggk8mEDqSFqKiosFgsycnJKSkpQscCABEMvYoAECp45CAA+KAAHalkMll6errQUbRMUqkUYxsmEokEYxsmDMNgbMOEpmmMbZhgbEOosLCwsLAwIyNDpVIJHQsARDCPx2MymRiGQa8iAASptLQ0Ly9Po9EkJCQIHQsACAwFaAAAAIAIxvN8Tk6O0+k0GAzoVQSAYKBXEQBCgud5q9VaUlKi0+liYmKEDgcAhIcCNABAS8K7HTavXBWN7A7QOni9XqPRSFGUXq/HIwcBIBhlZWW5ubmpqalJSUlCxwIAEYxlWbPZ7PV6DQYDZloDAB9cqEQyPv/rp54vnPjmjGz8OC5k+MrTOz5fun7PP3mVsqQ2PUZOuuW6XsnYT0KCtR5Y/tEX2/80l3HRaR0HXjd92kh9NFprQstrXD/vkbXahz+55yJstiHBl2596rZ3//RUv8Ckj3958bQOyLpNwR7/7N6H1jgGPfzGg4Piq3d69t9PZj9+dPTi+demVb/m/GnB7S/vcmZNXPjGZD0GuXG+Rw4qlUqtVoteRQBoNvQqAkCo+B45KJPJ9Ho9nocMANVQoYhYvCtn57L1h519OaEjaUn48p/enrf4cNZ1Nz/UW8Of3vHFsufnVTy7cEY2HuwWNPb0mpdf2UKPnP7o7CxJwa+rPnr32aq4t+7rF4uKSei4j69e9OXflXKt0IG0IJw130p1uPqBcdlnmjcoRboWZ9LNwZfs+WjpJd3u66uqd6fnbb/u+s2piJZZ9uw5eaO+PSrQDSsvL8/JyVGr1Wq1WuhYACCCcRxnNpvdbjceOQgAQbLb7WazOTExMTU1VehYAEBcUICORHzhjtfmfbIvp8LNk2Shg2lR+NJ93+739r/34alDYilCsjulOU/dt37bXzdl98EPh4LEGvfuNmrGvHrrZW0ZQjq0Ty7+865VP//L9uuNLBQqrn++eusbpl0mYxY6kpbEYy0oVbXvP2RgNxRDg0OndevE7f5w2ZAusy9W1l2C5isO7Dro6XLDDPXGD/fu+W9K+04Y9PpZrdbi4uKsrCylUil0LAAQwfx7FfHIQQAIRklJSX5+vlarjY+PFzoWABAdtHFFIir+ohsfnDd/4bzrO6B2F1K8zSPX9e7T6WxxhFFrUiXuSqdX2LBaBErZZfS0SYPSz17Y0AxNSaRSQWNqUXjHn58t/jFt6p0jUpDXQ4grLLDyKZoUrrLUWmTz8ELHE8EoZfcpdwzld3zwxSFn3ePIl/686xDbefDQoQMvUlp/2n3UU+efAcdxJpOprKxMr9ej+gwAwXA4HCdPnlQqlTqdDtVnAGg2nudzc3OtVmvbtm1RfQaAOqF+GZGk8RmGeMKX/qfA7AUhReuufnzBuX+y1l07DpF2N3ZUCBdSi0Gn9LryakIIX/zvT4dO5fz1/aa8rhNmZSMFhQZf8evHb+9ve+uCocm/7xE6mBaFK8wr9BbueGnGJ6fKWSKJbTNo8j13jm6Hycubg4q9eOptg//36vtfDX7t1vMnNuKL9u06zHe5rW9SdPSAXjE/7tv197TsHvj1SS0ej8dkMjEMYzAYUC0CgGD4ehU1Gk1CQoLQsQBABGNZ1mQysSxrMBik6DACgHqgUw6gTlX5v3z53NwP/tNPvuPyNNSaQofL/33rps3f/mSU6jpoYjCyIcGX/vTBe391nXn7wASMaGjxtqJSj0JpuPqZpatWLVv86GjlH0teXHLAjk7o5qHi+t0yvb9j63srjlbV/j++YO+uo3T2kH6JFFF0G9AruuTn3YfP+6tWzul0njhxQqFQoFcRAILB83xeXl5BQYFOp0P1GQCC4XK5Tpw4IZFI9Ho9qs8A0AAUoAFq8xQc+OKZu+95dSc9/JGFT13XFs9iCSUme9LzC99a8vH8Kz0bX37zWysKeUHji398f8mJ3nfO6BOH8nOoUQmjnlr+5Zv3jNDHyeRxmX0n3T2uXdlPP/7pEjqwiEUlDJ5+y8Vlm95bfdxd4z+4nD27/yNtOqRVmE0mU1FCW72sbP8ujLSf0tLS06dPp6amarVaisLeDgDNxLKs0Wh0OBzt2rWLiYkROhwAiGA2m+3UqVPx8fGZmZk0jeISADQEv38H8Mc7j6587vnVhR3GP7J4XO9U/Pg7VHjbf7t35aQMvrRTHEUIoaL1wwYbvvriPxNLUpCGgsPl/nusNKdo3uSt5157etx27bhX3r6lA1okQ4tOTtfKPaU2F08wA1IzUclDb7159/+WvLuu7y3nXuXMe/ac9HrY5Y/fs/zcnx7YfdDZd0D0hQ9SZHiet1qtJSUlOp0uhNUih8NRWVkZFxcn5n4ljuNKSkqkUmlcXJzQsTTEbre7XK74+HiJRLzHNJZlS0tLZTKZSqUSOpaG2Gy2qqqqhIQEMbf5e73esrIyuVweGxsrdCxNU1VVZTKZ5HK5Xq8PYbWoqKhIIpGIfOJXX9JTqVQymXjP8HmeLy4ujpSkhyNISPiSnsiPIHUqLi4uKCjIyMgI4WGlsrLS4XDExsbK5aLuAisqKmIYRuS/IHE6nU6nU+SD6Ut6OIKEhPiTXoTlOIDwcv217LVVFYMeWzDronhUl0LLsuvT9+mYi+cOjaUIIcRbWFBCYturMMxBo9uNn7dwxNnH4zkPLHlmY+z0pyd2T05HF0LQnPsWP7jMO+Wl+wb72svZnBNGd0J2Ziw23CBQKZfdMWXP/5a+t7HL2Se8sid37TZKL7r7o3mjEs+MrXP/6zNfOrDrN3v/IcpWPdwcx5nNZo/HYzAYxHzKCwDiZ7fbzWZzYmJiamqq0LEAQATjeT4nJ8fhcLRt21ahwPOSACAgKEADnOP5+8c9RZr+7dnjv/1a/SKdaOilx9S6QaKUvUcOXPbyZ68tZ8ZdnEaX/P3t51tL208abhBvd1PEoBTJOkPymX/wNmM0xai0BkMW0nsIKLr17+p56cNXE70T+qczxUe+/WJ9Yfa0qzpjcINDp11+x6Q9D370eyXTmRBC2ON79uZG9540wC/VRvcaPjDxxx93/2obPLT13qlyu91Go1Emk4W2VxEAWiFfr6JWqxV5lxkAiJzX6z158iRFUQaDIeK6tgFAQMgXANX4spxch9f47aLnvj33IhU15NEvHhog3l+XRQgqtu8dT85e9sm6Jc+vtvHRaR36T3v65tFZqD+DqFHK3nc893D8pys/f2ljBZOY0aH37c/dNEKLOmDQmIyrZk7Y89BnxwkhxHN0156CuAF39K7RWS7LHn6J5rstu34pv/Sy1vmTFJ7nDx06FBcXl5CQYLfbQ758p9NZWVlJUZTIf0Bts9mkUqnIp712OBwul4umaTFfirMsa7PZxN9Hb7fbq6qqGIYR+RQcNpvN7XbzfBgfZsFxXEiW4/uBs9FozMjIoGm6oqIiJIv1Z7PZJBKJyO+T+ZIeIUTMewHP8xGU9HAECQlf0gvrEcS35YcEz/N///13WlpaWlqa0+kM1WKruVwuh8PB87yYZ40ghNhsNpEfpwghlZWVTqdT5IPpS3o4goTEhUl6LMs2+71UWE+bAAAAAKAZpk6d6vV6w3dtw3Ecz/M0TYv8ypxlWYqiRH5ZgsEMoYgYTJ7nOY67AIO5dOnS4JPA1q1bly5dGtYrUt/lqMhrMRGxaRHspyGFwaw2atSom2++Ofjl3HPPPb4534NfVJ182TUiNi2CpBciGMwQujBJ77XXXlOr1c14IwrQAAAAAAAAAAAAABAWor4ZCAAAAAAAAAAAAACRCwVoAAAAAAAAAAAAAAgLFKABAAAAAAAAAAAAICxQgAYAAAAAAAAAAACAsEABGgAAAAAAAAAAAADCAgVoAAAAAAAAAAAAAAgLFKABAAAAAAAAAAAAICxQgAYAAAAAAAAAAACAsEABGgAAAAAAAAAAAADCAgVoAAAAAAAAAAAAAAgLFKABAAAAAAAAAAAAICxQgAYAAAAAAAAAAACAsEABGgAAAAAAAAAAAADCAgVoAAAAAAAAAAAAAAgLFKABAAAAAAAAAAAAICxQgAYAAAAAAAAAAACAsEABGgAAAAAAAAAAAADCAgVoAAAAAAAAAAAAAAgLFKABAAAAAAAAAAAAICxQgAYAAAAAAAAAAACAsEABGgAAAAAAAAAAAADConUXoD0/P9xRSlEUJc1+4nfvef/NHnu5n4ySD1p4gqvjn4Gr2nhzHM1k3r3TE5KoQ4Q99ExPKRU16v18/kJ9JJ+/5iZdxuTVhRfsE5uCL9z3+eLP9uQ38dttsVwHHu+RfMnCI26hAwEAAAAAAAAAgMjVqgvQ7l9Wrj3hJYQQ77E1qw6eX4GGUOKLNjx83/qsB54Zq6bCsHjn8Q0vTBvWWRMXHZPU5uJr7n9/XyHblPdzpuVzb//f8xuN9RWgq05/u/DOK3u1SY5VJut7DZ/y1JqjjhDEHbRmrrjbsnPR3df0NaSoFPLo+PQul06a++mvxX4rH9X7wXlX/PfsXe8ea9I4AgBAGPAV/2x8Y86UET0N2qSYqJhEjb770Bvvf2XVHyUiztEX5la3ADfUfapvq1/Yj4WQqKftoKXffZ+aQFMNkF30/BE2iJ6bMGleK0/tRiKhEkUziDu3tNqWnSasOJe/6+PX31j1h/3cSy0ut0RmMglQrZzDWd4eLqdk/V7GVXENyFSiVUcKqk2ws6DWXICu2rdi3WmWSe/UMY72Hl+7+jdRNSiHHZ15zdMfLHnvgaFx4SgHn69q/6uPrWDHP3RrOybky+bLf3r6sj7jnli2y0y07fWqisOb3rzz0v5TlxsDPUrwpT+89u5PVfWdkvKlu54cetHoh97/7rhbrW8TW/7PD18+N2HglfN/d4ZqHZqluSvu+ff98X1G3f/2pt8KJOmduxoSXKd2r5g/fXC/6atzqpMQlXj1nDva7HvxqTXibFkHAGglPKaNcy7p2OO6/y38cschYwmrTIzly0yHf1z55iM39u7Qb9aXx1xCh3ghuXMO7ty+84BR2AOw/231cCy+2bfVG3lj1dcNVw1kfV76R9Ar7OauuNuyY9G9Y/u31yZER0XHp2cPvemp5YfK6z1/qa/toDXcfafkCelt6qbTxkuFDg/EmlvOaKRlp4l74gUU9l6lauypj28bf/sDj7y7t+zc37bI3IJk0pohU4VHsCtO6klBtQh4FsS3WpXbZ2cyRNLhoe9WTEmiCdN+zk/umn/h/Xd+XymRDVxwnK3jn4FzbbhJRdEZd+1wN/63LRWX//nYREm7B/a4wrBwx545naUUnTzshb1FXp7neeexL6a2l1F08rWfWhr8stjS4z99s/ydZ2Zepo+mCCFM+4d+9tQR/IqJaTQlazdpyZ9lLM/zfOWpdbO7KyhK0f+Vf7xhWKMANXPFWcuSK1UUJes49bMjFRzP8zxflbN93tAkmtDaGZsq/P7y1KKhCvnFzx8+f1AAAOBC8J5aNiFLShEqpv01T3y+51SF76jD2k0/L3/2hi4qmlBM6pXv/F0lcJx14Up+X/fxkk+2HnWGcqG5746QE2nvF//2hvFTGuXa93BnWdrUDWVc6JfNle2dNyCeJhQdk9ape9c2CTKKUFL95K9ON3LKEcAbXV/fkiSV1ImhKULJB792oomnuaHT7BV3HlwwPJmhCEXHaDr16tEhLUZCEUJqP+AQAAAgAElEQVRFd7p9XU5da8OVbL+3s5Sq+6zPffCp7rKUG1dYw/DVCu7meIpIez13uOEBbfYlT5g070qq1loIkyiaQZS55dwSGtp3mrwnXjDhXnF/7qNvDo+nCSGyYYvNNda6ZeWWyEwmAaqVc1jz4mEyIu07/18Br/vFBpkqDIJfcb6hFOT3QQKeBbXeArTz2zu0NJFkP/6bu3zt5CSaMIb/7al5+SamArSn0uG6kBnPU+XyhHCTY0++MSRK0vGR/WGowXMly6+Pp6joS9/0v2Sq2Hp7JkOkPZ/9q6Fhs305Nsr/fkydO6H7l0c7SyhJxwd22/1erdxxl44h0p7PHBLqSNTcFefyPhgVRdEpUzdU+L/s+e2JbAmh0+/c7rcbsJb3RioY/f27wnHjAAAAGuH5+7VLVBShk4Y+v6+0jsOy7eAbV6bRhIru/ezvYixBh8F5BWhBghDlbfXm34/nea5460yDRN7lfz+UC1YbaW78lfvndpVRlLzDlI/O9AnwjmNrHxyYSBM6eeyy3OoVCqztoEXffY/MmlFICtARQpy5JbB9J+A98YILd6+SH9efLw1U+n5dfH71p0XllshMJgFCAboxyFThEMxZ3FkNpyAxnAW12gK0ffOMNJpIezxzyMvz5WsmJ9GEaXvfrhpXb80qQDuObXhh2rAu2jhFlCqt06VTX9x8qmz9+adNXPnhFU/fPLxrekK0XBGv7XzJjY8uPVDon9NY8+JhMip6wopT3z97TYc4CUXRMpW225UPfPG3g+dsR7565LqLdQnR8qj4zIuunbvmv8oaYbhM29+6d+zAjpp4hUymiNN2Gnz9nA9/tvpF7j3y/MVSIh/5Xh7n93E3rir9b9X/hreJZSiKlinTOg2bvmBHTo1tj6s4suqZqcO7ZsQrpLLoRF2vK2e+vt3S4Cmh99gr/WVMm/t3+49A0cdXyomk4yP7q5fuzdkws4uColV9H9lRFPCub187KZ6ioka9n1fjLVU778pkiLTv/KMNHCm8Ob9u3bRp06ZNmzZ+MKOTpM6d0P3Tg+0YIu33cq1DDmu3Gk8bTUVNbaRo/KsJUHNX3L3nf3qGyIa8carGZ3LWJVfICRU7eZ3/gYQ9/eYlMiZj9nZUoAEALjSudMM0DU3olHHL6j3z5ArW3JTBEDrphq/q61XwVpTbw3o+HeKb1g0LTwG6aasgytvqwdyP5wq/ntFGEtXrif2OEKxC8zQ7ftd3d2howrS778cawbOm90YpKUo+9C3j2eUF1HbAt+i775FZM4qoAnRw+VaUuYUPbN8JfE+8wMLeq3SOY/+TFykY9RVTx2iZutoPW1JuicxkEqALW4BuftK4oGdf/pCpwiCYFT+rkRQkirOg1joHtG37ik1WXtrjxhu6MISoLhs/Kp5mTetX/VQVzFL58r1Pj+w39vFPd/5j5RJ1GsayZ9nj1wy44aPjNR9wyOVvuntwv4lPL9v5nyuxQ7fOqezpPSvnTx/U76bPT9R6FKLn0CvXjX36m+LUPpeNHKCTWA9vfW3q5dOefPCKwVMW7XNl9RnQLcWb8/uG+ZOueeqn6ikgq/5adHXvUfcuWn8gX6Lt3KOrPr7y5N7VC+4YNuKxPQ0/N4+zbrn3yslv7LWlXjxi1KVd4ir+3fnJQ6Mvf/zc22x7nxzWf8K8ZT+cdKs79Oiqiyo+9M37D1wxZNbG+icK5nK/23rQqxp0aa8G5oLi8jbde/mkD47K+jy8YctLw5ICnZnae/zPI3aeaXvxRck13iLt0aeHlPL+e+jvBr5TRnvxFVf5DOucUOdHcpaf95tYJmvQ4LY1J6+mY9RZuqzMJEWAgRJCgvlqztPsFZf2n/9Xhb10211tauz+Fb/+fMRLSTt37yTxe5VOHzykPZX37ZbfW9cU6QAAIlC+9bN1+Zyk8+2P3Zhe3wkblXLt3Dt7SvmSTZ9ttPKEEMIZ37xETqtu2lDlPrFmzuWdkpRt7t159mkiXPGBJfeP6ZWVEB0dn9lzzJyv/qn467leMiZj9o7qB45UmXcsvm/coE7ahGi5PDo+vfOQGx5asr/Qb5o4zvL2cDkdM3F12fHVD4xomxitkEnksZrOw2cs3Jl77kSG/fuF3rLqp36xh5/rJat74uGoK5ZY+QA+3f7VOAWtvXN7FfH8+lgXCSUf+paJq/kpPnzFkZXPTB3RLSMxJio6Ib3LpRPnfvprkf98dgGuQp3YE6uX7/dkXDnG77SGL/5kdBQl7fToL9VvZnM3zsqOppm4fo/uLA54YkHnDxu+LyfywZMntPX7zmOHT75Gy3iObNp8vL5Z+Zr9RsKXbHn07k/zsh9497G+0YHGeVbjW0uAmhs/Z/7zryKOThkxpn+N4GntpcM6S3jv8aMnz75Tcenj6/zbDupDa64Y04cxrl6+N6jLghbGa/15yUM3DOqoiYuOScrqMuiGRz/+Ke/MySF3+qMxyQwdP+Kt//x2HtfBZ/tG01L97VsC3/4Jcf638cVbhmenx0cr4jSdh057actpV11vbyieuvgnCue3d6QzlDT78d9q7euV22Zl+P7DE+Cn1Jlvqwo+GRNLM6m3fF3zCVB84bLr4mg64YblJXWPiDhzCwlo32nCnhgYwXMLIYEnDUIIIbZdT8145c/4sW+8M61N3Y88Qm4hhFy4ZBLgJhRoziGE8JXH1z89cWA7dWxUVKym87AZC3ecd8LQvKThDvC9TTh14Ur/+PyxiUM6aeIUijhNpyETH1t2sLT2yjc1kfogU/kRRabyaTQFieMsKAxF7QhQvnZyMk3JBrx67MydhLLVkxJpwmTO3u7XSNzUDmjb9rsNEoqK6njzRwdLvDzP857CX94amyWhCCHn7qFxeV/dkEITOnXUCz/mnbmtVnzgrbFZEopSDX/r7NJ9t9oIxaRf8+avvt/devPWTtMxhBBKapi89G/fhBCVRxdfnkATpu3/9py5BWVfNyWRomQdb1t18mx3blXutocuVlB04rSvz65gXR3QhBBK3unWFcfPvM957MOxaTShk6Zt8r2NNb41LIqiE4e/9HPxmVkoy/Y/N0RFUQ3d2bStmRhHyQbU/IMaHdBs3ua7u0VTdFy/uTsD7332rdrm6Uk0kY94J6fW+6q2zdLQ5zf61oP979UB0rruAlV9P0tLE9nwt0+e/u7VGSOytXGKKKW6Xf/rH/7k16Km3h8L7KsJTEhWnCs79fvPu7et+/j5W3on0VRMzwe3F9danH3NRBUlG7gwsm5cAwBEvqrv7kijCdPuvGdU1OI5+GQ3CaETb97g4HmeZ0+/MURGxU56b/n0tjK5uvOgKya9+auH53mezd1we6coilC0IqVDz57tkuUUndj3uuFZzLn5l1yH3hyZwlCEksZldrmoz0XZugQZRQil6PbIuYmofL+aiho2/eZ2Ukqe1K7vZZcP65keTRFCRXV9uPrvap5psMZVc268vqbrBmTKKELFjv2ihAvg06sOLp07Z9ZIHUOYtCEzHpzz6Dt7Srla5zM8z+Z9PbtbDEUIJU8y9Ox9UcdUBU0RSqafuOy4p4mrUBfWtHiYnE6Yss7/j2r/rovN/Xp212iKjuv7aJNObDx/zOsuIZLOcw/UPB3hSpaOiaKouMlr6+lRbvYbubJts9tJJB3u/7Ghla5bQFtLYJodP2vePP+B+x9c8G1erfOUqh/vbcMQSZfHfj2/v6fes76z0fz2eLaEMTzYyK4XeZrbtFh5+N1rMiQUoZiY1Pbdu7dTRzMUoSQZY9783cbzPM+zpz8ak0zT8SPf/u/Msl0Hn+sTTUnbz/6uJOAdgCvbM29gAk0IoSSx6R07pisZimLSRl7dP7pmB3Sj8Zy/FjUSReX3d2YyRJL9xG81NgDH1ts0NCXr86LvCS+BfErd+ZbL/3h0DEWnTt9UI0vkfzRaSdHqKevK615/ceaWWjHWt+80a0+slxhyS02NJQ2u+JtZ7aRMxpTVeZx7592ZdXZAt6TcIvJkEuAmFFjOOdMB3XXSrGHJjDypXd/LrhjWQ6ugCKGiuj2y128Dan7SCPC9gZ66eE2rp3eMogjFqDK7Xtyrk0bJUISSd7zVf5LjQD6xLshU1USUqQJMQWcIeBbUKgvQXOnKGxNpSj7kjZPVX0nZ6omJNGEyZm07N6NC0wrQXOGy61QUJes17/caverl387UMX4FaO+xVwfIKVo9YXmB/67IlW25LZPx2+Z8mY6KvepjvxkW3D/ck8UQOnniKr/8a1txg5KiVFPWu868cdX/rhtz3f0rTf5xev6c111C5Fd+fDYB1F2AZvT37PTftt17HtAzRH75h74f9rp33JXBENmwt/1+C8yV/PThvCeefHnjiXoOQN5Dz/SUUnFT1tcosJ5LUq78Lfd0j6HouP6P/VC7+tk4x4rrFRSJumZZWa3/ODN1xkXPHwnk9wr17oSutZNiKCLtdtlwLUNRsriMTl07aJQSihAqynDTcmNTfokT4FcTmJCsuGvtpDOTBBFK0Wn6ipPn5xjP7092lVCJ0za1gB+LAQBEEN/MSER+1dLGLrmcq26IpojskjdPs/zZaxtpiiaz113rT5079HIFKyem0ZS80/Qvjzl8B3XLNw/1U1GEnHsAQGA3SgO7aV37TOO8FSzb/WivaIpOGf3ev76jTyCfft4UHLU+pWm3+RtbhbqI87Z6c9/oOvBEDxmjmby6GU+bEd1tdT9e82djU2jCGO7fVUcgjV16tdi77zfHU4SSJ2W1q0OX6SvObK21L3lcB57qGUXRSYPmrDl25irBeerrhwck0JS0w/0/+K6yWePH16hpOuHyd094ed71xwv9oilZp/t3NmFS8QBbeQKLp8ECNO/aeY+OIZJuTx702wLsm2ek0ZRi6Fun2YA/pZ58e6YCnXbrlnOXVWzO+6OiKVpz65b66hLizC01Nbrv1NLwnlgfEeaWhlecK1g3NYth2kzfWMjxfEPVnxaTW8SdTALchALMOdUnDFGdb1t14sybXSc+n5TFEFp969azF8nBJI0A3xvYqQt76oMrE2gqqtO0Zf/YfKWe0oOLr0tnKCbz9q3lTfnEuiBTnSWeTBV4CvIR8CyoNU7BwZduXfFtKR81aOI4XfX6x/lm4cjduHK3s3mLdR/YucfOS/vfMr2H3P911bBpN/hN3sCX/fTjH24q4cqbrk7xnzmBihsx5Rot4z2xZ4/Fr2Of0V3Uy2+GBTohKYEikuyB/eLOvShLSoqlSPXPGuiM619b9/W612/IrF47b/nx7Su+P9X4zwnolJHXDPT/NQIdF6+iCSFnFs/oO7WXU57dL97y+LLdx0s9hBBCJQy47ennnn34an3dPzYibI7RwtJqTUpd/88WfPvgFTcsPuQgMX2m3TEk8dxqefc/3EFS9291fWR95x9lCeHPrHk9c3ZwbNN+RVGbx+VieeL5a/t+9W3L/rKWmP/569/cUsuul69I85z4YtadS82B/8AisK/mQq649OJZ73/y0ftvPH/f+B4xx5dO7jP0yR9q/SqQSdWk0LzDYmrKT54AACBYfEVZOU8oiUoV3cisVIwqPpYiXGlxWfURifeUxE5YvPDaNtWzvXEnv1i0roDS3bp40aT2viVK0y9/8cM5PaXnFs+VelMuuera2c89Na7t2RmmZJqhN41pz3AOa6Gj1gGi7R3vLppgOPOHivbTHpzchuHs+Xm2AA4Y3tOf3zrx1T/YTrOXfXZHB2nTP71u7PHPF20sJOrr31w295I0349D6cTed33y3i0ZdMWudz76vcaPVJuxCuypw0edRKFvV8+0KGzB1vsvn/D2EWm/RzdseWFowFOK+XjtNidPqJjYmFrvo2JiYijCO+zOuiNr3hu5Ux89+uZfTL8HnrpO3bRASWi+ryDjrxtf/seSGVfcub6Q1k1+5ZHBUY2/4zzytu2zGM/RQ0db4ARkfFWx6XgdTuRW1H3mWL7ljXcOuROvfWP1K+Pan7lKULQZ89JXLwyP8R5f9tF2ByGE0FnTFi+4Orl82+P3fPzvH6/PevEXNvu+D58bqgp0w+KL1r/12UlW2vORrz6c0TOBIYQQSXKfu5d+eGtWjUuIwOJpmHzghHE6xvvPhvVHqjOCfcfKTVZeOWLaDVl00z7l/HxLpYwef2k0b926bnflmZc4y7rluyvpjHGTh8XUHZRIc0vzNXtPFG1uqS/enOV3z/4it+3t7y0ck9zI19KicotYk0mAm1DAOecMpu3t77x5vf7MhizXT5g9LovhKvLzz2yRwSSNpqW1Rk5dvAc/fGNbKd3hriXv3tTJ12tGx/e8c/ETw6K43G82+ybWbH4iRaY6SzSZqikpKEDhy1SNTGXUEvHFW1ZuK+d5fsddWcxdtf83f9PKXc5RVzR5CjzCV+Tm2jg6sXMXTa1dUdqlexcpOXnmX1yBJdfLM206tpPXWoLE0MnAkNxccy5Lzs3OyzD0eRsRJZNJG96yuLLDm75YtW3/n//8d/LUqdNmq93D84SQ2p9ZG52cqm7opgStu/WtRfsnPPDl9vlTv3+ZiUnrdHH/gUNGXHXDhKt6qOvbmDiH3clTGoWijpjZE5/Oe4dStWmbbDy145mHV163fGLamT+jUwdMmjnLWn95l9H1SqAIo1RGEeJ0Opw8qXFY4p0OB0+oGGXtnbhpJHI5QxFK1u/J5YunnJ0qR5I6+KGlL+3tOH3j9x+tPDX9QUPgd3Ia/2ou5IrTWZdMnnYJIYTc98h9S8b2nblp/syXxxx+uZ/fbN2KaAVFOLvNzhFSzz0GAAAIOUoVp6II762ocPJE3lBG5+w2B0+oKIXfX9Epw6/s7XfU50t2ff+bm0q9Ytxgpd9bJV2uvbbLswf/OvuujOtfW3d9jYXXfw+7npvWOYQ0es7N2/Y9c8PstXlxw19btWDU2auTJn16PQtu8Db/J2+f2LPHwvWuPstqzio0flv95XcOOUjsZefdVu8y6NX/6l8TaZ+XDu17NKvZd5eb80bb9lde+cGRdvPc2zs04wAf2PcV9hWvgS369dNnH3jy/T25HkXHyR+se39cWrPOAn133/+zmIp5og3N1ZxoSHs9d/DAE9kBf+PuX7ftLOGjx954Tc2xpDOvGN1D+v3+/XuPeK/pKyGEzrxp8cL1P0/bMOeSA+4itsfcJU/XyDaNfY6vlWdwna08SxacrP67QONpkKzfhPH6Ra/+s2HDP0/26MYQQiq+X7m5iCTeMO3aFKqpn1I73xJCpVw1/tLord9sWben8vKRCkI449oVP7nottdPrre8Idbc0hzB7YlizC31Y099PPPeNUXt7/li/qi6nyjkr0XlFrEmkwA3oUBzztllpl1+XY0TBkoZq/Rbj2CSRlPf2+CpC3tqx47/vJL24yb2839WFZ1+y/Kjo8rYmFRJkz+xBmSqs0SSqZqWggIUvkzV+grQfOGmFdtthE7q0Lt9Yo2yIe8wHTqcW7Bp5U7HFVfVc2u6ATRdXxFSHq3wKyL7tiyqjq/RtwSWa/qU5TXw5ftevO66p38s5GN1vQcPHDj28psN7bN7Ju6afe3L/zT2ZpquKzI/iuxbl/059rEdG9Z/s2P33n37969fsmvdkpce7zHr001vXVvnfTBKKpMS4vHUdfuE56mEwU99vf7Wk7dfdMu6NY88tnnkR2N8V6J0m7HPvD220dX1pmdlMOSfPEsuS9L8t+fKvNxSnpKnZ6YE1efPJCQlUKSqw6gr2tXYWyj1pcO7SzfuPXbkXy8xyAJaVmBfTbhXnPO6vSyhpTJJjf+XtJ0y86pHt3x6+pdfC7h+Gef+z+PxEkLJZLJIP0kCAIgolCorK54mRf8ePuolAxp4ii974u9jVTwV1daQce5qgElLT/O/NmAtp80ensnSZ9U89WN0Bp2E/OX3SsD3sBu7aV1/wKblt9/40m9VhhlffnFvds3lNvcO+tm3N+02f3NWQaS31ZvxRs70+SvLTFTnx+6+PK65h3gR3VZnC3/+YO69T336axEb037MEy+9+si4jspmn7rg7vtZvM1kLOb4qjUT46iJdfw/VVhQyJ65pKQzJr/16tq9t6wrZLrP/eDxfk1p6Am0lacp8TRE2vuG8e1fn39k/YZ/Hu/WlSHl36/cWkLSpk+7MoFq8qfUzrfkbA/01m83r/vJNXJEFHtizYr9bqbjhMl9671oEGluaaoQ7Ykiyi0N8h5757aHttqy56x/flhAibQV55YLlUzOaGwTCjTnnMWkZWga+MaCSRpNfG8jpy6s+bSZJYyho6FWHoxKytInNesTa0Cm8id4pmpyCgpQ2DJVqytA8/kbV+y0E2mfhzb+9EjHmmNZtupG/Y0rCzev3GG/6uom3WQjhFCxGRkJNFdy9J987rIs/5TAWU6ZvOcmyEhN10ioP4zHTrpJZ/+bUoQ99d9JljCa885gmob9e/E9z/5YnHLt2998Oqtb9dbLHv49ZBukJLHzqOmdR02fSwjvzP1t06I5d7/643t3PT/28ncvq+OmPp2cmkxzZSVldex2tPamTzY8NSiR6r/g2c933rVt2QNP33TJW8NVTQjG0L1LDHX41MFDZfxFfj858Bw+eNjDS7K7ZysaeHcAy++Y3VFK5XvPr59zHEcIkckDvCgO9VfT3BX3/vZE94Evn+qz4O89tTq3JTFKBUUqKp2V/o1fXFlJGUdJklMSW+OEPQAAwpH1uXRA9JL1p7/Z/NeLAy6qtwLNntiy+bCXiuo7dID/FZpEWvMdrNdLSB03wGvceG7aPexGb1rXyf7L8xNmrsxRDnph5aKrU2ucZAdzB/3sMgghTbjN34xVEOltdabJb/Qe+ujdH52y/rfO6NXA7Y0GiOO2ui+Ukr3zJ904b1sur+572+JX5t1+SXpgrQH1wt33aizLEkKrLppw2/CMOr4DSt5Ld+7KpSrvhMnGE5417t9v8fZp34QrzUBbeZoUTwMkvSZc32nB84fXb/h3btfOtu9WflNK6e6ZOjymOZ9SO98SQqjU0eMvid763aZ1+14fccnJ1St+80i6TpzUs/4hEWluaYoQ7Ykiyi2Nsu37bm8ZkcVtmzNyV3X8FacLOOL9feG1gz6XSTrNWvbRtHO/bm7NueVCJZMAN6FAc85ZDNNgagkmaTTxvY2curBelhCq4XCDSKTIVNWLEUOmanIKClDYMlVrK0BzuRtX7nISad/xY9udt0/FXTZuRNyq1UVbVn5vu/q62CYuWnrR0EGqD9fuW7r0r5lP9Ti3Cbv/+vKr387tn1TCgEu6S7cc2PrF5qLR1/vVDW0/fLHezEoMQ4Y0efOoofKv3//2ENXI22Z08793Umk2FgT9ewX28MIrxy4+mTVrzf/Zu+/4Jso3AODPXXbSpkn3gtKWPQXZS4aiIEMoe8qeAg6cgKgoIkuGws/BEFD2RgURsJQtIlM2bbpnmmaPu/f3R6C0pYXS5ppL+3w/fvzQS/Lek3vv3tw973vvHXqviRAAgJKHNh/46ZxjG0+sybofrycgfXwXFUbVjhKS2MTEPAJFJ6WhvUNClBQACKLGLvtoU8t3T303c8GwMwtay0t7t0Jdr049XvDatv/Ejv1po0aHPCzfem7X/gRGWOeV7mW5q7QAKvjlV5uLj547sOffj5sXuLuO1fx+8F87JWvWqlFpr9tKWTUcf3FBzSYN5NStK38eT3sruuANFY6bcafSGVpVt15o4UFzCUmMoFrtmmXoeUYIIVR2lKr7iD6B+zZf/2HB9ilbh4YWe3ZAsg4uWHXeRvn2G9OvhOn4AACADgoNpuFm4n0NAwXPgJikhKT8Hxzu+7DZ5O2TBs4/Z64+9Jct7zYt/MPiirVz3s3P2271Z/6g7exPm687JB0HxZTxvJMf3eoAAKYLX/TsMeeMtUafxZu+m9E2wAVjdbD3PR/lExriRRNbrf6fLYp5yrmg8cxn4xb+A3XbPJ9+9ticyWte/n1aqbNGpR3K8yzxPJmw8cABDRZ+fHnP3lvvBV/aeiiXrjtlZFuJy9bizED/fvjA7tML/WO3XXKInh86qN4T9k6eti2l56ojkT9tS2mx+oSLZxKKLtXd/+fMfRA5ehcc2lOV25aKakxKuQuVts0ppfI0Gq5r1gAABCHhwQLITriXwECjAkchybv6694LOb7Nevdo5FOONWJL9QCPWqpnaIJKibuWqoq1fGzSnq1xZhA17fda9ON7GqXqFtNVSbE5v23/I++Zy6b8ek8dESWwX/xy6KSfruaxAADEcOOXqcMXXrQXmMtFUGv4tFf9IGPb9FFLTmc6L/rY3Itrxk74MYH1bj9tfPPy9QqIA4N9KaI/89uJ/IfJme/9On/QpA2pLIDDVp55xAXVowK1mrt/ffP5huuGB6Wzuisbv/8tnRVGNGmkKvZgo/yfbxEtcPx3+T9HcS8/JKr/xopZTSX2q8unL71ke3i3whNM6NdUTQFQ/v1mjKxB5/0+b+amuzYAACDZJ+a9+b87rLLrjAmPBhrY4//asnnzz1vjnuGxgQBAR456f2g4e3Xx0JGrzmY7P2q6vfOtQR8dM9E1Rkzv93CWSWf5m7fExpfwPUtZNRx/cUrd4/V+IZTx8JzxS89kPgiVGO/ufmf0on8dwprDx3YpOAENm379eibxatayflXrrUIIIXejfHu//3ZrL5K+a8aIRed1xZw/Gi6tHDXxJw0ra/nuZwODnnTGS4d07FRfRNJ+33Oq4MOWmdt7917J/9Xisg8bAMB44ctB437WSFt8tHVN/8fS5a5Yu7Obn2T/tvlgVqHt9aCbv0Z5u/kfdqtrExPzHq+Qwt3qbeTMne9mLjhjAij9E4a9OvV4wQvMJ3bsTytQ/oPe5VpP6FZ/xg/aTm/dFc+KW/XtXdzgp9Iofbc6t1+cubFq2udnDP49v/1z+1suyT4D9r4XJG7eqa0CjLG7fy98TLHJPw2uFRrW5J3jVucCQ9y88UsvU01n/XR4+6PuKWwAACAASURBVJcvq/KOzZm85vYTz/0LETXr1E5J2U+vX3/FVnB5kaE8pY/nqQT1+w9oLLJf2r3n7IFtR3SipsOHN3l4tuuKtVBBr8Z0lLNJ+7f/sHH7VYekzZABj49/KoCvbUspue5I5EvbUirqUfstpAjbsWnVBCDuvCqRIcR2/oN6RTt9q2rbUlGNSSl3odK2Oa7+di7+7GMEtTt2CBU4ru3cfrng9yJZe2cPHTV66tprhCrXGrGleoAfLdWzNkGlxGFLVTTaSo2593VHCUWJW31101HsG9isTX2VFNC+g7ZrCXHc/LKlCMRtF99hCHnsz+I+ro2d3cqHBgBKpIpo2CjaT0JRdMBLb09oKabDpx61PYwjec+E+nIKKFoWXL9lqyY1VGIKgJJEDd54x54fbOKqzmIQNpl3qUCsjkvzmghB8tKaVPbRQuuRSSE05T1sj3Pfs/77ZVslBZTQr26HHn16dmle019C+zQdOaSljKLE1TuO/OxgMkOI49r850WPiip2dYQ4rnz6nAgkL3+f7lyh9fLiF9Q0ACXwCmvQsl2b5+sGK2gKKFn9KQfTWVICy9Gp1QSi1l/dKlA2m7W2uwSEdd47a3+00HDinfoiivLquPSG/fFiSsTmHH27iYKiaEWN1j1e6/VCXV8hRQnD+627W7AU3cbeUgBKPmjHYwcpIcztRW1EIKg160wxK2az/3z7OQUFFCVR12jYpE6wQkABJQjo9MXpvEdf2lk+SPtsyishzlJWDedfnE0/MLmenAKKkvrXfK5V6xYNwr2FFFCCoK5fndcXXkXeziEqWtFjbcm1ixBCiDv2O2v7hgkpoLzr9pu35azG4PyZYE0pF3Z8PrihDw2UsFrM2lvW/E8w8V93EIOo5ZdFznWY5I39AmlK1mDizvvOnwN76tGP2qlpigI6bMqfVkKsf04Jo0FYZ+of2Q8bfdPdg5/1qC6ioODJRynPGQqfaTApu0ZFiShBWP+N8cWehZVu7WzK6q4SEDaae/HBL13R85nkjX39aUoQ0mPRqQznehjtP6sH1BBRlHenFbcdz/QViq2Svz+sLxTUmBFrK7CwmLMay4V5zaQUJWvx2b9WQpj7u+ZOeVLv8tQFv6cxhBCi/3NqpAAE1Qf+dMf6oOzY91soKEr58v8SHp0l2O4f/2XTps1bTmgeLivlB51f4sJH9YUgajb/avFnxA/L3/TLX/dLOCMr5d7C9Re3X5jdQAjCRnMuPsOZ4xPP+gghjGZlJzGlGrJTX+zLnmuEigJR089KrHWnopc8eYcn1RBQdEDnuYc1D04lLclH5nXypylR3XdOmgghhM09OqOuiJI2nX3ORAhx3Pn2JRVNq15cdevhJn58jy3KcPSNaCFFyeqP3nBFxxBCCKv/7+dxDeUURVEFrqRKE8/j13GFG4oH77nxZUsxJar9XEMFJeu8Kr5gZKVbS0ntrROb+kN3BUXLveQ0Je/2v6SnnOXztm0poMRjp/RHoqe0LaX84sV9w4LZnyLFVJq2hdeNSWlPZkrZ5jhPGB47zO0X5zQSguTVdQ9XUp5Go5SfLe3Z11dtFBQlbzxp+x3nJ9m8q98PqC6g6MAh27PYZ1hjcbClcuJlS+V8R8lN0NO2z8PXuWupqlQCmrmzuK2YosSFE6GFsJkb+3hTQKkHbMlhnzkBTQghhpu7PhvZqX6Ij1Si8I9uM3jenjuG+193KJSAJoSw2su/zB3WqX6oSiaWKoPrtB/43vrzmQXDKnMCmhA25/x3b/RoEu4jEUt9whp3G7/ot3smRntsbufqXmKJf7eVtx1lTUATwuqvb583okujamq5SCiS+0U899Lrn2y9nPvE/KTpyORqAtlLa5IfvavYBDRhcw9PjhJStPqV/91/tlSs7t+f3o1pFeWvkMhUYY26TVh2NLnI4VT2BDQhhM27umX2kPa1g5RSicKvRvNeb6w8qilcztMT0KWsmmdSxi/O6i5vmff6i40jApVSscwnpF6Hge/8Ly7FVqR0Yjo8MUzg1f2HFMw/I4SQm1jvbp/eOkBIAQBFiRT+YdXDA7zFNAUAFK1+fuLm/wpdJ5ScEGHTDk5tKKeAEniFNmjWqLqPiFY8/9aMbhIQRL0VZyOl7igtSwLa+sekEBqA9mvy6qDBRY346i9Dadeet3WAN0XRfo1eiRn00f509rG8Utm7+UuXgOZvt3rpPkgIIY5bX7UWgaD6G8cf++EvXD7vu9XZ1DUvSQAoodSrWKo2XxSTIHnaWV+l7X0vW86IsLknPm6rpgEokTqyaevWTWv6SykA2q/D52fyCCGEzTk8pZaIkjb56OzD1sh+c0UXH6pA1uiJ5+EP1lPKoTxPjaeYb1FsApowtxe3FVMAQHn3Wp9WuLpLtZYnJ6AJm/rDKwoKAChl7w1P351427Y8UtKx8wxHooe0LaX84sV5Qvan8rQt/G5MSrsLla7NKW0CulyNRuk+W9pTF+uNH/pWF1EPCmvZKEIlooASRw7bkuB4pjUWC1sqJz62VIQQVySgOWypqlQCGrmP7cx7dYTyl9Y8revf0xl+6ec7YJvR3WG4jPHwxHCh36Bt2R5/loQQQh6N0V7ZtfjNQS80rBGkkokkXn7h9dr3nbxg2z+Zj506PjEhwmSd+/6t/i80CPZW+NfuNOHbs9mZ63pIQNj443+dBZWqo7QsCWjL/lHqEucIkfRcn1PqtRsvfjukWai3WCgL7LsumSkur1TGbv5SJqD53K1eig8SQtiUNS9JKUrea0PJv+8e0q1u//vDJ84R9lgVE0KeeulVeXvfy5gzIoQQ091fF03s3jTCTyEWy3wjmvaYtPRwvHPfY7MOjo8SUpLGH5wueApsu76kozdFq1785raDlCoBTUiph/I8KZ5iv0XxCegHt8cC7Td4u7aY6n7qWp6SgH6YgXaObXrS936wPv62LQ+UdOw8w5HoIW1LKb94cUrO/lSitoXvjUnpd6GntzmlTkA/5ds5PaHRePpnn+HUxZ52cs3M11pG+SvEYrlfVIs+M/93Kr3oKp+6xuJhS/UwTN61VIQQFySguWypKEKefUpqhJ4Zm7D65YZvGuZejptV3ol7eIy5veiFGO3X/3xRzom8eYJodw6rPeTimBP/LmwlefrbEUII8ZjDkJmhs4t8ggK8CvwOOy7Oea7l53e7r0/ZN1LtvuA8jP3s+43ar6y+6tbvE5/05EePZ9wSU33X4MRtA6rWbKWmPybV6bGj3c+3fhng6+rHv6MqhmRt6ldz5D7xsF13NvYpxYO4sG2p1LBtQZUEtlSVGqctVWXeXxCf0BGj5k2KurhmZazR3aFwxXphzajhG/xnjG1aKbLPAMzd9V/vo1+b+2ZLzD4jhJCnI9rtr9esVq3xzMMFH0Jov77vwC1G1LRj22d4RjkStZg8oxMdu/7nOy55OCNfMSmJ6WE1I8XujqNiEe1v63am1xz7Zm/MEKHyYpN3/vRHHhX82vCXStfEYttSiWHbgioNbKkqMY5bKkxAo4oib/vB0tepTZ+tu1tJ2ylBUMuJ647vGBtdOUZ4E+1vX3x9o8OnXw4MxpMkhBDyeJR/92E9/CB989uTvj8Zn2txWLX3Yv83fuhXlxj/nlOGRlWO366Kgt3qlRb2viOXITl/zF90zETXGDCiU2nHz2HbUmlh24IqEWypKi2uWyqcggNVIJJ3ed/229X69WtW8jyQiCdstw9tPqd4eUj7UOymQgihSoFN+/29vsOXnc1m8s/9KFFQx3c3bfv0xUBs658Ryfl9cssht2b+/ce0StLzXJgj6Z/TedXb1PevUldeRHtg7HOjUz88e2Ai9smgsmPvr+rZadFFbUq6nvXp9s0/v02KLH0Ti21LZYRtC6pssKWqjLhvqTABjRBCCCFURThyrv2x+8DJ6yl6UARENunYo0eHKG/sFC6Th93qMc1w9uzKAnvfkUuwKZuGtJq4X+/fuOfMJctntvN7tkYW25bKB9sWVPlgS1X5cN9SYQIaIYQQQgghhBBCCCGEECewCw4hhBBCCCGEEEIIIYQQJzABjRBCCCGEEEIIIYQQQogTmIBGCCGEEEIIIYQQQgghxAlMQCOEEEIIIYQQQgghhBDiBCagEUIIIYQQQgghhBBCCHECE9AIIYQQQgghhBBCCCGEOIEJaIQQQgghhBBCCCGEEEKcELo7gAo1derUvLw8LkpmGAYABAIBF4WXByGEZVmKomiad50NLMsSQmiapijK3bEUhRVaBtxVKCHEZrPNnTu3YcOGri2Zt5YvX37+/Hnu6poQ4qwsl5fM6XHt3CBclMzpIc8wDBclc9oacLepOd1DONrU8Ix7yKBBg3r27MlFGAghhBBCCCHkiapWAvr27dtr167l4qJXp9OxLKtWq11ecjkxDJOXlyeRSORyubtjKcpkMlmtVm9vb6GQd/thbm4uAKhUKncHUpTdbjcYDPysUKPRaLPZlEqlaxNAJpMpJSVl06ZNDofDhcXyXFJS0vDhw8PDw8VisUKhcHn5VquVZVmZTObykp3HtZeXl0gkcnnher1eLpdzkWHk7pBnGMZoNCqVSpeX7HA49Ho9R62B2WymaVoikbi8ZI4aCiedTqdUKrn4lddqtTRN+/j4PPWde/bsyc7OdslKU1JSCCEuKapYfO4GLohhGH52uxaEG9OFnBuTh4MAiqiAjWm32yMiIsq/U5lMJq1W65KQSuIRu5az4xaPU5fARs+FKmBjsiyrUCh8fX3LX1RGRobdbi9/OSXB49SFcGO6EG7MfA6HIywsrGxJPN4l/rgWFhbGxR4jl8sZhvH393d5yeXkcDjkcrlUKvXy8nJ3LEUZDAaLxeLj48NFoqqcpFIpRVEu+ZF2LZvNlpeXJ5PJuEhKlpNer7darWq12oUXjTk5OTqdrkmTJgcOHHBVmZ4iICAgODhYIpF4e3u7vHCLxcKyLBeJS6PRaDablUqlWCx2eeE6nc7Ly4uLrIRMJiOE+Pn5ubxkhmH0ej0XqW273a7T6ThqDUwmE03TUqnU5SU7GwqVSsVF16NcLlepVFz8ykskEoFAUJpuZqVSybKsS1Y6bNiw8PBwlxRVLJZlWZYVCAQ8P5N2OBwURfE8HekRG5MQ4rws4fnGZBjGmYCu4hvTbrffv38/Li6u/OfJhw8fXr16dWBgoEsCKxYepy6EG9OFPGJjct3osSybk5PTtm3bOXPmlL+0adOmCYVC7jYp7louhBvThXBjOtnt9sTExC1btlSrVq0MH69yCWiEkEcghKSlpel0usjISC4G6iKEEM8JhcKNGzdyV76zu4if3cD5nJfNIpGoNMPP3cjZp85Rz4qrMAyj1WrFYjEX92S4EBf92S7ncDhyc3M56iRmGEaj0TAMM23aNFdd6Pbu3Xvq1KkuKapYWVlZQqGQh/cOFsRpH7mrEEKys7M9pdHDXxCX4LRvXq/XJyUlXb16NSEhwVVlfvPNN9zd+W02m41Go7e3Nxf34blQVlZWKYcmuJHJZDKZTDzfmM5GD39BXILTRo9l2aSkJIvF8tlnn5X5DI2/Z8mexfVND8O4pBghRfk7Y3NRgQAAhhyXFOMF4CUCMOW6pDTX8nMeGbpMl5WY7pqffDGAi4fZJ9xwVUneAK66CGNooUZVg/Hxj46O5vN5LUIIIYSQC1ksFo1GI5PJXDL5BkKoKsvMzMzMzAwPD9doNO6OBSHkwex2u0ajEQgE0dHR5Tk5wQQ0QohfLEKpxjdKZjNFREXxfCoohBBCCCFXcY5V9PX1DQoKcncsCCEPRghJTk42mUzR0dF8Hv2KEOI/k8mk0WiUSmVISEg5u8YxAY0Q4hG9RJmkjvAzZgbq04Bu7+5wEEKo0lIoFDx8nEARNE3z8AEbj/Py8uLhwzaKEAgEXG3MvWtcWJgLb6gqpE13FxYmdN6RZjaC2TX3BQJAttmWbrSHh4fzfI6UYnnEceoRjR5FUR6xMblq9Iw6FxZGA/jLRC4v1uW8afCWicBqBKtrCnQwbEJ6JiUQRkVF8XliqGLJZDKPmH2Rq+P03mUXFiYHkANAnguLBAAXH1BU/h3eiS4sFQAAohq7sDAFgEImArsZ7GYXFgterpx4hHb57fIAuT16pHz8cVB0tEueluRh7RFCqBLLVARmegWF52qUFl6fJgJJ2z93fubg5WMaFDf5EZtzaef6Lcf/TdB7RTzXZfDomCZq6knLEUIIIVSFEYDkPLPRzuJzLxBC5WSx2RPSM71k0tDqNXAaH4RQmRGazpgxI6dfv4jp0xVnzrikTLy9HSHkfoSik1TVcxQBkTl3eJ99tiQf27jnqsnOFvsyk7Dri893JIb3mv7eG71CE7Z9/uWeROYJyxFCCCFUdTlYci/HaGNItFqO2WeEUHnojKZ7Kem+3l5h/r6YfUYIlRmrUGi+/jqva9eo4cMVZ8+6qlgcAY0QcjOHQJSgiqSARGfdFLIOd4fzBCTz6NKP151OzrORku5usV0+cOB+eMzXk16pJgBo6J975539B6+9OqnuteKXN+bvU3QRQgghxCmLg03INSnEwjClFHNFCKHyyMjNy9bpqwf5e8mk7o4FIeTBbNWqJaxcKU5NjRo8WGAwuLBkHAGNEHIni0h+16+21GGOzLnD7+wzAFCqZoPe/vjLJR/3r11C5x2TeO0/Q3Cz50Odc3MIqj/fNDDvv+up9hKWFz+KGiGEEEKVnc5iv6c1+spE4Zh9RgiVA0uIJiMrV2+MCg3E7DNCqDyMzZrd27zZ68yZiKlTXZt9BhwBjRByI51MlaysFmBIDzBmuDuWUhGpwqNVQLS3ZSVcKbJZGVnEL8D3Yd8e7RvgS7IyMh0lLGchwrkoLi7u559/zi/HZrOZzWYAsNvtOp3r5yRhWZYQYrfbXV4ywzAAYDQanfG7lsPh0Ov1XNxRSAghhHCxqQkhDMNwVDIAWK1Wh8P1PTcMw1AUZbW66Gk4hUsGAIPBwEU9MgyTl+fyJ608Krw09WixWGgae/cRQk+RabRmme3VfGTeYrwcQwiVnd3BaDKyBDQdHRYkwDMQhFA55PTvnzZrVsgXX6j37uWifDzjQQi5R4Z3cLY8oLo23sumd3csLsPYrA5KJsvPT1MymZSyWW2OEpaThx/MyMg4d+5cfjn16tVz5ulYlmVZrsZJc1cywzDO+F2Oi2RrPi4y8lyXzOkewlElApf1yN2mLmXhztw9dzEghDwdAUjOs5jsTJRaLhFgtgghVHYmq1WTnq1UyEJ8VXj6gRAqMyIQpM2aldujR8SUKYoLFzhaCyagEUIVjaXoJFWERSiNyr4lcbh+iKUbCcQSAdGZLQScd9MSs9lCRN7ikpbnf/Dll19u1apV/p+LFy+Wy+UAIBaLFQqFy+O0Wq0sy3LxsCOz2WyxWLy8vEQikcsL1+v1crlcIBC4vGSdTkcIUalULi+ZYRij0ahUKl1esnM8uFQq5ageaZqWSCQuL9loNNpsNqVSyVE9KpVKLi7AtFotTdM+Pj5PfadMJnMOTkcIocfZGVaTZ6EpKkotF9KYLUIIlZ1Wb0zN1ob4qdXerr9YQAhVHYyPT+KSJQ6VqubgwaKUFO5WhAlohFCFsgnEGt8oIWOLzrolIFyNr3QX2i/An7qfrWVBJQAAYHOzcym/Bn7CEpbnD3xSKBQFE81CodB5Fz9FUVzk6ZyFc1GyM/dH0zRHhQsEAi5KduKoZI4q0Tnwmbs9hLtKBI73EI5GAJVyU9M0zd2YdISQRzPZGY3OrJSIQrwkOFQRIVRmhJCM3LycPENEcIBC6vrhAgihqsMaEaFZtUpy61bUtGm0xcLpuvC2L4RQxTGJve7515bbjBE59ypf9hkABNUb1FOk/nsp0zkAkk27dDnNu36DMHEJy7nKpCKEEEKIT3RWR3yuOUAuDvXG7DNCqOxYQjQZ2XqTOTo0CLPPCKHyMLRrd+/nn5VHj1afNYvr7DNgAhohVGFy5H7xvlFBeSmhusTKdeXluHtk/dqtZ9NZAHHjHj2qx29f+fO5u4l3Tm9atSsxumePhuISlyOEEEKosssw2lLyLBEqmZ8cf/oRQmVnczjuJqcDQFRokFiEt7MjhMoup39/zdKlIV98EbRsGVTIHZzYZiGEOEcAMpShOTLfiJx7CpvB3eG4nCP5/IF995k2/VsFgTCq/wfv2v+3YdX7uyzysOd6vjexb4QAoMTlCCGEEKq0WEKS8ixWho1SyyVCHPqDECo7g9mSmJGt8lKE+Ln+sSUIoaqDiMUpc+YY2raNHDNGdu1aha0XE9AIIW4xtCBRHemgBTWzbokYm7vDcQFK3f2zHd0LLJB2/GBHx/y/BAHNh89uPvyxj5W0HCGEEEKVkY1hE3LNIgEVpZIL8JGDCKFyyMkzpOXkhvr7qrzk7o4FIeTBGLVas3QpEYujBw0SZmVV5KoxAV3pWU4tHLlC9uGm6c/xqLJZ7fnNSz/9/kDcnTxpWL0ug9/6fGqXGlJ3RwX8DMx26rs5K6RjNo2sU6gGzceGtHtvi5EUeq+4/bq4pa/7cHuFY0q+sHjj77/8q4nXOxR+1V544eVPhrZuKKMAgEnc32bitvOOYj4lCOt58odBrXDML0IIIYSqAOcjB32komCFmKOHoyKEqgJCSFqOTmc0RYYEyiQ4jQ9CqOwstWtrVq6UXboUNmcObbVW8Np5lJMshLnz0/RZO43t3v367Xaq/DM25ua6KR/d6LHqyz7B+ctMpxaPXxhrqj54yddDozC5VRTJPLhq5b7YPpMqYkKXUiLZv7/7Wt+1icEtXxo6Lsxy+eCW+cNir685+32fUPfemMjLwEjOiVUb/op9qX+RGmQykuKtVFDDjp0jCjx6QlgnUsTtFY496c+YNzccMqnbduzUP9Bx99L5ndtWH72Wc3zhq01EQMnDur3QOvrhwwUdApFJpBDbUy7HXkn3VwfgjacIIYQQqgJyzLY0gy3ES6KWidwdC0LIgzEsq0nPYlg2OjRIJMR0B0Ko7PQdOyYtXOi3cWPgt9+6JQC+JqABAIDkxP24vmOjGS2VJabUiP7v2AsmmVycFBd3b1BULWySH2LMWfHX/j66acHcrWlskLujKYDo/vxi4rr4um/sOD6vlQ8FQKb1mvxS/x1frZz66oJmbtwh+RYYa9amXLtyftOa1VuzyOM1yCQlxRN518mfb36xAp99TEx7f9px2BAw+uO537f2oQGAvHZk9ec99u6dfaz9vm4+tF+z+e81c743WxGQ7h0SqtPk7pzd/FTN2VO6ROHoH4QQQghVaoSQDJM9x2SL8JEpxHhpghAqO4vNrsnIkonFEUEBNE7jgxAqM4rKHD06c/z48A8/VB475q4o+DwikQ5u1IA+8f3GfwykpLeQvPOxF+31+49s4516Mu42U9L7qhySsb5vRJ0WPScvP5nJo7HPAEC0e3/cneTT46O3Wj6YKILy7/XBsm/mj2kps2Ngj8LJ3te3Y98W479YfkFbXA0SbVKKFkJqhVdsZpzRxF43CaJeeLulz4O2g/LuMqBLW4HlxMW7+fdvEIpOVlXP8gqMzL6jTNw/c92NqEGvvxXJ6+4uhBBCCLkLk3SoZcxk6rVi/hNO2XWWT2f4pnuHP50ysF7jRrJqdf1b9ImZv+9qgfnQGEISdBa91V7TT4HZZ4TczXJqycjB314ubnZAXik+Tr3JfD81w0chrxboh9ln9CwcSXHrRg/rG9qkpaRBh4he09745Uo2v7JChRHt7k9erz5ywz98+rl/DE/bk1MAgwEKRsUAtASgivxHSODatY079vjPfdln4PcIaMqr8bDBwUsXfre5/bIJTeTFtLlEeyb2MlNvdKdOfkm//HXqxI3hdRvgbW4AAJRv7+V/NcplgWTtnh6zJMnd8Txiu3DsrEncvHPnAsPaBRGdJk7q5L6YAIB3gVGqF5b/XDOXBaI9Nn3qpsdqkI3XpDCiyGiflL8O/Xs13SIPrdulXcMIGcenJowVvIMbNY6MLtB1RYklMgocdofzR42hhRp1JKEgOvOWkMnZ/eP231UvHoupjtOVIYQQQqhYlDykW/vm0UUuj1nduXN30n15NIWX/c6mmN5zD+mD2vYe3D/McffkbztXzTx6LuX4jklNxGBj2ASdWSKgo9RyGid9RsjdSNahVd/+GttrLJ8zb1BCnNl5hvSc3PBAP6Vc5rbIkEci2X8t6Dxhp8a3UcyAUbXEOReO/PbtnHEnU3+Ie6sRL59fySb9unTK7nuZ4a3cOiDxKfjZnhCAVQCxAAWjogC6AUTnv0cqNTZrBo7sa+duZti1AW4I8xE+J6ABKO/nR45r/+ai//3SfunYBo89Co5knY69SuqPa+knl7dpqvjrdOz1UQ2aFMxz5eTkmM3mgp9hGCb/MSACQeUdmCAMqNM8AABI6kUlb87aAYDNiL9noAJrqO5u/mj4t/tO3jf71GjQptuIObNiGnm580ydd4EJ1HUaqQGAZN4srgat8YmZDGt4v+/AVK2DAABQ4oDm7y+eP6+1L4fhSpqsWN2k8CKSdPL8aYfguXo1pAAWkSxBHSm3GcNyNTQQ07X9H/zFxnzwausyTRPCMI/6QAkhhJR4LwRCCCGEPBft23j+m40LLyPxh79p/k/k7PEd+DKFF8nbu2jJYV346HW7vu/mTwMA+8aROYN6/Lhq9q6Yn/v5JuWZfWXiIAX2uSPkXow5W3Ptwl+bFs3fms6ruSiLKD5OQkhyVo7RYsVHDqKyYBLXr9p3T9Vl/e7FI4JpAIBpvWb1Hbtkw7o9Y5YMVfHkB/URJungxIUn0gnFp6xVQTxtT8wA1wA2AWwFKBIVDTD/4b8t9eolrFjhFXfCNv+zFgCzAaIqOtJC+J2ABqB8Wr0+uvXM5Wu2tls8qm7haEn6ydgbdINJrXwpoBq1aSqPPXPi6pgmzQqkupYvX37w4MH8P5VKpVarzU9A+/v7V8R3QAUQQ56e7BAmlQAAIABJREFUEN3B97utt9Xs9urEl0Sp537fuWLaH+fTj++a2uSxTgYMrHhM+t0kO3GII/sv+GNsmxqQceHIT9MX7ps/Y37E7sVjKu6ZiY7401sHfnfZGNx59ssBeqkq2adagCE9wJgBAEAyftxwLCG696523mX7odNqtfn/ttvtBfPRCCGEEKrE2OyzMzfdier3zlsRvLlacfwXez5P0GDc2139H5xp0b5dpg5ru+GT2ON/3+naIdJbopLivZgIuRnJ3Ny37vRDDyYH5GtSq4Q4HQyTmJFNCESHBgkr8Wg5xB3TlRPX7d7desYEP9z55Q1f6xi8bMP9a0ksqHi2Uzk0q+atjg3vNjjoyDbz099e8fjZnhCAvgCHnvY23SuvJM+bF/Ddd35r1/YDiAJ4qyKiexLenNKViFK3H/163JvfrtnR7qvBBV9gk+NO3IYa/YPzEjV6AHVklDj2bOylcc1aPkoWNmjQwGrNn5kW/v77b4lEQuE9ce5DHIyDsHkZ8gmbDn/zcqAAANhZI97p3nPd0tm7BuwbGuiuuuFtYMWj/V57d3FTSeQLTUPlAADVOgz4YD+V2XD2qRW77o6aVhFP47RlXVv+3cb5f6XYQlqt+WTY80FBKd7B1XITvC065xuMl35bdlXY+/3O9craUEskj3qTaJqmab60+AghhBDiEDHs/Wnv7z4dj/UO59HwP4cJ1JGN2jSOLniaJZVRFNhN5upqmUrIswt7hKokSt1j+eH6uSyQ7P3Th6zk0VyUhT0ep8VmT03PVEilYf5qTFmgMhLUm/DpvMFRjQuMoGP0RguhAwJ8+LZT2S+tXzDnevS8DUOYeTxNQPOzPaEAlgPkAhCA6QDFREVRGZMnZw8dWn3mTK8zZ3YD/A5wDMDt51T8T0ADUP6dxo448eYPq3e3fP3RUjYxLu6ew85s+eiNLY/eev7ERVPLNvlT2wwcOHDgwIH5L3fr1s3b2xtbczeipDIZRYnbjJ/zUuCDk3Ra/dLM0W02zY3985xpaE8FBlYalLJ+63b1Cy2iw7p0biM6dfzaHQPU8uF07cR4/sDGcWtPXbH7de0/acnwdqrQCK1IFpV1S+KwPHxP3u49pxL92nzfuuwzmHh7e+f/WygUYgIaIYQQqgpMNw59cJKNebtb2abw4oqs84o/OxdcwBDm7PYDFxyipq2bqTH7jBBPCP3rPO8PACTtMq/moiyqcJzEbr2fkh6qUgaolO6ODHkyeVSPGOcsC6zFkJeTk3blr03v7NOGvvLewDB+HQ+mqz+N+U7T6q3/zYiGZe4OpkR8bU/qAAAAAXi8vWDl8qQFCyw1a0aNGCG5f98E8AFADEDrio6xGJ6QgAagAl+cMCzuzfVr9tV/+HRH5l7siQRRs2k/ftzt4ZS3prPLJi44H3vB0LqDW2cTRk8gCAoJFVC3w8L8Cxy9dFC1MCGc0+lMBBRuqjreBlZ6lJdSJQDCMAwB4C5aNnvHsq9GHs4IaN5nz9Re3aspNOoohrBRWbeF7KOHr7IZZ3+8YK3Ru31HXl06IoSQ5yCEGI3GgksUCn51hiLECZL54+YTCZHdd7Xi9Qm9xWE+vWfBm1+dNFcbPGdohEsuS4sc8q56+gXLsna7vWDh2JggxCs2AoxFHx7o7yd32cyPBQ95q9XqqskMCSEmk0ksfjSSEtsTnmLilw0f8OEVBwCtbj75189fqrh5OkvDeGnunF80LWbuGBguLG4ILyobe1CQZuVKgVYbPXiwQK8HgB8BEgB2lS9FVLA9YVm2zOcnvNoHn4AOfnnCkJpJ5/7JdD7ekbkTdzJF3vzFNupHW1HetEtbX9PFE3/r8VFl/KVo1LyOwHj3TmKB53QySffj7ZRPaKjSjdcZvA2sOI5rm3oNGDNyZ0rBp50yiQl37FRIRFgZZ1wuFea/Xd+OOZzToP875+fHvFhDfde/jsxuqpF9p2D2GYDEnzxz2u7Xq20NnAoRIYTKhhBiLszdESFUEYxX/lz2n7B3n/ZlnsKrAmTHx84Z36vPGxtvBvRYs2nuKy56rFORQ95VCWiGYRwOBzYmCPEQISQp2+gAEMhV3q7LPkPh9sRms7Es+/TPlALLshaLBdsTD0AH9Xvvq58Xvv/ZsBbKK6t7jl97zuTukPIR/aFlX67Mbb10To9IHv/WexxT06Z3t26VXbsWMWWKM/tsBFgG0BugXvlKLnjIsyxb5vbEc2pbEP7qxIF1pM7TO/uN2Lh0nzYvNi+UahM36NIxxPpv7DkdZqB5S1AzJqYxfeGHj3cn2Z1LHKl7F687zwb16tncnYNleRtYcYQR1dTJ135evfbX7If7uj11++pdF0m1AT0acJjztd1YseuOtXbvn8Y0EMtU8b7RAfq0UF0iBYUPOZL35/l4u0+9brU84x4LhBDiIZqmvQtzd0QIcY/odx88l+j7/ISWfL33jOgOfzejbdfXl/xpbjXp6/N/rBxb22U5oyKHvKumDRQIBGKxGBsThPjG7mDupWbYGVZGASVw8XVTwUNeKpUKXPRIQ5qmvby8sD3xAJSiTpuuQ/oPmf3pmqMftLCe/37OvgzX9EKUF8k9uWbiLmvf998cFuw5CUne08bExH/3XeD//hf6ySfUwzsedgMkAkwo9x3yBQ95gUBQ5slR+ZoeEtQc+c2OkUWWRcR8tS3G+e/g8T/sHv/Yp4R1Xl+9+3Xuo0PlIKg75pM3dwz4csJLN/b26VZTcP+vvbv+ya0+aPUnL7r314u3gRXHq/3smW3/mLevf9+EAT2ejxTkXI7788BNR6OxSz58jsOZ5ZnkW2dyiVhxc94qnV0oUdgMQsaZrqeUjboveTn8QYNivvnnTbu0Yd2WOP4ZIYTKoeCzWBGqCtisCz9etNbo0aqj2x+UUxzCpHw3ffjMnUkBL0zZ8+XU3pEy15Zf5JB3VQKapmmBQIDtCUK8YrJYNRnZSoUsOICT+1cLHvIikchVT9OhKEosFmN7wls2zdltF7IjWr3S4dGMG3REx3YN6fM3bmoYCORBxpdk3LqT4sjaOqvv1lkFl//SuukvgupDTu6d3AqfqvBMKCpj5kx9v34RU6Yozp/PX8wC/AhQA6BjuddQ8JCnKKrM5yd8TUCjSsyr5We7doR9sXD1wW3LDhF15POjF7w1b1zbELe3hbwNrBiC2gMXng7Z+vm6X3/buWmbTRJWu/k7C8e937uWi+4BLZ4jI1PDEEPCpW0Jlwq/QgUKWi96Odz5h/Xm9TgjXbNWBN+mLkEIIYQQj5H4MxdOO/ymtKrOwy5sB+s4+vW0t3elN5i89tc57flwEY8Q8lA6oyk5MyfI18dP6U3S3B0Nqkzif3/r3f11P3ru+OuPMtDEYNATSiaT8uPqnPJ97tUPJ7R4NCs50Z/eu/eYtd6oAc9X820cxo8oPQUBYNpN03foED14sDg5ueBL8QCnAaYA8OecChPQlRwVMvGIcaK7oyhK4N9i6tIdU5e6O47H8DAwKiDmyJWY4l4R1+gw4vsOIyo0mHZvnPlnqZixhWvjBaTEO3gkTV9POvR6BcaFEEIIIc9H9H9eSLArW3aL5t0VisXBJqQf2/TTJXuTtzd+hNlnhFDZZeTmZev01YP8vWSunPQZIQAQNW71gveefdu2nxs4o7UcAACY7N82/noD/Me1rcmPH1fKv1nvec0KLGCTFp3Zf1zXeOLUcTj2+ZnYwnzNGVqg6MiRI8UGQ5FX/wSwA3RzS2Ql4MceiBDiPYPEO1FVQ2XOCdGngIueioMQQggh9ID5zp+3HdL6Nfk2hZfOYk/WW3zTr1zJZsXKc1++fa9w/plSth63ZEgdvKxCCD0ZS0hSZrbV5ogKDZSIeNbSoUqBUnX5eHLTP75a373vncEvNQohWVdO/rHnal54z88/aosdHpWKoU0bzQftBX0XC+JW0MXlZ/4EkAK0rPjISoZnSgihp8uR+6Upw0J1SSpzjrtjQQghhFAlZL1zM85E1YyuxqspvDKN1iyzvZqPTPxvisZBDLeO/3SryFvoQEGvRUPquCU8hJCnsNkdCemZIqEwKjRQ4KIZmRF6jLjhuFVxwd9/uuHIro1ncx2S4KgmE+aOnj3seV7OLIrKKKd//7RZs0LmjJcwxQ8NtALEAdQEUFZwZE+ECWiE0JMQgFRlWJ5UFZlzR2YzuTschBBCCFVOksZDknYPcXcUj7CEJOVZLA42Si2XCGh4aXF22mJ3B4UQKi0qeMyR7DHujuIBk9WmSc/yUciDfX2KPL+LV3GiyoCSN+w1Y1uvGe6Oo9To8Fmbj856+vvciT/HKREI0t57T/fii5Hjx8suXz5SwtskAEkVGlepYAIaIVQihhZqVDUYmo7Ovi1ibO4OByGEEEKoItgZVpNnEVBUtFouoPk0JBsh5Gm0emNqtjbET632Vrg7FoSQB2NUKs3ixYyPT/SwYaLUVHeH88xwFD5CqHgWofSuf20h64jKvoPZZ4QQQghVESY7c1drkgkFET4yzD4jhMqMEJKu1aXl5EYEB2D2GSFUHtaIiHubNgl1uqgRIzwx+ww4AhohVCy9RJmkruFnzAjUp7k7FoQQQgihCpJrsaforUEKsZ9c7O5YEEIejGHZxIxsB8NEhwaJRZh4QQiVnb59+6SvvvLdvj3o66+huEcOegRsBxFCRWUqAjO9gsJzE5QWnbtjQQghhBCqCISQDJM9x2SLUMkUIoG7w0EIeTCbw5GQliUWCaNCg2gKb6RACJVd9vDh6VOnhs+ZozxS0pzPngET0AihRwhFJ/uEG8XeUTl3pXZ85KDbEEIYhgEAlmXtdrvLy2cYhhDCRcksywKAw+GgODjVJoQ4HA7nKrjA0QbhaFM7HA7gbA/hLuz8PYRw0HXvjJmLfS+/8Ke+zXlwcREAQohTLIFEncXOkmhfuViAsxQihMrOYLYkZmT7Kr2C1D7ujgUh5MGIWJwyd66hTZvIsWNl16+7O5zywgQ0QugBh0CUoI6kCInOuilkHe4Op0rLzyqyLGuxWFxevjO7zUWazJkVtdvtzlW4FsuyVquVo9Q2IYSLTU0I4agSndXncDg42kMoiuIi1+/cMWw2G0f1aLVaXV5sfuGl2dQOh4OmMXWFkIexMWxCrlkspCNVOOkzQqhccvIMaTm5of5qlRdO+owQKjtGrdYsW0aEwuhBg4RZWe4OxwUwAY0QAgCwiOQJ6kgva15oXhKFw/fcTSAQSKVSABAKhd7e3i4v32KxsCwrl8tdXrLRaDSbzTKZTCx2/dSZOp1OoVAIBK6/LTonJwcAuNjUDMPo9XouSrbb7TabTSwWKxSuv7wxmUw0TTt3QtfS6/VWq1UulwuFrj8D0Wq1Xl5eXKS2rVYrTdOlqUeJRMLdIH2EEBeMNkdinsVHKgrxkrg7FoSQByOEpGRr9SZzZEigTIKTyCOEys5Sp07CihXyf/8NmzuX5myETQXDBDRCCHQydbIyPMCQHmDMcHcsCCGEEEIVJMdsSzPYQr2lKileFiGEyo5hWU16FsOy0aHBIiFOIo8QKru8bt2SPv004LvvAtaudXcsroRnWghVdRnewdnygOraeC+b3t2xIIQQQghVBEJImtGms9gjfKQKMV4TIYTKzmKzazKyZGJxRFAAjdP4IITKjKIyR4/OHD++2gcfeB875u5oXAxPthCquliAJHWkRSiNyr4lcVSS2zoQQgghhJ6MIUSTa2YIifZViDBbhBAqB73JnJSZ4+fjHahSujsWhJAHIxJJ8iefmBo3jh4xQnLnjrvDcb2qnYDm4BlZLmPncTYw4T93R1ACHY/nZe8Y4+4IirKFhyesXCmKjogmBoFfkLvDQQghhBCqCFYHq8kzSwR0hFJGczBrPEKo6sjOM6Tn5IYH+CkVMnfHghDyYPbAQM2KFbTVGjVsmFCrdXc4nMAHtSNUFZmaNbu3ebPi338jiF4A+MhBhBBCCFUJBhtzL9eklIiq+2D2GSFUdoSQpMzsLF1eZEggZp8RQuVhatz47tatsv/+qzF2bGXNPgMmoBGqgnL6949fvTpo2bLQTz7BCy+EEEIIVRHZZptGZw7xkgQpxO6OBSHkwRwMey81w2ZnokODZBJsTxBCZafr3j3+u+8Cfvgh9JNPKIfD3eFwqGpPwYFQFUMEgozp03P69o2YMkVx4YK7w0EIIYQQqggEIEVvMdiYSJVMJhK4OxyEkAez2OwJ6ZleMmmon5rCGykQQmVGURmTJ2cPHVp9xgyvs2fdHQ3nMAGNUFXB+PgkLlniUKlqDh4sSklxdzgIIYQQQhWBEYg0uSZCIFotF+IjBxFC5aAzmpIzcwJUygB85CBCqBxYQpKWL7dERUUNHy6Jj3d3OBUBE9AIVQnWiAjNqlWSW7ei3niDNpvdHQ5CCCHkVkaduyMohfQEd0dQOkHV3B3Bk1hocYI0QC6ShPn70ph9RlXWvcvujqAUMhLdHcFTZIqUWRJVtaAAbzlO+uxRPOJHHwCiGrs7gkqE35VuszsS0jNFbZtH52oE33/u7nAqCM4BjVDlZ2jf/t4vvyiPHq0+axZmnxFCCCFUReQJ5fdkQWqHsVqgH2afEUJlxgKlkQZoRV5RplTMPiOEysNktd1LzVDIpBHa+wLCuDucioMjoBGq5LKHD0+fPj103jzVr7+6OxaEEEIIoQqSKVJmin3CLVlKBnvfEUJlZ6cEGlmggLDR5jQBYd0dDkLIg2n1xtRsbYifWu2tcHcsFQ0T0AhVWkQsTpk719CmTeTo0bJr19wdDkIIIYRQRSAUlSzxMwkk0eZ0CWtzdzgIIQ9mEkg00gAlYw6xZONtFAihMiOEZOTm5eQZIoIDFFKJu8NxA0xAI1Q5OdTqxGXLiFAYPWiQMCvL3eEghBBCCFUEBy1MkPhTQKJMqUIcq4gQKodcoTxF4hdky/Wz690dC0LIgzEsm5iR7WCY6NAgsaiKZmJxDmiEKiFL3bp3t2wRpafXGDsWs88IIYQQqiIsAvFdWZCUtUWa0zH7jBAqMwKQLlGnSnwjLJmYfUYIlYfN4biXkkFRVFQVzj4DjoBGqPLRdeuW/OmnAd99F7B2rbtjQQghhBCqIDqhIlniG2DTBdjz3B0LQsiDsRSdKPGz06JoU5qYONwdDkLIgxnMlsSMbF+lV5Dax92xuBkmoBGqRCgqc/TorPHjq73/vvfx4+6OBiGEEEKogmSIVdki7+qWTC/G4u5YEEIezEYLE6SBYsJEmlIFQNwdDkLIg+XkGdJyckP91SqvKvfIwcdhAhqhSoKVyZK++MJSu3bU8OGSu3fdHQ5CCCGEUEVgKTpJ4mehRVHmNAlrd3c4CCEPZqQlibJAH4cxxKoFzD4jhMqKEJKanZtnMkWGBMokYneHwws4B7SrWE4tHDh4xb+8uT/HnvTnstGvNAsN8pP4hkW0jnnjh/PZbp4Hz3Zq7dzBm28/tomI4d6xj96d3qR7L+92MfVHfDh9x/WsigrVlHTu08/m1Os7QtZ1iP+g92P+F3fVXMJ5Bsndveit6lO2/8NwHhUD0BKAKu4/IcDZh28bUvglgdkcMWtt3OAhFZV95mOFIoQQQqhKsVPC+7IglqKiMfuMECqfHKFXgiww2KYNseZg9hkhVGYMy8anZZqs1ujQYMw+58MR0K5BMg+uWrkvts8kfuTZSPahtzsPWKvxaxEzcmYtSeaFA1u/nd7jZPKvcR+3kLsrJu2pVZvjYjv3KbKJbHe29xq9OpYJ79at+6sqy43Tx1bPn3lcsyjurSZKjkOyaw7FTPv+kNG3becX+wcxd/85vfPnr49eyTq+7LUmoqLhJx35fsrBhMzQ5yrgyoYC6AYQ/djycwDpAAEAAMAAxAMEAXQGYNRqY9OmoowM2bVr0foK2gd5WKEIIYQQqlJMAolGGqhkTCGWbMrdwSCEPBcBSJP46oSKCEuGgrG6OxyEkAez2OyajCyZWBwRFEDTeHryiKcnoIn2t7njVl96lBMUhMUsXDWqtqCiAmDMWfHX/j66acHcrWlsUEWt9SmYe+u/3HRP3Xt93MYRYQIAgA+GzurwypJvl+2ZvnmouoIPANacm3bt6oVNP/ywNYs8tolMv67dFGuMeGfdmoVNpAAA0/ovmzDh7S0bNg9bPDmIyxH6xLh33S+H9YGj53/xfTsVDQBs/yMr5/TYtWP2kU77uqsKbiYm5cjEFWfTCVUxtwzQAPMfWxgP0BxgNkCUMySAeICuAN+8+mrK3LlBX3/td/RohUTH1wpFCCGEUFWiFXmlitUhNq3abnB3LAghD8ZQdKI0wEHR0eZUEcubW5oRQh5IbzInZeb4+XgHqnAAXlGenoBmM9IyqNq93urX4MGgdkoWFlpxSS6Ssb5v5MRDD7pIeZNcM/x94pLNu/eQmLCHiXjF86+9GL5s9c1r8QyoK7TSSc6vfV9edMjm/OuxTcRm30wwgm+nbvWlD5YIw19pV/29i0n/JbLAab6SiY+9ahTU7PV2G9WD1dDKLkNebrtv7YkLt63dW0jz3+lIXrVwY2zIC4MDTmxz01NtWICZAFEAbz1cogXQAoQOn5E6sX/EG28ozp2rmEj4W6EIIYQQqhoIQIZEnSNURFgyFfjIQYRQOVgpoUYWJGGtUeYMGqfdQAiVQ3aeIT0nNzzAT6mQuTsWPvL0BLQ9I12rrNW6Q9tGFTbmuSDKt/fyvxrlskCydk+PWZLkjhiKIWwyYfm3g2sXSKGCQ28wETokQF3RGUDKp/3y9VG5LJDc2OkztxbdRLRvrepyuHnjVLy9ay0RAACbffZSKiOKqh3GcagOKyhDGz1XM7rAeiiJRAbgsDsKTCthv7Tlmzm3IuZ98xrzldsS0HsBfgc4BpA/e9A9Ec1Aw6COtZP79D6ao5UDdAGI4D4S/lYoQgghhKoAlqITJf52WhhtShUT7h/NgRCqvAxCWaLE39dhCLLm4qTPCKEyI4QkZ+UYLVZ85OATeHgCms1MzyCB9QNZszbbKFT7eYsqeHoJYUCd5gEAQFIvKvmTXlPU7TGiLgAAsJY8bU5W0pXDq97Zmh362qKB1Ss8SoGqTgMVAJCs28VtIkXvN94ceX3h/Ekz7vTp8JyP5eap3zdeEHd/+40xIRyHKm224sdmhReRpNgzpxnhc/Uj83P3pv92jvkpudXkL2fUgGXcBlQiE8AHADEArR8usVWvdi48kzl3f9nEqankwbmSGOB9gHkA3B4EvK1QhBBCCFV2NlqUIA0QE0eUOY0m/Hj2CkLIM2WLlOkSVaglW+UwujsWhJAHczBMQnoWBVR0aJBQ4JbBsZ7B4xPQqZmOzKMLxqy7r2NA6F2j3dA3JveoKX+Ygfvjjz9u3Ljx6O0sazQaKerBywqp9PEiKxXm9rLurT78xw5Aq9vO/nVVvwqcnqS0hMHPT+jT8NeVf//047WfAAAo74YDp3WOqPCHJdrjT24a+O1FY/BLs3s8nCrCdH3ul3s0z43b0SdECKkVHdFDPwIkAOx6mFk2tG2buHBqev8RxGGJBPgDoAbABYDpAPMBIgDGuCtQAHBphRqNj84FGYZhWR5cZ7I5l3au33L83wS9V8RzXQaPjmlSeFJ1+9mlw784bi48foIO7ffVN6MCDrt3wnqEEELIsxkE0kRpgMphDLFqcawiQqjMCEWlSHwNAlmkKU3G2twdDkLIg1ls9oT0TC+ZNNRPnZ9sRMXy7AQ00Wdp7TKv6F4zPukQBumXDqxZ+cMXPwSseKOll7Pa4+LiDh48mP9+pVJpNpurUAKaDuv3+YYamtS7F/b/8NPnPWMEv+56p6WXu6MqiBjjVr39yrr0xoM/3DuiTUOl9fbZ/e8v3NR7rG7Lhvf6+VdQvtyWeWX5tz/OP5ZkC2m7ZsHoV7wpAABiOLTmm5W5zX5Y1DWSBnBT8tMIsAygN0A9AADI6d8/bdas0PkfD09nOwC8AOBM7HYA2A/QEGAFwCgAtyU1XVqhZrM5/9/8SEAzCbu++HwH88Lo6YP9MmM3rfv8S8GSL/pWK7C5hbV6vf1+a0f+RTHRX9qx9mLNRiE0m+LWCesRQghxyXJqyYQVsnc2TWnMv3NrR1Lcxjmr9x26mpztkARHNek9dOK8QY38+PYTZDk15NUFW0yF08qiFusOzH1dSQFAjtArTaIOtWlVvHjkIJ9rHCHueEJ78rTGhKEEGqk/oehoU6qQF9P4YHvicbDKqqDiK11nNCVn5gSolAHufeQgMZz/ffen+87HJZmkAdW6vPTa5zFNavBvIhDPPl4odbe5W7o9/KtayyHT+v07detfl8a3bOec8XvUqFGvvvpq/vs/+ugjHx+fKtQpQXnV6dSnDgCMHD+0Xu8mb381Z+vQ38byKOnFZhz5dPNd8Qsf7H63WxAFANC065gd8txGUw7M+aVf7zfqcL6DEsP5vWvH/S/2it2/68AZy0a1b6hw7h4k9+ymiQdsfeeMHxbozh1mN0AiwPcAIBCkvPdeXteukePGya5cUQHUL/zOMIA2AMcBDAA+7ggVXF2hPj6PvodQKBS4/WYW2+UDB+6Hx3w96ZVqAoCG/rl33tl/8Nqrkxo/atop31ot29R6+Bcx/PPtBnOnya8386as7p2wHiGEEHdI1qFV3/4a22us23tKH0Oy/1rQecJOjW+jmAGjaolzLhz57ds5406m/hD3VqMKv9vsSZjM1HgbFVSvVefwAhdMwuhIEUUA0iS+OqE80pIhY6zui/ERHtc4QtzxjPbkCY0JAFhosUYWKGMsYbx55CC2Jx4Hq6wKKrbSM3PzsnT6aoF+3nK3PnKQ5P2+an7f/VnBDZoO7e1nuXN+y7rFsfennv2gdSjPcp+enYAuivYPC5XYtXoLARkFABAVFRUVFZX/OkVRIpHoUQKa4UOHp+vZ7h3fdjojomP/DtXyU82CiJe6NRScuHH9LgM8SkA77t+9ahM0bNEkoMCB4d20WUvxvn037+WROr6cHjAC2RjCAAAgAElEQVRs1o5Fn478NSOgZf89M/v2DpMUeI1k3I1PceRs/Xjc1o8LfmZv6857BeF9Tm4c2Yr7PCIL8CNADYB2KlX80qWMl1f0sGGitLRi30wBqAAIgBt3a9dWqEgkyv83TdNu7zpiEq/9Zwhu/Xyos+YF1Z9vGrjz4vVUtnFE8ceU5dqWHy/We33pcwrK/RPWI4QQcj3GnK25duGvTYvmb01ng9wdTTGYxPWr9t1TdVm/e/GIYBoAYFqvWX3HLtmwbs+YJUNVPPopYlLT4llZ19ff3dyx0IgdhhLES/0ZoKPNaSLW4a7w8sPhe40jxB0PaU9KakwAQC+QJckC/Gx5gbZct8RWGLYnHgerrAoqvtJZliRlZlts9qjQQEmBrIU7EN3f2yYeyKg78IPjY+v4UACkZ69Fs/sf3bkypsWCOvwa/ObZCWjT6VVvb3QMWzCjvQ8FAMAk302wqRtU8+bLz5+b3N3+1oSf6y5sdXzao7wY0ev0hJLJZLzaNpRc7gWsNjePhaBHoRp0WhbEcrmE21iZ/7Z/Pea3nAaDPzw4sXFg0Qwi5duoy4cjmxRI5hpO/3b4mLXWqD6NqqnqhVXIdowHOA0wIbym5sdvZJcvR0yeTFutAOAA6AugBlgPkB84A3AHIATAuyJCK55bK5RzbFZGFvEL8H34zWjfAF+SlZHJQrEJaCZh37q//GKWtFJS8PQJ68+dO7dr1678D+fm5losFgBwOBx6vd7l34VhmPz/u5bD4QAAs9lstbp+kBrDMAXn8XchQgghhItNTQhhWZajkgHAZrNxMTuNc9+w2+1PfeezcpZpMpm4qEeWZQ0Gru7NL2U9Wq1WmuZPPy/iFsnc3Lfu9EMPWjte1rvpyonrdu9uPWOCH4Ynb/hax+BlG+5fS2JBxZ/LEqJNSdNSAbVCCoVkoUUaWaCMsUVYeDFW0QNqHCHueEZ7UnxjAgCZImWm2CfcnKlkzMV+soJhe+JxsMqqoGIr3e5gNBlZApqODgsSuP20nxj27j+d5NV8yeDazrQoUMpeI8d/Uys1UMK4cXLWYnl2AlrWqHVD+4LvF/k6BrYOE2RfO7R5T2aDUa/W8+xvVW6i5zu9oPxp34Yfz43+tLUCAACYjN/WbLtBgsZ1rs+rjSOq06pb0NY1+37Z0e/DwSFCAAA27/j6PSccXq90bMztnVy2ayu23bTWGfLThMezzwBA+TfuNq9xgQVs6qK//zieV3fimCEVMPbZ6U8Auzi40eaNqq0bA1evBvLg0ksIoAb4GWAgQM+Hb94OcBHgLQA3dsC5s0K5x9isjoKdOJRMJqVsVluxF8REd/KX/YaO73d1zuDy1Anrk5KSjhw5kv/xevXqOTO5DMNwkSZ2cq6CC1wkLp1sNg4fFMNF0pzrkj10D+GuHrnb1ISQ0hTucDiEQl790iIOUeoeyw/Xz2WBZO+fPmRlkrvjKYag3oRP5w2OalzgsSeM3mghdECAD6+6hdn45AxGWC1amf7X0etXsyzy4JqtWjeh1IG+DkOQVevu8B7wgBpHiDue0Z4U05h0bllXqPI3CSTR5nQJbx45iO2Jx8Eqq4Ier3STxZqWka1UyEJ8VW6/RRsAwHHn2DWruG7jzopHwQiCG03s28iNQZXEs6+RKK/mEz57V7Vh26YF+/IEvuG1m4//bHhXHs0w4R6Ub++P32v7x0fLune4Prhn8xCSfuXo7j0Xc8MHfP9RZ57lACVNPnr3lUPv/TZ8UMKWbi0aK623zsfuvpKjbj9z4StqTo9mJunmGS0RK/77P3v3HdhE+T4A/L3LbkaTtumeaZllU6YiMmULtCAiyFJAUOCHIIhliCwZIoiCgIoIInsKsrcIiLIFvhTadCdNurJzd+/vjzJKBVrbJHehz+cvmlwuDzfeuzz3vs+7YOGKJ48YQtGw55JukeyfGwSxX4CEzUd2/vSTwGPHyryZjNBhhJIQ6odQDEJXEdqHUH2EprES6iPs7VAP4AlFPFxotWEkLkkqW602LJA/tbY/k3F491/qjkvqPJxxsLyC9a+99lqLFi0efX7x4sU+Pj4IIaFQKJVKXf5/sdvtDMNIJK4vVmW1Wm02m0wmE7hhLFJxcbGPj487qoEXFhZijJVKpcvXXNJrW6Fw/awUJb3jxWKxm/YjSZIikaj8Rf8js9nscDgUCoWb9qNCoXDHvWB+fj5JkqUL0z+LRCLBmP1+msBD+AG1mgYghHDOVQU3bz99NN0SS4rRMTZTkdGYc+3khkl78kO7TOkfxqmInamZBpoxTx06JrugZCpfQqBuNvHTqfMbc2kOHe7vcQDcxzvak6c1JgEJo+fNWdKAFmAu1eyF9sTrwC6rhp7c6YzTlpajD/fz9VewOOz8CYxRd89CBIZIUw6uH7Tj/Nksh29IZKsW7acPbF3fh3MJGPaTbFUkCG7x1pQWb7EdBseI6o3ffiZ04exvdu349niBUxxcs8XIJROT3305hHMNJRnSfvLZNbXnfrdv18Ht+20CdUTtwROmTn+rWZSbj00qN1dLY1PqX+tTy7xDBPJeWtQt0r1fXx4sEt0f3Pjcdxdr3FwXZtT+e4GaCJ1DaC5CBxDaglAYQpMQmoqQ6/Nn/w1rO9QDSH91AHHfkP9wjCFTYCgg/OOfNu83nXL8eLrmtcnhzzrj/lWwXiqVlk408/n8klH8BEG4I09XsnJ3rLkk90eSpJtWzuPx3DcdpZvW7KadWFJ5w31HiPt2InLzEeKmzggV3NQkSbqqKMq/y8LI5Vy52QXeh05dOqjftGsUQqQq4b39cztxq8MGo0/JpjBNx/SceuitpkIhdeHUpoWLdy76eEHNH6cPD+LcLyg3KXPKu+ppFk3TDoej9MqhMQFVwuX2pFRjcnhgk2Be0YHf98xfvOvrydMbVafGBD3ZnthsNlcNmCspd1Z6sBe0J6A6wBg5MGJspshgtUrs+j46lYatlmKEC39f1/lXKq5Fs1HN+dk3/9y+ZeXhm/knFvRo6KKH+KXbE5qmK/1jx/tzQtxAhIw6Yh7FdhSlELJ6/Wdv6T+b7TgeIwJeP3Lx9ae9QwY2en3ZV68v82w8olbvG06+/x8+QIZMXrVlstviKY0KDExbtoxwODJ23OE/LftcIhqhNR6J56m4tkM9gBcZX0e6+/IV/ZsxwQRCTM6VqznyuvFh/85IUbdOnMqt0af145tcKFgPAPiv/l30A37jgcojg/pOWRidqUu5enzttpU93uXtXzuiOXfGxRHK3mOTG4sjXqofqherCYTe6PJOW4e23vxLy/elDRkRza0Shm5T5pR3VQKaYRiapkuvHBoTUCVcbk8eNiZt6wU5+dJMUWznHtHVsDFBT7YnTqfThU/HHQ4HtCegWmEw1uaZKIR4Pkopl7LPCCFMMxTGRfmikbM++7qFkocQwn0HL5/Z49ddySde3tPZNfPDlj7lSyZPqtx6IAENALdYGjTQfvml4uTJkHnzCLcV0gWVIWzQrVvk1K1f/Rw6/BU/3fHvdqTH9v2gnhAhKuXIhpOGOt37tQgiEUJ02t+XC0Ja1ylVdAQK1gMA/iuSJN1RFgZUU4S0VqsOtRBCSW8MrDG64ew10/f0PDDgabNgsIKQ101I0JDCNLFayjjC7HkExmFtWrdadOnE7fsmFF1++ZsXQplT3lUzmvL5fJFIBO0JcBkutyeEvG5CQl2EdEKlQSCPtOlltA1Xv8YEPdme+Pj4uGqCCh6Pp1AooD0B1YeDotJy8vgYSQhE8Dj3850QCiUEIaz32vTmD6eCJWSdBnRq9duGU3/esXRu7pJqnqVP+aqMSObc5gOgOivs2jVz5kz16tXq779nOxbwb3xN0scfOb/9ccXUHTafsEY9pozqE8VDCFGZF/ftuU+3SmoRhBDC+mtXcyQ164SXapahYD0AoBJgPkNQRQ7t+S2XDFEturR5fMUho155qR558dZtLY24kTBCCCFUxJdmiPzUjkK1s6jkFUIqU/IRpmkaI1Q9Bgy56ZQnCIIkSWhPQBV5S3vCEGSGyN9GCjTWHBHjRNWyMUFPtieuLVDG5/OhPQHVhNlmT9cZfKU+QWoZNxsPnp9fKA/9LzAgoFR8pF9AGB9dMFksGEldEXfpU74qjQk0HABwA0Ho3nvPMHBg5PjxsvPn2Y4GPANPnTAoOWFQmVfFr3y87ZVHfxHBvRdu7/2vj0LBegAAAJ6W+tvEj/bW/qTRiaGPM0bYZCrGhEQi5s5PqeyU/QM/PxPcZ8rGro+7J9KZmXedREhECJSrAoATvKE9sd7Z1WPRed9+n21+TfhoykFoTAAAlWAsMuUYC0L8VSq5FOewHc2zSKISIsn9GVnpuHHcwyaO1uWkUsg3wE/BsUaPI88pAajWGB8f7bJlhd26aQYPhuwzAAAAAFxC0KBFWzl9fsvWC5aHL9GGAz/tv4UCXm0dx4V+KJggMsTqYk2N0IxrW7/7cX/+w6qCTt3WdQf+xqH9OtYUsBohAKAE99sTC0+UVqOeX9aNPau/OWh8OOceNCYAgP8IY5xtKMjNL4wKVqvkLili4TZkaOKrMeStQzNP5D2o30rn7/75yEVG2fPlGtyqVw09oAFgnSM8PO2rrwQ5OZo33+Q9Ofs5AAAAAEClEcr2M99rfHjhuq597g7oVD8E5107e3jX9aLwHnM/aS1mOzrkJHhaSSCJsIaMmzkq4djCw0lDMvp1bBBDFly9cHbfXWf9gTOmxUPKCABO4Hh7ki+QZYv8gu28uSObnoHGBABQWTTDpOsMFE3HhQUL+NyfuJSs3eOt/zs+f8GC6bdOt+gcTt7/+/yO26bIDmM/bSZhO7ayIAENAJvMTZqkL13qe+BA8MKFhIvmJgYAAAAAQAghJKz3zoozwWtm/3hkx0/nCyhRsKbhyBnDkt9qGsL2MEgLKdRKAhW0NcRmIBBR8/WPzwXtnbvp+IG9O7Y4RWGxDSZNHzC1S4xrpm8HALgAR9sTjJBOpDLypVFWnZS2+UFjAgCorJIpB0UCviYkiCS9pNXwqfnZgo/D1m1f+fvppX8gVVjcsPd6z+pVJ4R74UMCGgDWGJOSciZPDpk3T7V7N9uxAAAAAKCSiODhRwzD2Y7iGQifej3Hb+k5nu04nlAokGYK/YIcBf7OR2O/hNEtE9e0TGQzrArj9B4HwH24154wBJkuCnCS/FhLjhBTCCHvakwQtCdeCHbZi8pktaXrDH4KWZDKt8xbHN/pPN+aY8d/PJZDbfPTQQIaABZgHi9n8uSCbt2ixoyRXrrEdjgAAAAAAB6iEyoNAlmkTS+jbWzHAgDwYg5SkCZWCzGlseaQGMaSAgAqr2TKwdAAlVLG7aLP3gwS0AB4Gu3rm75kCaVUxg0YIMjKYjscAAAAAABPYAgyQxxgJwUaa46IodgOBwDgxUw8cbpYraTMIfZ8hHD5HwAAgKfBGGcZ8k1WW0xIoEQkZDucFxnb5d8AqGbsUVH3NmzgFRZqBg2C7DMAAAAAqgkHwU+RBDEYaSzZkH0GAFSFkS/TitUhjvwQuxGyzwCASqMZJjVHb3dSsaFBkH12N0hAA+A5ppdfvrdpk+LYsYjJk0kbDDv1OMfRj9u0n3XG+a83cN72MS93X3gJfg4DAAAAbmDhie/5hMhoe5RNx4OR8gCAysIIZYv8dCJljE2ndJrYDgcA4MVsDmdKVi6fx4sOUvN5PLbDefFBCQ4APMQwaFDu2LHhM2YoDh9mO5bqhi7Q3sksZpDj6t9/XhJfvXFDJXjifWy/ffzUhbPFmTRqCo0iAAAA4FL5Anm2UBliz1dRkC0CAFQeTfC04gAakbHWHAEMpAAAVEGxxZqhN/r7ygOVCrZjqS4g1wKA22GCyJwzx9yyZcyIEZKbN9kOp/rBBTtHNx5+wP7gz7GNdz9lIULy8vA60CICAAAAroMR0olURr40yqaXwpSDAIAqsJECrSRQQjuibDoSym4AAKpAX1CkLygKV/srpBK2Y6lGIN0CgHtRJD9NGkJEmWPfeINvMLAdTrVEyF6esGptIo2oS6vG/Sgc/cXwBmWaPoIUBzZ5rWsNGHYDAAAAuAhNkOliNUWQsZZsIabZDgcA4MWKeeIMsdqPMgXZ89mOBQDgxTDGmXn5FrtdExokFgrK/wBwHUhAcxWXC9AYc9mO4Bn+d5XtCMqySVVptV6WFujDMs4Q/9eb7XCehlcdGgFRjc5DayCEnHEZOzNEA4aPaAVXGgAAAMCNHKQgTawWYkpjzSWh6DMAoAoMAkWu0DfcblBQFrZjAQB4MYpm0nL1BCI0IYFQ9NnzqkPuCQB2FPpHZMY2U2fcVGfdQjQUKeMAQduZv7VlOwgAAADgBWfiSdLFAX6UKchegGCkPACgsjBBZAr9zHxJjDVXwjjYDgcA4MVsDmdarl4mEYf6qwiCYDuc6ggS0AC4A6EPrZUXXjfif+fl+ZlsBwOeRBVn3rmTWUyV/UFM+tdIiPODKxEAAABQBUa+LEekCrUblZSZ7VgAAF6MIsh0cSBGKNaSzYcyPgCAKig0WzL1RrVSoYYpB9kDCWgAXIzh8TPiWth8lJprR0TWIrbDAU+wXV89uPf47Sm2p3THEvfbWrAlSeT5oAAAAIAXAUZElsivmCeOsekktL38DwAAwDPYSGGaWC1lHKG2PJhyEABQFbqCIkNhcWRQgEwiZjuWag0S0AC4klMo0dZuw6McsdcO8ygYJsYxTMaPEyduTw9o/8H4N5qF+JBPvsuLag6loQEAAIBKoQmeVhxAIzLWmivAUHkMAFB5RXxphshP7ShUO6E3DwCg8hiMM/QGm92pCQ0UCeDXPssgAQ2Ay1jkAdpaLynys0LuXSJgvh0Ocl7+/aI9Yth3u5Z3lrEdCwAAAPDCsJECrSRIQtuibDroqwgAqAq9QJEnUkbY8uQw5SAAoAqcFK3V5fFIMjYsiEeS5X8AuBkkoAFwjfwgTXZ0k+C0K345/2M7FvAM9sJCGxlbv64P24EAAAAAL4xiniRDovZ3FAU6CtiOBQDgxTBBZIr8LaRIY8kWMU62wwEAeDGL3a7NNSikkhA/JUw5yBHwEACAqsKIyI1qmBPRIOrWKcg+c5okrlYkvnnuYiH0zQIAAABcQe9E6eKAMFseZJ8BAFXhxOieJNhJ8jVWyD4DAKokPz8/NUcfqFKE+qsg+8wd0AMagCph+IL0uJZOkTT22mGhHWZ75zZB8ymrJp3o937SNPrLSb3q+QvhWgQAAC5mLmQ7gooxe0O2VJfOdgTPgwkiU+hn5ktirDoJA/NegOrq3lW2I6iYoCi2I3gei82u1RkUQjJEyBCyMLbDKY9XXEGkvmxHAP67a6fZjqACgiLZjuB5MMY6i9NocUQFq6ViEdvhlKfBS2xH4FGQgAag8hxiWVrtNkK7WXPjKEnBg3rOcxz/4tPjDmnR8QX9GnzOl/n5ywSlUtDinmture7B+YsUAAAAwDqK5KeJAgiEYi3ZfEyzHQ4AwIsVmi2ZemOQn6+/1ch2LAAAL8ZglF5oczI41s9HyP3sc/UDCWgAKsmkDE6v0cpPdy9IexVhqOngDQixMig4WhUc3eRp7wpr+kFRIgAAAKA8Np4wTaSW0bZQu5GAKQcBAFWgKygyFBZHBgXIJGIECWgAQGU5aCatwCrkkxqVDwkjnTkJEtAAVIYxUJMT3Tj0/iWlPpXtWECFCVpP2rxzEttRVATGmGGYkn9QFOXy9TMMwzCMm9aMEKJp2h0rxxjTNI3d9rzHTRvETTuRpumS9btvP7ppJ6KHwbtj5RRFuanQWwX3Y8ked0cAAHBEId8nU+SvdhSqnUVsxwIA8GIMxhl6g91BaUIDRQIB2+EAALyYyUGlF9mUYkGIDDo+cxckoAH4bzBBZmkSipXBMTePS0zwlB64BcMwdrsdIURRlNns+trij9LELl9zyTptNpvD4fp6oDRNWywWd6QXMcYYY3ds6pJnCW5aM0LI6XSW7E3XKlmn0+n6ykIlR4jVanXTfrRYLC5fbYkK7keHw0GSMJgCvLD0AkWeSBlh08spK9uxAAC8mMNJpeXqBXy+JjSQB9dNAEAVGK2OHJMjVC5SiuFRFqdBAhqA/4AWiLQ1W9M8Qey1IwKHu9IcwL2w6da+79Yf+Ouejm415YexqnOHzXU6NlRz6mLF4/EkEglCSCAQyOVyl6/fZrMxDOPj4+PyNZvNZqvVKpVKhUKhy1deWFgok8l4PJ7L12w0GhFCvr6un62Fpuni4mJ3rNnpdBYWFopEIqlU6vKVWywWkiTFYrHL11xcXGy322UyGZ/v+juQ/Px8hULhjtR2Xl4ej8eryH4Ui8XueCQAAOsYRGSIA2ykQGPJFjEw7wUAoPIsdoc2N08hlYT4Kd00bgkAUB1gjHPMjkKbM0blI+HDoyyue5ES0NhhLqZECh92/k+23z9/e7lk2oZxjTiyTS139yz+bPmmE9dSjQ5pSL22/d7/9OP+9WQsXOAtGRcX/7hv099pqUWUNCCy7avdPx3cup7kYST282/2/eIXy5MDlgVNftg+Zajc3dEyGTfPTz9w5WBagYHmB4eE93qlzaw2Yf6lvrYo8/r8vRc239ZnU4Lw6No9x8wc67BpUk6RjAfn28HWnbsPjNfF7HqncRMSIYRo/ZVWK/68+LQQeP71z45v3sITba/j97WfLhcP2TCo5qNjnr7/U6s+qy4+bZA6L2rg2T1jW7g+c/gfUfc3Du387s93rRghQiUeyjjuLe/75m/Rg7/du+atONenTAEAAACv5yR4WkkgDzOx1hwehkcsAIDKyy82ZxvyQ/xVKrnrn6ADAKoPGmNtgZXGONZPKoCqz96AI8lSF6DSds2csiP0ox8+aMLCfwrrf13x1Z5Tr4/myC25887qxHYTDhaFtE4clhTpTDmxc/viYcd+zzjx24cNPVsSx5l+KHHcdwfNfq1f7ZAUSKVcPr/9l+XHruedWPJ6QwFCCNH63FQHEVQroV1YqeQfPzqG7/YWxHD9t3Zf/6WVhSW+3KoG33zp8vVvNm44mz/ozOthJf1CTfdOdV52+iLy75qQ0EdBn/rr8pcTR+SMeGtDgut7pD4bzrj6+5hL+Xq/8EfdjQixqnN9TWyZo42xXLiVm6uQqT3S9uL8sys2nD7Vvk/pKAhpTOcuHWPLZMaZvAvHr+YGBnkmsOdi7q0aMfqX/MYTN3891vJZ/ESEkOS16WvGaN9fOWpog4STH9ZiPUMOAAAAcIqFJ9KK1QraGmIzsH8lBwB4LYyxrqDIWGSKClZLxVCnFQBQeXaK0RZZxXxelFxEwkAKL/GiJKAdd7ct//mmVRTq6S+mrXmpN/48tmH+jM05TJCnv/0ZcMHu2bMO5UcN23pyTfdAEiHETDvyYcdu33yevHnQnreDPHd2YvPudZsPFQcOmz1nTWtfEiGEk46smNlt547ko233dFESCNE5uamMuMOg8Rtf9mzvU8a47tcr96S1101LHKwiEEKoe4PJ89YvOXpuV8ekgVKEmLyvNp29SMZ8Mbn/wIR6+rC60y//NGfGV19uPzO8fteOnrploo13Rv2alotQ6T7NpDxyTlLkkwvi1D8PJfwvMLlHbY17dzBjzc++cf3PDWtWb87DZY55MvDlOQteLrN86rbJCWfik6e9rmF9TAx9Y8N3Z3DbpRsX9o92bivJNRPKhoOWb7fcjX9//abr42c1fFEaRQAAAKDqCvg+WSL/IEeBv7OY7VgAAF6MZph0nYGi6djQIKEAbrgBAJVXbKcyim1+EmGQFIYwexPWE0IuYftn01e/8eIiPN53EevW9Ymq1azHe8vO6jnS9xkhhKhrp84V8hoM/bBL4IMdTPq3//Dd1oLi08cu2j0ZCZ126rqZF9v+w5a+DyIh5O3f6NSaZzv91107Qgjh/BxdPqGuEeLxnWfPOq2l5bXrJ6oe5mtFob3jfUlH3o08BiFE6+7szGDCW7Tp2fbl/OC42BtHlU7pJ11qyPJv/XzHU6UP6YIVuy6cUsUNCCrnVGWK7k44lKNp03pieUtWETb+2qdD/2bvLVz2V0FFjnkm9+CEZZc1IyZNrMGBGstUyu0UVOPVthFlNhIZ2vqlOJR6N9WDhVUAAAAALsMI5YpU2SK/KJsess8AgKpwUNS9LB1BEBrIPgMAqsZgdaQXWcPkYsg+e50XoPXH5ivrV5wMfnt6szOT13n4uwm/XstO1i9gEM7bOS5xSYaHv/5ZnGbkV6P+K01jSyV1CbGPhECU3eHRRDltR4qQ+g01saXyfYRIJCEQ5aQYhBBiUjN1ND88Vq47efLWdYPDJzCmfUKNKLH7e2mTwSPf6jEgOKzUHFtMsc2JSZlaSiCE6ILCDIYMb9CNEfporh3mO+0IIXlQQAS6/VdaPl0/0P0pc/rKmdPTs/xmvVuf3pmy5TlJb2zbfejP32R1jr/k5+42mPBts2x9bAGDcMGJceM2lXPM48LdS7/9za/v8be5UV2Z8FUqkFGXRyP05O5z5mbrsUzORo10AAAAgHMYgkwX+TtJQawlR4ifNrcDAABUjMlqS9cZ/BSyIJXr52QGAFQfGKGsYpvJQccofSQCqJ3pfbw+AY2L/vz+6/MxIxa/GvDXGc9/PV9dK0GNEMLZfyu405vcp8vyi12efInJ2L3znFPYqEUj8dM/4x6ixsvXNH7yJZxx+vw5it+obowYIYScqVlGmrFMHTkxu5DGCCFECP3jp34yflZjX/cmA0UB3VoHlIRks1mNxUXXrl+YdMES2qRzf38CIWTzU/mQWJeRGnHzBv/hfDuOwiIdxoyhmEZuT0BbMq4MP1HYokuv8Wq09PlLaq98fA0n9m/Q0gOdjHnKWvWUCCGsv1PuMW/5e/3HB5nEhYNaevSwezZhk07tlN/+/Pnaca3GlCphYr2+csEv2YpO7ZtwoJc2AAAAwC4HyU8TBwoxHWPJ5iFc/gcAAOAZjEWmHA1WRY8AACAASURBVGNBaIBKKYMpBwEAlUdjrC20YoxiVT58mHLQO3l5Ahrn/7561bV6oxa1VhGmp7w/f/78w4cPP/qTJEmDwUA8rFDur1R6Jky22VP3JfefctgcNTx5SAyreXJn6u8/91952RzcMbmkPAhjSMmhMMXEdJt4+I2G0ch46czucSuPzZm1KmrNR8MDPdKsMIalS1ZPS2MQIlRxbfcPqhtKoMKAyMyGEW2XH1t38PtNTROH+pMIIWTPWX7wlh5jH4fT7b/G7DkzdlzVxrTa1kzBR0XPWxIXfXfkdlpwwx11PNBv/L9gMr/7andarSE7OlTyWYLBYHj0b4fDQdNVL5Dh22P67E4Hx45r1fLYGzG3Kbt8/4o5B09sXL//Dr/tkhm9VdzaggAAAICnmUlRuiTQlzKH2PMRZJ8BAJWFMc4y5BdbrDEhgRIRJwZDAgC8lI1i0gosPgJemK8Yphz0Xl6dgMaGk9+uTUkYt6iZL/H0G2SJRCKXyx/9aTabSZIkqtPx6sg8vmzKh3O2/eOISVq1Y1EX9hJsDv21ZavWzTme4QhttWrukC5yAiGECN/eoz9qLAxrGx/ogxBCwW26j9xLGOstvrz8gHbIkChPDKsgFH0T+0YbilNS76z9/WSPFeTGBSMjY2pE3jnzaa/ah76/+e78dQcSYmrwTH9c/ucikgWRdgvPzWl8bD948PRXlvC1Q2rGkAg9t2yK+f6NpWlkr36163CnDz5CCCHzxc1L/xL2+rxXpQMjycefdNVpy685ettxefL46WtW7TIzGK2c9AdPrmk/7oclswfHQ/9nAAAA1ZqRL8sRqUId+Urn03p2AABAxdAMo83NoxkmNjRYwIeR8gCAyiuyUxlFVrWPUC0VsR0LqBKvTkAzWbfv5GfmzRx44PFrs/oeDe278OuhNXkIITRhwoQJEyY8erNz584qlepxJssFHSo5DOdfXP3hO8m/XLOHd5jww9Jpb9RTsJR9xuaLe354Z83pa86ADv0/WPr2S/V8HkZCyOo2blz3iaWJsNYtWvEvn7ijNaEoT9QJI4S1ateuhRB6KWFA+KZGm36f8+f4Q6YjEluxrPnrpyWByQeu/Hb6j71CRZPGHY+1c4ybfzRNLHTrpiz438VRl6g+Sa3fKrfrMLbuPHc3XRG7praIW89VcP7Onw+mB3Za067ypVRUKtWjfwsEAh7PNTev0vi3lh4ZOF+fcuuezspThMTWilZB6hkAAEC1hhHKEfkV8qVRVp2U8eiU1QCAF4zN4dTq8iRCYVSQmoSR8gCAKtCb7XqLI8JXIhd6dfYSIOTlCWgyLnHmkg4PiyFYLq79dI982KwBDQLCONYVlAV0+rb3erz9Y6q689RdX07qFevDWiRM3rbFc9/+Tadu1nfXuN69wsp/ZkVIpUoewjRNY4Tcdsfi0N/fctccVSu+jd+D73CI5VTfrjU3r9Se38WPDkMIIcSLrv/yhvovP/7U7d+0NBkTqHTnmYN1OcYs2rJ586bNm0u/fq3ljGs8//pnxzdv8fAIZwrvf3eXim4R9wrHMqhM9rHvzlij3+zyCkcfUhJidVwjdRzbYQAAAADsowlSK1bTBBlrzRYwMOUgAKDyii3WDL3R31ceqFSwHQsAwIthhDKLbBYnHesnFbl7DDrwCK9OQBOSgKjYgAd/4OI0H4KnCI2NjfTq/5RLUP8sHzJ8fVb8xJ2/zm0fyOapSv+zbfnw34zxb0z9dWT9f5d0pv63t88Xf6h6jV/X9XGYdFbWXYoICQ+Su/V5ue7mxHVXa/cPP9FBSSJklgek135Zem6Bg0ESAUEghHDRiT/u3pVGDmwQ8DB/z1z7JzWHUL1dw61TThJ+kTWnvRpWqn++/dxft4471UOah0ZIg8IebxacevPeOVo2pk4A1/LPqUePnHMGj+lQi2OBIYSYgjunjp27nWOiytbt4cd1eee1WBgjCAAAHGL7fcnI5ZJJG8Y04ObtneXeocWL1246809qvlMaXKvt6yM+/b+e9aRc6vFn+/3N7vN/sTx50RM0+2HfjKEKAiFkJ/haSZCIsUdZdSSLRZ/Li5NjuH5kAm9DZZz5afrKPQevZxooUbCmYa+Bo2a9Ud+fuymXp58ChiJTrrEgXO2vkEpYC817NqYXXEHA03nPJQDn75z9f+NT2u36YUgTjv3Off7x76QZbZGNJAgNV6Yc5PRO95bGpLKbjr53ZN3hlIr0kODHdhraUcOxY/0FZzu1fPl5e9OZ6z9jN/uMkOPm8m137LXeWP/OU7LPCCF+WLAq5+7PP+3o32pUDyWBEEKUfuuGI3/j4Int4tyauxRER7eVXN5z5q8LL7evGaHJiW4cknL8zMajt5DsndpqPkII4ZvnDn2gjaKSB4wOIBBCTv2VWacNothOQyPcu1kDomvPii71N1O06O7tE9agUR2atij9zdh29E6e0ye2M9f6/OP8o6dvO1WdOtflWv6Zvvt9Urv3dmc4nvYDW9xv61BIQAMAAIfgvIMrvtl/queI586GwBrn3Q2JvWYcLA5q3WtAUhiVcvbA9hUTjl3IOrFtdEPOTLhF67NTHURQnRbtwkvFxI+NERAIIRNfki4K8KNMQfYCdqccfH6cXMPxIxN4G2w4Ob/dyO1av/qJ/YbUEBovHTnwzfR3zmavPTOxPnvjWJ/n36cAxjgzz2i22dmectBrNqZXXEHAU3nPJYDJ2P/FmJ339OEtnGyHUsbzj3+Lk9YWWhUiQYhMxJEZ3Li8072oMalsApr6a/X7o7faKrCkuN/WQZ5IQBPyDjO2dXD713gD+u65P3SMUHF2weh3n0xMEoo245cMiffYExs64/Yf+Vjoc2vB4m/KRtKgx5KuEXyfJskjGh9eejzp3ax+7eJjeIVXL/6x7x5V/40p09ycuySktWd2izi8/dxrix3dOiTEGr6/ffnvXVpreLPXP6kjQAghwndQj6bfLDs/YeH6c82jgiy5h66kXEeaLwc1rcGRfK8j52gGI44Oac61nKn56tFrTnHTRs051t4h58XVC/ZmKdtOXTIjsWGgpMx+JH0juBYwAABUU7TVoL1x6eSGRXM25zJBbEfzdLho96IlhwrDh/2wY03nABIhxHxwZPob3b5bkbwjcc8ANTd+MSE6OyeVkXQY+tHGV8pe5AwCRa5IGWozKCkzK7GV9pw4ucQbjkzgdej0dSv23FO2X7dz8eBgEiGE3u85uc+IJT/+sGv4koFKjrQlJZ5+ClA0k5arJxARGxrEd9GsLZUN0Es2ppdcQcCTvOwSQGf8Ourz07mY4Ej24rHnHv8/9VFlcWjKQc7vdK9qTKqYiiTEwY069Unq26VZhPQZRzUvqD7XOkG+6ChtqpbCpn8Orv+nzDtkIL/foiHxnotEp9PS2JT29/q0Mu8QgbzWi7pGIMSr2ePDc4EH5m49deDA3i1OYVhM/KSpSVM7Rbn/9oBXp+vbm+vdXbb9zLFNa3dQ/OCQ8JEDWie3jQx5+NWKmh2PTVRN331p/5nzBTx547qv7Hq9ZY8ArqR77RnZZ+xEXKgf10am2q9fOmMm4urW4FpgiMnJzCEbfbRizqB4ruxFAAAA/4L1G/vUHnfwwUx4nPvd9AD1z6mLRbz4dz7sEPAgRNKv/di3Wv/46enTl+0DOonZDe8BnJ+Vk0+oa4Q8cd3DBJEl8jfxxDGWHAnjYCu4Up4eJ9d4x5EJvI7l2umbTnnnHonBDw8qn3q9Xwle+uP9GxkMUnLopHjqKWBzONNy9TKJONRfRbDeWdFbNqZ3XEHAE7zsEkBpV8xaeSq884CgI1usbAdTxrOP/1PH/0zt0CbOVyLjxpSDXrDTvaoxqexOFXX/8tSONtu2bd/+64FVyft/imrRrW+/fv36dm0e+axM9AuNCBl1xDyK7SgeEHVbY7CvYTsKhBAStRxjODamvKUE0c17rWneyxMBlWIXy7V12tSNLdgXXotk6GcsRQTGJnw7McGjkf0bqZg8etjkf70sim2d8VlrFuJBCCFEqHsf+av3U98StZyUcXWSh+OpEF5EdATvDrv9MgAAAJSHUHVbdqhuAYOwYe+4N7/KYDuep6MsSBVTv1WD0rWbCLFEQiDK4eTMCE0mNVNH8yNiFbknj928nmfzCY5r27wuoVJjgoy1ZPPxs26BPOwpcbZvVitKwnYy60necWQCr8OrM3L2rAGaBqXSBHSx2YZJtdqX66dAodmi1xvVSoWaI1MOesvG9I4rCHiCV10CnFfWzZ9+M3bWj2/SsziYgH7K8Y9FYoJATqs1SuUj43MlqegFO92rGpNKP1WQhDbr80GzPh98bsv5+/DObdu2bf/ho61LP/QJb941MSkpKbF7q2gZVw4aAMooVgZn1Gztl5sSpL2KMJsVD4FH8RuNGPfq6tkfr+29YVQdKdvRAAAAeAZ+QK2mAQghnHPVrdP+Vomk3fKj7Z58icnYf+AcJWjUNJ4z/U2cqZkGmjFPHTomu6Bk9l1CENBs7NxPFzdgeKwWfX7SU+IUBjSYOnPyrATujJn3kiMTeB0fTbdEDUIIIcZmKjIac66d3DBpT35olyn9uTbRy5OnAGO3ZOflxwT6y31YnHLwSd6yMb3jCgKe5D2XAMv19cNXa1tM/HZ8LFrKdjBP8a/j30FTf2z99RIlaNyqiS9nss8IecNO96rGpOrd2sXBjXu+17jne3Md+mtHd23btm37hmlvLvtIEpbwWt+kfkmJ3VtrFNDfEHCIIaRmbni98LsXFEYuPsEC7sTTDP9iyoZmY5rEfd0yoUaA+ImLiLDVh+smtoSSQQAAbsAYFxYWln7F19eXrWBABThSDy7oP+uUOWJA8oBIrvxIYfQp2RSm6ZieUw8PbOLPNx86u2vh4p3LP5pZ/8fpw4M4k9p9Ms5oZLh0atu4rw7NSV4exak43azMKc8wrum6RFGU3W4vvXJoTDiKTl06qN+0axRCpCrhvf1zO4VypSkpi2GQDSPGaYsJDZQLOHn37D0bEyHkjitI6VPeYrHQtGvGuzAMU1RURJKPY4T2hHPMV2ZM36RtNmFb/3A+8oKMh8VpPbdr3qRFZ60RA6a/GcXpM9ULuOV2tHR7QtN0pe9PXFhXRaiu3/Xd+l3f/dRp/OfE7m3btm/fPOOtr6YoBu3KXd+LC9XDQbWHSV5mTFOzMjjm5nGJOZ/tcIDnWX+f3j/5rBkjx/2rf2SXaY/FvoO5NkYFAFCNYYydTq5NWg6ezpF1dtmnn87Z8z9HVPdV62d04U6fXULZe2xyY3FE23pBZoFCL4x9vVtIO0davfmXlu9LGzIimiudRErF6YMQQiFter2/lzBwLk43c9MpjzFmGAbaEy9ABvWdsjA6U5dy9fjabSt7vMvbv3ZEcx+2o/oXJ0Wn6YsQQnypUsTN7DPymo2J3HYFKX3KVyVhVAbGmKIoaE+4CxcfXLrgq4KWa1d2iyER4vzP29z7Jxd9+tnqgylOrt1BeSH33Y6WPuUxxriyVQTcUdhboAiOjIgIDwsNkN7U2ew2LsxsAgAllKTVfIlAOPbqIb7TxnY4gA2Ocxs3/EM2HP/rns+7RsBjMQAAp5Ek6e/vz3YUoDy48OKPn74zd9c1e0iH0V8undirnpxLv50Ied2EhDoEkSnyt/BEsdZcEeOQt2ndatGlE7fvm1A0V/qtEfK6CQl1n3wpjINxulmZU750H8Oq4PP5EokE2hMvQEhrtepQCyGU9MbAGqMbzl4zfU/PAwMCOdUf0GKza3UGuZAvJhAiOBXak7xhY7r1ClL6lJfJZAIXPSrg8XgqlUqlUrlkbcDVcMHZVaN22PvM/7+3grl1sP8bZgoOrZ01/vM9d5ycvIPyLm6+HS3dnvD5fF5lZ9VyZQKaKrhzavfWLVu37jxyVecQ+Nd5tfe0/+vXr3d7yPMAttmkqrRaL0uL9WEpF4lnTjkIXnT2nCwDr+mkCa9B9hkA4A0IAm7EuY3O2jZp8Nub0tXt3t81771eMZypgloKRfLTRAEEwhpLNh8zCCFCKlPyEaZpGiPE4UPMW+J0ITed8iWrhfaEsxza81suGaJadGnzuEgEGfXKS/XIi7dua2nEoZxpgcmclZcf5OfrJ+RkX2Kv2pjuvoKUPuVde/oTBAHtCVdh3Z27WVTe5sl9Nk8u/fqmlo038SLfPLv7vRbcGFJEOzNXjx88cUeG+tWxu+aP4eYdlNdw/+2oq055FySg6cK7p/ds2bJl644jV3LtfP867V6furp/v97t4wO4OiAHVC+F/hGZsc3UGTfVWbfYjgWwiq/y98U30zMdKJpr9fgBAAB4G+qf1eOH/5ITP+b7X5Nf5lJW4zHT/3b3XPiHf9LMza9JHk05SGdm3nUSIREh3OlpRN3e0Wfh76o+k9f1CHq0ITkYJwBukfrbxI/21v6k0Ymhj5Om2GQqxoREIubI4Y8x1hUUGYtMUcFqqViELWwH9CzesDERQl5xBQFeiPBr1H3ayGaPO9zh4nO7dx+31xnSr2mEX4MwbpwDDtp5bPkHk3fm1nvv+1+nw/FfRd7UmFQ+AU0XpZzZu3XLli07Dl3OsfP9a7/a66PV/fv17lAP8s6AOwh9aK288LoR//tDnp/FdjCAbZJOU+d1PzhhzIQWmxcl1ZZzu3UGAADAafY/lq/+y97ww/XTOHq7X8iXZsbFq7O+27Fm9YHmH/RQEQgh5NRtXXfgbxw6sWNN7tyx88NDVdm3f163uf9LnI4TAHcQNGjRVr5rz5atF/qPb1nSsZg2HPhp/y0U8E7rOHdUzPyvGIzTdXkOJ60JDeRu0WeEkDdszAc4fwUB3okIaNJrVpNSLzAZi/7Ye6Kwwaix73Ck77PJQafrT/yy/oqz4YfrP4Hjv8q8qjGpbCNs3zMssveGQiQKbthp2Nx+/Xp3bBAoRAghVGQwPLEkIZL7yYRVDBOA/47h8TPiWth8lJprR0TWIrbDARzgOLXux3Qh7/rqN+p+L/P3lz3ZAIp7rrm1ugcU5wAAAFAB9L1Lf+gZoezCgg/vPXnDTyhavrPkzVrsZjp0QqVBII/EdeaMbHp64eGkIRn9OjaIIQuuXji7766z/sAZ0+K5lEWSNkselXCY+3EC4AaEsv3M9xofXriua5+7AzrVD8F5184e3nW9KLzH3E9asz9mz0FRaTl5QgFfExrIc1Fdcvfh+MZ8hONXEADcxGh15JgcQfrrVwyMUAHHvwt4V2NS6WAcNjvGCNlyLu9deXnvymnPXFDcb2vBliTI6QDPcgol2tpteE577LXDPAomwgQIIYQIsTI4ooFfRIOnvius6VfuTTVjvLJ93S8nLqcVy6IatR8wLLGhqsxAJpx/YMY7K688niaWF5b4+YohNXkV+CwAAACvQWWkaylsunNi/Z0y75CBvJ6L3qzFSlQIIYYgM0T+NlKgseaIGGfN1z8+F7R37qbjB/bu2OIUhcU2mDR9wNQuMRybZ57nJXEC4A7Ceu+sOBO8ZvaPR3b8dL6AEgVrGo6cMSz5raYhbOd7zTZ7us7gK/UJ8VeyHEpFcXdjlsbZKwgAboIxzjbZi+xUjEpCXs6E499VvKsxqWwCmqfp/O5of2f5CyJBUw03uvqD6sMiD9DWekmRnxVy7xKBGbbDAZwhaD1p885Jlf88nbZj3txtdNth4wb4609t+GHuAt6SeX0inmjiGF2OjqjZc2Lf+AcjPwhJWChZsc8CAAB4AhE8/IhhONtRPJ2o02JDzmK2oyjLSfC0kkAepmOtObwHt0DC6JaJa1omshxZ+bwlToS4fWQCr0T41Os5fkvP8WzH8QRjkSnHWBDir1LJpWXe4vQpwMmNWQY3ryCggjh9/JdBhk/eeGxy+cu5F42xtsBKYxyrkgp4BPLC45+zO927GpPKJqD5Td5ZvvKd8paiLAVFNr6MU32+wYsuP0iTHd0kOO2KX87/2I4FvFgcV/ftux+e+OXoLhE8hOoFFNydtPfXG91HNyhdZMipy81X1GjZpnV93n/+rKfZbLa0tDSSJCMjI0UiGKgCAADezcITacVqBW0NsRmg3zAAoNIwxjnGwgKTuWTKQbbDAQB4MRtFawttEj4ZpZCQBNyeVGtuHYji/HNms8Cw4Xvs7vwSAB7CiMiNapgT0SDqn1OQfQbPhE239i6bNmbIgKRByy46qbunDlzRV2Q4B51+4x9TcJOmoSWZZV5k08aBRf/czH6ijz2jz9XhwJBAxpqvyyt24v/yWQ+6ePFiUlKSUqmsXbt2zZo1VSpVYmLilStXWAoHAABAVeULZKniwCBHQShknwEAVUAzTFpuntlmiwsLhuwzAKAqiu3U/QKrUiyI8IXsM6h8DWgAuIUheem1X3aKpLHXDgntFrbDAVxF3d84tPO7P9+1YoQIlXgo47i3vO+bv0UP/nbvmrfintsdmcnT5WF/9aNC0aSf2g/n6fQMinr8KI/RZ+sp/bH5w3+4X0gjvjz6pYEfvNctTlDeZy9cuLBjx45HqykoKLDZbAghiqKKi4tduQUQWr58eXJyculXrFbrjh079u7du3DhwhEjRlRl5RRFlazQbnf9s0eaps1mM+GGexeMMcbY5Zu6ZM0Mw7hpzQghh8PBMK5/kEHTNELI6azIo5n/pmSdFovFHfuRYRiTyeTy1T5aeUX2o91uJzk/RxN4wWCEdCKVkS+NsumltI3tcAAAXszudGpzDSIBXxMSRJKQLQIAVJ7B6sg12cMVEoUIEo8AoeqegOZxuPwqQ7EdwbPF1GM7grIcDEqz0sKCXM3dcySBkNiH7Yj+JaYm2xE8Q3gNtiPwJObeqhGjf8lvPHHz12Mtn8VPRAhJXpu+Zoz2/ZWjhjZIOPlhrec0CrTDThESieThvTghkYgJh92BSy2Di/PynRJZbM/xn7YJQ7lX9q36au28terl75b32YyMjCNHjjxaT506dUoyuTRNl6QCXeXnn38uk31+xOl0/t///Z+vr2/Pnj2r+C3uSFyWcDjcOKeoO5Lm7l6zy4+Q0koOQndw335036bGGFdk5RRF8fnV++YKeBZDkOmiACfJj7XkCDGH7x4BAJxnstrSdQY/hSxI5ct2LAAAL4YRyiyymZ10jNJHIuBw2g14FvxGAl7PRON0K+MnJIPuXUQYl/8BUG3RNzZ8dwa3XbpxYf9o57aSKyGhbDho+XbL3fj312+6Pn5Ww2c3ijyhiIcLrTaMxARCCGGr1YYF8id6TROqzjN+6fzwr4jmb77f9/LYzSevDH2lnM+2a9euTp06j/789ttvfXx8EEJCobDkHy5hNBpnzpz5/GWmTZvWp08fmUxWua8o6fsslUoFAkHl1vAcJpPJx8fHHd1Li4qKMMa+vq7/ucUwjNlslsvlLl8zRVEmk0kkEkkkEpev3GazkSQpFLq+RrnFYnE4HHK5nOeGZ8BFRUVyudwdfasLCgpIklQoFOUuKZFIMFyJgKc4SEGaWC3ElMaaQ8KsywCAKjAUmXLzC0L9VUpZ2SkHAQCg4igGpxVYCIKIVfnwYSAFKAUS0MC7GR1MjgOHikilgIDsMygHlXI7BdXo2zaiTAKTDG39UhxafDeVRs9JQJP+6gDiviGfQUoeQggxBYYCwj/e/3nZUDIgLFTkzC92+JXzWZVKpVKpHn1OIBCUpFkJgnBhb8rt27cXFBQ8f5mcnJy9e/cOHjy4cl9REjaPx3NHJ1CCIHg8njsSlyXcETNN067diY+UZDlJknTHykmSdNOaS7LD7jtC+Hy+OxLQqMInI0mS7iiKAsC/mXjidLFaSZlD7PkIwS0QAKCSMMZZhnyT1RYTHCgRsTk/NgDA29koJq3AIhPyQxViyD2DMqBMIfBWGKFMG6Nz4BgJTymAxg1UAOGrVCCjLu9fBQucudl6LJPLnnsc8SLj60izL1/Rl/zKZ3KuXM2R140PK50NtZxb8d6YL88UPpp8MDMlzaGKiFBGlf9ZDzh9+rQLFwMAAMAWI1+mFatDHPkhdiNknwEAlUYzTGqO3u6kYkODIPsMAKiKQpvzXr7ZTyIIg+wzeJrK9j9idNdPXcstp+wkfTPNWsn1A/BcNEZaK4MRipPy+NC2gQoSNunUTvntz5+vHddqTOTjl63XVy74JVvRqX2T5xeNEDbo1i1y6tavfg4d/oqf7vh3O9Jj+35QT4gQlXJkw0lDne79WgTWb1nPOX/NIj+qf8swnuHGwY279PFDutfhC5lnfNaj8vLyKrKYXq93dyQAAAAqByOUI/Ir5PvE2HQS2l1FzwEA1YHN4dTq8iRCYViAH0w5CACoCr3Znmd1RvhK5EIotACerrJHhvPU7K79tlZknm1xJb8BgGexMVhrxRIShYkJuFMC/4Vvj+mzOx0cO65Vy2NvxNym7PL9K+YcPLFx/f47/LZLZvRWlXM48TVJH3/k/PbHFVN32HzCGvWYMqpPFA8hRGVe3LfnPt0qqUWQLGHkZx8pf9yyYf6eIp5feM2Edz8b1CGURIh8xmc9ys/PryKL+fv7uzsSAAAAlUATPK04gEZkrDVHwOUJqwEAnFdssWbojf6+8kBl+TMcAADAszAYZxTZbBSjUfmIeFBlATxTZRPQ/Lr9k2fFV+S+lx9fF55/ANcppnCGDfsLiUAh5J7Bf8avOXrbcXny+OlrVu0yMxitnPQHT65pP+6HJbMHx1dg0jyeOmFQcsKgMq+KX/l42ysP/xAEt3hrSou3KvpZj2rVqtXmzZvLXax169YeCAYAAMB/YiMFWkmghHZE2XQklN0AAFSBvqBIX1AUrvZXSF0/lTEAoPpw0oy2yEYSSANTDoLyVDY3zKub9MnMJJeGAkC59HZG78DhElIBdTdAZUnj31p6ZOB8fcqtezorTxESWytaVYHU8wthwIABycnJJpPpOcv4+fn17dvXYyEBAACoiGKeOEOs9qNMQfZ8tmMBAHgxjHFmXr7Fbo8NCxYJoKcYAKDyabuBswAAIABJREFULE5aW2hViAQhMpF7ZgEHLxT3XnIoS0GRjS/zk8F0BqCKSqYctNAoVsoTwagOUFWEWB3XSB3HdhieFhQUNGfOnAkTJjxnmcWLFyuVSo+FBAAAoFwGgSJX6BtuNygoC9uxAAC8GEUzabl6AiFNSCCf5/FicACAF0ihncossgVJhf4+kPADFeLWTJ7zz5nNAsOG74H5UUDVOBl8z0I7GKzxISH7DKoKm27tXTZtzJABSYOWXXRSd08duKJ3sh2Ux4wfP/7jjz9+1rvz5s0bNmyYJ+MBAADwHJggMkT+eUJFjDUXss8AgKqwOZwpWTlioSAGss8AgCrAGOeaHVlFtiilBLLPoOIgmQe4zkLjFAsj4ZExPjwovAGqirq/cXDjJq9PmL9y/eYd+//OZRyXlvdtHNNgyMa7DrZj85R58+bt3bu3ZcuWxMOBUiRJtm3b9uTJk8/JTQMAAPAwiiBTJUEOUhBryZYw1eYqBQBwg0Kz5V5Wrp9cFhbgR8BQeQBAZTEYaQttRXanRuUjFcCjLPAfQNUnwGmFFM60MkEi0h+mHAQuwNxbNWL0L/mNJ27+eqzls/iJCCHJa9PXjNG+v3LU0AYJJz+sVU0uoR07dmzfvr3JZLp79y5BEDVq1AgICGA7KAAAAI/ZKCZNEiJlHGH2PALDlIMAgMrTOQlDXn5kUIBMImY7FgCAF3MgMs1oFvAIjdKHB1MOgv8IEtCAu3QObHAwkRJSBj2fgUvQNzZ8dwa3XbpxYf9o57aSXDOhbDho+XbL3fj312+6Pn5Ww+rUKAYGBgYGBrIdBQDgxSL1ZTuCiuF2nEVFRRkZGWqzXm3Wsx1LBbTqznYEALAnKIrtCJ6HwThDb7Bhp0YpEjE2ZLaxHdFzfT2L7QgqZvYPbEcAXlDcvjkx0yjdQfpKpcF+vl4wkILbG/MBcwHbEXgUlOAAXMQglGalC51Y4wPZZ+A6VMrtFFTj1bYRZVo+MrT1S3Eo9W4qzU5cAAAAwCN6vT4zMzMiIsI7ss8AAK5yUvT9bB3D4NiwIBEffvgDACrPSKE0OxkkYEL8lV6QfQacVJ06+wEv4WBQmpUWEEjjQ/CgaQMuRPgqFcioy6MRerLUhjM3W49lchkcbhxG0/B8AADwgsMYZ2ZmWiwWjUYjEonYDgcA4MUsdrs216CQSkL8IFsEAKg8jFCOgyigUJSIkVaTgpXAPSqbgGZ0109dyy0nG0DfTLNWcv2gyix39yz+bPmmE9dSjQ5pSL22/d7/9OP+9dhMsNl/XzlluWjUhuF1yhx2lvtHFy/7cdPvt1MLnD6BNZq+Nvjj97u+qiTdf6tEZ1w/O33vXwdTjQZaEBwS2at9+1mvRviX/lpsvXjq2Owj18/k2MR+we1faje3a81ogZvjKont2pnpe/48eN9ooAXBoVG92neY1T7ycWyO62++t+EX25NFIQW1f1gxdKjn9zKTf3HjF7PX7Dtzt0gcVqf9gIlzx7aP5mCJOWGTTu2U3/78+dpxrcZEPn7Zen3lgl+yFZ3aN/HEngX/zZ9//vnll18eOXIkNzdXLBY3aNDg7bfffvfdd4VCmHAZAPBCcTqdWq2WJEmNRsPnQx8RAEDl5Rebs435wX5KP7mM7VgAAF6MxijdQVIYxUmwAJ5kgaqp7N2t89Tsrv22VqSElJuTULTu4i/fbTx6Jb2A8Qmu1br3sCGdND5wXjjvrE5sN+FgUUjrxGFJkc6UEzu3Lx527PeME7992JCl/jTYeHLF90dPdR7AlAn13i+JSXMOmtStuyd1D3L8c+7wke+nXryae2LjiIbuzS9hw9W97ZZe1MrDE195pYbAdOnSlW/WrT1rfOdMYoTPg0XMv61f0+dYQXCNWgM7KG1pN37Zvv5Uxhvn36sf6t6DDBuu7G635IJWHpHYtm0NgenSpcvf/LD6rHHkmX6RJbHRRkOqkwjS1GkXVCppyguL8XzFEmz47aPefb5PD27eaeA7Ybarv/4y561TN1edX/N6KOeG+vn2mD6708Gx41q1PPZGzG3KLt+/Ys7BExvX77/Db7tkRm8VtB1cgjFOTk6eN2/eo1dsNtuFCxcuXLiwatWq3bt3azQaFsMDAAAXslgsWq1WoVCEhIRAX0UAQKVhjHUFRcYiU1SQWiqGgRQAgMpzYCLNTogIrBFhmHEQVF1lE9D8uv2TZ8VTFVkyvq77+nDQqds/X7if7DRs6phIfu6fW79bOdvu+9X4FvLqfXLggt2zZx3Kjxq29eSa7oEkQoiZduTDjt2++Tx586A9bwd5duvQVmPWjavnNny9fLMeB5UNtXj30uWHisKGrfp5dhtVsRNHTRpzds7b3X78NnnP63uSAtwYKmNct/uve7K662a9OdiPRAih15tMnrVmyaFTu7oMHCglEMKF1w6NOm6s3W34if7RvgRCuE3PNV8nnTvyVZf4+Rp35lYZ47pdl+7J4td99taD2Po0nTz92yUHT+7qOmigjEAI0XpDKhZ2eH3gxgR2e+3iwqPzRv2QWvuDbSdmtfAlEMLv93yvU9K2hV+N7T6/Cec6cPFrjt52XJ48fvqaVbvMDEYrJ/3Bk2vaj/thyezB8dD/mVumT59eOvtc2vXr1zt27Hj+/Hm1Wu3hqAAAwOUKCwszMzODgoL8/f3ZjgUA4MUYjNN1BidFxYYGCQWcuw8HAHgRE02kOwg/PgoS4PKXBqACKntZ4tVN+mRmkktDqQQ67ezptJAei0Z0jOEhVLNGgOHK2K1/3KZbJFTvyy117dS5Ql6D8R92CXyQJSX923/4bus1H54+dtH+dg9PlkbAhp19Ws046HgQR9m36VunLhXz6gx9o4XSSuFYKU9AqNqPGtB647zTZ6/Zk9q5MVRb+uk0Wt60caLfw6hEYb3r+y49rL+hx0hKIGzZfexqhk/dJT2jfEsS4YSsZ5++X0fnBQpp907gadOeTqXlCU1KxRbeu4Hv0kP6G3qMZARCOF+fn0+oagSyXYQJ5+/+bmeGb7clE5s/3EoBPT9e+nWjlECJk3NV5mlLQaGNFzdw6ZGB8/Upt+7prDxFSGytaBWknjnnypUrCxYseM4C9+/fnzJlyvfff++xkAAAwB10Op3BYIiMjJTJYKQ8AKDyHBSVlpMnFPA1oUEkDKQAAFSBkUI5DiJUyCg59oMeeDXvPpoIWd1uQzTxYQ9zcCSPJPgCSCU5zcivRv1XmsaWSk4SYh8JgSi7g3n259yB8G2/bGvNAoyw8fC4kT9klHnbaaWVUTWb1I0VEDEismRYByESSwhEOZzuDZUXOnJI3wEhEaVy3EyxzYkJhVpKIIQQnXH8jkMYW7Od5PENHE9dY1TnGm6N60FswxIHhEQ+JbYH9Z1xaq6R5gXGSo0nL6Rez3f6+Ie2rx8ZJfL4vabj0vHzFmFCu3aKUlsp6tVRo1/1dCQVYd03Mmpw7tw7x8dFidVxjdRxbAcEnmnZsmXlzjr4008/LVq0CDoMAgC8FMMwGRkZdrsdphwEAFSRyWpL1xmUMmmIv5LtWAAAXgwjlOUgTDQRI2YknKuoCbybdyegycDGXXsihLDh9u9X72deO7Ivu17/0fGP/1N//vmnVqt99CfG2GazPaqsJxZzcJY0V/DpsvxilydfYjJ27zznFDZq0cjT/2e+X62GfgghrPtH8a/2q1jQ5v0tL80QkkHCR+lLJuPgoXOUoFHjOu4NVRTYrU0gQgghbLNajMWF166enfS7ObRZj/4BBEKIKTDcsxGBgeKU0/sGHbx2NtfpGxjSqmGz6a83rC92c55XFNTtlaDHsRUVXrt6ZtJZc2jzXv0fVCWhUnVFNLZN/eSL7GIaI4QQIVRqpo4ZOCveo1MQMrrUeyYiMFqZsvGTQd/sOXvf6hsd36rz4OmTE+tXORCb7XGZeZqmGabKjyR8WnRoLUk+d7Hwgygo98xxR48eLXcZiqJOnDiRmJjogXgAAMC1HA5HWlqaQCDQaDQ8HtvjmQAA3sxYZMoxFoQG+CllPmzHAgDwYjQitHYCIxQrZjw/txR44Xl3AvohJuevA/t+z87MEdTqEyItdZ7s3bv3119/ffSnQqEwmUwvfgK6LHvqvuT+Uw6bo4YnD4nhzkMsgwPn2plwCal43LY5Ug9/0X/uWXN4UnK/cA+FyuiXLvhq2n0aIUJVs+P+YfVKJhjENlsxxoWX9nY+Tsc1rDuqAS/77j/b9289fLf4xEdtGnqmoz2jXzrvy2n3aIQIVa1O+0c8nPyQKUjR05hiYl5963D3mtGo6NKfJ8b9fHHO8m1R84YM9/fctQKbiooxLvx1aud1jrjO3Ud1EmRf+G378vcPX8w9sWNsw6qdYSaT6dG/XZOAJqPe+f6nfxI/GbJQsfS9DrEK+MHPXdnZ2RVZLCsry92RAACAy5VMOejr6xscHAxTDgIAKg1jnGMsLDRbYkICJSL3TuAOAHix2RikdRASAocJYcpB4BYvRgKaF//mnCVvYkvK9jmffL5MuWJ2t8CS86VTp04ajebRcj/99JNUKq1WN/qOzOPLpnw4Z9s/jpikVTsWdeFGt0+MUKaNMdM4xoeU8B6E5Mj+Y9m8eXN+TXFEdlm1ZmoXX0+FSvj2fWNAdF5Ryv2ba08d7fEFsX/iq83FCDMMhXBRoWDk+DFfN5LzEEK4w+AfV/Y4fiz5j0Z72nhkpkvCt++AgdF5RSn3bqw9eaTHYnL/pHbNxQgRst5vvt1YGNi2hp8PQgj5t2nXdy9RVG/t7eUnc4b0DfFYYhVTNIWZIp3PyA2Hvn4tkIcQYiYPntS1xw9fJO/ot2dgYFW2klQqffRvHo9HklV+JOE8OWf4F1dI2+VpXWp8IvYNUMkEpdYp7rHq+sruMAaaG+RyudForMhiHggGAABcKD8/Pzs7OyQk5P/Zu+/4Jso3AODvZTYd6UzbpCNtAhRoy96gCMgQocpeAoIMNz9BZdiyBEEFUcCBqExlIxsZsnfFhQgILW2SrqRpmzZJM+7u/f0RKaUUqDTJ3bXP9w8/5XJ583jjvbvn3hEcHMx0LAAADqNoWlNQSNG0WhEhFEC7CgDA4yujCJ2DCBXgcJhyEHgMpxPQuOzm6VM54V26Ng4kEEKEr6pbF/Wm729qKBTu+h/r0qVLly5dKr7w/fffSySS+pKAxsXpX0+bkLr5ij26x//WLJs1LEnKiv9xEiOtlSIIQu3L/7fpMy5N//6DCR/uu+KI7DHhw2VvPpvkzWEkCHFC08QEhNCT7UdGrWm+4UTa+VYHu0kJoVCCCFFCp7TmAf/e0BG+Pft16HjqwKkr2dYnkvweWqrbYktMSkAIde0wMvrb5uuOpZ1rdbB7II/wbZrYuOm9q0a1SuoouHHidr4ZyQO9EJvrV30kEoIQdZyY1vPOfIi84J7/G9dx4+xTP1+yjuxXm60kkUgq/nZPAhoJfPz9/UUJXfomVPOhKC6IPR0E6r2WLVvWZBSOVq1aeSEYAABwC4yxXq8vKipSKpWVX7ICAMB/ZXM4NfpCiUikjJDxoLEiAKAWDE5kcKJoMQ09hIFHcToBjZDu1LpVPL/WM59ytUYlDQVFKKAhO/KszKK021/pN2ZdlqzXjF2fvp2iZstwYBihTAsVLCAUPndulKi87TMnjtmmkz05ede8iSlxXhoXxaHP2PqPWdmk2RN3B6zgKZMbJfFuX9cZKSQVBgYq+OhmSFBYpeOJFxQUxUeXrDYrRn4eO84cBbe2/mNWNm1+T2zNEpJ4mdd1RgoFVpsmJSSSIB7CNEVhhLx1DvAj5Ao+cTMqKqxSTLyImCgBumQyeXQrPQ5h5+k79k5nOgpQE2PGjHlkArpFixbNmjXzTjwAAFBLFEVptVqSJNVqtUgEPeUBAI+vzFquMxSFSP0jgr3W7AQAUAdhhHIchJUiVD60DzTGAh7G6UOM8G/Ts5PvL+s/2Xz6yj83r17YvWLlweKGvbur6/1rG/La8rHj1+cmTv0xffds9mSfSYQoJx0sJKIqss+IuvbdO+O3FyRO+jJ9zRteyz4jhFDBn1NXb3/vl5LK4wrjclsZQhKxkEAI+cjbKHiWfIO2Uh8UqrAoi0SBIYGefctR8MfUVVvfS68uNpGQQIjMOtV/9udjThZVXoHSG26RhDwy1CuDg9zhl9wmgW/JuKWtFAqlu53lJAIVCva9C7Kb9AXV0OsLi00WO8V0eOCuUaNGtW/f/iErCIXCTz/91GvxAABAbTgcjszMTIIgVCoVZJ8BALVhLDVr9cYoWQhknwEAtUFiItNGOGgE2WfgHdw+yoiAdpPSXm1Pnflmwczp8z4/VNRk7NxZz8fW+/yz7dTy5Rftrd9Z/373cNbsYb0T2xHiCwiZuFJM9kvLv/vDnjxx/TsdvRyqMF7d1Ze+eOrSJfudRbT54NE/ruOAp5pGCBBCPNmgDgpe5vk5F0ucrhWo0t17LqTjgP6tYz06ULBQ1aCrL33xxIV7Yjv823Uc8FRipAAhQURYsEH7w65jB0rvZMfJ4m27L/6GQod0iPHO/Ij/4jcYNKgZ7/I3c37U/buVyLzdS9ak0xH9+7Vh3XDK9r0TlZHViIiQhQQFSCRSReJTI99b/6sRUtGM4/P5O3fubNq0abWfCoXCL774omvXrl6OCgAAHoPZbM7IyJBKpUql0h3DSQEA6imMsc5gLDSVxsvDpb6SR38BAAAewIaJDBvhw0PxPljAunZjoG7i+BAciPCNf3ry/KcnMx0Hq1C3zl/Q0yLp2cUvT7z3KYeQPjFl6dhEL+91GiOdjS53YglCVQbgpm7/dsFAi/wvL57xXpUHMmn7F5cOaei5UAn/pnP6xx3ZcuqZuQXDW0XLsfnK1b92ZZVHdxjyXqIrhctr3L3vW+e/W/zV59fTk3tF8m5fvbLztjW207B5zTybWSX8E+c8F3dk08ln0gqGt46Ro7Irf13Zdbs8uuOw95KECCEkaZw6NOHId78MnmUY0lEdzzP/+eeVfVoy+dkXZzXw8u7lNx4/763tQxZP6nl993O9GvBvn9y989eS2GFfznuafbPDCdu98dVcW9qCfQUhyd16dk6MlvLM+dfOHzr6B9ly5OhOgabsK2d++ujFXfv+PnJucWcYnZNhCoXi/Pnzs2fPXrVqlc1mq1jetm3bTz75pPL4/gAAwFpFRUX5+fkKhSIoKIjpWAAAHEZSlFZvxAipFRECfr1vcQUAqAUTReTYCZmQlnm18Rqo77iegAbVIDVZGhKbrx1af63KJ7xwwZCPxyZ6MxgnjTU2zEdILammzQ+Zm6OhsPnm6fU3q3zCCxc88/GQhp4MTZD0zNgzwcfnH/lr59FbJZQwUh476YUnU7vHyyuS5D7K9999KWrH0S8v/7bsNxwcETtuZLe5T1dawXOx9R1/Jvjn+Yev7Dxys4QSRiqUk8Y8ldqj4qd5jbqNPh9yduHBXw+eOLWVFEbFqN9+uceMzvIg77+99G/3/s7tUR98+OX+rcsO4eD41uMWTZ07oZOchW28eJH+Wbt/Lu/20fnt01rdHSDE/OdnQ/p8pp96ev3SKFR4Ynqvvp8v3rZ474sMRgpcpFLpp59+umDBgtOnT+fm5hIE0bFjxyZNmjAdFwAAPBrGODc3t6ysLD4+vvK0ukyEYk7/6cf5e9LP6Kw+spjuPZ9fOKh5HHsHArGdWzppueTtja82Y/GDCieCBFxU/aFlczizCwy+YnFUWAizUw5aMw8vWfLNpjPXsoqdfpEJXZ97ad5b/ZPYMusLde7SL8sFCRtbBVU5Ma3FeUsu3NqkMWXZaD9/addGDeZ1iE5iS+oN6hPOYfkuI3VnNqR9uefQXzlGUhypap4ycvLcYcmhdx7P9U6i0IlixDiAFW+yWL4xuYHdNfNdsIvrIHHf1Ub7aqajQAghK4U15bRUyJOLCMJ32NF/hlVZQdx9ofH2QkZiQwghQpTUsffWjr0fsgo/IPa1F8e/9qK3QqpAiJI6PbO10zMPXkMQ17zr6uasGIKAH9b2tU+2v/YJ03E8kvPShnVXw0cdfbPVPcNT+zd7dfbIFd3mfzVtwPstw7q+/fITK+ecR+hFpsJECGGMaZp2/UGSpNvLp2mapmkPlYwQoijKjYX7+Pj07NkTIWQ2m319fT0RtouHNoiHdiJFUa7yPbcfPVEyxhjdCd4ThZMkWaWrjXsLf+Rqrj3uiQAAt1AUpdFoKIpSq9VCIaNJDlz608oFA/YWRia2HJkSaruVvnnNklO3X7s4s4OCdQ8mCCGECw+t/OLAqf4v0Y9elzGcCBJwUbWHVqm1XKc3yoKksiApY5EhhBBy3to4KGX2obKITinDB0eRGWcP7lj5v2OXck9sf7k5C95p4fL8lb/lnVKrqpyYzuLbgzb/ccjh06lR3GApnaHJ3ZH+y7Hc8hODGzZnQQIO6hPOYfcuw8aTi7pN2qEJSR40ZGxDUdHlowe/SJtwNu+bM1OTfRDS2QkbTah9aDE7mouxe2NyA8tr5sogAQ08pdiJ8+y0XMwLFrLy+QbUQ3SxsRj7+vvdd7UlfP39aG22jkItBYSvvy9hsTAR3100TdvtdoQQSZIWDwRTkSZ2e8muMm02m8Ph8EThVqvVE+lFjDHG2BOb2vUuwUMlI4ScTqdrb7qXq0yn0+n2kl1HSHl5uYf2o9VqdXuxLjXcjw6HAwb5BTabTaPRSCQSFgz6jE2/bJ28T9946MwTLyUEEgjhfv0/Th18bMeKQW0XJbAg9XIXVW7UXL18cuPHC7YU0BFMR/MAnAgScNEDDy1DSamhpDQmPCzA14uztVcLl+7+eOlhU/S4NTtX9wrjIYToN46mDev77crUnYP2DJcx98iHy8utV/MNGy/9vcWC7jsxnbvP/X3Y7jsupetqlZiHEOrU+OiJU31/u556PWZPog9zYUN9wjlc2GWUdu3KPZlB3df+uGR0JA8hhF7v/86Al5auW7Nj3NJOEj6fwGofms98hoYLG5MT2FszVwMS0MD9MMZ6Jypy0EoJz48FdRsA/xImtWrG/2Hbt8ffatkz9O6RiYtPfbv1Gj/5xaZChGj9T/suUiqGB5bn8/mu/tpCoTAgwP2jadtsNpqmfX193V6yxWIpLy/38/MTidz/vtVkMvn7+/M9MO5hUVERQigw0P2zyVMUVVZW5omSnU6nyWQSi8V+fu4fr9xqtfJ4PB8f9z/rlpWV2e12f39/gcD9dyDFxcVSqdQTqe3CwkI+n1+T/ejj4+OJVwKAQ8rKynQ6XWhoaHh4ONOxIITNu/ee1/m3WTq8UaDrzCCk/cdM/LxhXriYQohFCWhs+H5A4zcP/Tv9Mkvf4nAiSMBF1R5aGOOcwmKrza6OihQLWfDYTl47lV7KT5wwrUfYvyHyQrq/NqrTunmnT/9uH96TqQQ5tmYPWP3boX+bVdx3D0CbTuU6+bIG0+LvtPgkRN3bxHf688/TmmJ7opyxsKE+4Rpu7DLrldN/OwN69RsUeSdC36Tnn4xctu722UzUIxnJRZgNCRpubExOYGvNXC0WXMlA3UJhpLVhkkZqX56I0RHKAKiKFzdu/uvfPvPJc22ujxk/+ImmCn9kzrt2Zsd364/pk979ekJc1veTRryz/hfrkyteYDpWwAySJDdt2rR9+/abN2/SNK1UKlNSUsaNG+eJZD0AoO4xGo0FBQXR0dFSKcM95f9F3jp+1S5q3KxbpXEA+ZHJkwckMxhUtYjgvp8dblpCI2zc++aIFTqm46kWJ4IEXHT/oeUkKa2+kEcQKkU4W6YcJK0oOD65YzN1pXAIH4mEQKTDyeCrV8JH/tmwwBKMcHnOm3tuVT0xaRL5+CdHB6srPZgSAoEEIZJi8o0x1Cecw41dxm8yaf7c4apmldKOVF6ZDfPCY0ORQsSWRhLc2JicwNaauVqQgAbu5KBRdjkt4iGVH/RABixESLt+ePRQ5NQpH66Zc2yVa5hWgh/YZOCHP30xtUsAfenarwbl0I8//uRlNcORAib8888/AwcOvHr1asWSGzduHD58+MMPP9yyZUvHjh0ZjA0AwHIY45ycHIvFwvyUg5XQRfpMKxEu98s4tP6FnRfP5joC5bEd23dPG9kp2ZdlrQQEYQmtwxBCOP9PKWtvIjkRJOCiew8tTDozcwtC/STykCAPTWzwOCTdlv/c7d5FtO7AwfOksEXrRCYb2fHECZFihBC2lEjv31qCyOWjI+9dhHW3cs7TvBbyICbDhvqEczixy3xVfQepEEII0TZzqdGYf/r492l7i+W9p78Yy5rKBHFkY3ICa2vm6kACGriNmcLacjpExIsQsalqA+AevPAnpm389Y3lt37/7XqOifIJi2vWOjnKj+cwXL1BtVnwS+YCpiMEzMjOzn7mmWf0ev39H2m12h49epw8ebJt27beDwzUWxjj4uLiykuCg4OZCgY8HEmS2dnZBEGo1WpPDC/z2HC5tQxh07m1vfaTDdq3ndxOkPf3Lzu2fnnk7+ITi/uxbWoaUOWUd9d4PiRJ2my2yoVDZcJmJEaUtSQsKEAudf8gbG7lyDq0eOjcU5aY4anDY7mTQaKzMq4OPam3SONSE++fGKbuqHzKWywWd80sTdN0SUlJ5SVQn7AUlfXJC0Peu0IixAtu88qBD3oq6vDhDu7ySM1cuT4hSfKx709YdIsMOK3IQec7sELMC4IpBwEHiEIatOvRACFEldw8uX3hvE2bdx673f2H4q2DxUyHBhjyxhtvVJt9dikvLx85cuTVq1c9MbY1ANXCGHtiplDgdjabLTs729/fX6FQsKitIkIIIUzRJMalxeJJc9//vH0QHyGEB45ePqff/l2pJ7rs6RXErnDrPQ+d8q6JdqE+4QR9qc2OEN83MJTd2WdH7tnP5s1bsOemQ/nsV+tn9+FIXeIoM3x26s8F/5Q6AqO/ei65D9saB7pV5VOepmnX5NW155peG+oT9nMQEW3e+nh5nqH475/BTjaQAAAgAElEQVS/2/5lv4n8A9+81A7GFKzTPFczVznlH7s+gQQ0qC2MUK6NLiNxvIQvYccAZQA8CrZqL+7bumnzpm0Hf82zYUTwJIqOyVHwWtjDaJo+e/bsiRMn8vPzg4OD27Rp07t3bzb0VU9PTz937tzD17l169b27dtHjhzpnZAA4PF4YWFhTEcBHsFkMuXk5MhkMplMxnQs1SBEIglBiJJ6p7UL+vcejfDvObxnx582nvrlH2uvdu6fwxTUQpVTnuemAe2EQqFEIoH6hOVojHUGY7nZLiEQIWDx225sSl83b8LCXVfs8h4vf7psakpSACeyz870P/6ccEZ7hZL0aN1mWYeYJBZvY7eofMoHBAQIhUK3FMvn80NCQqDVM8uZKaR1BCR37NFLhBEa8kLDl5vPX522p//B4eHwvFs3ebhmrlyfCAQC/uPOTAAJaFArFEaachoj1MCPL+DEvQeo3xz6Pw7v2Lx505Y957LKKIwIQVCjp0eOGDlq5MCuDQPhBYpHpaenT5o06ffff6+8UKFQLF26dPjw4UxF5XLkyJGarHbgwAFIQAMAKhgMhsLCwpiYmIAAlrZV5IeEKPjoZnhYWKWbNF5IWJQAXTJbrRj5wc0bACzgcJLZBQahQKCOZPdoqFTu9rdHj9mklXV7fdcHr6TEM9+GoEawdfuRc2P+ssjiEnZ1b5QSBLf8oM5yaC5+d8no17Jv/zgcxHc1U+Upn+ycxEu/fkNDIUhA10XcqZkhAQ0en43GmnIs4aEoH4IHDzCAxaiSf07u2rJp8+Yfj10zOjEiBIHqLr0C//n56pNf/751SJ3uf8cSR48eTUlJKS8vr7I8Nzd3xIgR2dnZ06dPZyQwF52uRnMvZ2dnezoSAAAn0DSt0+lsNptKpRKLWTx4k0TZJpZ3QJerxS0b3LlVo/T5WSQKDAupZrYuAIDXWe0OTUGh1E8iDwlCBWw+LclrX08Zvzk/8dXv9qd24U4eC1/79ZfxV8sT23Tc/0R4OJs3MAC1gxHKv/XTezP3NpnVcpRafne52VyGCYnEBw7/uohLNTO7owMsVkqiTCsdJCRiJDwey0Y8BKCylUPaxMgb9xg3+5vDGbyEXi/N/nr/b7qCm8dXDFHyEIKD1wvy8/OHDBlyf/a5wowZM44ePerNkKrw8anRW4gargYAqNucTuft27dpmlar1azOPiOEeIpBT8Xzrh+ec6LQ6VpCFe/+4Wg6HdS/S0N2hw5AvVBcZsnK00cEBypCg9k2iHxV9gvLv/7V3vy19bPYnuO4B2lY/muRPSJhfRfIPoO6jMIoy0bYm3Z4KoBK37b1krXiA+PBDQeuo7CnOjWA9qd1EKdqZjgCweMw2GmDA0dLeFIYdwOw3ql9l/McAUmj5i+dPbZ7o+A7tR5MneE9H374YZX5su83a9asp59+2gvBZGZm3rx5kyCIRo0axcXFuRYmJCTU5LuJiYkejAwAwAVWq1Wj0UilUrlczvZsEUII8Rr3G/XW8UWLF6ddP92+VzTv9m8Xd94wx/Z4bV5b9vbQBKA+wBjrS0qLSs3KSJmfDwfeB1GZly8YaJH/pcXTMu/NchDSDhOWjkhgZ2aBKim6YMEiUeHiI2VVw45usDRRys6wAfhP7DTSOHg+PKSM6DbvlZY/f7T2mQG3hvdMluPCK2eP7PqrNLrfwvc6QUuaOohbNTOrggEcgDHOsdFWCqv9+GLWv2ABACEUGiIicsv++mH6C38eHTRixIjhKV3iA+Dg9aatW7c+cp309PTbt2/Hx8d7LowdO3bMnTv3r7/+qljSokWL+fPn9+/fv1+/fnPnznU4HA8vYdiwYZ4LDwDAfiUlJbm5uREREaGhoUzHUmO+jd5fPDNq7Y4vz51edgEFRzUY98rzc1OayNmfPAeg7qJoWqs3khSlVkSIhNx4JCd1Wg2Jzf+cWP9PlU944fz+H4+o0bt87yNLLRoamY0F641VPiHCeVEfJ0oZiQoANzLThNZOhAhQhJBGSJQ0YeWZyNXz1x3dueFiCSmOVDWfNHtc6qjWcngArou4VTNz42oHWMJJkpqcPB5GKl8eNH0GXPFlVs6rh7f98MOmzXsOrpq1f1Wqb3S7fkNHDG1TYGc6tHqhtLQ0Nze3Jmteu3bNQwlojPGUKVNWrFhRZfnvv/+ekpLy7rvvTp8+fcKECV988cVDChk4cGDHjh09ER4AgP0wxnq9vqioSKlU+vn5MR3Of8MPbPTalJmvTWE6jpohIscfNY5nOopH4ESQgLUcJJmdXygSClSKiCojGbL50BL3XGLMX8J0FA9D+MUfnVL1TlKsam2c2pqReGqIzTsdVItVu8xIEgUOFC3G0n+nHESI8E3qP2Vrf25c9Vm1MbmI/TVzZfU7Ae1kcfpJyLp+WFarVaPRSqVSubmEeEQzQYb4sXQOeoQQkimYjuABivKZjuDBAmXuKUcYlvzsK4uefeUDS/a5PZt/+GHT9iPbll7YihBCAuuWz7bFvtC/rQLmZPAUp9NZwzUf2QD5sX300Uf3Z58rfxoSEpKWlpaZmfnTTz9Vu06LFi2+++47D4UHAGA5mqa1Wq3T6VSr1SKRiOlwAAAcZi63afXGEKl/RHAg07EAADgMI5Tr4JkpFO9DS6B1M+ACOE5BjZhMpqysLJlMplAoIE8HOIrwU3YeMf3zvb/rcq4c+GrWC11VUnxr+/ShHZSKpr0nLtj4iwE/uhDwX4WEhAQE1OjlkIeaP+fl5c2fP//h6yxcuLC0tHTv3r2pqam+vr6VPxIIBC+//PKZM2cCA+FBEYD6yOFwZGRkIITi4+Mh+wwAqI2iUrOmoFAeGgTZZwBAbVCIyLLz7DRSQ/YZcEf9bgENaoDTfU4BqJYwNPGZyQufmbzAqr2wd/MPP2zadujIN2mnTI2HbB3Mur4HnEcQRN++fbds2fLw1WJjY5s1a+aJADZv3my1Wh++TllZ2Z49e95+++3333//rbfe2r9//82bNymKiouLe/bZZxUKtvZgAAB4mMVi0Wq1gYGBcrmc6VgAAByGMc4zlpRarfHycIkYXmUBAB6fjUbZduTLw1FizIPmgYA7IAENHsbV59ThcKhUKrEYMnOgjiF8YzoOe6fjsHeWFV37ecf2vDh4e+wZM2bM2L59O0VRD1ln1qxZBOGRG6iLFy/WZLXLly+7/ggJCRk9erQnIgEAcEtRUVF+fr5CoQgKCmI6FgAAh1E0rSkopGharYgUCvhMhwMA4LBSitDZCZmQlgmZDgWA/wjSLeCBKvqcQvYZ1HWCkCa9J6a92Aau4p7RokWLRYsWPWSFAQMGTJw40UO/XlJS4sbVAAD1AcY4Ly9Pr9crlUrIPgMAasPmcGbkFgj4fJU8ArLPAIDaMDiRzo5ixBiyz4CLIAENqmexWDIzM/39/ZVKJZ8Pt0oAgFp55513vvjii/uH8eHz+a+++urmzZt5PE9dj8LDw2uymkzmpkkvAQAcR1FUdna2xWJRq9Uw+BgAoDbKrOW38/RB/n4x4aE86CoPAHhcGCGdg1dM8tQSFMCHmYsAJ8EQHKAa0OcUAOB2r7zyynPPPffdd98dP348Pz8/ODi4Xbt2Y8eObd68+SO/+/fff2/duvXy5cskScbExPTp0yclJUUgqNElrGvXrhs2bHjkal26dKlJaQCAus1ut2s0GrFYrFKpPPdiDABQHxhLzQVFJdGyUKmfhOlYAAAc5sRIY+fxCKTyoQXwJgtwFiSgwT0wxvn5+SaTKT4+XiKBWyUAgDspFIrU1NTU1NSaf6W8vPyNN95Yu3Zt5SGkV69e3bhx440bN7Zu3fqRJQwZMmTmzJkGg+Eh68jl8r59+9Y8KgBAnWQ2m7VabUhISEREBNOxAAA4DGOcU1hksdlhykEAQC1ZKaRx8KR8JBfRkHwGnAYtO8BdFEVlZWW5+pxC9hkAwDiHw9G3b99vv/32/gkMr1+//uSTT54/f/6RhUil0s8///zh6yxduhQqPQDqOaPRqNFo5HI5ZJ8BALVBUlRmnt7hpNSKCMg+AwBqw0QRWXZeqIBWQPYZcB8koMG/bDZbRkaGQCBQqVRCIYxpDwBg3pw5c06cOPGgT61W65AhQywWyyPLGTJkyOrVq6ut2cRi8fr163v37l2bOAEAnIYxzsnJKSwsjI+Ph8HHAAC14Zpy0EckjJfLBDCPDgCgFvROItdBxIppmHIQ1A2QgAYIIVRWVnb79u3AwMCYmBgY8RAA4GKxWPbt27dy5crVq1efOXPm/mbIHlVSUvLZZ589fJ2cnJzVq1fXpLQJEyb88ccfo0aNkkqlriVBQUFjx469cuXK6NGjaxsrAICzXN2/7HY7dP8CANSSyWLNzC0ICfCPCgshCGitCAB4TDRCGjuvhEQqMe0Pb7JAXQFjQANkNBoLCgqio6Mr8jIAgHrOZrPNnTt3xYoVVqu1YmFMTMzChQu9lq49dOhQeXn5I1fbvXv3//73v5oU2KRJk40bN9I0XVBQQBBEREQEPBwCUM/ZbDaNRiORSKKiouAFPACgNgwlpYWmspjw0ABfeJUFAHh8Dow0dp6AwGofzIeHFVCHQAK6XnP1ObVYLDDlIAA1Qhf9sWPt5hO/Z5f5K1t0Hz5uUPPgqjcFuDzr2Ma1u85cyysXhcY17znixedbhgkQLj44e8KXfzgr1uNHDfpw5dhGbHyjXVpa2rt37wsXLlRZrtVqx4wZc/ny5U8//dQLYWRkZNRktZs3b/6nYnk8nlwuf6yIAAB1SllZmU6nCw0NDQ8PZzoWAACH0TTWGYw2h1OlCBfDSIYAgFqw0oTGTkj5SC7CkHwGdQwkoOsvkiSzs7MJglCr1QIBHAkAPBKVvfODhdupruPeHB5qOLVxzcLF/KUfDIipnEPGpnOfz1n5V+zzo99pI8dZx77fsGBO6fyl4xOF+nw90aj/1IGJ/05GQ0iiFCxtbffiiy/en32u8NlnnyUkJLzyyiueDqOGzZOhFTMA4DEYDAaDwQDdvwAAteQkKY2+kM/jqaMi+NCRAgBQC8Ukkecg5CI6GNIzoC6C47q2rLf2LHl/+aYTV7KKHH7ypK5DXp83c2iSP9sTIjabLTs729/fX6FQeCt94zj3ddpyn/EbxyTcc9iVHx/RefpmC75nXVGXNWc+eTHQ04FRuj+Op+28eCjDaKSEkVHxKb36zO0ZF1rpZ615fy7ZenzTlZwsM+kXrOjaudu8wa2SfLyxxay6S0vW7N30a1ZWKekXpuzavd+8MZ2TJNX9NC75ccn8Kbc77loxpJX3GtTaz301c7l40sZxje+tR0jdmQ1pX+4+dCXHSIoj1S1SRkyeOzw5tA7ckDv+3LfvdvSgT1/uE8NHKCms5Nbbe/dfffblZnfnN8fF5w9dJDu8+e6YJwIIhBIbR1pvT9l15MoLicn6gmJpww5PdEpmY5vnSk6ePPnjjz8+fJ20tLTRo0f7+/t7NJIGDRrUZLWGDRt6NAwAQB3j6v5ltVrVarVYLGY6HAAAh1mtVk1ugdRPIg8JgjfiAIDHhjHWl5QWOZBSTPux/HERgMcFCehacf7z9aBu/ztUKu80aNzgWGfGiR93LBl37JzuxE/TmrP4icZkMuXk5MhkMplM5rUfxUWnV647earnYPre5ZRel2UnIpKe7KastMkECfFCT9/DYeOv27otPqeRKgf16NFQWHb50i9ffL3irPGNMyPifBFCCDlzTw96b9uh8sBOHTsOllEZf/2xY9e6Y9eLT8x5urmHe9c5NYcGvb76kCWkU7enB0dQGb+e3/HDp8euFJ5Y9vx9P411R1e/uj/boGjhrLYsz8BFp1auOX6q17B7dyg2nljUbdJ2TUjyoKEvNhQVXT5y4Iu0l87mf3tmarKvF8PzBEp79Zo5skNrheuWgB/bumX4jt/+zqObKSuy67jMKVa2adv4zjsovkweIXCUW0naUKDH4U3D6fJio0UQHBrg8QP8cX3//fePXMdoNB44cGDo0KEejaRXr15+fn4Wi+Xhqw0YMMCjYQAA6pKK7l8qqUhgymc6nEfxD2Q6gpo5uonpCGrg6RFMR8AmFhPTEdSMH6tPgZKSktzc3Ag+GUo6kb6U6XDqhCd7MR1BzZzfz3QENfD0SKYjYBN2VyYURWm1WpIk1aH+In4daLfFDpy40vkFMR2BV3E+Af2A4Va989slu+fPPVysHLft5Opnw3kIIXrW0WlP9/3iw9QtL+wZE8HO/JJery8sLIyJiQkICPDKD9LlxblXr6Rv/OrLLYU44r6PKZ0uC/v2eGXh9097N2dPF67dfjEzoNnaD8ePdrXOHdL+nXc/W7r/6K7+L430JxAu371l/2FL6Lh3p65uE8BDCOE+R7/7rO/BQ6ln2u3pJvXg/sWW3Ws2HS4LH7fgg9Wdg3gIIXrw0RVpfXduTz361J5ngir/NJV7dPLyiwWY8NaVii4vzrn6x8WNX6zYYrhvh1LatSt3Zwb1WLtryehIHkIIvd7/nQHjl65ds2v80pFB7Dwnaoou1BfiUFnInS3NC5GF4EK9gUZ3E9A8Zf/3ltz9CqU/dexP1GBYgoTOzTOQhmOLxq+5baKQICCu88g3XunbwPfOJrl06dLOnTsrvlhSUmKz2RBCJEmWlZW5/f+FoqiK/1Zx+fLlmpRw6dKlZ5555v7lJEkihMrLy+12e+1iRDwe74033li8ePFD1omJiRk2bFjtNxHGGGPsiU2NMaZp2kMlI4QcDgdN049c+b9yHRtOp/vfarnKtFqtnmgpRtO02Wx2e7EVhddkP9rtdpjLjrXu6f5l0DAdDgCAqzDGer2+qKhIqVT6FdRoygoAAKiWw+HIzs4WiUQqlYpXqGU6HAA8iOMJ6AcOt+rjjV8nr5w6b+I3mzKtT/i/z5q80O7TJnZaPe30sXT7mH5eCeI/oGlap9PZbDZv9jnFxj0Dnlp4yOH61/3P5LhYl1uM5A2jvX4o2rJP36YC2rcbVDE2hDj2+ZbByw4UXC3AyJ9AdM6p6+X8uO7TWgX8uwbh3/25Lp0O7zj9Z7a9W7IH9y+VdeovC79B/2kdg+4cWtLuI3p32vPd6cs37c+0vfvTZM7KDzeckncdLju91ea5gO7Cxl0DOs994A61Xjn9tzOgV79BkXc+8k16/onIZetuX9XRKIjbvYkoh50kJJKKUVAIicSHcNgduPrV7fmXdny1ameG6oX5vSNR2Z/FTom/uv+UeU9EoYI/9n214psPvpEtf6Pdv22ldTrd0aNHK77cpEkTVyaXoqhq08Ru4fqJKh7Z4tjFZDI9JMXsrsTlm2++efHixePHj1f7qb+//5o1a3g8Xu2T3S7uKsebJXv/CHELh8PhoZI9t6kxxjUpnCRJmFaBnRjp/gUAqHtomtZqtQ6HQ6VSwTA+AIDaMJvNWq02JCQkIuL+pnoA1DXcfkZ68HCrbUWP/natOS0opGHyk63VlbJqhI+vhECk3eH+Bmm143Q6NRoNn89Xq9V8vvfygERQ189+aFBCI1x8/M3XNuqqfk5naXIpYbw6MPfkod//KrD5Khp375ykrHakY/fiR0+aNHK4Iq5SHpkuK3dgIlAWQCCEEGlHAeHJTWPVlbKshEgkIRBJUp7dv6QdSRXJLRrc89NisQQh0klW+mnnH5s/T/tHOffz56mPvJSAJoK6fba1YQmNcPHRNyevq7pD+Y0nzZ87XFU5O0+VWWyYJ5N5fERvj+OLxHxsKrdh5BoEHJeX27AwoJrKxlmQvvWrr3f9hZKfn750aNtwIULiXrM3V3QqjGk34vWBv7+25eQfE9t1liCEEOrWrVuTJk0qSli1apWvry9CSCQSuf5wL1ezWR+fal6jxMTE3Lhx45ElqNXqoKBqegy52j77+fkJ3TQL/L59+959991Vq1ZVSYY2b9587dq1SUlJbvmV0tJSjHFgoPt759E0bbFYPNHjhCRJs9ksFoslEonbC7fZbDweTyRy/7XUarU6HI6AgABPXIlKS0sDAgI80ba6pKSEx+PVZLY6iUTiapwOWEWv1xuNxtjYWE8PXg8AqNsqt1X05iMVAKDuKSoqys/PVygU1T5VAVD3cDwB/aDhVhHyRgLat8/y9D73LqJ1u3887xS1aN+CVc2frVarRqORSqVyudzb82PwgxOSgxFC2HBDWk2nZHuW1kDR5hkDhuYVkxghhAiRrM2MJQvmdgjxbKDiyL7dIhFCCGFbuaXIVHLlt+NvnzYrOgwaKiMQQkicuHxJ4r3fwbqLv58n+S0aRXt2//q0Wv5tq6o/ferCeUrQoml8xU9br+0Yvz6n/SuLp8ShZR6NpzJ+cEKzYIQQ1l+rZof6qvsOViOEEKJt5tKiovwrJze8vadY0Wf60CjO90nnhcrCiNvG4jtNuekSYwkRmlhlekVsvb71/QXbDY0GTV85sE3EA6oiXliUQuwsLrNh5HrbEhwcHBwcXPG5UCh09eInCMITrSldydxqS+7Vq1flttgP0rt372q/7gqbz+c/Mmyz2bxmzZr9+/dnZ2cLBIImTZoMHTp04MCBVYYvEAgEK1eufOutt7Zu3fr777/bbLb4+PjevXv37t3b7QMdeGJTUxTloZ3oynLyeDxPFM7j8TxUsusaVJMj5PEKFwgEHrrM1XA/8ng8TwyKAh5bRfcvaKsIAKgli8Wi1WoDAwPlcjnTsQAAOAxjnJeXV1paGh8f74mmJACwE7cT0A8cbvXOklWrVp05c6ZiBZqmS0pKKh5Ng/zce6rbs/alDp1+xKIcnzo2nj3JtuLi4ry8PLlcXjm9xRZUQYbOiUlR/OBFR17qGIf0l4+uf/PDPQumLFD+uGS8witbkS5YNmfxrAwKISK4ybMHXm6pqD53QWal7xm67polvFNqt1Dv7l9n1tmNQ7/4zRLZM7VvxL8/bf179uJdmhYTtj8nF6A8r4ZTE1TWslGDZ10hEeIFt3n1wAe9HmNnlpSUVPztdDo9N85ADfFjE5v47f79D8OI+EgCITr/jz/zA5omRt3T+sV2ZcMn20o7z1rycqvKQ15bz6+ctoEctWhKF1dLcConI9sRnBgTwL524ePHj//ggw8qb/z79ejRo2XLlrX5lRMnTowYMSI//+4MYH/99de2bdvatm27ffv22NjYKuur1eqZM2eaTCZ/f39ocAQAqCGmun8BAOoeV1tFlj5SAQC4g6IojUZDUZRarXZXn1EAOIHbCehK7hlutSKlk5ube+3atYqVpFIpSZKeaBvlyDn+2fRpC7Zfc8QP/mrnx32CWZFVumd+DD8/psOpDi/0+XeXtBTHd22p8EUIoZgnhszcSxiSUs8t35kx9vWG3nhYJIIHjh4XZzBl3Przm2MH+i0iDszq1e7eFs4O443P1u9YcDbfEdHyq5mD+vh7b/86DFc+++LbBcd1DnmnrxaN6+NKWGLzoa8+X1HS6puPe8TzEGJhYztexMAZH8XlGDL+OPbN9i/6TeAd+HZCu/84kkTlIRdcc8S5Ocj/StSsb9/YGdtW/KAY/2SI/vi3O7XqgW8kiRAiM45uPGls8uyQ9iF/nzxTKO/QkLp1+ZeK7/FC1C2SOyQ5F63+OIQc2iGKb7x66PtdhsSxzzZhYRUcGhq6atWqYcOGPXyF2vzEyZMn+/TpU+1wuunp6V26dLl06VJkZGRtfgIAAJjs/gUAqEMwxvn5+SUlJex9pAIAcITNZtNoNBKJRKlUwrTVoL5hYfbjP6tmuNU7ZsyYMW3atIp/Dh48ODQ09O5DCOmOSZBwcfrX0yakbr5ij+7xvzXLZg1LkrLiIYeiKK1WS5KkWq32xDie7kFIm3bo3PSeRbyo7t06Cs+duHrLjBq6f0DWamIQJyQ3T0AIde8yMuaL5t8eSjvd7mDPO7P/YWv64R0TNqZfcQb3SBmzbEjrJC+MT/3vT5vTd383YdWpK86wHkOnLBvbJcnP9dO45OLGyfscA9ImjgpnxcFWDcIvoePTCQihwcNGNprcfN7qtN0pB0eE/6drbGhoaMXfIpGIBfN6CVSDZ77rXLVu5YydNt+oFv2mTx6g5COEyJz0fXtuUx0Ht+Pl5FrI7EPL3z9091uEzxMzvn+n46T33w1at3Xjoj2l/JDoRm0mvv9CD++08f/vhg4d6nQ6J02aZLVaq3wUHx+/a9cutVr92IVbrdaRI0c+ZDI3rVb78ssv79q167F/AgAAWN39CwDAHRWPVA0aNIC2igCA2igrK9PpdKGhoeHh4UzHAgADGE/o1NIjhluVSCRVhtQhCMKdrWAo7fZX+o1ZlyXrNWPXp2+nqN0/V9jjqTw/BuderBH+0iA+whRFYYQ8ll915N/Yer1MmdT6ibCK3+ApWzZJ4t28rimkUBAPIUQXb//y8zHHjbIWvXdN6JkS6cU8Pl24/eP5Yw7oZe0G7/rfgJSoysNWYn1GVi5ZtGXOhC1zKn9nd4duu/nRz53dMKY9Q/2MHZqLW38xKjv0eeJuapWnfLJzEi/9+j8aCv23BDQbG6zxZW1eSG3zQpWlPk/O3P6k68/+i3b2f8B3I9uPmt5+lCejc6NRo0Z17dr1008/3b9/f1ZWllAoTEpKGjp06OTJk2s5Ttn69etzc3Mfvs7u3bv//vvvpk2bPnw1AAC4Hwe6fwEAOMJut2s0GrFYzMVHKgAAqxiNxoKCgujo6JpMag1AncTxBPQDhlv1FvLa8rHj1+cmTv1x/8Lu/y215klms1mr1YaEhERERDAdyyOQVzcOmHssePiCtYPuJiwpbfYtJyFXRnl2eNz8X6euvNh4nOrEsyEVP42t5WUIScRCAiGE6Gv71o0/XpKY8vL+0QnebWpMXdv26fiDRYnDZ+2f3Oy+Q4sISe4+a0zzSiMim88fPHzc3nDsc8kxQU2iGEzbZh2c+u7exu+1ODHu7g7FZeYyTEgkPuxLJ4OHiY6OXrJkyZIlSx696n9x4MCBGq4GCU8AEzkAACAASURBVGgAwH9F07RWq3U6nazu/gUA4AIOPVIBANgMY5yTk2OxWGDKQVDPcTsB7XzAcKstVV4Zg9l2avnyi/bWc9a/z6Lss2t+DIVCERQUxHQsjyZQxgTnXP3hy++GPvVev1ACIYScedu+3PkbjpnaN9GjndyE6kZd/c7v+fnMpadTOriaF9NlBw9evo6lE5LlAoSQ8+byfbftDZ5dP8rL2WeEHFeXb71hTxixftL92WeEEBHWrNfcZpUW0Hkf/3LkRGnjyeNHMNX22UWY3KFrwK49W7ddGjalg6s/AGU8uOHAdRQ2oVMDblc3wE00Gk1NVsvOzvZ0JACAOobT3b8AAKzCrUcqAABrkSSZnZ1NEIRarWbBkJIAMInTJwAuefBwq14YoIu6df6CnhZJzy5+eeK9TzmE9IkpS8cmennjYoxzc3PNZjOXXqz5d0n9X6cjc/cMHpA9pG/reH7Rn2d+3neDTH5p6awWnm24RAQ0nzNQfWTD0WfezRveTinHpVf+/H1XpjW68+j3mokQQlRu5oUSLJJkLP5yY9X927T70u5yz+1fSnfjQjEW+V1b/NHKqj/dvP/SvrGsPW+J4O5zXm155MM1zwy4NfzpJDkuvHL2yK6/SqP7ffBeJ59Hfx/UA2Kx+NEr1Xg1AABwcbVVDAoKksvlTMcCAOAwTj5SAQBYyWazZWdn+/v7KxQKNg4vCYB3sTaRVROE7CHDrXoeqcnSkNh87dD6a1U+4YULhnw8NtGbwVAUpdFoMMZce7HGbzT0w/PyLQvXHDi4Y+NWhziqUZu3P5wwI6Wh58dUESSlvHwm9ND8A7/vPHijhBJGRsVPeunp1F4N5ARCCJGFRg2Nzbq/1+uqfJEI57f6uLsHn2/JggINhc1Zv67Puv+nO3/cN9ZzP11roqQJn5+JXD1/3ZGdGy6UkOJIdfNJc8anjmoth7ZoACGEUNOmTS9duvTI1RITvVqFAgA4DdoqAgDcgrOPVAAA1jGZTDk5OTKZTCaTMR0LAKwAl9XHJ+672mhfzXQUCN15sebr6xsVFcXaPqeEbNDRK4Oq+0QU98To1U+M9nZACCFCnNQlZWuXlGo/FLd+wbi96mRz3iHu+Lrx5Ov/4Qs8+TtfbX3HY/FUiwgfevT60Oo+8E3qP2Vr/yneDQdwxrBhw9auXfvwdXx9ffv3Z+7tIgCAOzDG+fn5JpMJ2ioCAGrJZrNpNBqJRMLmRyoAACcYDIbCwsKYmJiAgACmYwGALeDKynmlpaWZmZnBwcExMTFwqwQAYLk+ffp069bt4eu8++67YWFh3okHAMBdFEVlZWVZLBa1Wg3ZZwBAbZSVld2+fTsoKAgeqQAAtUHTtEajKS4uVqlUkH0GoDK4uHKbwWDQ6XQxMTHh4eFMxwIAADWyefPmRo0aPejTAQMGpKamejMeAAAX2Wy2jIwMgUCgUqmEQi/M/QEAqLMMBoNWq42KioJHKgBAbTidztu3b1MUpVKpYEobAKqAITi4CmOck5NjtVrVajVUbQAADgkPD79w4cKUKVO+//57mqYrlvv5+c2YMWPmzJl8Pp/B8AAA7FdWVqbT6UJCQiIiIpiNxJp5eMmSbzaduZZV7PSLTOj63Evz3uqf5MemiYZs50Y8u2izFd+zUNh2zb7ZL0rZEielO9Rxyq50qpqP+IqeZ1cMbM+6y4Lt3NJJyyVvb3y1GTxNcXprVDxSqVQqHx8GZ8wmdWc2pH2559BfOUZSHKlqnjJy8txhyaGsay3G9jg5Vplgc/pPP87fk35GZ/WRxXTv+fzCQc3jRExHBR6X1WrVaDRSqVQulzM75SAHbk7u4soVhBNxsj1IdkYFHsHpdGo0Gh6Pp1KpYH4MAADnBAcHr1+/fv78+QcPHszMzPTx8UlISHj22WeDg4OZDg0AwHZGo7GgoCA6OloqlTIbifPWxkEpsw+VRXRKGT44isw4e3DHyv8du5R7YvvLzVmTQaAMeVkOIqJJ+27RlWISqOOFLHoQJXzlvbq0UdP3LqVNly7dKggJlrEmt1UBFx5a+cWBU/1foh+9bt3H3a1BkmR2djZBEEw/UmHjyUXdJu3QhCQPGjK2oajo8tGDX6RNOJv3zZmpyb7MhXUfDsTJpcoEl/60csGAvYWRiS1HpoTabqVvXrPk1O3XLs7soGBR9QxqyjXlYERERGhoKLORcOLmpAJXriCciJP9QULuknvY82INAABqIy4u7pVXXmE6CgAAZ7jaKlosFlZMOYhLd3+89LApetyanat7hfEQQvQbR9OG9f12ZerOQXuGy1hyi0bl5WfRkh4vvvv9k+x77ryDF9JswVvN7l2Gsw5/3ubX+NSJT6hYsikRQogqN2quXj658eMFWwpohpvfM4/bW8M1i7u/v79CoWD4kYrSrl25JzOo+9ofl4yO5CGE0Ov93xnw0tJ1a3aNXzoyiDUnABfi5E5lgk2/bJ28T9946MwTLyUEEgjhfv0/Th18bMeKQW0XJbCqnTZ4BIyxXq8vKipSKpV+fn5MR8ONmxPuXEE4EScngkQIEtCcU1JSkpuby4YXawAAAAAAXkOSpFarxRir1WpWdP8ir51KL+UnTpjWI+zfRnW8kO6vjeq0bt7p07/bh/dksDN/Jbg4N7+YkDWUcyydQRsv/m/jLdXAt6cqWbCv78CG7wc0fvOQ3fUvVrWlZACnt4arraJMJpPJZEzHgpD1yum/nQG9+g2KvLMZfZOefzJy2brbV3U0CmLNycuVOO/FzsoEYfPuved1/m2WDm8U6MoIEtL+YyZ+3jAvXEwhxNKNCe5H07RWq3U4HGwZ9JkbNyecuYJwIk5OBOnCploYPBS7XqwBAAAAAHiLq62in5+fQqHg8dhxb01aUXB8csdm6kqJAsJHIiEQ6XCypvMjnZWjpwQxamnByWN//1Vo841s0L1tglLCmiZQ1cLm3et3/xT45PGUaFY12yaC+352uGkJjbBx75sjVuiYjodZ3N0aer3eaDTGxsb6+/szHQtCCCF+k0nz5w5XNauUGKLKLDbMk8kC2XSqciXOythamSDy1vGrdlHjZt0qDcvLj0yePCCZwaDAf+VwOLKzs4VCoUqlYsscNty4OeHMFYQTcXIiSBdIQHMD616sAQCA5xUVFW3btu3s2bOFhYVhYWGtWrV64YUXwsLCmI4LAOBVpaWlOp2OLW0VK0i6Lf+5272LaN2Bg+dJYYvWiSxpYYSQMyvHSNGWGS++mldCYoQQIkRhzWbMeWduG3Z0mK+O9fqhmWfpQdN6dWDbPa8gLKF1GEII5/8pZcd7ECZxcGvQNK3T6Ww2G7seqXxVfQepEEII0TZzaVFR/pWTG9/eU6zoM31oFJu2LFfirIS1lQldpM+0EuFyv4xD61/YefFsriNQHtuxffe0kZ2SfVlbN4N7WCwWrVYbGBgYGRnJopFRuXFzwp0rCCfi5ESQCCFIQHOC68WaSCRi0Ys1AADwsG+++eadd94pKSmpWLJhw4b58+cvWbJk/PjxDAYGgHfQNF1YWFh5Sf18+2IwGAoLC2NiYgICApiO5eEcWYcWD517yhIzPHV4LFvu/2lDRh6JKSq+/4wjI1vFIePlU9vfXHF4Qepy5bq08RGseWCuDBu+/f50dvwzO9v7szI+D6pyytO0exqrOZ3O8vLyyoWHSYRuKZlbXLO48/l8tVrN0kcqKmvZC0NmXSER4gW3eeXAwp4KtlQl9+JKnCyuTHC5tQxh07m1vfaTDdq3ndxOkPf3Lzu2fnnk7+ITi/u5Zaa4yqd8WVmZ0+l0Q6EIURRVVFREUVTFkvp5c1JUVJSfny+Xy1k/gzorb04A11SuT0iSrFwD/CeQgGa7ihdrcrmc6VgAAMBLFi9ePHPmzPuXFxcXv/TSSwaDYfr06d6PCgBvIgiCpSkSb3FNOWi1WtnVVrE6jtyzn82bt2DPTYfy2a/Wz+7DnrbFRNDzr6W29InpmhThixBC8idSXt9LGJMWXV6+L3vsS3EsPMIsV35edk2Q8laXJvXvQdlDpzxBEFCfcGMWd17EwOkfxeXoM/48/s32L/tN5B/45qV2vkxHdT+OxMnmygRTNIlxabF40tz3P28fxEcI4YGjl8/pt39X6okue3q54SpS+ZTn8XjuOuwJguDxePW5PuHQyKjsvTkBXFPllH/s+gQS0KzmerGmUCiCgoKYjgUAALzkzJkz1WafK8yYMaNLly6dO3f2WkgAeB9BEKxvVuNBrraKPB5PpVKxYsrBB8Gm9HXzJizcdcUu7/Hyp8umpiQFsOkBjwho2qZN03sXRT3RqePHl0/cuG1GcYEMxfVAuOzH/Ze0IW1Xt/Nj03b0kiqnvLuGOxcIBD4+PvcUbjG5pWSuKC4uzsvLi4yMDAkJYTqWhyL8Ejr2SEAIDR42suHLzeevTtvT/+DwcNalTzkRJ7srE0IkkhCEKKl3Wrs7szcS/j2H9+z408ZTv/xj7dWu9nnNyqe8n5+fu66kPB4vKCio3t6fUBSl1WpJkmzQoIFQyOKuJCy/OQFcU/mUFwgEj31/wq7LBKiAMc7Ly9Pr9fHx8ZB9BgDUK/PmzXPLOgAAjrJarRkZGRKJJC4ujtXZZyp3+9SBXWfsK2nz+q6TR4/MeY4TD3iEn3+QAGGKojDTodyHLrz87W/2uM7tn2TXfGGAqzDGBQUF+fn5SqWStdlnh+bixh8PnM6tPOIKT/lk5ySe/foNzWP2c/YArsTpwvLKhB8SouAj3/CwsEoXDV5IWJQA2c1WK/sqZ4AQcjgcmZmZrlfjrM4+c/PmBNQHkIBmI4qis7KyLBaLWq2WSCRMhwMAAN5jMplOnDjxyNWOHz9uMtWvBlwA1BMmkykrK0smkykUCvb2lEcIIfLa11PGb85PfPW79O+npsSz8YaNvLGz/0tvj9lXUDljROXk3HIS8hg5+x5IcdaFy+fJ0P7tY1n8ZA84g6ZpjUZTVlamVqtZ3VM+66ep785+73B+5fMUm81lmJBIfFh0mnIlToQ4UJlIlG1ieRZdrrZSrpnS52eRKDAsRMqyrQkQQmazOSMjQyqVxsbGuqt7imdw4OYE1FssblTiBUI2jidos9k0Gq1EIlEqlSyt2tQtmY7gARq1YTqCB3vcYdo9rh4P4AXYKSsriyTJR65GkmRWVlbz5s29EBIAwGv0er3RaIyNjfX392c6lkexX1j+9a/25tPWz+rCsp7ndwmiFcF5N35Yu2Vo5zf6BRMIIeTUb1t78DesmPp0I9blZXDZz5ezndJ2vdT1+wkFuEPlWdxZ+kh1h7BZ+64Bu/Zs3XZp6JQOrpGUKePBDQeuo7AJnRqw52TgSpwIcaEy4SkGPRW/4NvDc060X9stTIgQoop3/3A0nQ56sUtDNiYp6jcujYzKhZsTUG+xtUaur8rKynQ6XWhoaHh4ONOxAAAAA9jd4BEA4Ck0Tet0Orvdzv4pB12ozMsXDLTI/9LiaZn3PuIR0g4Tlo5IYMVNtl/b1Mltjnx0ZPBY3ZCnm8XzSv68dHbfLWfyyNmzElmXf0blt36+Sfo0bdCOfaEBbjGbzVqtNigoiBOzuBNB3ee80vLIR2ufGXBreM9kOS68cvbIrr9Ko/stfK+TD9PR3cWVOBHiRGXCa9xv1FvHFy1enHb9dPte0bzbv13cecMc2+O1eW2hySqLYIxzc3PNZnN8fDwn+qZz4+YE1Fdw+LGI0WgsKCiIjo6WSqVMxwIAAMxQKpUCgeCRjaCFQmF8fLx3QgIAeJqrraJQKFSpVHyOdM0hdVoNic3/nFj/T5VPeOH8/h+PSGAkqvvwGz0383zE3oWbjh/cu3OrUxylbvZ22vAZfeKD2Peyz37rxhkr0UAdA93PQW1wqa3iv0RJE1aeiVw9f93RnRsulpDiSFXzSbPHpY5qLWdXA0auxMmRysS30fuLZ0at3fHludPLLqDgqAbjXnl+bkoTOZtjrmcoitJoNBhjtVrN6hkpKuHIzQmop7hxFtV5GOOcnByLxcKVF2sAAOAhgYGB3bt3P3z48MNX6969O7yrA6BusFqtGo0mMDAwMjKSQ30gxD2XGPOXMB1FTYjiOgxa3WEQ02E8mrjZCN2PI5iOokaIyPFHjeOZjoIt2LM1MMb5+fkmk4l7j1SEb1L/KVv7T2E6jkfhSJxcqUz4gY1emzLzNbZvznrKZrNpNBqJRBIVFcXyYXwq487Nyb/YcwV5OE7Eyf4gIQHNPJIks7OzCYLg0Is1AIBHYYxpmnb9UZMBkf8rmqZpmvZQyQghiqJqU3hqauojE9BpaWluj99DG8RDO5GiKFf5ntuPnigZY4zuBO+JwkmS9FAGs4b70bXHPRFAXVVcXJyXlyeXy4ODg5mOBQDAYa62ihRFqdVqoZC9Iy8AANgPRkYFwBMg3ckwm82WnZ3t7+/P+qneAQDeQ9O03W5HCJEkabFYPFE+8kwS0FWmzWZzOByPXUizZs3mz58/e/bsB63w/vvvJyUluXHLYIwxxp7Y1K53CR4qGSHkdDpde9O9XGU6nU63l+w6QsrLyz1xycMYW61WtxfrUsP96HA4ONRMhlkYY71eX1RUpFQq/fz8mA4HAMBhdrtdo9H4+PiwdxZ3AABHGAwGg8EAI6MC4HaQgGaSyWTKycmRyWQymYzpWAAALMLn811dR4VCYUBAgNvLt9lsNE37+vq6vWSLxVJeXu7n5ycSiWpTTlpaWmxs7NSpU4uKiiovDwkJWbZs2ZgxY2oXZlWuXwkMDHRvsQghiqLKyso8UbLT6TSZTGKx2BOZO6vVyuPxfHzcP6dQWVmZ3W739/f3RI+f4uJiqVTqidR2YWEhn8+vyX708fHxxCuBuoeiKK1WS5KkWq2uZXUBAKjnXG0VQ0JCIiIimI4FAMBhrpFRrVarSqXyxG0wAPUcJKAZo9frjUZjbGysv78/07EAAADrjB079rnnntu2bdvZs2cLCwvDwsJatWo1atSo0NBQpkMDANSKa8pBkUikUqmgrSIAoDZgFncAgFtUjIyqUqlgZFQAPAHOKwbQNK3T6Ww2m0qlEovFTIcDAAAsFRQUNHHixIkTJ7r+aTKZ4I0dAFxnNpu1Wi20VQQA1BLGODc312w2c2/KQQAAy8DIqAB4ASSgvc3pdGZnZwsEArVazefzmQ4HAAAAAMBLioqK8vPzFQpFUFAQ07EAADjMNeUgxhhmcQcA1BKMjAqAd8DV2qusVqtGo5FKpXK5HF6sAQAAAKCecLVVLCsrg7aKAIBacrVV9PX1jYqKgmF8AAC1odfrCwsLY2JiPDHvDgCgMkhAe09xcXFeXp5cLg8ODmY6FgAAAAAAL3G1VaQoSq1WC4VCpsMBAHBYaWmpTqeDtooAgFqqGBlVrVbDyKgAeAEkoL0BY6zX64uKipRKpZ+fH9PhAAAAAAB4ic1m02g0EolEqVRCW0UAQG0YDAaDwQBtFQEAteR0OjUaDZ/Ph5FRAfAaSEB7HEVRWq2WJEm1Wi0SiZgOBwAAAADAS8rKynQ6XWhoaHh4ONOxAAA4DGOck5NjtVqhrSIAoJZgZFQAGAEJaM9yOBzZ2dlisVilUkGrHwAAAADUH0ajsaCgIDo6WiqVMh0LAIDDXG0VeTyeSqWCKQcBALXhGhk1MjIyJCSE6VgAqF8gJepBZrM5IyNDKpXGxsZC9rk6tnMfDh2+/HeS6Tg4BTYaAAAAtsMY63S6wsLC+Ph4yD4DAGrDarVmZGRIJJK4uDjIPgMAHhvGuKCgID8/X6lUQvYZAO+rK1lRnL837fXvrlJMx3GX0WjUaDRyuTwiIoLpWFgKG/avXLHn1I0imulIOAQ2GgAAAJYjSTIzM9PhcKjVaolEwnQ4AAAOM5lMWVlZMplMoVBAT3kAwGOjaVqj0ZSVlanVapiXCwBG1Il3yNiWc3zDrr+s7diRk8MY5+bmms3m+Ph4eO6qDlVemHX1l2MbF83ekk9Der5mYKMBAADgAJvNlp2d7e/vD9kiAEAt6fV6o9EYGxvr7+/PdCwAAA5zjYwqEoni4+NhykEAmML1BDQ2HPtkzprzOaUOjMKYDgYhhCiK0mg0GGO1Wg19xKqF9WsHxE8+ZHf9q660wfcw2GgAAADYz2Qy5eTkyGQymUzGdCwAAA6jMdYZjDYnpVKpYMpBAEBtWCwWrVYbGBgol8uZjgWAeo3rGVIiqNWwabHP4dJzXy08wXQw/7b68fX1jYqKgkGfH4QISfnsZHIJjXDhj28OWqpjOh5OgI0GAACA5QwGQ2FhYUxMTEBAANOx1EC4kukIaoATQQIu8gtkOoKHcbVVFAqFanUcB9oqqpoxHUEdAhsTuFtRUVF+fr5CoQgKCmI6lhqA674bWUxMR1AD7L4cux3XE9BIGBStDkK4+Kakul6eubm5JtM9hx1JkhUdQt3bQrm0tFSn00Grn0cTyBLayBBCOO83KWTpa6hebjSSvDvVIsYYY8xgMAAAAB6EpmmdTmez2aCtIgCglqxWq0ajkUqlcrkchvEBADw2jHF+fr7JZIKRUQFgCc4noB9u1apV+/fvr/inVCotKSmpuJUJC3PbqB0ca/UDABeUlJRU/O10OimKRbOMAgAAcHE6nRqNhs/nq9VqDrRVBACwWHFxcV5enlwuDw4OZjoWAACHuUZGpShKrVYLhUKmwwEAIFTnE9CJiYl2u73in7/88otYLHbvu3Ro9QOAh1Q+oXg8HgxrAwAAbANtFQEAboEx1uv1RUVFSqXSz8+P6XAAABxm/z979x3QxPUHAPy9u2z23qAJKIh7oLgXDtx771mtWuvusr9qW6vVaqtWW0ddde9dN+KqW9E62SB7j5Dc3fv9EcGAhARISNDv5y8N716+d7n75u6bd+8KCqKjo0UikZeXF1xCAmA6PvAC9ODBgwcPHlz03y5dulhYWOjxAkk16oeiKKlUCo8cBEC/1O8n4PF4cPYAAAAmJSMjIz4+3snJyc7OztixAACqMZZlY2JiGIaRyWQCgcDY4QAAqrGcnJyYmBhbW1snJydjxwIAKAZqphUHo34AAAAA8BGCsYoAAH1RPXJQIBBIpVIYbQAAqIzU1NTExER3d3dLS0tjxwIAKAkK0BUEo34AAAAA8BHiOC4mJkahUMDkYwCASoKxigAAvSCExMfH5+TkwCMHATBZUIAuNxj1AwAAAICPk/pYRXjkIACgMtLS0hISElxdXa2trY0dCwCgGlM9cpAQIpPJYGZUAEzWB3JwYpvuSw50r4I3Uo36USqVMEMZAAAAAD4qubm5MTExVlZWLi4uxo4FAFCNEULevHmTlZUFYxUBAJUkl8ujoqIkEombmxtM4wOAKftACtBVo2jUT82aNWHUDwAAAAA+HjBWEQCgF6qxiizLymQyPp9v7HAAANVYVlZWbGysg4ODg4ODsWMBAGgBBWhdqWYos7a2hlE/+oJdppzPnWLsKKoZ2GgAAACqGCEkISEhIyMDJh8DAFSSXC6Pjo4Wi8VeXl4wVhEAUBnJycnJyckeHh4WFhbGjgUAoB0UoHUCo34AAAghxKU9PPjXnssPorLNvRp2HDpuQAMbrGsbXZYFAAATw7JsTEwMwzDe3t4wVhEAUBnZ2dmxsbF2dnaOjo7GjgUAUI0RQuLi4vLy8mQyGTwPGYDqAn521kI1Q1lSUlLNmjWh+gzAx42NOvTD9wdi3HvNXDCjl2vUvu+XHYlhdWyjy7IAAGBaCgoKwsPDKYqSSqVQfQYAVEZqampMTIybmxtUnwEAlaFUKsPDwxUKhVQqheozANUIjIAuC8xQBgB4R/HoxIkI9wGrp3bzoBGqa5/xau7xk096TK0v0N7G94n2ZQEAwJSoJh+ztbV1cnIydiwAgGpMNVYxNzcXHjkIAKikvLy86OhoS0tLFxcXjOF2UgCqExgBrZFcLn/9+jWPx4NRPwAAhBAb8+S/HOfGTVxVTyClPZs0csz67+kbToc2Sh2WBQAA05GamhodHe3i4gLVZwBAZTAMoxqrKJPJoPoMAKiMzMzMyMhIOzs7V1dXqD4DUO3ACOjSwQxlAIASuJSkFGLnYFv4ux1l62BLUpKSOeRFaWvDaFv23r17Z86cKXqvrKwsuVyOEGIYJicnR+/rwrIsIYTj9F8AVyqVCCG5XK5QKPTeOcuyeXl5hjjdJIQQQgyxqVXb2RA9qz4+pVJpiM4ZhsEYMwxjiJ4RQnl5eYZ49hTHcbm5uXrvtqhzXTZ1QUFBdX+sFiEkPj4+JycHxioCACpJLpdHRUWZm5tDtQgAUElJSUmpqamenp7m5ubGjgUAUBFQgC6F6mmq7u7ulpaWxo4FAGAqWEUBg8ViceHlExaLRVhRoCA6tGG0LRsZGXno0KGifvz8/FR1OpZlWdZQc0UboryoYojqs0pBQYGBekYIqYr+1atnhmEM9zmqfk4wBMPtIYbb1IQQXTpnGIbHq8YnV6rJxwghMpmsWq8IAMDoMjMz4+LiHBwcHBwcjB0LAKAa4zguNjZWLpfDpM/AeOTXV07+VTx357T6cH5cYbDpioEZygAAmtACIU0y8+UEiTBCCJH8fDnhWwh0aaN12Q4dOvj5+RX9d+PGjRKJBCEkEAhU/9AvhULBcZxIJNJ7z/n5+QUFBWZmZoaYuSgnJ0cikRhieGlWVhYhxMrKSu89q8bkWlhY6L1n1eh4oVBoiG8ruVxOUZRAoP85yvPy8hQKhYWFBU3Teu88KyvLwsLCEIPsMjIyKIrS5WdpsVhMCNHazDTJ5fLo6GixWOzm5lbdx3EDAIwrOTk5JSXFw8PDEN+AAICPh0KhiI6O5vF4MpnMEGePAOiCpJxdu/5USK8JMIVmZUAB+h2GYaKiojDGMOoHAPA+ys7BHkekpnPImkYIIS4jNQPb+dtROrThaVvWxsbGxsamqB8+n6+q/mCMDZGOVGNmDdGzKmyapg3ROcaYpmnDnXoaImaWZQ30IaqqnBRF15U1kwAAIABJREFUGehzNFDPquqw4fYQHo9noLu8dfwcKYoyxOQ2VQAmHwMA6AWMVQQA6As8chAYG5ufGv3k7pWdK5buTeTguSiVBMNb3lI9clAkEtWsWROqzwCA99Ge/n5mbx48TFYNbuQSHj5KsKjj70br0Eagw7IAAGAsycnJMTExbm5uUH0GAFSGUqmMiIjgOE4mk0H1GQBQGenp6ZGRkU5OTjCJPDAWkryrX61Gzfp/tuZGSrUcYGJioACNEEKZmZnh4eG2trZubm6Q2gAApRPUDw72jNz/29//vo55dWPn2kMxsp7BdQUIMa/P/7Vl761ETnMbjcsCAIAxEUJiY2PT09NlMhk8+gIAUBl5eXmvX78Wi8VeXl5wpzwAoMIIIYmJiQkJCV5eXuo3iQJQxbBN8Jp/zt+8dP7GgVnN9D/B5EcHhvrC01QBADriSQcumq/cuG3twkNyiVvDngum9POiEUJM3O0TxyLYwIHNnTS20fQ6AABoVGI6ab3/Rl40+ZhUKoXbvwAwOgPNIK/qVr1zQwy4UT1y0MnJyc7OTu+dAwDKS/2Q129uIYQYNJ9wHBcTE6NUKmUymSGeRwJAOfDsazexRwiRhEeWH/HwXX3lkI/6YgNmKAMAlA/t0HTkV01HlnhV1HbRgbZa2mh+HQAASsNxXGpqqvor9vb2euxfLpdHRUWZm5vDna0AmIgSh7y+JpRnGCY/P1+9c/0mE0JIUlJSWlqal5eXmZmZHnsGAFSY+iGfk5OjVCr10i3Lsunp6erZSb/5RKFQREVFCQQCqVQKz0MGwESo5xOGYViWrVg/H28BGp6mCgAAAACThTHm8w11s59qrKKDg4ODg4OB3gIAUF4GOuQxxhRFGahz1VhFhUIBA3oAMCnqhzxN0/oq5qqeyWygfJKTkxMTE2Nra+vkBA97A8CEqB/yGOMKj1z5SAvQen+aanp6Osuy+v31Ty8YhsnIyBCJRPqcYERP9fqcnBy5XG5lZWW4C+wKS01NxRjb2trqrUc9bTSFQpGVlSUWi01wgEl2dnZBQYGNjQ38ogMAAJWHMbaysjJEzzD5GACmqcQhr6+CEY/HEwqFhsgnqrGKfD5fKpXC6R8AJkX9kJdIJPo6QimKsrS0NEQ+SUtLS0hIcHV1tba21nvnAIDKUD/kK/OD1sdYgFalNhcXF5jPHgAAAAAfD5h8DACgL7m5uTExMVZWVs7OzjCNDwCgwgghb968ycrKqlmzplgsNnY4AABD+egK0ImJienp6TBDGQAAAAA+KkqlMjo6mqZpmHwMAFBJMKAHAKAXLMtGR0ezLCuTyUzwxmgAgB59XAVolmVXr15tbm6u9/nsCwoKCCEikUi/3VYex3EKhYKmaRPM5kqlkmVZgUBggo8XkMvlGGMTHB2m+kB5PB6PZ3IHr+oDFQqFhhgF8/z5c733aeJ27txpYWFhoIOXZVlCiCH2IoZhGIYx0HGtUCj4fL4hdjDD5XBCiFKpNMQjvA2aDRiGwRgbokZp0MxfUFBgoLyt+5fCy5cv27dvb4gYKknvk48BAD5OhJCEhISMjAwY0AMAqCS5XB4dHS0Wi728vEywJgAA0C+Tq2EZ1Pz58ymKMsR119GjR3NyckaMGKH3nispOTn57NmzUqk0ICDA2LGU9O+//0ZERHTu3NnZ2dnYsZS0d+9eHo83YMAAYwdSUkxMzJUrV+rUqdO4cWNjx1JSSEhIdHR0z549DTFvV0BAQI0aNfTerckaNWrU8+fPT5486enp2apVK733r3p0tSHO8+7evRseHt6hQwc3Nze9d86yrIFy+IEDBwghgwYN0nvPhBCO4wxRyY2Pj7948WLt2rWbNWum984Nt4eEhoZGR0cHBwfrc5L9QgzDGKIcTwjZtWuXlZVVr169tDYOCAjw9vbWewyVlJ6e/ubNG2dnZ0NsdgDAx4Nl2ZiYGIZhvL29TXB0CwCgGsnOzo6NjbWzs3N0dDR2LACAqvBxFaC7du1qoJ7Xr18fFxfXuXNnA/VfYWFhYStXrpRKpSYY271798LCwqZPn26I6kklLV26VCKRmOBGCwkJWbduXdOmTU0wtvPnz4eFhX3zzTdSqdTYsVR79evXl0gkP/30k6urqwl+1mV4+vRpWFjYxIkTW7dubexYymHFihVKpbJ6beqbN2/++uuv9evXr15hh4SEhIWFLVy40NfX19ix6IoQsmjRItP8JtWKEJKUlJSWlgZjFQEAlaR65KBQKJRKpTBWEQBQGampqYmJie7u7paWlsaOBQBQRT6uAjQAAAAAwEeC47iYmBilUimTyQwxDwwA4OORk5MTExNja2vr5ORk7FgAANUYISQuLi43NxceOQiqEew8/nzqeGNHUe1BARoAAAAA4EOjGqsoEAhgrCIAoJJUjxx0dXU1xDRrAICPB8MwUVFRGGOZTGaCzzQCABgUHPMAAAAAAB8U1VhFa2trFxcXY8cCAKjGCCHx8fE5OTkwVhEAUElyuTwqKsrc3NzV1RWehwzARwgTQowdAwAAAAAAKCYoKOjcuXMVWBDGKgLwYejevfvx48crP0jwyJEjcXFx06dPL++CLMtGR0cTQjw9PWGsIgDV19mzZx8/fjx37tzKdzV48OCNGzfa2NiUd8HMzMy4uDgHBwcHB4fKhwGAdrmZxo5AB2ZWxo6g3EaPHr1s2TJXV9cKLAtnEgAAAAAAHwJCSEJCQmZmJoxVBABUklwuj46OFovFbm5uMI0PAKAykpOTU1JSPDw8LCwsjB0LAMBooAANAAAAAFDtqcYqsiwrk8n4fL6xwwEAVGPZ2dmxsbF2dnaOjo7GjgUAUI1xHBcbGyuXy6VSqVAoNHY4AABjggI0AJoQRW42I7SUwFECAADAtBWNVfTy8oKxigCAykhOTk5OTnZ3d7e0tDR2LACAakypVEZHR1MUJZVKYRofAABkAT0hCce/WZo8dM14f9rYobxD8iMv7vzrSOh/b/IFdjUaBA0b27eRvSl85GzS7T2bd114GJPBSZxrt+w7bkyQVGJqjyFgoo4sXnDIdf7WGY1NYZshhEj66W8m/v5QWfQC7Tbgp7VjalXtLse+2j5z3sHcVvNXz2llXfShsc+3TvvyWfDaZX2ci17Lu/7zpJ9C8jyHrlw9XGpCx4Vp4dIeHvxrz+UHUdnmXg07Dh03oIFNyUNBw4FsjP1Bh2g1ttFlWeOFbUIbuRxhaw7PWFtb2/sqb60a+cPl/OLPnqBc+y9fN8bhH2Pnt7K/x01wx1ajGqtoa2vr5ORU9e8OAPhgEELi4uLy8vKkUqlIJDJ2OACAaiwvLy86OtrS0tLFxQUeOQgAQFCA1g8ij7u040hYXgBn7EjUkczr6xavDfPsO2peUxcSeXHXjqWLs75bOd7f2GeTbOTBn5afooLGLZzmyUu8s3/z798VWP02q7mFKX0tKV4d+PXvp/nCisysbihcUkISrtXr8/7+AtULWOzmapxhbiQtdPNfbevNCrDU+KGR7Dshd/PEEkFsaGj4EKkPVKBLw0Yd+uH7A2y7cTOH2iWH7Nz6/TJ65Q/9PNQ3lsYDmV/l+4MO0Wpso8uyxgvbhDZyecLWmBOMtbW1vy/Pp9echS2YogI0yX54YMt973ouFBdv3Pym5XvcBHfsd1JTUxMTE2GsIgCgkhiGiYqKwhjDWEUAQCWpHjno5ORkZ2dn7FgAAKYCzi0qiSRfXLV46424LAVB9sYOphiSfuPsLabFzPmj21hghPx9nfMiZh0593ikfzOBUQNjo65djXLpuWJC55o0QrV87FMfTt9/8znbvKnp7I3y/3b/dob29qBjjB2JOmVSYrqlT4s2LesZu5hLOdfz5a7+uaNNnWlNzEsvQZOs2yH3lXUGjXc49ue10JcjfHyNHbQpUjw6cSLCfcDqqd08aITq2me8mnv85JMeU+u/O0Y1H8j1qnp/0CFajW18n2hf1nhhm9BGLk/YGnOCTssaJ2Zs6xMQ6FP4P5Jzb/22/PafjG1sgQuMl990+B43wR1bFTohcXFxubm58MhBAEAlyeXyqKgoc3NzV1dXGKsIAKgwQkhSUlJaWpqXl5eZmZmxwwEAmBCYJbCSsHXjIXMWL1u5eGAt0ymfIoQQItlKoVfTZr6F9UHawcWJp8jPY4wbFkLYvE7wmGGt3AqLDBRNYZ4pPS2J5D7cvvaK8+hPOjma1PHBJScmEUcXRy4/PSklW0m0L2Ew2Lz+iMntycU/dj3KKz0Okn4z5BHr17p9+5aNzZOuX32mLLXZR46NefJfjnPjJq6qg4H2bNLIMeu/p2/Uh2BqPJCrfH/QJVpNbZQ6LGvEsE1nI5crbE05QadljRWzOvmTPZvv+40d0dAMGzW/af8eN8EdGyHEMExkZKRCoZDJZFB9BgBURmZmZnh4uK2trZubG1SfAQAVxnFcdHR0VlaWVCqF6jMAoAQTK5pWQ3xrd5k1IukvxSZ2tkZ59fry53f/ZZNCLj5C3kNqG/0ilXJs1L0XQoikPr/+KCLu8fkTb+oOnupvKrsiybqzZd2tmhN+bm9/L9TYwRTDJb9JZpIv/jh+a0Qmi3gWNVoNn/FJsLdxJs/GFk1GT2w9e8XG3a1XTXh/VheSciMkjNSZGGAnkQQ2MrtyI+TpGP8Gxh16b4K4lKQUYudgW/hDB2XrYEtSkpI55FX024fGA5mLr+L9QZdoNbVhdFjWiGGbzkYuV9iacgLfSFtbp5jfYaOObb1iN2Blc0useV2qJr9p/R43wR1bNVbRzMzM1dUVHjkIAKiMpKSklJQUDw8PCwsLY8cCAKjGFApFVFQUn8+XSqU0DXe/AgBKgouWj0FBwr9/L1n0x0vp8MldnU2mTs4l3Dt94uTZ61F8r1ouZiYSFkm//seGx3WnTGppjMdIlYlkp6QrxeayXv/7a//+HWsXBps/2PTDpts5xhoJja2ajx3XIvf0hr3PCkr+jSReC3lG+bdpbouRuF5gI0nazath77UCrKKAwWJxUdELi8UirChQaPhMix3IqMr3B12i1dSGKd+aVnXYaoy8kcsVtqacYKytXa5NTTKv7T6e03ZIJ0dc1roY804PNaa2Y2dlZanGKrq7u0P1GQBQYaqxihkZGTKZDKrPAIDKyM3NDQ8PNzc39/LyguozAKBUpjLsFBiIMvH2vg1/HAlD9fouWDm4maMJzXRB+w9bunIYyXt9cOmXP62xXvtdsKOxa74k9crGTa+bzlzRzAojEyl8FME2Xb7Z06Xwfx4Bwz7t/2D63isPJwW0MtKodmzTetzY0NnrNxxotXyo+h+4uNCrL1GNgc5ZMdHZCNnUlApCboU8nNg4wNgPwDQ25a1VI3+4nE8QwuYdv9o2XSCkSWa+nCCRqgiXny8nfItSRoqXciALq3p/oHWIVlMbXZY1EN3f2hQ2crnC1pQTxrY1ztYuz6fMxZ47es+h80q/wicOmlx+K8akduzk5GQYqwgAqDylUhkdHU3TtEwmg2oRAKAy0tLSEhISXFxcbGxsjB0LAMB0QQH6A0bynu1bsvRAcq0BC9b2b+pkIvMfkOyXV0PiHFu387XCCCEskXZoLdu962U0ixyNvTty8c9fpMelLB5++t1r3/a/4Np/+bqxtUztzJyyd3MVKtOz5QQZbfoXbN9+wqirszf9fjhg7LtXuZjQ0HBGye75csaed01vX72fFxAoqfogTQm/8dQ/to8nBCGMBRI+FeVgjyNS0zlkTSOEEJeRmoHt/O2KD2jU7UA2/P5A2WmPVlMbng7LGoguYZvORi5n2KWHp7A1ztYuR8zs60uXYqRd57lriskU8pt6OKaxY6seOZiXlyeVSoVCoWHeBADwUcjLy4uOjra0tHRxcYFJnwEAFQaPHAQA6A7u3PxwyR/vWLU/q9Win78eajLVZ4QQQrEh2zYcul90azWTnJiGLKwsTeDkl/IesHjlqkJLh9XhmzWfvGLlF708TeBAybux9pNpq0Mzix40Fvc6SmHj4WFh1A2HHTtPHuEbf3DDsajCx1uy4SFXo/iNP/3r6LFCe77sYJl7N+SuqdxPbzx8iZWVtbW1tbWVlYSPaE9/P7M3Dx4mq7YLl/DwUYJFHX+3Yj92aDiQq35/0CVaTW0Euqyp8cI2nY1crrA1hWftZZytrdOmRgghxDy7HJLo06alU9GGNM38VsQUdmylUhkeHq5UKqH6DACopPT09MjISEdHR1dXV6g+AwAqjGXZqKio7Oxsb29vqD4DALQy9pBTYDDKp1dCU1xa+LCv7t4pepGylTWSGnd2Y2zeNKjljp+2r9pD92/iTKU9PbvzdLrPsI4yExhhjMX2XjL7t/8h2VESTFu6ymSeJnGYiOu1qKv88c8VtszgFm506pOzu44k+4/p4Wfs4CjnrpOHhc7ZfC+f9kMIIfZV6LV4SdNhgWr7maRRx5a2V65cvZPdur0p/NJgMgT1g4M9F+7/7W/X8W1tky5tPhQj6z+jrgAh5vX5nVdS/XoMam6r4UBuWPX7gw7ROmlqQ2ta1vCq10YuT9iOmsITcMbZ2rrsIRRCiI26/yDDpaWfWo4wyfxmQju2gcYq5ubm5ufnW1lZ8fkmND9XCRzHpaWl8fl8KysrY8dSlpycHLlcbm1tzeMZ+2tZM5Zl09PTBQKBpaWlsWMpS3Z2dkFBgY2NjSnPC8EwTEZGhlAorF6T4RhurGJKSgqPx7O2ttZjn3qnSnqWlpYCgSkNzSmOEJKamlpdkh58g+iFKumZ+DfI+1SPHBQKhVKpVI9PpMjPz8/NzbWwsDDxn9tTUlJomjbxKUfy8vLy8vJMfGOqkp5BvkHM9HngV4tvENNPetUpx4HyIBlx8blM1Nlfl5x99yIWtVm4a16gcU8TsEXA5K+n7dh6eNPSA9lE4lyrxZhvRwV7mu41honA5k0nL5lvvW3fzh+PZdG27rWaTloyspOrCYzNpt17TBkcOm/7K4QQUj4LCU20CpzctNjIRYF/x7Yu/5wK+TezXWdrqEC/w5MOXDRfuXHb2oWH5BK3hj0XTOnnRSOEmLjbJ45FsIEDAyjNB3KV7w9ao23upLGNpterQPXayLqH3dxJY06gjLS1ddlDECLJjx8liGv5uauFZJL5zVR27MzMzLi4OCcnJzs7Oz13DQD4mHAcFxMTo1QqZTKZKV8/AwBMX05OTkxMjK2trZOTk7FjAQBUG5iQj/6meAAAAAAAExMUFLRr167U1FQPDw9zc3O99w8joPUIRkDrEYyALtK9e/fjx49Xfqc6cuRIdHR09+7dBQKBh4eHHscqFoER0PoCI6D1qLp8g1TBCOizZ88+fvx47ty5le9q8ODBy5Ytk8vlrq6uhjjkYQS0Hn3sI6D1qlp8g1RN0hs9evSyZctcXV0rsKzpniUDAAAAAHy0lErlhg0bLC0tDVSGUyqVDMMIhUJDVKP0hRAil8spijLlayeEkEKhYFkWNqZeqDamSCQy5emJOY4rKCigadqgF6K5ubl66UepVF6/fj0vL89wk7Tm5+eb/q6lSnoCgcCUf9tA1WRjQtLToyrYmBERERWrFr2PYZhNmzY5ODgYqFzOMIxSqawWxynGWCQSGTuQskDS06NqsTGrJuklJSVVeFkYAQ0AAAAAYHL27t3L4/EMV4NjWZbjOIO+ReURQhiGwRib8shiBBtTr6rRxqQoytAXon379q18TerFixd379416OWoUqk0/V2L4ziWZavFrmX6G7MaHaewMVW8vb3r169f+X6OHTumUCgMVytXHac0TZvybxuoWiU92Jh6Ad8g6rp16yaRSCqwIBSgAQAAAAAAAAAAAAAAABiESf8SAgAAAAAAAAAAAAAAAKD6ggI0AAAAAAAAAAAAAAAAAIOAAjQAAAAAAAAAAAAAAAAAg4ACNAAAAAAAAAAAAAAAAACDgAI0AAAAAAAAAAAAAAAAAIOAAvSHiota01ZImQ09WPDen5SXZ3jy+P5f3WOMEFdl5Ef8s2Zm/5a1XW0kQpGFg7RJ8OQVp17nGzssAMAH7v7Xdfm0x6eXlMVfVrzaPqSGgLJo/Pk/SZxxIgMAAAAAAAAAAEweFKBB9cC9OT27TcPuszeEZLi37j967OCgRjbJVzYv6NW08/9uZBFjhwcA+MgwkXsmdJu0P8Vvxv7TP3dxhC9TAAAAAAAAAACgdDxjBwCADpTP1o0a8esjuwHrD/0xpaE1Vr3KxJ+Z22PAr9+P/77L/Z8CRcYNEQDw8WBjD03tNvbvN7U+2Xf2l25OUH0GAAAAAAAAAAA0gstmUB6sooDR72hjVqnUeus6ST36vyWXcv3n7t42taj6jBDiuXZbtmZSTe7FX39ezDPMW1eYQTsHABgR9+bkjG4jt0bLJu0++2sP5/J/jWpND5A/AAAAAAAAAAB8QKAA/dHjwn9pLRS0WPGSfffS65WthIKWP79SlUBydvcXC1v9cGLzuMZO5mKBwMypbo8vjkcr5a/2ze7s62gutnTxbT9586Pcd50WRJz6cVynum7WYoHQ3EHarM+cbQ/fzZORs7u/WNh65c0LS3r52IqFfJGtZ4OuM7Y9zik9QpJ6YtuxFHHHmTMCxCX/Jmr52aYtfy7r46Yo7J1Lvf3nZ72b1LA1E5nZ1mjS+7M/b6e+K+Xo8NZ5zw9+M7SVj5O5UGhmLwsc/M2R1/KiP+a/Pr50dDs/Z0uxuUPNxj1nrg9NYPXRufZPQUtgAIAqwSX9Myd4yMbXXuP/Pruutyut9qcy817B4eEWwubfnzsyP6imtVjIF1l7Nukzb+dj3RtofQsAAAAAAAAAAMAkwRQcQCfMk5WjZ1k1G7t4Zc28f3es27dsaPfQehmvqK6TFvSgn+5fu23TJ6Ncmtz9X0MeQiTxwIS2Q3dnSIOGTB7gKc6LunFk3y/j/02wCNvZ365w/DIbtXX8oFiq7fhvp3mwT4/8sW3dhN6ce9i6TmbvvbfyztVbcp5/+zaO+L2/IV6NDqPHF/2PZF5e0LHHyjBBneCB04Zbpz88dfC3Ke0vvTgZsry9lS5vzcX/Pab96EMFdXoPnTnCgYm5un/30sEPs8/f/6WtBCmeru3bftZ5Re1ug6YMdFRGhh7+89POJ29sv7JtsDtVuc61zh9SZmAAgCrBpV7+uufANY8kvTef+b2vu3r1WZe8x75aP3pYotIneNzs2oLYa8eOrhxz9U7SlbOf1xPo0kCn1AoAAAAAAAAAAJgcAj5MbOTqNoIyPnhenS/vKgkhhH29qpWA33z5C+bdsq9+bingB654yRJCCMn+u58IUS5D9sSr/s9GrG4jwNis1fKwAkIIIVzyzn5WWNjljwSOEEIyd/c3o2z67UjkCvuLXd9RRLtNu6BqruoQi5t9fSv7bYvcy7O8aZ7votvK99eES9kSLESivruytK608uG3DfmUQ/C6p3mFHT/5tZsdJWj03SOlLm/NvdkYJKTshx/MePtXxcMf2zg7NfnqppKw0Ru6WNAOPTa8KCiMLPP6F03EtPPY41mV7lzLp1DWsgAAA7v3lT+Pch3+3cKW1pRAKMC0x6hDRQlORVvekx8aZo4R5dx304v8tw0S/5lVX0hZ9twSz+nSQHtqBQAAAAAAAAAATBGMgP6gYV6tHp8Ee9PFX+ViL209+KR8PVH2Pcb1dVEN86Vc/evY4n8bjhtbR1XixtZ1/D3ok0qFkiCEkXnfrdHJRGz1bshxQQGHCKNk1EMTd5w2s5n52/9JGjbx45OnCkVp95JznGoSCq0j/Njnx4494aQzv5zoVzhXh6TOlC9G/XJu3bETL7+o50drfWueUEiTnKdXroR37SU1w4hff2HIm4UIIUTiTx64ki+d+fUEn8LCPrZsMWNy65XTLpy9q+zZnl+JzpHW+V7LWBYAUAXImz2Ll1sGfn1uvefPQZP+njGrZ4tdg12KprHSKe/x6kxaPMbn7Q0PlGPnxYt6bRtx6vC59LGjbbU2wDq9BQAAAAAAAAAAYGqgAP1hEzQau+KXAcLiLyovzzh8uJwFaCwSi95NGE5RNMLmlhZFJWGKVptNnBJZWmbdP/HnqeuPnodHRke+fBL2OqUAOxXrkLKt4WWF1XrUOB05tnRykmA2PjaeRbXo9/7MxN05/yDZqk67wJp05OtIht+mYV31od+Ceo38+ezNV1EseluALuOtsf3Ab5ceePzFb319/nSqExDYIrB1h+D+fVrXMMNM5MsIhnm9ogV/RckAJcmpLEL8SnSuad31siwAQA8ItmjxxbETi9vYkJo/H286bt+smb1a7R3u9vYQ1ynvSRo08VX71sWWTQJ86SPhLyNZZKu1AU+ntwAAAAAAAAAAAEwNPIQQlIIQUvHHWpH0y1+0qtV0yOL9T/Pt63Yc+tnKQzf+GGRZslBaRsm5BEHTls2ETNiFywmljBNmHv0+tlevIavvcqrA0XsjpSmKQoTj2OKvaGLWZPbx55F3j234amgjSdzFDQtHtvP16/v7kwJE0RTi1Z2y9fiJEo4fnBfIq2TnpSn+KZRvWQCAnlHOw7//uo0NRojyGLl2VT/HpEOzp++IfpuVdMx7JfITpmgKI47ldGmg81sAAAAAAAAAAAAmBUZAA4QQQoRTq4Awb2LfcMilYj1x0Tu//eWOaODfD3YPcX5bi80/tJ6reEUbO/Ua0WXh+dNrfrk+/OfW5sX+VnBv/+HnrKRzUCszhDgvWQ2e8umDJ8oRgfzCFsonD58qeV5Sr/cHT5cSfNrLu68ybXya9JzUqOckhJAi7uRnQX03LlkbOv7bWlI+eS6SdenxbnJtkhF29tx/fHNLXQ6kMjqfsK4mQmV9CmUt+3unsib7BgDoB0XhwmIv5Tbs11+OXR9xYO60re2OTqhB65j38h7ff870qV+UL7If3HnG8JpJPWiEWC0N9J9aAQAAAAAAAACAKgEjoAGfz0dsxMOwzLd1DDZ2/2/7otmyF9KMS0tKYShbmcyZcuFCAAAgAElEQVSucOdSRB7eH5pfiQixy5Bv5wYI/1szdNiqmynvIlPEnJg7+df/iMewmYOcMUK0b69evtTr7T9ueSF/20T+fPMP28Ipv169fHUpQDP3f+kbGNh/5b3CccUCZ18fOxoxSiV26NqvrTh6x3e/PynsnKRd+mZw72ELTybzNXWoY+daP4UylwUAVDXKdciaNUNc0k/Pn/rna1bXvMc8+XPJrnCF6j9cyuXvfziSLm7Vp4sD1t7AAKkVAAAAAAAAAACoCjAC+qNHubRuX4d/Zd/U7sLHI5pZpd47vGnH/TxzXkXv6+b5desm/emX30YP5SYGeeHEp5f27rlPrC1Q0o29W8/XGNGplrn2TkoSNlqwZ0t48Lgtc1t7/946qF09V2FuzIOL/9yMzrdstnD78m6qaZd5DWb/Mv1QrzXTAlucHRJczyrj0am9xx7L/T9fPbuBTru6IHDECN8tP/8U3Pr5oKD6LoKM5xf27b9O1180oa2Akoxd8e2eDvM/b9XwRK/ugd7iN9f27r4Q4z5y97yWQu1da+lcUPanUNay5d+cAIBKw84DV/92PHTQrkVTfu94ZqK2vMdHCCGRq/D61MDAYwODavNjQw8fDI0VBi5ZPtaz6KfgMhpQ2lMrzMYBAAAAAAAAAMAkEfBhYiNXtxFgyZAD8vf+pLj0qQfNq/PlXeXbFwpeH1rYp0lNBwkPI8xzbLXg6J8jbQSBK16yhBBCsv/uJ6I9Z1xWFHZQcOETN0o0cF9+4QvKB4vr8wQd1saoFsh/vm9eryY1HcwtnGo37/npxtupWde/a+siFlh3WR/JltIhIVk7+4ho2Zxrai+9h8t8cnDp+K6NvOzMhXyhhYO0aY+pK06+yiux4kk3fp8R3NDdSiQQWXs06jnrj1spbNFftb+1Iur0D6Pa1nYyF/D4ErsaTXt/tvFmcmEHXPaTvV8Mal7TViI0d5Q2DJrw8/lYhZ461/IplB0YAMCA7n3lz6Pcp18smaC4pKNjPWls2W7VU4WWvCc/NMyccpx44vWpb/rUd7UQCi1c6wd/tuVeOve2L60NtKdWAAAAAAAAAADAFGFSiafNgQ8MKUh/k0Y5uFjpNKMEMAz4FAD4ABUcHm4/8MLQUzF/di39rgWtDQAAAAAAAAAAgOoJpuAA72ChjWsFHz0I9AY+BQAAAAAAAAAAAADwwYCHEAIAAAAAAAAAAAAAAAAwCChAAwAAAAZGOTfu1jOovoPGL12tDcDHarQNhcsgaLz0CatbT+yLn5oLsLDVytdcKf/9MJGEgyO93IcfSDZ2IKUiyTd2rt0emvABfwCGIL/9ZQP7tiufKIwdSDVGsv47tnruiE4NZa52ZiIzWxdp/fZDPlu+/0Gajtnk41GUQ6rVnJU65pYPMwVxCSFbflm9/0FOuZeE3FIxypvza/Mxxpjv/9U9xsBvpvdTF/bR/xrysajLxoTKH+PVM12AMkFa0De41AUAAAAMjB84d//RnTMaa5z3SmsD8DHDQhu3GqXzcrWGJwZoQlKOzp91xPPz//VzMET3ea+Ofj+mg5+LlcTMrkaT3p9tvJFcruodF71n0aTZS49FlXoZrYi99OunvQNkjpZiocTarU67YYu23Uk1iUJRRVdcEXvx15n9Wvi42khEEms3//Yjv9nzKPPdhXrB8bJ/bhE0+/E/FiFR0zmLu738bvrvL6BYWhHK6GNz29Zu0Hf2yr8vPopKY81tLUhGdNiVfWsWDGlaq/nUv1/IK9SvIu7+pQuXbkfl6Tleo1LLIbgK39awuaW8zapQZVccIcRGbJk4YNLnC36/lvHeauW9OvnT5G4NvWzNhCJL59qtBs/fckv9DSC3VIji332HXjMIIcS8OLj/vqEr0KbLwOmiwkeHDgsqr8z04pXxtWtUFVxxXU+itJ2ZQFrQO2M/BREAAAAAAJRulDVG/EZLwphK98Q8XxbAR4KWP79iS/nvB0h+Y76fwHn00QxO/31zGdcWB1pTCFNmzr7169awEWCE+dLhuyN1/aC4tAsz/fiY9pl3U/neHxXPNvR05mGEKTMX30aN69awFWGMsFA2en+scT+uCq943v2fO9rThavUoJazGQ8jhCW+kw7HvV0l+fGxdnxeqWgKIyxsveq1qqni/jf1BY5D9iYZ4KP9sDEROwZ78jHCZj69v9oZGpGl+tjYnOibe74bVMeSQph26r7+aUG5e+bif+8kRPymPzytfK4yGYbMIZoYOLeUu1mVqfyKE0IUz9Z0tKYQQoIOa2OK5Uou7fKiZpYUQlhg5e5bz1/qIKExwnzPAVteKNQ6gNxSXvLLM2rQiHbzrW1FIV6t+TcV2pepBL2funBp9w5v2bT19LO8SnZkkqccui3IpWwJFmGMqfe+e8XNf/zPmCm9oiuu60mUDmcmBNKCnkEBGgAAAADAREEBuoK4hJ39bHnen4fKDdB5buhcPz6m7Dt8fy2FIYSQvBe7RvsIMGXfZ1vZFWI2/dX1M3vW/29KZ6kEI4RKq/6wsZu6W2IsqD16+5Ms1fVOQdyFxe3tKES5jj+RZYAV0lVFVzz/1qK6AoyFtUZsfpihapf74tCclrYUouz77Ygv86qOSz09RcYT1pl9ObOwHRvxa3uxsMnSMJOonFUbyqer2lpiRNm1X3ojvZRtnn1/dXdnCmFJ0+/ulbcE/QEWoA2aQzQxbG7RvVmVq/iKvyN/+GNLc9XY05IFaHno5948TNm1/+ZcdD4hhBA27cHmEd58jK2CN6m9AeSWcsq/MM2DRrxa8/7ZO8KOQrTP3OsGrUCb6qmLaZ5y6Lig8vYiXx4W996RboDgK6OCK67rSZTOZyaQFvQJCtAAAAAAACYKCtAqnLJAUZ5A2fDVbUS82gtuGeBSmEvbM9AaY0m7Na/VQso6PcmDRvyG3z0u67PK/rufSP1OxFKqP9ybP7qIMOU4+mixUrPy7lf+PES5fXKh/KNT9aTCKy7/Z7ILhWjvWVdy1V9mozd0McdY2P63KM2fLZd8fHwNnqjRV7fUl2VjNwSJaelnIVVZG6zmuPSjY1woRDn236Hxyp1LPDjSnUaU3aDd5RzrVXUFaGV+rrwqityGzCGaGDi3lKNZFavMihfKvfV1YzHt0G10T1e6ZAFa+e9CXx6ifebeUP80uaTN3cUYS/ruzHj3IuSWcsk7O9mVQjz/L+8qMg8Nt6MQLZsdWuZ3lLJArqzEQFITPXUxyVMOnRfM3jvQDNPexQ8P46voiut6ElWOMxNIC3oEc0ADAAAAAFRzJOvJvv+N7lTP3dZMJLFxq9Nu6KJtd1LKOWNdGZ2QN392lVCU5YDdGUXNmdsLffkYU2a9tqUUzZfHPFxcn49p54mn8zW9DXN7kR8fi/vuyi72suKfyc40bT/+tOpRL1z4L62FlM3oo/E3Vo9q6mopEvIE5g6y5v3nbbmTqm3F2NcH9txSunfv2ejdFNkkdWuwCPN9F/5bNEclG39sqr+Eoq2aL7yUqvNTg/IuHz2fiYSthw+uqXYebdFxeG9XWvnkxMlXZUQnbvfl4RMnTpw4ceLYH+N9S530nXn93ysl4dVuXN9M/WXao4YHjUhWZlZ5H29UEHNx7az+rXxdbSRCocTaza/NoHmbbiWXf97Xiq44F/PwcQpHOXbq2UKi/jrl2q6DH48wr56Fa9pkJO3Uwk+3vfH//PcvAtSXpVy69WxGRx3Yc62g3Kvxsco8vf1wAsfzm/TFEDdNF4DYsc+iTxrySdqJ7ceSCEK6Ha05u/uLKddPLhQg5Z0v6vCwsP1v0ardi0t/sPOLoW18XazEYisX3zZDv9hxP73Enqc9d3Gx6zoKKbMh+yIvLOlT297CXCwQWrnVD57z9395iOQ83bOwX9MatmYisY1nk75fHHpVYhJrJunmpnmDWtV2sZKY2XnWaTVo4Zbrb5TaNpdBc4gmBs4t5WimG6PnlneyQ74Zv/yhdb/V68fUoN//M8dxCGG+gK8+OS8WiEQUQhzDqkUMuaU8ci/tPZbA8f0HD2nAt+w0oKsNxUYe2X+r2PPa3h6/Qw9kvDrweaeathKxgCe0cPHrOH7lpfgSM0aXb48iiVt7WlC009jjxZ84SZJ39LWiKJtBe9IIQohkPz3w3ZhO9TxsJAKhmV2NxsFTV1+MK0wB7NPvmwqKPYSw7PalMs1TDl0XZKNfRigIT1ZbqpcH0Rg9Leh4ElWeMxNIC/pk7Ao4AAAAAAAonU4joNk3x6fVM8MIYaGdrGHTxrWdxBRGWCAduuNV0dg2bSOgtXTChq9qLcCU86Qz+YXvGvFLawFCCFEOY08Uzp7IRv/WXoixzbCDmmeKUA1GE/XZWbxJwdlJThRlN+6UanAK+3pVKwGWNO7QwppCmBI7evvWtBVijBAW+ozZH13W6Cc2em0HIWUz4nCO2otcypbuQsSrveCWapuw8cen1ZVgyipg4aWUcgzIUj5YXJ+HeH6LbhcfN8il/dVThLHV8EO5GpYsHuPLFYH8UocfMgW5uTm58hIvZ5ya6EFjQcCy8k3IKH+0JsiRxgjzrTzqNG7W2N/LRoARwuJ6C67maF9cXYVXnI05uezzz+b8fPZNiQ+t4MrMGjTi1fniTulDMLmMc9O8ebxan115P1Tl3S/9ebRsjmFv9/6AFPwz2ZlCtLe2G+SV97+ux0OU7aijuYTodrQW3P9r0dypQV40op3bjJ8zd+H60HSOECb6wLjaIowwbelRt0kjXxdzGiMsrD1BbXJNnXIXG7O2gwDzfZs0sKAEdrUCg7q08rHlYYRoj4FfzW5lQ4md/Nt06dTU05xCCAv85l3LLwo0P+z33u48jDBt5uRTv763auZfnnvPNfeyy9oMBs0hmhg8t1SkmUamkFsK26WemerNp91HHHjDKS596vHeCGiSf22eHx/Tbv03Pn57Sz4piDs7p4kEU3a9/yp+SwDkFp1lHR3tSOGiGx8yDw6zpRDtNeOS+jhR1fEr6jBulDcfC+28Azp37dDQTYIRwqK689X2FZ32qGKnLlzClmAzTDmNO1HsOE3YHGyOKYcRhzMJIVmhXzaxwAhTEkefBk0b+7ma0xhhfs3xR1V3eTBPljbhI2HQhjeqHUNb+9KY5imHzgvKT4yxxbTH9KP3Dy2fPW5Q985deg//dMlfobEVGO5rEmlBt5Oo8p2ZQFrQGyhAAwAAAACYqFHWGGGhnad3KeqM25vCEcK92T3IkUKUU5fvr7xRnRqzqbd/6+fJw9iy42+FBeayC9DaO2EeL2nEV7uYIul/97fAPImZENM+8wrv3MzYPcASY/M+28u4vipHAVpV3+74v/OqCyEuL+Lkota2FNIyAWD2waFWWBBY/B7dYleD7JuTn9aTYMqq+aLyVo4KTo6zo5Cw0/q4EssVnJvqQiFBm9URutwarFP1h8uIuHfz6rnDW5aObWpHYbOGcy6klivanMMjbDEW1J64P7zwN4KC+HPzmogxZTvmeH6Zy5akpxUvwsRs7+dIIVr2WUjpgchvf9VAQLsMP1DqdX/OwaGWWNBypWndiG2yuKRN3YQICXv8laZlD8rbP0iCkaDtmkiW6Hq0ljIFBxvxR3cbCot8x+z4L5sjhBA2/f7avm40pj0mnc5ULaRb7mJj1nYQIIRpt95r7qgmr2beHBrjRSOEMF82/K+nqsJG/rO1XW0oRNecHfo2H8lvf9NQhCm7VnMPvnhbq8iLOD4/0IbC/FqfXS6jHmLQHKJJVeaWShegTSe3cImHR3vSdI1xx5I5QkovQBMif7F7amMbCvPtagUG9ejevqG7GcZiaZ+fr7+XUyG36Cjz0HB7CgsCV7x4e9RnHBhmSyHaY9oFtR3g7fGLsNB3wt5Xb3eWvBd/9nOmEGU35kRhU932qOKnLm8r0M4TTr2rRbJxG7tIMOUy4VQOIWzUbx1EmLLt+OPN1Ldlx4xbS9pYYlzYRfECtPb2pTHNUw5dF2QjVrcRICw0k/DUbxBA2KL+pH3h5csOppMW3ir/SZSmMxNIC/oCU3AAAAAAAJgwUpAa/aoUr+OzWITYVzt/PZaMHAau2bGorbPq9k/Ktun0rRvGulNZIes332O09I906oT27dJFymPCL1+JYBFCSHE35GYur/HEic0FXOTV0CgWIYQKbl++kYNEgd072eIy3q4cKLveK3d+3clNiBBCWFwjeOneVT1tUerptTteaLrvlI0Ie5aHxFJvDTMNsImnP+s6eN0TfvOFR099396ufKEyOdl5BGEzC7MSy2EzMzOMSG5OXqXvxC+kuPhF28A2Qf3Gf/XX3bxaY7cc+rFjuTYsl844tu3RZ9qSb/rXFL99TeDSfmRPH5rLTUrOLVeg+lxxkvlg0/hunxxJpryGL1/QWlRKEy5i88I1j+nmn3/T16G0dRbW9PGklc8ePdM6mQJACJGsjEyCMM/SUqJlD6ItrS0w4tJTM8p/y/Q7zP0/V59Lp2pN3/T7SF/Vg+Eo64afrP2qg4iLP3PynhKVN3dh825LNs5oYo0RQoh27jmutxuNKLsBy9aO9lPdaC2qPWZ8ZwnmUpNSVKFnnlq9/pHCts/qA8v7+7y9yVpco+ePu7/vaMa82rH5Qq6m8A2bQzSpytxSWSaTW7i4PZ9O2xVfc9KGlT3ty/gc+Nbu3lJHMVKmvrhx7uTpyw9icxHPxstX6vDeEQG5RSck4+zeM2lE0HzIANnbWU+sOg/oYk2x8cf2h743Bxddc/Lvvw6Wvd1ZxD5j5gyvQXM5CW+y306IUJE9CjsGD2gnIUmnD18tfEMu9vCeq/mUe//hHcwQYl8/e6kkvAYDRjWzVQVJWTWb/tPKb75c0KcWfr/P8rZXLWSapxy6LshEvAhnEFHyfCduuRGZLlfkJT07v258I8vcR5vGDln2QFFa56UzmbRQpHwnUWWdmUBa0BcoQAMAAAAAmDBNU3DIz0x0xCTj+pUHCmzTfWQvx2KzW1p1GtHblWZeh4bGaq0j6dQJr2G3zi408+hiSApBiHkWeiMJe7YZOLqTH495dCU0nSDEPL0SmkT4jbsFOeup/oytuo7u76LeGeU6cEIPG6x8fDk0RdPVYFxULEs5uDiWMhUoYhPPzuk2aO2jXGTWbMzkNmqXIsyt+bV4uAyCgGXPWITI27fVsIocW86pt8vAbzJ149bNG1cvnTWggdmrv4Y3a//15bRyXMJR7gNXHT5++JdBHkVn/Ezmqwt7z0eox1i1K86m3Nkys12d5pO3PyW1hv9xemP/UneW7AvLl1/OdR6yaFKt0j5GhGgnF0eK5MZGV37m3Y8BtrSyxIgwWVnartm5nOxcgrBILKzEQcxGXLz4kuH59B/aXKz2MuU2ds+zV8+vfNWUp2Paefcy7dW4kVqBkbKxs8GI59+yudW7FwV2dhYYFa6g4s65S2lE0n5I7+K7GOXRLbgBn8u8de2Jpl/nDJxDNKnC3FJZJpJb2IgtU2YeTPGZ/seyLjZl1JXSzs3u0GXeocTaE9adeRCZlpP15nno34va49Dlg9oM+vNl8f0AcosuSPrpvWfTiajV0P5eRftAUQV639W84s0px6DeLYtN5G9lbUkhhAqPV932qJKwY48B7SQk4dThtyVvLurQ3utyqubA4a1FCCFa6usjxMqrP4z9csfVV+lKhBDCNoETv13y3fxe0vcP7/K2RwiZ7imHjgti1+6LVq35/VDolfVjW3hZC/lih9qdpm06s2WYG5V3d83KU9mlL18KE0kLanQ+idJ6ZgJpQV/0MtM4AAAAAAAwAi4xNp4hdI3a3sISf+HJfGU0io+PiWdRjbJHHOjYSUD3Tna/b7t18XruhL5Z10OfcdaD2zaua9XGhXp088pN+djgpKshL1le3W5dvSiECo6Pdu6zI6PoVF3Q8uenV+fIyjf2gVfD16fk8FiRr7+MJvfiouJZ5FTamSyXm5NHsItYXMplC/t62+L12LJGTfuoiIv/m7+v756hhVcZlFPgsClTkzSX62mvRjYY0ebmIoTy8nLzCLJUfweSl5tLEDYzLzlcp+Ioz7bDx7RFCKFZC2Zt6hcw5cSyKT/1DPupOV/bku9wGWEndu0/d+vhfy/DIyIiY5JylIQghN591FW24mzyzT8Wzfxm250U1syn51c/rljQv7Z5qctw0TuX74jGfl982tVKU6diiRgjLic7h0NIQ10AFMGWnp7WFEp5HvaMQYFl7D/s66cvCggW1ZS5V2KrsjGRMSyiZbVlJY5QkZ2n1O5tm3LmLpqm3tsXsKD4Y+XUkezoqFSOFBwcaoWHlvJ3nJyYzGq4GDZsDtGUG6syt+iD0XML82L9xHmns/3nHlnaQWOiQAgp7678bP3TAueh20//MfDtrx21Wg37/mgtXqtWS04t/OJA/31D1calQm7RjqSe2ncukxBycbonPb3kXxNO7AvJ69JNreBM2Ts5aP32175HvUc1Bvr02ZOHr8uDOonY1wf33lLQtQcPD1BN4eU14bdfbw3+/O8Ly0af/4k2c/Zt0qJlm049Bg3u0cChlGO/vO1VYZvmKYeuC/Jr95xe+72lsWOvaUNq7FkVee3KQ2Xf1rqfcxg9LRSjy0mUjmcmkBb0BArQAAAAAADVlqqIgUs5D6coCiHEcjrcSK9bJ5LW3dtZbDt09eIdRVD61btKQUDb5hKBWfvWlmv3Xgt5qGgVfvm+kpZ16VqbRgjR7q0GjyTvhlvyfOpYaLlaKG1cSWkx0RRCiNU4+gXzBXyElMrSbpQkBNu0/ub4kQnhkxqPPXxwwRcngzb3VFUeqBr9/reuX9kRIoQYN093Gv33JjaeRc7qJ9L5b+LTCRa6eThW6gZDjlEwLKL4Al6xbng1R0zpsfDUtsh/7yRyzd11ewuSeeOHvn2/vZJMLLyatm7Zsl/XUTIf/4a2IdP6/PRfUasqWXGSdm3ZsCGLz8UTh4CJa5cvntTWTaD5rR5t/v1KnqDFhPGNNF/2KpUMQlggEJhUTc5kCZq1C5RsOhJ55uTjHwIba9ys7OtTJ8MYLApoHyjR1Eal7FFgLMMihGm6rOt0veSusmJgWYQoy8aDJ3Ys7YDBwkZemsIzcA7RkBtpA+cWfTKJ3JJ9459rGUhgdW5uUEhRYFmRiRxi7q3s02qngOc7dcfmMZ7RVy69YrBdt5E9i421R+KGI4Y0+PH+nasX7yqHdnmXkCC3aEWST+y9kI0ou1pNfWyLfTgkN/pRWHziiX2Xcrv1MHv3OkWVdqirLafTHvU+7BQ8oK3k9D8nDt/4pVPb8AN77yp5dYcOa1i4H4n9J+x42O+Li0ePnLl49dqNW7eObAo5vOnHLxtM3Xbitz7vT5pR3vbIZE85KptPeDW8a/BQeHpaus6J2CTSQrlOospxZgJpQU+gAA0AAAAAUF1RTm4uPPwg6kW4Avmp3+yO2IiX4SyiXdyctY7V0LUTy/bdWokP/BNy+dGdzBtZtH+blvYYUS3bB4h2X7x69XmHVzdzKbegbg14CCHEazRl4/Ypuq9JQVpaLkElhjszUc9eyVFdM/XXFC+ehrOIcnZz1nDxRNk72VNcRlppc9hSriO3Hv2mlS1u8fN3Oy9NP7fj829Htv2to6XucfJk9euY4bCI+48ySGO1KQGUYffDlITnX99fXMbSWjF3v6rf8qeIZj8/DS0xXJxnZi7GKCs/L1/XG0DZp2tnfHcl1bHPujPbptYrGkLEht2ryAVUZVY87+4PPYO/vllQo8/PO/+Y1dKh7F1ScWv7rqeMsO2QAWUM3ecy0jI4zLN3tDWZmpxJw9bdR/VxPLbr6aYf90/bO9y11K1GUk7+uPa2Atv2H99fw3SmKqUerWpoF3dnGqVGhUexqJ7ap02ywk4dvZtm27h3cD1LfeSuMmArVxdziih8Bi5ZMUBLNb0kA+cQDbnRwLlFn0wntyAuO+r+zaiSr2ZG3LsZgfhM73yCCMdxBCGhRFxyf8JCsQgjxBX/qQNyi1Yk4djeSzmI32zesesLahffrBn7h0iH7Es+ue9iTo9e5rr2WPE9SlWBPvPPicM3frIP2feQ4TcZPsSvWEw8W78u4/y6jFuEEMmLv3vi17mfrriyYfrSfl1/71zaj3FltS8l65noKYduC5KMsH/OPcmyqNO5a73is9hwmekZHKIcdBi6/pZppIVynESV58wE0oK+wPYDAAAAAKiusE1g2/p8knp618niUyJnX951JIbl1WjTRsv8G+XoBNt36tZMwD47v3Xf1Vjk0rK1N40QdmjTvi6PeXR+4+GQZGTfuXuA5pGtakhOdo7ae5GMi6euvV9ZJRlndhxJUH+ZJBzafDyF4/m2ba2pAM2T1pLySHpMTNb7lVrKwsXFEiOEaOmEX74MlLCv/vjsx5t5COk+L6F5++B25ij/6oHj6oEV/HvoeBTL8+nWXcOcxTqivRv4S7Dy8YXLCcWjZ56HXk9kKWtfP1dd3yD/8b2nSmQZNHF8PfUbWPNjohIrMiFjhVecfbb20+9v5tj3XH9h/+faqs8IKW7sPRTJCZr3613WQG82NiqWpT1qeZeztPjRwra9F85pYU4SD80ateJ2Zim/YuQ8/G3MlO3RnDhg/pLBTsVuedbpaFVD12rbxpVmnhzc/0j9CVYk5ehXw8eMm77lCcH6yV1lETRt39IM5YYcPlO8fy5u+1AfV7cGcy8XaFrUwDlEE8PmFn0yjdxiM+a4vOSzERSXPvWgkaDD2hiWEMXtRX40ot3r1bWjuIRLZ+8X/8RJwsV/Hiox379hHfVBeZBbtOHij+0LyUP8RgP6eb/30Vh17t/JCnMpp/ad133yYF33qNJgpx4D2kq42OP7N+3YH8YIA4cNKoyKDVvZxaemd6efHhZO840lrk0Hf/f1AGeKS4mIzC5xfJe3vYqpnnLotCDmvdwxdfiQvhM3Pis+FTrz/OixMIZyaNOhvq7zb5hGWtD5JKp8ZyaQFvQFRkADAKNFRpcAACAASURBVAAAAFRbtM/IT3usGHNk38wxjd3+mh3oQCPEZdz/Y/LkzVGcRbtPJzXV4WRP104o96Cu9Xgh/27ZSljzAW0bCxBCiJa1betJ3QnZsqOAtRoa3FrbID3KwdmBQs+vbfwlZPCydrYUQij3v7+mzt6dyL0/4QaXeuTzUT967JjX1pmPUEHMP9+P+uxICrLu9um4eppWDNs3aSajL/736D8GtdF85cSvM+PXebtb/e/+mpmrhoZ+1YCn27yECNv3nzX625Prznz72c62O0bJBAiR1Kvfzt74irPsMmty0Z2/SBl55eC1WI7n1WZQaw9dK2nYJnhsf5cj2/75etIq/79mtXDgIYRI7usjX45b8YDh+Yyc0LFwPLiqf5b2aDWwbY3SNobA0dkWk8Sbp6+mBXdWPfsoP/zUyhmfbHvDIQGjeHvDsI4TMlZ4xZmHu7bfyaf95343uqYOOyMTdu5CHMurH9SxrDG4XOLTp8nEvG1AHbiY0RWv7uztv95oN/nIxUWdWvw759sF43s29TCjECL5b+6f2rri2+X7wrIoj/7rtn9WtFXLdbQiUiAvUF3yC1pPnR6wZcHNlWNn1T+0aqBMjBDJfrJ5+lcnsrHD0GFBVkhPuasM2LH/jBHfntq4e+pgmcW2L4I8hAihgvgLy0bO2f86s9ac/s01Ti1r4Byi+W0NmVvKobrkFh2JO0yZUHfHD4/XjJ5Ua++vYxtYUwghedSZ78fMP52JHYdOG6zeF+QWbbjYI3tD8xE/oH9f2ftVO2zdZUAny4MH007vP5fVt7+OY3113KNKpapAnzn711fr5Ky48/ABnoUfJ+0pdUyPPhex7vttvbaMr2OOEUJc5uMdf55O5HiyBvWsSxyN5W3/9v1N9JRDtwXNO48fLt277vbSEbNr7VvW39sMIcRlPd0zf9jSfxWS5p/NDpIU69/k04KuJ1HlOzOBtKA/pTxUHQAAAAAAmIBR1hjxGy0JY8pqxMYdmVxHghGmxM51Apo3qGEtwAhhoXTojlfKwkbM82UBfCRo+fMrtpT/6tgJIco7X9ThIYSwsOO6mLeLktzjY+wphBA277M9hdO6UmzMjv5OFEKYb+/bNrhnUDOZrQBT1nXre/Eou3GnClSNXq9qJUA8WYegWiKMaXNXv/q1HMUURggLpMP/jihzi8gvTveg+S2Wv1BrxaVs6S5EvNoLbqmtTs7VuXX4GJu3XfVM+X43GnFpF+c0MMOYMqvRIrhvr3a+tjyMee79t75W7yVzR28RQlgy5MB7o/QIYV+uCOQj2mfezffemEs88YmfBCOMRfbeDZu3aObvbsHDCNNOnZbfzi7ZPxL12ZmlIc6CB8taWmKEeXa+bYL79OzY1NteSFk1Gj0sQIyxwLPt6CUn41gNy+ptxbk3G4KECGGeyLxU1oE/qO/fzIvlLfiI9pxxWVFWJFkHh1lTZsFbErXvb0Bdwev9M1s48DBCCGO+mb2bp7uDhYDCCCFM2TSZsuu/vGLtdTpaCSFZewdZYEzZ1es2YMiXxxM5QgqebernyccI821qNmoRUM/Lmo8RFtQcsSeq6PPWKe2wMWs7CBCvwbcP1feTh9824CFh0IY3antAwfmpLhS2GHGk8IjjMq4ubmlDobdBtGjkbS/CCFF2bb6/qemoUTF0DtHEsLlF12bVJLeUptgI6HfyH6/v7SHACFNCG8//s3ff4VFUaxyAz8y2bMqm975L7x1FOlKlN+ldBUFBxIICAiIgiFQVBQUv2JAughTpCIhK7xCSTSF1UzbZbJs5949QkpCQZLNhZpPf+/jc57LZzHxz5syX2W/PnFO3cQONn7OEIYT1aPHeoUJ/tJBbSsBFrWirYBh5yyU3i/47zKdu7qdiCOv18q/pxVy/lFovz28kI4qu6x60cyl71BO3Lnl7vL++mwtDCGFUvb8vcOJMlz5r58kSwkhcg+u2eOH5prUCXFiGMMo6r/+exFNKrVcXNJU9ziQlvr9Ior3lKNUv8plnPmnnzTKEkalCajdp0bRWgDPLEEZZY+QP+d/nOGmhNDdRZbwzQVqwGxSgAQAAAESqVAVoSimffumnOcPb1wnyUMqdVAE1Ww9+b+O5lPy/VVIBulQboZSajk+NkBAirT/nwqMPAHzKxp7ODGGcOq+NL93Nefa1X2b2bx7h6SRhGEIYRVi3BYcvrOkoL1yAlj2/9EbimbVTujcM8VAqnL0jmvWZ9s3p5JKagxoOTQqVKAuEU+SnQcpnHJikljKsZ7ev75Xtc1Hmhf+9O6Cl2sdFofQIrt/l1eWH4wt9oCxHkYjPvPTz3DEvNgj3UznJle6BtdsMnvH1yYSCJdmSPw1SyuvOffNGj4Yh7gq5k3twgy6vLN0XZeDSj8zpEOYqV/h0WX27xLYs74E//M6iOAULE3zC2s5ODOPc6/u0p3Ulw4HXgiWu3dcn4MOgDbj0y9s/e+vldvUi/D2UMoWrd0jt1v0mLdryX0qRNZGSr1ZKKc05/+XQJkFucqnSr9+GB0UGS+KptdP6tlD7uMjlzt7q5n2mff1XUqEeV3LaKUcBmlJKDXf3Ln2te+Nwbxe5XOkV3rjHxM8PRBdXvsz3axWeQ4pTsbmlVG9zkNxSlGIK0JRSa8q57z8Y1r5usIdSrnD11bToPXnFgXu5hTeA3FIC7s5nreQMIy9Ybi2AT9nUx40hjOegn3V8KQvQpexRRRegH1ag8/ZYKBj9tV/njuxYP9TTWSaVOXuHN+o8Zt4vlzIevK1QAbrE9xdNxLccpfhFSqk5/tiX0we+UDPQQylXeobU7zR63i+XCx2zQ6WFEm+iynZngrRgPwylpV3IBAAAAADAjricZG0S5xse6FroSV4+annb2tP/brr02skZ1cr+jLnl7Pv1W68OW3Prj9eeupiao8v5eUDY9iGxWwZVrWkJDQcn1uyx9YUfb/00yAsr0j8zxV6tlVJVySHFQW5BbnEcNHVz/2qjdsuHb7+zqU8ZVvizm6qSLpAWkBbKqzJfHwAAAAAgZhIXv0h1BdSzZM0nTW3PHt/4452SFjByaFxCbFJwtchSLftYedD0fRu2JVUb/1ZvfBR8pirqahWnKpJDioPcInQsUHp8/Lb/HcxiAvqO6CxE9ZlUmXSBtCB0LJUACtAAAAAAUMmw4aPnTlSfX7v6eI7QoVQU079rR4/43mfq+MZVa1Ec7u7GFbvZvnPealHsGnIA5VcFckhxkFuQWxwI1R1csPSIgY0YNLK9YANzq0C6QFpAWrCHqliAXtfViWGcunydaI/JR0y7R7qzktApR/JW9eQuzWskK8PGS/n+QnuxL+7Wpy3ljOKFZXeLX4vUfvio5a0VjKLNiuin761QVGVtWJs9sx0VyZSRmBCfkJRprugdCXuYT0MTt40IDxm2NUVsgRVmPPdhQ5+2y65W+LkCAADbOLea+fkYZvPHG+5W0hFJEv8Wr204unW8poqMSM1D0/ctXHGjzfzFgwMwFgkqVqXPIcVBbhE6FigV/t6aHuHhQRE9v7nLu3d6Z+oLQlYIK326QFoQOpbKoSoWoAEeM8efP/LnkXMxBqEDIYQQ86kPmoWGhL3w8T/2/qZBVIf5FDR117tTd4ZNn9fPt2JSvOXYm+FSpgjy5ouuF7pbMEXvXzape+MIHzdXH3XjjsPnbLuR7yttp2Zvf9Tt9vzJX92qpDcZAADCYnzaT1224vNpHW3/g8B4dV2yfePwwMwsewYmHtKQJm3q+FStoUiEWFJlbRbu+PYVdZX6DAzCeJxDxD4wwr6QW8AxKDzc+NRMNqjF8M/2/PhapLClrcqeLpAWwB6qWg+qaGxo77nfhGQEtnYv3aelsr6/yqqohqJpv73TfdLx+gsvnplZW1KBOxKWoxym6ezSD37hBvw6vloFpXiaFXU3mWcYViIpdIcilTD5m4KmH5/To+/CsxnEJaCGOsIYd/3ojxeO7Tv6yaE/3m+S93AX49VrxqsRLRfO2Tbsp8EVVC8HAKi6GFXjQVMal3sjDfqMb2CXeEAk5NW7jq0udBBQZSCHVB3ILQ6HDRrxS+wIoaN4DOmi8kFasDcUoO2L8Wzcd2wZPi2V9f1V1jNrKEHPCOOkdGIe/G8F70mMHY8mbV2y/nbYmHVdK6wszt27HWUlTr2+T9g1wuNpkfz6+ssLz+aoh6zb9tXYBu4sMUbvfLvPsK9Ozp/8Rd+T79TKq4/LGoyd0GrpO0u+udb/w7rIpQAAAAAAAAAARcAUHIVYzSZr5Xxowk6o1Wx5FnNFOzRbe5G0dqO6Csa5boPqpatmcvqsnIrorcJcBXz0z1/vy9IMeLn4Cf7LHZgx6nYsxwbXqObytHdZ/lkxd2sSW2PKhnXjG7izhBDiFNF32YpxYWzuvz9uufZozg02rP+Q1uyF79afNpUnKgAAAAAAAACAygsFaD7ui44K1mXI1ow7W6d3ivRyVsqlCrfA2h3HLTuSYC34XsPt3QvHdKwb7OGsdA+s3X70or3RxoLlMO7aJ83kD9Z2M+x/NVjCyOp++G+hzeQenBiS9wNL/veXfi/WczNryxhl3x/0BV42H3g1QCLxGbcv/7JoptjDa6b2f6FWkKezQuHsEVy7zaB31p9NKUMNmY9a3lrBeo7alXB6xchmQSonhVTu6qtp2f+d7/5Jyzf9bVmiIoTwmRc2vt27aYS3i9LVJ7Jprze+OH6/+JmPi2ooPv3C5g+GtKkV6K5UugfWajPkg03n0wsd2NMOP/un/ko2aNKfJmL554M6UkbRfrWWL2pHNOvqlnmjOtUP8XJxcvYMrtNuyMzv/0nNP/Nv6XsR1V/bOn90p/qhns5yhYt3RJMeE1ccjn9w4IyqcbMaTrWbNix6AV8+ZmVbBasasctkvrttRtda3q4Rbx4x2+Mwy3IV8Gnn1k/r2TjM09nZI7RRzxk/Xc+6/HFjuSTk9cOPT/FTD7OYU3x3689nLSHdezaW2dKwpcJpb98zU6mmpvppFX7LP79svWWVNh332vP569RO7T49FxV9Z/fkfPODsIHdejaXxGz9+RQq0AAAAAAAAAAARcFj43n45L1vdt+8OValadqplUvqlbMXj2x45/S55INnPm2dV4Oimafm9ej18V/pPCN1C9IEkbiTmz48eeBIj4jiymDO7V7uE/zdV7d27bw0r2mTxy1tOLZl930qbzpiZCMZuVnwd8q+l6cyXV7V68Xph5J5qXtI9doNnUzJ926f2vrZqd/33zlwenHrp44CLcR8deWAHsfOZBKlr6ami+7evXM7Pju3d9fxzX9+NzC0zN9j0KxTs1+c/dN5g9JPEx6Qejfm/J41b+zfdeirQ1vG15CV/PuEcLHbXuk8YuNNE6sKqV23tjXh9ukti07t3H7s58Pf9A1iS3P48tp93prh/8+v6w7G+bYZPbyln6aJiiHZhXbEJ+55o8uQry7nEIW3unZ999zY6ye3LD6xY8sf3x7YNEKT/woquRfpT83u0H3hv9mMs6+mRkM3c8KtS398Pf3Qgctbz67v7csQSc3B85c1qfX0Se75xJ0T3xr1Y7amWfuuTQIl9jnM0sVP+Pu7J3Z8ef0NE6P0rVYziI879PmI1id6N9IVKPyXdJhFHlXCgX3nraqB7Ro/ef5LEVjpWO/dvmeV+FXzS9i5dPFv527EZsr8ajTvMmTskBeCHw275uPOnNVykrAXWkcWPA+si29Y4d2xwa3bVGdO7d/7n6Xj86XquQAAAAAAAAAAVQuter7poiBE0XntfZ5SSrnYNR3khBBGUWv8L3cMeW8x3FrXL4AlrPfoPbl5r+j/nKKRMoxTzZHfntdZKaXUkvL36n5hUoYQwoZMPmymlFJqvbqgqezRxo1H3giXEGn92ectj3ef/fu4AJZRtl8dzRV+f2n3Yvn7/VpS4tRnc1aBAzPtf8WfZb3H7jU93NWO4V4MI6854dcow8P3JBx8p6mSYb1G//bgyKj15uIWMiJv9dkdrsj24u5+/oKcEEJY347zDsUZKaWUN9z7fWZrL5awPn2+j+PKENXjrfl1/uRogolSSvmcqD3vveDFEsat/crb1qKiKtRQ3L1vunuyjFOt0Zuu6/NeST+/pm+whJGEvrIvs/SHzyd81UlBZM0WXrPSIs4g5e//NMiPJax/l0+O3c9rfS7t3Op+YVKGUXVc/bDJSteLuJjVHZwY1qvjojNpebvjMs5+3EbFMMW3foEzEb2ijZyR+QWGNp68897D82ePwyzlVcAnbRkSwDKKWmN/vJXDU0qpOe6Pd1qqGEIIGzzpT1M5DlO/bYg7I3++0BtKGVgpcfdWtJETRuHiLC1QBWfcGryyJerhRWo6NDGIJfKOX0RFH1g6rlPdIHelk6tvtecGvrvhn9Qnw8/eNkTFyFstu1OmUAAAAAAAAAAAqghMwfGAJPLVr1YN1ijz/qWsPvrtYRESPjvxvp4SQmjqztX/i+Jkjd77ad24Rp4SQgiR+jSfsnHd+LCnDFZVtBrcP1xivb5r59VHA5izD2/Zk0xdO40eFFa48W3cS7H4dKtf25f6vP7xnP6RDw6MyAPbj+hZXcLnJKeUcfZg1rv3ss2zO+UNFGWUET0W/PJ5Ty+Stm/NpltcSb/85NZ8B6zcPLNdoJwQQhjnyJcW/vJ5Ty9Gf/LrDRdKHuxtPb9uxcF0tsbk9V+NqOXKEEII69Fo0ppZHZz4hD9+/89CiH0On7uzedXuFOI7cOWmmW0D8ga4sl7NJm9YOyaEzTr+5bf/FQj26b2IcHdv3LZQacMBI5t75Z1Q1r355E+XzfnwvT41mFKeDmrRuQ1es6xPhFPev+15lkuIn4/6YdWOJCZ8/JpVQ6s7M4QQIgvuunDdjEay/PVcmw6Tu3flhoEo1dWCi8pJJQRWWtZ7t6KshFqktSZ8dzo63Wg2JN849MW4xqqcS+vHvLz4Qt4UIjQrM5MSmrJjQqvu7244EccGasLccqPPbl0yrnXL0b9oC/V2RWT1MInlxqUbZYkEAAAAAAAAAKCqQAE6D+vXuXer/BPvsu4eKpYQQighhJjPHTmZTWXPjRnbsMD6aKoOowdFPqU2LG85eIBaYr2+a9f1B1WrrENbfk8lXj1G9/F7YiYCW/dS7EGFDPx8x287lg96PEWGNfPOn78culf2gjFh3LuO6h+YP2Y2aOD4lzwZy+WjJ1PLujAc69VjVO8CLcAGDxz/kidrvXPqr4SSJqjm7h0+fNsqrd5/SEtlvpfZ4DE/37hz89isZlJC7HL4NOOvYxfMjGf3Eb0KBMu4dxreO0hivXvyZFy+YEvoRUSirlVdwVhOLBzz4aYTd9IthBDCeD4/Ye7H89/t9fRpN/Jv1K9j92aPO4gdz3IJ8VPd8UP/mhn/bv1bu+Z7k7ROnz518gdv02Fy8TFxHOsb6FfUz0tqWOvZd2tImaeQt1h8gyOECeo+8/OVX20/eezLMc+FeyhkSt+anV5f/8d3Q4NZw78rl+3VE0KIxWjkKLFc/vOs74RNl5N1sdcv30xIjzv+abcAy90fJk7aGFugg0r8A/1YmhOnLbmBAQAAAAAAAACqHswBnYf18fctvhhPsxIS9DzrVbtOYKE3yeo0qCMjUcX+pqzZoAHVly++unPX9Q/r15OQzENb9ulIwNjR3T2fqD/bvpen4DOu7Pnh14NnL16/HXXvXnRscraFUkKIosTfLEQaUau6U6HXnGrV1Ujof/ExCRzxL1NXkkTWqlY4BKdadTUS8l9SQhJPnhgdXgAXGx3LEYmmpqbQTp28w9Te+V8o5+HzSXEJViqJqPlEsFJNLY2EJCTEJnAk4mGwT+9FhLDh41evOjt4+o9/Lh516FOJS0Ctps+1atPppUGDX2roW+r2kwQEBxSq0trpLJcQPxcXHWuhkjB1WMFYJeGacCm5/Hgzthwmn5NtoEygUlnUDNElNqz/80Nfm5hc/BcXkvDGngwhspo9J9d84oeMX6/XX474+fPoU8cuWvq2lkkVCglDGHnL2T+vGV7rQcBS/9bvbFx0qubY3Ye+3XJv7Nuax/EonZUM4bP1T2wYAAAAAAAAAABQgH6IZZmi10Z78NPiyl8KZyX7lF8k0saDB9b6bMGVnbtuzqxXW39gyx/pTPgbozoWtXSa7Xt5pMBIZJp5emHfvnOPpVC38GatW7Xq13WkpnrdRl7HX+/z6fXSbK2gIgJgJSwhhONKGGtbyvHReVuTykpeyo2zcoQwEslTBw3b4/DzIi+qa+SdLI7nC774tF5ECFHWHb/pYr8PDu/a+cfhE6dOnz27c/3xHesXfdhw4vd7VvcpcvaJJxVsIXue5RLi56xWQopojid+y4bDZGRyGSEWi8WWwNiIfvO+6PeUN5RAGlEtQkqi0nXpPCFE4untyRBTjS7dqhXIj4xvu44NZLtP3bp600o08kevWyxWQhi5vPBWAQDKZ9myZSaTqeK2z3Ecz/NSqZQp4W+XwCwWC8MwUqmob1kdojEppVarlWXZEm6ghIbGzMPzvNFonDdvXvl3ceHChb1799olquI40HUqkUiK/8wlCg7UmCK/Tgka8yGTydS4ceO+ffuWf1PffPNNampq+bdTHJ7nOY7DdWoXaEw7QtLLk3dzMn36dC8vLxt+XdTnWDQYt5AQT5bX3bieyL9YYHAuH3dPa31qfVXaYPCgup9+dGnnrlvvBVz8ZX8GW+v1Ua2KGppanr0QQggx6XQ5lDwapsxdW/PG/GNpfn2++OP7ifVVDy8T7sp/tlwx1pgbd4ykXoHCufnWtSiOsAHBAU9JaIWiehDEvRt3TKRW/lkViPnmtbscIwuNCC7pNlsSGBIgIWkxUTEcqZ/vzTTryt5d/+q8mvTuUd+dt8Phs/7BgVLmQsytKDOpnX+2D8Ldux3FEUngE4ORSyb1qt1lbO0uY2cSQg0J/+5ZNWPK0mNrJy/o1/WrFwuPMS+Zfc/yU7H+QQEsuRl7T8uRavkOm4uLiXvyK4gyHibr4+/D8hm6jJLmX7Edzbhy4ODVLLc6L3atX/ABBD4zPYMnrG/eOGtpzbo1ZUyi9cliOM/zhBC5osDly2foMnhG6uNXYYEDQBW1d+/emTNnVtz2TSaT2Wx2dnYWczmSUpqdnS2RSJydnUt+t3CMRqPFYhF5Y/I8n5OTI5VKlUplye8WTm5urtVqdXFxEfMHZo7jDAZDxTWmyWRKTU3dsGEDpWWd564I0dHROp2uW7du5d9UcfR6PcuyLi5FDbERjbykp1QqxVzmQNKzI0dpzLykV0GNSSlNT0+/dOnSjRv2WbHm0KFDw4cPr7iL3Ww2m0wmJycnWSmGpQnIgZKeyBsz7zp1lMas4n9BLBZLSkrKli1bcnNzbduCeNtOVGRN2r+gWrf99MaNl1+b0/DxUEfz5R9/+rfoMZuPSOoMHNRgwayLO3aeDT53KFPW+L0RDYtu9jLuhWbrsylxe1hJoxmH957KzVfqzb383zULUXWeMO5xXZIQkhsbk2TDHNA0449NOxP7DA94tCmauP3b31J5ab22rfMVoEuKKg+v27fpt+SXXn48szK9v+3b3WlU/vyLbb1LKp1KarRtEyS5eHXbr5fer9/4UUPR1F2zho3eTfv92Oul+nY5fMbz+bYNZHvP7fvh99QeA30eb0Z/9IedsZxU06ZNROk/G3FXlnXvtyYqbOK2/e/ldQHGOajZ4Pmzj2w6sTb1XrSeEqcyV43te5afig1s276O7OjlP3b+ZejY/lFG427v2nU531qMth2mVF1DLaXHY2OzKPEpaytYz75b54Wlt4s/YFnzRZdOvx9ye9PEYT/mNFt4/tT7tfNdg9abu3ZfsbK+bTo0kBFCmICuLzWTH/57z84LHzXLN9s2r/3j9wsWRtmkZf38f8C5uJg4ThJao1oZgwYAKAHLsi+++GLFbT8nJyc3N9fd3V3MH0t4ntfpdDKZzN3dXehYniY7O9toNHp4eIj5YwnHcenp6XK5XKVSCR3L0+j1epPJ5OnpKebCltVqzcjIUCgUbm5udt+4TqdLTExs1arVzz//bK9tRkZGVmg+SU1NlUqlHh4eFbeL8stLeiqVSi7iB9copWlpaY6S9PAXxC7ykl5F/AXhOE6r1XIc5+rqeu3aNXtttm3btp6envbaWiG5ubk5OTlubm4KRZknDX2WUlNTJRJJxbWDXRgMBoPBIPLGzEt6+AtiFxWa9PR6fVxcXNOmTQ8dOmTzMHDxjiwQFca79+SRaonl/OJhE/93JYsnhBCafeOnySM+PW8pam6K/CQ1Bw5qLLde2Dhl6YEspxdGD61RzO10qffC+gb4ssR86uvlx3UPBozmXN848a2fkvIPH5X7BXgxVH9m3wndw7ETuVF7F7w88fv7PCFWcwmF88L4tJ3TRy46npj3a6bYAx8NmbYzlXi8OGVsfWnpo3q4tZRt00YvPZWcV7g0av+Y9fK0XWkkoP+0EZqSO6W89cTJLZytl5eNmbr1bt53L1R/9dvJs/boGd+eQzu7l/HwqcloKnJ8iaT6iCkveZPkLW+OXnY6Ja/AyWecXzv+1W9jeLfWU15pVoa7BEmY2i9de/fYF598fy37we74zMub1u1L4qXhDet72HIR2+UwS3sAdSe83cuX3ls/Zfr26Lynwq2JRz6asOSfvIUGH7zLpsNkfJo210is1y9dtxb146fLmwP6KV7t39iTIa4vjhumlpjPLRj+1vY7OQ8iy7r245ShC/42O7eY9lbnvKo6Gzn6/WEh/JXPho1aczYtr/cabm+b/vKHRwxsxMg3++dfkZJPunYthbo2aVGn7HEDAAAAPEYpTUpKSkpKCg8PF3ldAwBEzmg03r17VyqVqtVqMX+fBwDil5KSEhsbGxwc7OdXrie/xTtMQ2Rc2s/f8P7fvRae3TC6weapYTVDpfdvReksPi9OfyVz9fqEp/6upPqAwc3mnPvrwhXGrdfoaiBsqgAAIABJREFUgU9ZYK+Ue2HDBrzac9Gp7Rc+61zzt+dbVFOkXP/3YlSGc9364TeuZD98l7z1q288t3nmX192r/Hn8y1ruhvjb1y6HGWpM2Jg819/Pnds4ctjUt5b9EGPoNI1gFTToYPk5Kz2IYsCa6hd027fScnliVw99MuvxoWzZYiKEEII41q9rl/c/vfaBC8IqhHhnHLnbmouT1waTPl2+QC/0pRhJXWmblh5usuknWsH1/4lol5NX+v9Wze0GVZZ5LBVi/t5M6U/fDcvLznDXf1iVK+rdZqOWfVx94I7YoOGrVl/4uawdXvfbR2+rFb9cFnyzesxGWaiUL/85fpJ1cr0p1z10nsz2+x999ivrzTY91GtOhEqLu3ejVtJOdSpzqTlb7ewafiAfQ6zlNig4V9uOHNr0JdfD6z2Q2CtGt76uzfirA2mvdH5i5V/KpwUTDkOU1rvxQ6Bn35z9kw016Z6Ge+QSjsHtFuHTzbPu/zS7ONrBtb5X3C1akHOBu31W0kG6lRjxPof3q73MB0yXi99tnHa+d6fb3nz+V1zwquHKVLv3EnK4Vnfdh//uKRzgXFjOef+umB1btW5taifGAIAAACR4zguNjbWarVWq1ZNzKNKAUD88sYqenl5+fv7Cx0LADgwSml8fLzBYNBoNOUfSo8CdGkxHm0+/vPvJss/WfXTwfNRt6NcQ5q8/MZ7C2Y03NN9dUm/y6r7D37uw9PHLV4vjerz1AJrKffChoz43xF5zVmf/XTk8ql9NzlKFGFd529c7LGgxZsXH71L3vDdPX96ffTRFztO/X0o2sm3Rst+C1bPnNzF82xE4ujPT53deyJqdqkHxDJ+PVbvWHR0wbyvdp6+FWN2Dmvape+r738w7jnfR8XC0kVFCCGM+4vLT09MXrXoq61HLt3W8ipNq96DJ3/47pAC00g8lbzm+C1/1/528dLvdp+8+l88dQtp1HvMhPdmjn/eT1KWww/q+cGnQ+4u2HPl0N4kZc8iZtpmg/qsPXWmw/JPv9565MLl80aZV+QLg/tOeGfGiGY+Zf0mWV5/+p5T4csWfbXt6Pm7589aZO5BNTqN7jdh+tRB9d1tfIjBTodZSox/j1VHjzZauGTz/pP/3bwf2Hzsmk8XDbo28gvCuLq5MuU5TMVz/XoGrd148HDSjOpBFTSxP6Nq+cHBS63XL1v9w++nrl6/YHLyq9Zh1MBXZ0wdVK9AZIxXx6XHzzZf8smaLYcv3bnBuQQ27jlu9FvvvNIhtGDOzT1z4LjeuW3/br6iXosAAOBJLi4uIp9ujxDCsqyPj4/QUZTM1dXV1dVV6ChKIJFIHKIx3dzcKmJeC/uSSqX2bUyz2RwTE6NQKNRqtZgnvy6OQ3Qth0h6DMM4RGM6RNJzlL8gdk96aWlpSUlJISEhIp9wqUhKpbJC5tY3Gey7PR8354rYLMlKs+PGnAlxJoRk2Thdb7F8Q+24sQpMeimxdtyYCyEuhJBMezemXbGE+BBCzLkkJcsuG7TyNCYjhyFEralulzmCGLssbQEC4nKStUmcb3igawU9WMNHLW9be/rfTZdeOzmjWmlviCs8KhCANTslOdMic/f3zX9arednN2rxyd3uGxN2jyrXw6KWs+/Xb706bM2tP14LdpBPXoaDE2v22PrCj7d+GuSFCjQA2Ffnzp0PHjwodBQAUOGys7NjY2OfHKvYvXv33377rfwf+Xbu3BkfHz958uRybgcARC5vrGJOTk5YWFj+Mu7+/fsvX748Y8aM8u9i8ODBX3/9tePNEWT3SnEFsWsBuqLYtQBdgexagK6CjFY+JiPHVS4NclMyfo9P+qhRoxYvXhwUVMq5FApwkDIPFE/i4hepFl2dV5xRQbnQ9F/HVAsNbTDtQP6/35Zru/fc4mSN27Yq7zfssuaTprZnj2/88Y6910+sIDR934ZtSdXGv9Ub1WcAAACwhU6n02q1gYGBeFIeAMrDarVGR0ebzWaNRlMhg4gBoMrINFqidNleSnmwSmnrioNFQAEaAEqH8ek+vIc3Sfrh7YnrTkVnGK2m9KjjX78ybMlFzqfn68PU5f66gQ0fPXei+vza1cdz7BFvRePublyxm+07560W4l1VGAAAAEQqb6xicnJyZGSkh4eH0OEAgAPLW3JQJpNFRkba5Ul5AKiyknNMCfrcMA9nXxc7VzpQgAaAUmIChqzZNL2ly63Nr7aO9FTKnLw07Sb+75Zb25k/fjUsyB7JxLnVzM/HMJs/3nBX9IOgafq+hStutJm/eHAAhj8DAABAmXAcFx0dnZubi7GKAFBOWVlZUVFRXl5eISEhjB0HKwJAFcNTqs0wZOSa1Z6urnL7f5WFL8egJIxP+6nLViT5tcEya8AGdFt64taYgzv2nLqWoCcuvpEN2/bo0UbtZq++wXh1XbJ946+3M7Mo8RR1h7Okytos3NF1aPkHfgMAAECVYjQatVqtUqkMDw93xCUHAUA8UlJSUlNTQ0NDxb98KwCImYXjtZkGCcNovFwlbIUUY1CAhpIwqsaDpjQWOgoQDalX3e7j63avqM0zqgZ9xjeoqK3bj7x617HVhQ4CAAAAHIxer4+Li/P29vbz8xM6FgBwYHnT+BgMBrVarVBgTkAAsJ3BwmkzclROskBXp4p7kAIFaAAAAAAAgAqXkpKSkpISEhKiUpV38WYAqMosFotWq2VZVq1WY9JnACiP9Fzzfb0xwM3JSymv0B0hVQEAAAAAAFSgvLGKOTk5kZGRmPQZAMrDYDBotVqVShUYGIhJnwHAZpTS5ByTzmAO93B2qYBJnwtBARoAAAAAAKCiWK3WmJgYhmE0Gg3GKgJAeWRmZsbHx/v7+3t7ewsdCwA4MJ7S2EyDhaMab1e55FmsSIEbIAAAAAAAgAphNBpjYmJcXV2DgoIwVhEAyiM5OTktLS0sLMzV1VXoWADAgZk5PiYjRy6RqL1cKmbFwSKgAA0AAAAAAGB/eWMVfX19fX19hY4FABwYz/NxcXEmkwlLDgJAOWWbrbGZBg8nWaDbM50TDAVoAAAAAAAAO0tJSUlNTQ0NDXVzcxM6FgBwYGazOSYmRiaTqdVqiUQidDgA4MB0BnNitjFIpfRwkj3jXaMADQAAAAAAYDd5YxWNRiPGKgJAOeUtOeju7h4QEIBpfADAZpTSxGxTptEc6emilAnwVRYK0AAAAAAAAPZhsVi0Wq1EItFoNBirCADlkZ6efv/+/cDAQE9PT6FjAQAHxlGqzTBwPNV4ucqeyZKDT6paBehbt25xHCd0FMXiOI5hGJYVpis4Op7n0XS2QcezGaWUUoqmsw06ns3Q8WxGKeV5vqI7np+fHxamB6iy8sYqqlSqwMBAjFUEAJtRSpOTk3U6XXh4uIuLi9DhAIADM1k5bWauk5QN93Bmhbs5qVoF6ClTplSrVk3oKIplsVgYhpFKq9ZJsQtKKcdxaDrboOPZDB3PZpRSq9WKjmcbdDybPYOOl5iY2KdPn9GjR1fQ9gFAzDIyMhISEvz9/fEtFACUB8dxsbGxVqtVo9HI5XKhw4FCjH8tHb9K+e7mKQ1FeTtujTu2bvbKX/dfjE2zOAVUb9p71NS5Ixt7Y+yKLRyiMUsIUm+yxGXleinl/q5OgsZZxQrQhJAvvvhCnIMRKKVpaWlSqdTDw0PoWBwPz/NZWVloOhvkdTyZTObu7i50LI6H4zi9Xo+OZwOe53U6nVwuV6lUQsfieKxWa05ODq5ZG3Acl56eXqEdb9OmTTzPV9DGAUC0MFYRAOwlb8lBuVyuVqvxxJsI0dR9a9bsOd77FVHe8NG0P2d3GPWj1qvxgGETq8tT//1j15fvDjl1/+eT7zd2Fjo4R+MQjVlCkGkGc1J2boi7s0rxrJccfFKVK0ADAAAAAADYC8/zsbGxFosFYxUBoJyys7NjY2O9vLz8/f2FjgUK4XLTYq7+c3Tzp/N+SeJFenq4mI2f/xrl0W3j/i9HBkkIIeTtge90HbRs3dqdr60d5inGsZji5RCNWXyQO15b247NzbFwkZ6ugiw5+CR8nwYAAAAAAGALs9l89+5dQkhkZCSqzwBQHjqdTqvVBgYGovosQjRlUz91/eZ93lj5V6ooxz4TQgjJOX/issWtbf8BQQ8Ljs4N+3YIYnPvXNWKdzk0kXKIxiw+yL+u6s0c1XiJpfpMMAIaAAAAAADABjk5ObGxse7u7oGBgULHAgAOjFKakJCg1+sjIyOVSqXQ4UARGM+eK/+sm0EJTd315uCVcULHUzRpvVeXLBlSrXG+uX6t+uxcyvr7emL4aRk5RGMWFWRaVi5lfHw92QhPIZccfBIK0AAAAAAAAGWj0+kSExODgoKwGgQAlAfHcVqtluM4jUYjkwk/TysUTepTs5kPIYQmXlSJpvxYmHP1HkOqE0II4Y36DF3a/cuH18/Ylh7Uc97gENEGLVYO0ZhPBHn2wLp3t+sCus96tbYrK6LiMyHiKkDTxN/mLEgZsnJc3aLGh/O6i9s2/nz0QozeNbxRxyFjBzTMm3KluNcBAAAAHBbP86mpqflf8fHxESoYAMiPUpqYmJiZmWnfsYqFLnl7rWhqsVhyc3PzbxzJBEA8jEajVqtVKpXh4eF2XHIw/yWv1+stFotdNstxnE6n47jH8w8gn4gUF7V8QJcPLlgJYT1bTt/72UtBoimZOh6HaMx8QXo0n7ZvRV87Bpk/n1it1vwZoExEU4Cmxvgjm3ZeMbQo+kaLi9m+8JOtXLuxbw7xTjm+ecMniyXLFvYLlRT3+jOOHgAAAMCeGIaRSHBDAyA6FTdWsYIueYZhkE8AxEmv18fFxXl7e/v5+dl3y/kveZZlGTs9hs8wDMuyyCcOgA3oP/uLiLiku+f3r/9pec8Rkr0/TG7hInRUDsoRGpOyAa3eXr5Mm5h16+jGn1f2HCGzY5CFLnmb84kYCtA05fDnH204HZ9lpqSYb8/Ml/bsuRcyYMXEbqESQur5ZNyZ8dvvV1+aWOtq0a83wAIgAAAA4MAYhvH09BQ6CgAowGQyabVahUJh37GKeQpd8vbavlQqdXJyQj4BEJu0tLSkpKSQkBCVSmX3jee/5F1cXKRS+1R+WJb18PBAPnEAjGvNNt1rEkKGjhxWa0TDD1bP3jZg36gAEY7cdQCib0wLx2szSViLF1/orJSyE0bVtnOQ+S95qVRq8/2JGFqM8Wjy8tsfLV720cAaxWRFLvbq9eyAJk0fLOsoCWva2C/r+rX7lmJeF++apAAAAAAA4ICys7OjoqJUKlVYWJjdq88AUHVQSuPi4lJTUyMjIyui+gxVljn61OYtO0/E5S+JScI7tK8nMd24EW3jvAlVlUM0pjn61Hc/bd9yNUspk0R4uEhZVoRBPiKGEdBE5hGi8SA0/baymHHcfGpyKvX29Xp4n8d6+XrR1OQUazGv8yQ876Xc3NxCsx1RSivoKMrpUWCijVDM8hoNTWcDdLzyQMezGTpeeaDj2ewZdDxKKU4NQKWUN1YRSw4CQDlZrdaYmBiGYTQajb0GJgM8cG/39De31prf7Oirj5fJo3q9njJKpRNWSysbR2jMzJs733lre41ZB4c2UD8KSWxBPuIY+Y4zm6yMUvmoPs0olU6M2WS2FvP6o09+ixcv/v333x9tR6VSpaWl2Wv+o4pgtVrT0tKEjsJRoelsZrFY0Ho2Q9PZzGw2o/VshqazWYV2PIPBgA+TAJUMpTQhISE7O9u+Sw4CQBVkNBpjYmJcXV2DgoLEXJcAByVr9EI71S+7f9j894j3n3MmhBDCpe77bucN6juhbU3coZaJ+BszOceUqm7W1u3Xvb9u+XucSIPMT2zxFE0iV0hoZq6RkrwKPs3NNVKZm7y41x/9okajadGixaN/3rp1SyaTiTbRWywWhmHwwdUGlFKO49B0tkHHsxk6XnlYLBasYWIbdDybUUqtVmuFZjyJRCLa2wwAsEHekoOUUoxVBIByyszMjI+P9/X19fX1FToWqJwYz24fTWt+cP7a7l1vDunWKJCmXD7++86LmSH9VnzYBl+glo2YG5OnNC4z12jlNJG9P35r6xFRBvkkx7iLYr19fZh7aek88ZAQQgifkZbBeNf1lhbz+qPh8aNGjRo1atSj7XTp0sXd3V2cnwwppWlpaRKJxN3dXehYHA/P81lZWWg6G+R1PKlUitazAcdxer0eTWcDnud1Op1UKsW0dzawWq05OTnoeDbgOC49PV0mk1Vcx3NycuJ5LEUBUEnkjVV0dnYODg7GpM8AUB4pKSmpqamhoaFubm5CxwKVmLzepI0nA1bPX793+3cnMyxOAdWbvrpw0qzRLQPxR6zMRNqYZo6PSc+RSViNl6uEZcQZZJEcowAtCatb22XXhYspQyMDGEL4xIuXEt3q1A2WF/M6BtQBAAAAAIDNsrKy4uLifHx8/Pz8hI4FABwYz/NxcXFGo1GtVisUCqHDgfJiAiYcypwgdBTFY1zq9X9/S//3hY6jUhBfYxosnDYjR+UkC3R1ejC4VnxBFkd8JfHHrHcPbfzul7NJPCHyBj16hEX/uvrHv+/G3jm9ec32WE3PHvXkxb4OAAAAAABgk5SUlLi4uJCQEFSfAaA8LBbLvXv3eJ7XaDSoPgNAeaTnmqPTc/xdnYLclOKc2uHpxDwC2hp/bs/ue9zzA1v6E6l64Mx3LV9/v+b97Ubn4EY933utX7iEkGJfBwAAAAAAKBtKaXx8vMFgQLUIAMrJYDBotVqVShUYGOiI1SIAEAlKaXKOSWcwh3s4u8jFXMh9GhHFzXh2/3hr93wvOLWdubXto39JfJuNmNVsxBO/VtzrAAAAAAAApWa1WmNiYhiGUavVWHIQAMojIyMjISHB39/f29tb6FgAwIFxPI3NNFh5qvF2lUvEPI9FCXBfBQAAAAAAVV3ekoOurq5BQUEYqwgANqOUJicn63S68PBwFxcXocMBAAdm5viYjBy5hFV7ubIOfm+CAjQAAAAAAFRpmZmZ8fHxvr6+vr6+QscCAA6M5/nY2FiLxaLRaORyLE8FALbLNltjMw1eSrm/q5PQsdgBCtAAAAAAAFB1JScnp6WlhYWFubq6Ch0LADgws9kcExMjl8sjIyMlEixOBQC20xnMidnGIJWTh1Ml+SoLBWgAAAAAAKiKeJ6Pi4szGo1qtRpLDgJAeeTk5MTGxrq7uwcGBgodCwA4MErpfb0xy2SJ9HRRyirPV1koQAMAAAAAQJVjsVi0Wq1EItFoNBirCADlodPpEhMTg4KCPDw8hI4FABwYR6k2w8DxvMbLVebISw4+CQVoAAAAAACoWgwGg1arValUgYGBWHIQAGxGKU1MTMzMzMSSgwBQTkYrp80wKGWScA9XttLdnKAADQAAAAAAVUh6evr9+/cDAwM9PT2FjgUAHBjHcbGxsVarVaPRyGQyocMBAAemN1nisnK9nRV+LpVzTjAUoAEAAAAAoEqglCYnJ+t0OoxVBIByMplMWq1WoVCo1WqWrVRPygPAM5ZmMCdl54a4O6sUlfarLBSgAQAAAACg8uN5PjY21mKxaDQaubySrCkPAILIzs6OjY318vLy9/cXOhYAcGCUkPhMQ46Fi/R0rUxLDj4JBWgAAAAAAKjkzGZzTEyMXC7HWEUAKKe0tLSkpCQsOQgA5WTlaUxGDkOIxstVyla2SZ8LQQEaAAAAAAAqM4xVBAC7oJQmJCRkZ2dHRkYqlUqhwwEAB2a0cjEZBle5NMhNWelWHCwCCtAAAAAAAFBp6XS6xMREjFUEgHLiOE6r1VJKNRqNVIpaCgDYLtNoic/K9XVR+FbSJQefhKQJAAAAACA+yTFCR1A6LuKt6lJKE3WZmTkGjFUswGQQOoLSUTgLHUEpXDstdASlo2kodASl4CTqdUGNNWpoV69WXrwY/MpY1pApdDglUXkLHYGYmHKFjqB0rp4ROoJS8IsTOoLS+feo0BE8TYqfJjWwRqiXu5uiClVlMf0ZAAAAAABUNhzPRyem5BiNmiB/VJ8BoDz0bdve+/57j127Qt99l63s87QCQMXhWYk2slm6T7j65okqVX0mGAENAAAAAACVjNFs0SanKuXycH9fVIsAwHYMkzJ2bMorr4R88IHqyBGhowEAB2aROWnVLSScWXPzhISzCB3Os4YCNAAAAAAAVB56Q25cis5L5erv6S50LADgwKhCET93rqFRI83IkYo7d4QOBwAcmMHFU6turspMCoy9xFAqdDgCQAEaAAAAAAAqibSs7CRdRoivt8oF024AgO2sfn4xK1cyZrN6+HCpTid0OADgwDI8gxPCGvjHX/dOjRY6FsGgAA0AAAAAAA6PUhqfqssxmiID/ZQKudDhAIADM9auHbNqlevJk0ELFzKWKvekPADYCyUkObiOzis0POqciz5V6HCEhAI0AAAAAAA4NivHxSSlMoTRBPlLJRKhwwEAB5bZrVv83Lm+33zj+913QscCAA6Ml0hjwxubndzUt04qTDlChyMwFKABAAAAAMCBGc2WmKQUFyenYB9PhsGSgwBgK4ZJnjQpbdiwsGnTXM+cEToaAHBgZoVLjLq53JyrvnFcwluFDkd4KEADAAAAAICjyswxxKfofD1Uvh4qoWMBAAfGOzvHLVpk1GjUI0cq7t0TOhwAcGA5Ll6x6ubu6fGB8VdJlVxy8EkoQAMAAAAAgENKychKzdSH+vm4OTsJHQsAODCLv7929WpJerpm6FCJXi90OADgwHTeYYkhdQNjr3jqYoWORURYoQMAAAAAAAAoG0ppXIouXZ+jDvJD9RkAysPQuPHdX35RXr0a/vrrqD4DgM0oYe6H1EsKqh1+9yyqz4VUrRHQlNLs7GxxTgxHKSWE8DyfnZ0tdCyOh1KKpisPjuPQejaglKLpbJOX8dB6tuF5Hk1nm7yOZ7VaK671TCYTy+LbfYAKZ7Fy2uRUlmHUQX5YchAAyiN9wID7774buHix544dQscCAA6Mk8pjI5taJfJqN0/IzAahwxGdqlWAZhhGoVCItgBtMpnyIhQ6FsfD87zVakXT2YBSajQaWZZF69kAHc9meRkPHc82HMfxPI+mswHP8xXd8aRSKcUsbwAVzGA0aZPTVC7KQC8Pcd7YA4BDoCybPHWqrn//8ClTXM6dEzocAHBgJoWLVtNCYchS3/2b5TmhwxGjqlWAJoTIZDJx3qfmfV5lGEYmkwkdi+PheR5NZxt0vPLgOA5NZxue5wk6nq0YhkHT2YbjOEIIy7IV13oSiSSvewNABclbctDfy91b5SZ0LADgwHgXl9hPP7UEBWmGDJHHxwsdDgA4sGyVX2xEE680rX/CdSw5WJwqV4AGAAAAAABHlJyRlZapDw/wdXHCUyAAYDtzWFjM6tXy+Hj1qFEspjUDgHLIW3IwSHvJIx1fZT0NCtAAAAAAACBqPKVxKWkms1Ud5KfAIyAAUA7Zzz8f+9lnHr/9FrhkCcFzSwBgK8qyCaENst18I2+fVhoyhA5H7LBODgAAAABApWWIOjD/9cG1G9RXhtbyad5nwILdV3LE/HCo8a9lo4Z8ecma7yWzxXo3PpHnKarPomT8a+nwIWsuWkt+JxSPzzq3bWWvgf08m3UO7Dlx+Ddnok1Ch/Q04jrpBkLmE1KbECUhPoQMIOTKwx9xhLQghCn4n9vp03VeeCF08eKzglafDXf3zn+lV+2aaqVfiE+DLgM+2i7u5AyOcspoVtTJmR/NVPceqewxocabqxeeTRFjOhF10rP+tefHIfsTnkhxXNyV42MXrQh6bY5iwsfhczaNueyeJHfV3DwuaPXZGnfsq7H9OwZpqivC6od3GvPG9+fTRPnNGgrQAAAAAACVk+XO5gE9J879Lda7zZAZk4Z28Uvas2Zam6FfXzQLHVkxaOr+NV/uPX4r/dFHJ4PJHHU/2VWpDPf3kbD48CI6NHXfmjV7jt9MF+WnXQdBM/5YOKnt3N1XlPWGDe3TIyB156oZbWb9mSDWNhXVSbcQMoCQuYR4EzKDkC6E7CGkDSEXCSGEMIR0IWRI3n8M06dOnR4dOw5yd1ET4kSIr4Bh394woMuYubtivNuNmDFlVBf/+3tWTmwzYM1FEdXgoABHOWXZ17Z2eXP1kn9Nddp1nfZSw8DkM7M+/GjsUZEVJMWd9Kj+xpr9147fzy0YDk279FuHZft/vK9o37btjB5N1SRm85JpExb/YrYI2Alo2p+zOwxb/ONtVfthE99/pWd9499fvjuk85LzBuFiKg6m4AAAAAAAqIxo1q6lyw5khozdsH1dFx+WEMK/cWj2yz2+XTNr+4DdQ3zFtDA3l5umvfrvsc1LF/ySxPs/fDVdn3M/LT3Q29PTzUXI6KAIXG5azNV/jm7+dF7+UwZlRzNPrX1tS3ytsSuPvtXQnSGEDu/14biBe9avHt1+UT2J0OHlJ8aTvouQA4SMJWTdw+F1hwjpQcgsQnYTwhKygBBCCOfhoV22jFOpwt98Mz4zpxkhswhRCxU0zdy1aNGBjNCxm/9Y192XJYTwbx96v3ePbz6ftfXl3cP9xJScgRDiOKeMj1u9auc5tsHnq2ZMjVAQQviRHd99e+GKtTvGPTfhRSehw3tAtEmPz9VnXL13Z/Pug79k0sIpjtdt3PVflGudjXOH9o0IjItsMlW7b+nE2csOHN3ZbdgwF4G6ABez8fNfozy6bdz/5cggCSGEvD3wna6Dlq1bu/O1tcM8xdIx82AQAQAAAABAZWS9fvxclqTuy2938nlw0896dZw8vJU058SJC6Ias0VTfuhXo3Hz/tNWnk7NG3BEKU1Kz0zUZYQH+KL6LEI0ZVM/df3mfd5Y+VeqOIasOSyauevnQ3FubT98pYF7Xq2A8ez1+swv3h3QQmEROLaCxHnSjxMiIeTtfKWNjoS0IuQEIY+ynLFatbs//yzNyFCPHCm5f38aIWpCpgsTLyGEEOvV42czJfVGvN3F92HODN+XAAAgAElEQVRy9u44dUwrWfaJY/+JKjnDAw5yyri4f3bc5UJe7Dsx4sFSvayqzodDm7qmnP1RPEO1xZr0aNa//aZ+1vyznStv5RSR4oyxJ2I4tzqN29WqHhvRODj6P790rm99d9accjVFuJlYcs6fuGxxa9t/QNDDwr1zw74dgtjcO1e1nGBRFQMjoAEAAAAAKiOrgXhG1n++gSbfcCLGSalkiNVsEU/9iBDCePZYeaBOBk9o2m9vDl0dR3ltUirDcZogf7kMH1jEiPHsufLPuhmU0NRdbw5eGSd0PA7Mcu3IeaO8QcsOro+HqklCWrw2ooWAQRVJtCe9PiGafP9kCFESYiUkL8vpW7eOW7LE69df/VesIJTuIOQPQo4QIhcmWEJIXnLW1G/dqIjkbDKLKjnDAw5yyrjUlHiO1QT55VstgXELDQ5lzv13M4lrGSaKRyrEmvQYlzorZwVkUEL1V99ceaJwipMEvTJmQJdG3Q2+Eepbp5yMekJ4vdFCGZWvUMOfCSHSeq8uWTKkWuN8o9ut+uxcyvr7eopuwDHu5wAAAADEiNIC4ykYRlyP0YEDUHZY9WeHgi/xcXv3nbbKGjWtK5YncfNIfWo29SGE0MRLriyx5mQwDKMO8merUrcvdMnbd7P5N26fNpX61GyWd8ouqkT3IdeR8KnxUTnEL0R1d8fyEZsOn9Ka3EOrPd+2z+zXutQXsKhRJFGe9FVPvBJHyGlCGhHiREjaiBFJkyeHzJ6tOnSIEGIgZCYhAwh57tkHmp/yxVUnXyz4Eh+3Z89pi6xR8wZ2Sc75L3n75hZKaYF8UkWydMWfMrtgXVzdWT4hWWclvo++YjGnpSXzPJ+o44goCtDiTXoSl5pqF0IIzUhQPRGI1TWs1vgBtXk+7OZxqz4jQZ95+dKpGX/lBDXvOdhHuLCdq/cYUp0QQghv1Gfo0u5fPrx+xrb0oJ7zBofYLU3bK4egAA0AAAAgOjzPp6Wl5X/Fx8dHqGCgsjBH7188eO7xnNAhs4aEiaZ8VEC20ZJLCStThPn7iDPCilPokud5+wyqs1qtubm5+Tfu4+Zsly2DXdCcbD0lmYeXdfnVUq1du9fayO5fOL7tu48PXkw9+s3whgqh43M00YQMJiSHkA/l8oQ5c3Keey5y/HjltWt5P/2WkBhCttvraxi7MUfvnT/4w8M5YSNnjQi3S+rLf8lnZ2dbLPaZ2YDjuPT09PzZqarenNj/lNmFNLJBR59dXx3c/eOA6WP8JYQQkntv1c9nUyhxNpmEmyeiAEdMekZn95jI5q5ZyUFxVxguceni1R/c4whhPGu8uHdsvSAxJBQuavmALh9csBLCeracvvezl4Ls1y/z5xOr1cpxNk7ugQI0AAAAgOgwDCOTyUp+H0DpmBNOrZw3b8Hu2+bwl9b+b043DzF8WipMl5V9PyVHQQirqIqTPlfQJc8wDMuyyCeiRTnOSvmsVKdXV337RTtvCSGEHzdywas9t2ycta/b7r7eYrxWRclMyEpCFhBiJuRLlUetVSvMUqnm5ZelD0snOYQsJ6Q3IbWFDbQgc8LxlbM+WLDjpjmi79qfPrFXcs5/yUskEpa1Ty2KYRipVFrF80kFnTL7kNd5/5Xndi06/cqkWfs6NKguST9z6sw54uHPGg0SMYx+JsQBk16mZ1B8aEPfxFu+yXcJIYRx7//ykIjUrLv3rq0//mfPz5m909u3EHwYPBvQf/YXEXFJd8/vX//T8p4jJHt/mNzCTjdT+S95hmFsfu4BBWgAAAAA0WEYxt3dXegooFKgmee+nzfhk52XTYGdJq5YPr13PTexfbgjlNKEtHS9ITfS300quuiekUKXvL0KRlKpVKFQFNi4yWCXLYNdMAonJcPImw6e3cb7QX2Ide88vv/z21cdP3XZ0Ld9Vfw2puzOETKBkMuEdCJkcfWarmtWyS5cCJozhzU9XnhtByGxhKwTz/BnmnHuuw8mzN162Rzcacra5e/2t2Nyzn/JOzs7S+xUfGRZVqVSVd37k4o8ZXbChHSacsI1dNbmo3/8/ttvcu8mbUYd7pf75qTNMc5OIonVsZJecmDNNJ+IsHvnXPWpD15iFDXr1K1JCGnbcljwhoabjs4+3WRfB6HnJWJca7bpXpMQMnTksFojGn6weva2AftGBdglqvyXfHm+0EIBGgAAAACgkuISts4YOeqnWN8OU3YunNQ7Uil0QEXgeF6blMrxvCYoQJoqliFaAM+GxMc3SMrcDigw6QzrGxAsJX9n6Q2UiG0iaBHaSsgoQnwJ2UlI+y5d4ubP9/rmG9/vvsv/Hp6QbwmJIKStQEEWxsVtnTpo1OYY307Tdy6d2lstxuQMBTjMKZNGtBywueWAR/82n/9Wy0kiQ/xEUv5zmKTHSGIjm3NKN/XtUwpjtjn57pZb2eG1G7R5PESbDa9fox5770ZcGkeEKUCbo09t+TslvFXvNo9nfJaEd2hfT3Lmxo1ojtinAG0vogoGAAAAAADsxXr9m6njfk6s+/p3536YLs7qs9FsuZuQJJVI1IH+Mimqz1D1ONdopmZzYmJi8036zd2Pi7Yw7gF+Ty6EBYVcJ2QcIXUJOccwz48bFz9vXujMmYWqz4SQaEJOE9KLEHFMHmG9/uXEcT/cr/vmT+d+fV/EpUx4xEFOGU07uv/Q+tNx+Z5z4S7/ezWRDWjbwFss5T9HSHqUIZx7XZ6VaG6eUBizCSEk6dL0dVs//Ccj//oMNNeoJ0SpkAkW9b3d0998+8O9CQWi0uv1lFEqxTLm/RGx9EAAAAAAALAn05lV3/xnajj5fx+09hPlXb/ekHvvfrKHq0uonzfLiu2DEsAzIQkf0L0me3nrR38kPlgnjkvZ9fWOc9S7V6d6olyOS1xWEWIi5HuFwrxoUfrAgeoRI9yOHHnybX8SYiGky7OPr0jGU6u+PGdqPO1/c9qJMzlDYQ5zyui1/RtfW/j9/+4/KEhaEo7O/T1BUffFMdVE8xWv6JOewcXFwDDEmh1296yEexCjLFLTzpk/e/zvvx/N68Nn7zt08QZ1a1/HX6jR5bJGL7RTcWd/2Pz3o+8cuNR93+28QX3bt60pkjHvj4gtHgAAAAAAsAMu6t8zKbzc9e/Fb0cV/LzMqJ6bsGyowJ9MUjKyUjKyQny9VS5iHUoG8CywtV5+46290xa/P+7GgU5dIth7Zw5vv5IV1mvuvNaimgpVjDhCzhAil8pnPfec5PffnefMYc3mvB+pCFmWr97xJyFOhLQQKtCCuLt/n0nh5aozi998o3BybjVp2YjaKNOIjcOcMsZnxOguX777+7Q3557uVMc/O+bAqQtXSP0V0ztXF1HdXNRJL907LMEpR06pJDuKIZpHrzOudT7qFXHwl+Pd5yYNaRISSLMvX72yMzo35LlBH9YV7MkKxrPbR9OaH5y/tnvXm0O6NQqkKZeP/77zYmZIvxUfthHdzZVYLhMAAAAAALAja1ys1kqzbx39361CP2H9JL2WDq0pSFSEEEppfKoux2iKDPRTKuRChQEgFi4NPv5mZfCa9V/9uW/5MeoZVm/se2PmDmscKKKCkUhZCYkhJNtq3nHsWKEf+RGy9OH/NxFykpBqhKiecXzFsMZptVaafePQ/24U+gnrJ+27dERtQaKCp3CgU6ZqOOLw5/6zvzuw9/ffM6RejZsN3Dmud89Accw984gokx4lJDm4js4rNPy/fTL65M+l9bqPPul5ZP7BK9sP3cngZAGBYa+OaDurY2SgkE9wyetN2ngyYPX89Xu3f3cyw+IUUL3pqwsnzRrdUoR/QVCABgAAAACohBSdP0tL/EzoKAqzcnxMUgpDGE2Qv1RS+IlgJmDcobRxggQGtmECJhzKnCB0FA5P4lV/8pyVk+cIHUfpiOekG7t3P/nRR/6rV3v/8MNT3qYgJO6ZxVQKiq6r0zJWCx0FlIFDnTLWr27Xr5d1FTqMEogt6fESaWx4E4vCWXPzhFxW99B3nxTxJkZe7/muW54XWdsyLvX6v7+l//tCx1EyFKABAAAAAOBZMJotMUkprkqnIG9PhsGkzwBgK4ZJnjQpbdiwsKlTXc+eFToaAHBgZoVLjLqF3GxQ3zrFPpz0GewOBWgAAAAAAKhwmTmG+BSdr4fK10Mkz8EDgEPinZ3jFi82qdXqESMU0dFChwMADizbzTc2sqmHLi4w/iqhRUy9AfaCAjQAAAAAAFSslIys1Ex9qJ+3m7PoVsUBAAdiDgmJWb1alpSkHjpUotcLHQ4AODCdd1hiSN2g2CseulihY6n8UIAGAAAAAICKwvM0LjXNaLKog/wUMpGtgwQADsXQpIl2+XL3ffsClixheF7ocADAUVHCJIbWy3QPiLxzRpmTLnQ4VQIK0AAAAAAAUCEsVk6bnCphWU2wv4QV34rsAOA40gcOvP/OO4GLFnnu3Cl0LADgwDipXBvRlJPINLdOysy5QodTVYijAM3rLm7b+PPRCzF61/BGHYeMHdDQs8CaJJazn49YeDS34GQsbFD/JV+M9j0wZ8JXFx9PEi4JHvDpmtE1Ci+oDQAAAAAAz5LBaNImp6lclIFeHlhyEABsRlk2eepUXb9+4ZMnu/zzj9DhAIADMylctJqWTrlZ4VF/szwndDhViBgK0FzM9oWfbOXajX1ziHfK8c0bPlksWbawX2i+GrK0eq+333/O+qgATfUXt353vlr9QJZPSExmavSa3r+uPO9HjDI4CGMrAAAAAACElJGdk5Ca7u/l7q1yEzoWAHBgnEoVu2yZ1ctLM2SIPCFB6HAAwIHpVX5xEU280rT+8deEjqXKEUEB2nxpz557IQNWTOwWKiGknk/GnRm//f5/9u47von6/wP43WU0adOkK91p2oSCDMuQvYegIiJTUYZ+QRmKoCjjK+BXUX+gKIoLVBwgKCIgSwRBliDgYCMF6cjoSmea0Ywbvz8qWEpbSppyF/p6PviHNHd55XOXu8s7n/t8zt8/NU169SlkRGrnbqlX/sfZT3y0uqLvtMc7hJJuS0GpMrVrr+53os8zAAAAAADvOI6zlJWXlNu1seoQWRDfcQAggHm0WsP770tNJt1jj1F2O99xACCAFat1BXHNE42nlWV5fGdpivjvLMyYzl+wx3a4K76ygixKuqt9dPmFv/JqnVDAdX79ZydbPj62XQhJsIUFFi46LpqtKLUU2bxcbcsAAAAAAECjYznOaCmyOSv08TGoPgNAQ9i7d8/4+mvl/v3aZ55B9RkAfMZRVI62XVGMPuXyUVSf+cJ/D2i2yFLERaojrpTCqQh1BFdkKWQJbU3Vccaw7YuDkSPf7qIkCYJgC/MK6cJ9iyd+kWVlCHFoco9Hn5k2uFnwlSHmKioqvF5v1eU5TqBV6qvBBJtQyCobDU3nA+x4DYEdz2fY8RoCO57PbsGOx3EcNg00ZR6aNuQXSSXilLhoTDkIAA1RMmpU/uzZ8a++GrZjB99ZACCAMWKpMaUTR5L6i4fEXjffcZou/gvQjMdNk3K5/ErNmJTLZaTH7anx2xtnPfLNdnvveQOiSYIgCM5WVOqVK/QPzHylVwJRcHrHyvdX/d8q9XvPdFZUrm7JkiU//PDD1cWVSmVxcbGQp0Chabq4uJjvFIEKTeczr9eL1vMZms5nHo8HreczNJ3PGnXHczqdYjH/F1cAvHC43CZLsSokOC4yjO8sABDAOIkkd+FCW48eKZMmyc+d4zsOAAQwl1xp0HUKdpQmGE5RXK1DLcAtwP93JJE0SMRZK1wcIassKldUuDhJqLSm57LmPVtPqO9+u+WVGQfDB720ftCVv2o6PzJ9xKmnvz14+snOPeQEQRCEXq/v3Lnz1eUvXbokkUgEW4D2er0kSeKLqw84jmMYBk3nG+x4PsOO1xBer5eiKJEIA/jfNOx4PuM4jqbpRj3iiUQiwV5mADSqknJ7fklZfFREmCKY7ywAEMCYsDDjsmWMQqEfO1aSn893HAAIYOXh8WZNW3X+JbUlg+8sIIACNBWpjiKziktZIkxEEATBlhWXkZGtI2u4Z4/J2L/fpLtndmJt9/NRUQnxQd5Sm4sjKntUT5gwYcKECVf/PmjQIJVKJcxvhhzHFRcXi0QilUrFd5bAw7JseXk5ms4HlTueWCxG6/mAYRibzYam8wHLsiUlJWKxWKlU8p0l8NA07XA4sOP5gGGY0tJSiUTSeDueTCZjWfStgKaF47j8EqvV4cSUgwDQQK7UVOP778vPntVOm0a5cac8APiuMFpfGJuqMZwMteKnLEHgf2g2UVLrliF5p04XVo65weafPpMf2qp1wvWd4uj0A4cKUnt1j7laP3Ye/WDaU+8etl4ZroPJyTB4wjWaUCFWmAEAAAAAbisMx2XnFzpcLkw5CAANZOvVK2vNmrBt2zRz5qD6DAA+4wjSnNyhNEqr//sIqs/CwX8PaEKaNnhw0rzv3v86fmLvCMv+zzab9COeaSMlCDpj79qDxS3vH90lhiIIgjGcPFUW171l+L/VZfmdXdt4F3+6NIJ+qGuCqPj87nVbCls/dn9LAbwrAAAAAIDbmZtmjeUVQdIgbYyaotABBAB8V1xmLXjzzcT585X79vGdBQACmJcjjZycknp0lw6LaQ/fceBfQijVinWj/jvH+/HqD+ZtdgUntBsyd8pwrYggCDrn9x3bsphuo7rEEATBFZ49ky9v3jKxStdoUtFx8qtzwlZvWLt4W7koIrF5xydfHTcgnv9u3QAAAAB+5rDynaAeQgJkcJizv/CdoB42reI7QV3ssSmmLg9EZJ6OkXgJrsbpw4Xkwal8JxCSIIzT7T+JzflOUD8C3ugcx+Xk5DgcjhSyXP7acwTxHN+JbqQ8ECaCVkbynUBIAqU1OvTnO0HAc7o9xqJSpVwWp0kgW7bmOw5cQwgFaIIQqTuOW9BxXLVHZb3/u7H31f+RscPe3DTsukUlsV3Gzu0ytpEDAgAAAABApeLUuwpa94r/c3eY6QLRvhvfcQAgUNE0bTAYSJLU6/Xi3//mOw4ABDCr05VTXBYTFhoZGsJ3FqiBMArQAAAAAAAgeJxIlNthkD06OeXgenkpxlUEAN+5XC6DwaBQKOLj40kSw/gAgO8sVnuxzZGkDldgRgqhQgEaAAAAAABujAkKNnYdyonE+p/XiF0OvuMAQACzWq05OTlqtVqtVvOdBQACGMtx5uIyl8eri4kMkqDIKVzYNgAAAAAAcAMuldrQfXhwcW7Cn7sohuY7DgAEsMLCwqKiIo1GExoayncWAAhgHpoxFJZIRCJ9bJSIwoRwgoYCNAAAAAAA1KU8sbm5431Rl/6I/usI31kAIICxLGs2m10ul06nCwrCnfIA4Lt/pxwMV2IYH+FDARoAAAAAAGpDFrboVHhH18TfflDmXuY7DAAEMK/XazQaRSKRXq8XiUR8xwGAAFbqqMgrscaFK8MVwXxngXpBARoAAAAAAGrAicQ5d93jjEzQH/g6yFrEdxwACGBOp9NoNCqVyri4OPRVBACfcRxnsdpL7E6tOiJEJuU7DtQXCtAAAAAAAFAdLVcYug0nWVq3b63Y7eQ7DgAEsLKystzc3JiYmMjISL6zAEAAY1jWVFRGM6w+NlIqRkkzkPhja3l+/u+A14MW7365p+TaP3BFm54e9nny8q1z7sJeAQB+QtP0rl27Dhw4YDQaCYJITEzs27fvfffdJ5FIbrgsNATLsnv37t23b19WVhbLsnFxcX369BkyZEhQUJDb7d6xY8ehQ4fy8vJIkkxOTh4wYMDdd99NNWAiiF9//XX37t1///232+2OiYnp2rXrsGHDlEqlH98RAADUxhUeY+g2XJGfGX9qL8myfMcBgEDFcZzFYikpKdFqtSEhIXzHAYAAVjnloFQs0sVGUriRItA0pDDMlBkv5dhYwnPm5B9/ys6cPx9+bfWHc1/cf+i3I7YchkABGgD8IjMzc86cOXv27AkNDZXJZARBHD169LPPPuvfv/8bb7zRvHlzvgPetnJycmbPnr1jxw6lUimTyUiSPH78+Jo1a3r27Dlx4sTPPvvsyJEjSqUyKCiI47gjR46sWLFiyJAhS5cuTUhIuNnXKisre/HFF7/66qvQ0FC5XE5RlMfj+eabb7788suXX365d+/ejfEGAQDgKqvmjpwO96jTj6ov/sZ3FgAIYCzLmkwmj8eDKQcBoIHsLrepqCxCERwTFsp3FvBFAwrDXNn3U9tP/NH9z3+fbr+1hieR8p4TW6L6DAD+YDQan3jiifT0dL1eX7VrrVqt/u2335588skvvvhCp9PxmPB2VVBQMGnSpFOnTlWbMUatVv/xxx+HDh0KDg7W6/VVh/NTq9X79u2bNGnS6tWrY2Ji6v9aDodjypQpP//8s06nq9qrXa1WZ2VlDR48ePv27f369fPL+wIAgOuQllbdi5t1SDq6RWEx8B0GAAKYx+MxGAxSqVSn02HKQQBoiBK7M7+0PD5CFRYi5zsL+KgBtWFS0fPZlatGMgT958oZq6VTl01Mq7Y2kpJFd7jnvlScawCgwTiOW7hw4YULF67vUUtRVFxc3N9//71gwYK1a9c2ZNgHqNGiRYtOnDiRlJR0/Z/cbrfT6bz+S4VIJEpMTDxx4sSiRYs+/PDD+r/W8uXL9+zZk5ycfP12jIyMJEnylVdead++fVhY2M2+CwAAqBsrlpo7D3aFRun2rwuylfAdBwACmMPhMJlMKpUqLi6O7ywAEMA4jssrLS+vcKXERMqlGHUzgDWkc3JQ6qDHUwmC8DYzf28OGjNxUjfsCgDQWH7//ffNmzfr9franhATE7N9+/bDhw9jiAb/+uuvv1avXl1jy5eXl9tstqCgIJvNVl5erlKpqj0hNjZ29erVTz/9dKtWrerzWiUlJVu3bo2Nja3tV4SIiIgzZ85s2LBh8uTJN/tGAACgDt7gUGP34SJ3hX7fVyKv+8YLAADUoqSkJD8/Py4uLjw8nO8sABDAGJY1FpYyLKuPjZLgRooA549+gpI+/9u1bR6qzwDQmA4fPhwSEiKufaJbkUikUCiOHDlyK1M1BUeOHJHL5TXO8Wi32ysrxRRF2e32658glUrlcnn9N8qxY8cuXrwYHBxcx3NUKhW2MgCAfzmjEjIGTJCXFmgPb0L1GQB8xnFcXl5eQUGBVqtF9RkAGsLl8WbkF4tFIh2qz7cF/w3PTNtyLl3KsdFctcepyNSOzSIwOyUANEx+fr5UKq37OUFBQXl5ebcmT9NRR8t7vd7KcZ8pivJ6vTU+56Y2CrYyAMCtV5qSlte2X9ypfeHZZ/nOAgABjGEYk8lE03SzZs1q7LsAAFBPtgq3ubgsMjQkWqXgOwv4h39GSnWd+2T0HdGa1h27dL1O7xf3efzyIgDQpEkkEo6r/gtXNSzL4mLX7+po+asDZXAcV3UGwqpuaqPUcyvfsEgNAPXg+vXtCWM+OkPzneM2wZV+/8rjSRNWn2D4TvIv5tfDB8ccL6l9EzNHjhwcZkzJadNbe2Qzj9Vnxry788hp5LAa/omf2nxcQE0K0FicGTsXPflAyxY6eXRiVNqgkf/bfM5xgysioXG73ZmZmRRFVZtH+pbj7FmH57/037YjHw0d9HirJ1+bsfViEctfnPrgir6f+0DS8I9O4JQM/hAQx5O6QxbbHKai0oQIFe/V59ugMYXDHz2gWfPqWbM2maL6PzPz4U5xwdVq2iJtZ5SDAKDBdDpdRUVF3c+pqKioY5Bo8I1Op3O5XDX+SSqVVtaLOY4LCgqq8Tk3tVEqX6uOcnblCnU6XT1XCAC14Yp2f/DRzkMPTBL4t/IAwZp3Lnvq+8zCxC413wzCB85p/uC48dAdzWvbxIwn/80T5qMKZfK+r0Ic1lsa7lpkcNygnh311YKy1t9+u1wQEa7G1MJwu/P+/cXIe+futsV2HzZuVCKd8cv2Tcun7juec2DrM21rvrwSHLvdbjKZIiIiYmJi+E3iydz6wLTPDzHxgwbcfb/Knf7bLyvefPGA6ZXD09so+U1WK9a8ZdFT6y8VansL5wwCgSsgjid1hEyTEjklZQ6XRwhTDgZ6YwonZCV/FKC9p3793a35z2db3huEnvEA0EgGDBig0+kcDodcLq/xCS6Xq6Ki4u67777FwW57ffv2bdGiRVlZWUhISLU/KZXKvLw8kUjEMIxSWcNVvcPhuOOOO/r27VvP1+rUqVOXLl2ysrJqGzSQYRir1Tpw4MCbeQcAUBVTUWw8/+fBtUtf+7aA5blOcLtgzD9MeeOXAo4URqWUq3Daz+fmrf3l1Ld2oqZNzFU47adKyj/+/c8dJWxM7s9SR9QtD3kNKiLttefSrn2My/7pw44nUhY82UuHofzg9sZZty5e/FOZ5j9rd316n5oiCIJ9fu+8oYM/WbZg48PbxkYL/xNQXFxcUFAQHx8fFhbGd5aKnV99d8ipeWHF22+0kREEQUwe+s6MZ5/ftH7dQ69OE2RbMsaNU17eI5gzCAS4gDie1B5y/obR7w4UUySpj40Si/j+TAR4Ywoo5BX+2KJuq9VF6e9sVdekUQAADZOcnPzAAw/k5uYyTA334jIMk5ubO2vWrObNm9/6bLe36OjoMWPG5OXl0XT12wKDg4MjIyPdbndkZOT1MwfSNJ2Xl/fII49ER0fX87WkUunUqVMtFovbXcMUWJXT2tx///2DBw/24Y0AAEEQXOG64c3bdxrx7PKjQr8jOWDQxg9eXnEocdCY5oKYHodzXB6+7PtO644tN7pq3MSc4/LQd77v/tnPq8+UsQRBsELscscWH3927WXdiEdmaf03Yw2AMNHnDx23itqMe37Qle7+VGT/mY93l9h/OXhC4FOCchyXk5NTVFSUkpIigOozQbAlF01OIrzNoBayfx4Rx93bVSP25l7IEeRoPnTmB7OXHtI8OKalIM4gEPAC4nhSS8iuEvuh3QcpqSQlOoL/6jMR2I0prJBX+AJ8RaIAACAASURBVGOjypu1SOL+Ovq7VYhjjADA7WPOnDkjRozIzs52OBxVH3c4HNnZ2UOGDJk3bx5f2W5vTz/99IQJE7Kzs202W9XHKyoqaJpOTEykabraACk2my07O3v8+PFPPfXUTb3WqFGj5s2bZzAYysrKqj7udrtNJlP79u2XLl0qwiTIAL4iwwcv/2nvsf17j26c2QmDpPmB9/SXixf+pX/5lUfaCWN0elKuWT5x8LEnBh99tHWnmq70S1ve8+yXq/cseLq2J/CPs29ds3WXqvfyoYnCaFSAxkQ7iXD9nT3b6atc3ZAyuZwkaLdHyL8UMgyTnZ3tdrv1en1tdyjealRYaqKcsP79q/FKtwm25Pi5fEYS2zxOgFePntMrX1x4tsXLb01qJ7A75SFQBcTxpKaQ5ZyYIwiGI2MjVHUMxnhLBWxjCi7kFf7oUyDpPHflCwdGTx/1IvPuC0PbREqFsbMAwO0mKChoxYoVrVu3/u677y5cuCCTyQiCcLvdLVq0+M9//jNjxozKR8DvxGLxO++8c8cdd6xbt+78+fNXWz41NfXZZ5+dOnXqypUrd+zY8ffff1eOBO1yuVq3bj1z5swpU6b4UCx+8cUX9Xr9J5988scff8jlcpIkvV6vy+WaOnXqvHnz1Gq1/98hgCBVu+3APx1BxVEt7ooiCILLP6MUZvExoDjPrZn4ibHLrI9n6ol3+A7zD0rWIl5GEARnL1Fee1HOkVR+u/7W+NT+R7fIRTYuLlQpyKt2Z/ru/x5hRz4/qGsTq8hcf6eRX3Acx7Js1ZWLxehXLiTyu987XG0EOda8Y8dRr6RdpzTBXtq6XC6j0SiXyxMSEq7OSi0AIUOnTJuQvvy1Z/97+f6u7ZTui8d//uqU9L7pT06MFdzxznlqxcT3MrrM3zgz1f9nkKofeYZhbjjL902tGccT4QqI48l1IQvLy89t3HaGlrTv1lkoIYlAbczGCFn1I9+Qg4k/Dhae/cte2e8JKd+/ZHTaG2JFRKRCUuXgLnvg0/RPhjSxy0cAaCRSqXTWrFmPPfbY4cOHjUYjx3EajaZnz54oSjY2kUj01FNPPfroo4cPHzYYDF6vV6PR9OjRIzY2liCIl156afLkyUeOHDGbzWKxWKvV9uzZ0+c7MUmSHDNmzNChQ48cOZKRkeF0OuPi4rp165acnOzPtwQgbCzLVrsPIEqOHssC4zj90sJvjJ2e3fhQopgw853mBpggubHLUEYq0+9fJ3GW8x2ndlzhZ+t+MaTct7mLQnDlokZW7SPPsv7pukTTtNvtrrryqCieR/2GOnmydy56aP4+R9L4BeO0wqnsVmWz2cxmc2RkZP2HWbtlxDFtJ9/fcufHp9asSV9DEARBhrYaNr23RnDjhdp/f+n5z4zdFm4cpxUTBr+vvupH3ul0+uv3LYZhysvLq3ZQxfFE2IR+PGE5zlxkydj9xpy3jjiFGvIKoTcmQRCNFLLq8YRhmBrHRK0PfxSgSVlYTGxyeGxyh5r+Km0eIdQtAwABKjIy8sEHH+Q7RVMUFhY2ZMiQGv8UGxs7cuRIP75WcHDwwIEDMd8gNFkkSV53V4cgx69ssjjb7neWvF/WddWKwSkUQQjtLsdruZRRxh4j5KX52iObKKZRutn6i+Psz+9cEA99rmfLpvcNotpH3l/3IFMUJRKJcJdYQPDkHlq+4MXXvr/oSR628pvX7w0T4q8whYWFhYWFiYmJNU5AzTPOefiThfeuLUwb+dzWMZ3ahLr//mP3vHe/G/p0+fqPZ46IFEx7cuW7/2/++yW9V301MkXUKKf3qh95iUTir17qJEkGBQXheBIQhH888dJMxrmda5b+34c7Lws2ZCXhNybRmCGrfuQpivL5eOKXITi6v/Dt9y/4YUUAAAAAQBAEQZKkQqG45iGHlacscD2u7MjKKZvdwxc/NzZW6IVSW2yKpcsDEZmnY84eIghhz9nC2b7/4TdTRKdPO4cI8btdI6v2kfdXAVokEkml0urHExAaruz3z1984uWNZz0JA6avfGfOiDahgvsQVE456HQ69Xp95ahrQsMWHly0IUva47nvn+0XQxIEEdq+79iNwdY7Z/20cOOQoVOaCWO0CK7swNIp31QMf+9/Y+Mb6wxS9SMvk8n8NYEKRVEhISE4nghdIBxPnK7CHz6c+793dqR7hRuSIAKjMRs7ZNWPPEVRPl+fCOMIfKtwHGe324Uyovm1KgdSYVnWbrfznSXwVI5th6bzGcMwaD0fcByHpvNN5REPrecblmXRdL6p3PFomm681nO73UIaChMaD2e5dDmXLvp29vBvZ1d9/Juu7b8RJT1yZOu0LsKY74pVNTd3eSDlj13KnEt8Z7kxtujPz066kwd36Y3JB6FJYcwbZ46esNagHjBry9KZQ3XCmNDvWjRNGwwGkiR1Op1gh/2lDVnnPKI2d7VWV/nGH5qW1lm6a9vfhnKuWYQgKgGs5UJ6Lm359qme314zV/eqrimrRClPHNk3u4tAGxgCQSAcT6y2jC+eGfPfLTnRAg5JEIHRmIERkiAIfxagOXv6js/W/Hgi08J0m/vF0+FH9zha3t1WLbTRCiUSiWAL0G63myRJiURobRYAOI6jaRpN5xuXy4Udzzcsy3q9XjSdD3DEa4jKgbfQdD5gWbayQNx4reevHkYgeGREu/tfnNzp39umOdvRrVv3u1s+NvouTURaggAuNjmKdFMEq2qRfOhbZWkB33Hqg8s+9udROvKpLkk4wEFTQl/4aOrEdXmtZ3zzw8t9ogX5I6bL5TIYDAqFIj4+XpjfpiuRwXIFwZVa7Szxb0NyDlspQ0iD5UFCCU5FdBz54oyeVc4gZUe/+3a/K+2x8d00EXclCHIfgAAh9OMJx3EWq/WPD6Yt3FrYRqghrxB6YxIEESAh/+GnAjSdte7xQU9+fbmCIwgyXPY468l8b8Qju5LHf7z907HNBNOFoXLEImGeMq/2zhbm3UwCx7Ksy+VC0/mgsj8gRVFoPR8wDON2u9F0PqicWAk7nm9omvZ6vWg6HzAM43A4GnXHE4vF/po3DISNjOow9OWq05+w5qXHth+wpk15+gkh9H2m5YrstE4scUycs0deGs53nPrhbD//afAqOw/So+8fNCWuI+999Lu7/X/XvCTQ2oHVas3JyVGr1cKf9FvS7K5B0VtW7ty0cehzY2LEBEEQrO3Aup2/MCH3dm8lmHkIyajOY17uXOUBxrD08IYDZXdNmTUTfZ+hQYR9PGE5zlRU6nEc3rrutEeoIf8l7Mb8R0CEvMIvhzc2c+WkqetL28/69sOnna+2nkUQhPyehZ8+ZZy+YsrjaR0PPt9CANfhAAAAAAC3P1dYtKHbsODLq+UcQTAuvuPUW8Xln/+mZa2adUb/Z2hKmIzfjhWyUuWxJTOeubZ6QCq7T3t7XEt+C5IWi6W4uDgpKSkwhv0NunP+swN2L9w77jHT+gEd0kLdl/789fu/ysK7TX3jbkHOGgbgV0I+nnhoxlBYIhGJtPb034UasiohN+ZVARHyKn+EYc6v/eww1+eddW8+lOzdWFlrJsPajntvk/Ny6+lrvjk38+W2gnrTAAAAAAC3o/LEFua77lWnH406eVbgMw5W47588bCTbKbXKFElgqaENhuNNGdP37smvdpfqGjxsKXjWvKSiiAIlmXNZrPL5dLpdIFz3xUZ13v6kQ9SX1+ze8ve7TtdYnVi6vinnl34UHstKhLQBAj2eOJweUzFpapgeWxYqOekSZghqxFsY1YVECGv8sdhmM64mEGkjuijqdbfm4rv3qMZ8dblbIZAARoAAABAOMjYiXuLJ/Kd4jZCJc5et2/2jZ/XqMjCFp2K7uim+f2H0NzLhKL53gXN63r2jZ5wiwWlPWL+/hG+UwDcakH3vF9c9j7fKarzer1Go1EkEun1+kCb3oCKvvO+5UvvW853jpsg0s7edp7vMwjcDoR5PCmxO/NLy+PCleGKYEKoIa8XEDkDIuRV/igMk6owJVFiKWII4tpTk7cgr5BThCrQiwEAAAAAoNFwInFOx3ud4XG6/euCyov4jgMAAczpdBqNRqVSGRcXJ8z5kwAgIHAcl19mK3NUaNURITLBzA4HPPHHINXSDgP7heV8/caqv91VH644t2LJ+jxlz/4dMI4bAAAAAEDj8MoVmX0f8cpDdfvXovoMAA1RWlqanZ0dHR0dHx+P6jMA+IxhWUNhqcPlbhYXheozEH6ahFA1ZOGigbufntGt676HUy7S7tCdH7y2+8C6NTsvifu8/dKwcJy2AAAAAAAagTMizth9uDIvI+7kHpJl+Y4DAIGK4ziLxVJSUqLVakNCQviOAwABrHLKwSCxWBcbReGnLCAIwk8FaELcfOrG/aELZi78dOUWB8sRK144JgrV9Z/xxduLxrdG/2cAAAAAAP+zJrXMaT8o5vwvkZdP8J0FAAIYy7Imk8nr9er1eqkUfRUBwHd2l9tUVBahCI4JC+U7CwiI3yYHDGk99p29jy4uzEjPtFSIlHH6FsnhKD0DABBOpzM/P18kEsXFxeGCvhqWZS0Wi81mi4yMjIiI4DsOAEAAIS2tuhfr2ycd/V5hMfIdBgACmMfjMRgMUqlUp9NRlD9G6QSApqpyysH4CFVYiJzvLCAsfitAEwRBEKRM3ayduplf1wkAEKj++OOPzz///M8//zx37hxBEO3atevVq9fkyZN1Oh3f0fhXXl6+YcOGffv2HTlyhCCIli1bNmvW7JFHHnnggQfwzQcAoG6sWGrufL9bGak78HWQrYTvOAAQwOx2u8lkCgsLi4uL4zsLAAQwjiNyS612lzslJlIuRYdUqM5fBWi27NKhfUcv5ttprvorNLv3iXv0Ij+9DgBAgPjoo4/mzJkTFhamUqlatGjBcVxJScmXX3556NChBQsWDB48mO+AfLp06dL06dNPnDgRFRWVmppKUZTH4zl27NjOnTsfe+yxN954Izg4mO+MAAAC5QlRGbqPkFTYdD9/JfK6b7wAAEAtSkpK8vPz4+Pjw8LC+M4CAAGMYVljUSnHEfqYKLEI3YmgBn4pQDOXPx/Vb9pWs6d68ZkgCEI2+rvHUYAGgKZl7dq1c+fOTUpKqlpIDQkJCQkJsVgsixYtCg8P79atG48JeWSxWGbMmHH+/PmkpCSx+J/TkFQqjYqKCgsLW7dunVgsXrZsGSZeBwC4njMq0djtQZUpPfb0PpKr6dobAKAeOI7Lz8+3Wq0pKSlyOe6UBwDfubxeY2GZXCpOiAijKHyJg5r5owDt/f2TJdtzw/rMe/ulkW2j5dV+6qBUGgx5CgBNicViWbFiRVxcXI3deMPCwvLy8pYsWbJx40aJpCnemvTBBx+cPHkyISHh+hKzWCzWaDSrVq0aMmTIgAEDeIkHACBYpbq2eWl94079HJ59ju8sABDAGIYxGo0Mw+j1+qZ5OQoA/mKrcJuLyyJDQ6JVCr6zgKD5owDN5ufkU+3mfPDauNbo6AwAsGPHjvT09JSUlNqeEBkZuW/fvmPHjvXq1etWBhMCm832008/qdXq2p4gkUjCwsI2bdqEAjQAwFUcSVra9C5JbqM9sjmk0MR3HAAIYC6Xy2g0yuVyrVaLiTcAoCEKy+2FVntiZJgyWMZ3FhA6f5xvRJpkjYgSofgMAEAQBHHy5EmFoq6ffymKCgkJOXny5C2LJBxnz549f/583UM8KxSKU6dOcbi1HACAIAiCYKQyQ6/RttgU/c9fofoMAA1hs9mysrJUKpVGo0H1GQB8xnGEubis1O7UxUSi+gz14Y9TjrjdpBl9sz/476oLDj+sDQAgwFmt1qtDG9dGLBaXlZXdmjyCUlZWVp/G8Xg8Tqfz1kQCABAyT2h4Zr+xJMPoDnwjdZbzHQcAAlhxcbHJZEpISIiJieE7CwAEMJphMwuKPDSji4mSSTGMD9SLXyYhFOkmLpu7ttNTHZp92LVjapTsmqq2tNvzX87qih0SAJoMpVLJMEzdz6FpWqVS3Zo8gqJSqW7YOAzDSCQSzIcDAGCPSTZ1eSAi60zMuUME7gsBAF9xHJeTk+NwODDlIAA0kMtLGywlCpk0PkKFeeOh/vxSgK74deFDC444OMKTdeZYXrVO1TLVeNYfLwIAECDS0tLWr18fFRVV2xM4jnM6nWlpabcylUC0adOmZcuWdru9jhlv7HZ7z549cVsoADRxJSlp+W37xZ/YE2b8i+8sABDAaIY1ZWdzHKfX6294IxoAQB2szoqcYqtapVArMeUg3Bx/fL33HF239gLVduYPBputuLA606qhQX54EQCAQDFkyJDU1FS73V7bE4qLi3v16tWjR49bmUogVCpVv379CgsLa3sCTdOlpaXDhw+/lakAAASFI4gcMsTSqkfKoW9RfQaAhnB5vRn5RRKJJDk5GdVnAGgIi9WeU2zVRIWj+gw+8McZyJ2fWyy664Vn79Gg0gwAQMTHx0+aNGnWrFlJSUkyWfUJGcrLy4uKiubMmSOVSnmJx7sZM2b89ttvFy9ejI6OrvYnmqbNZvP48ePvueceXrIBCFpIUxy3p7EIuDEZgjC6SIYj9BFiyZCxfMepB11TvKEH4B/KSL4T1KW8vNxcUKBWq9VqNd9Z6iE6ke8E9ZPYnO8EcJsS8PGEZVmz2exyufXNmgUFBULpr7yY7wRQnV8mIQyPVHEWU47HD+sCALgdTJo06aWXXsrOzrZYLG63myAIjuMqKipyc3MjIiJWr17dp08fvjPyJj4+ftmyZampqUaj0W63syxLEARN0yUlJVlZWcOHD1+yZAnG3wCApsnFEhkuSkwSOhknwbCKANAAhYWFOTk5Go0mMKrPACBUXq83KyuLZVm9Xh8Y1WcQJH98w5cPnPd/9zs/ferZDek2DPcMAEAQJEm+8MILP/74Y79+/WQyWXp6enp6ukKhGDVq1Oeffz5y5Ei+A/IsLS3t448/nj59enR09MWLF9PT0//+++82bdqsWLFixYoVSqWS74AAADywMUSWmwoTcZogjkL1GQB8xXGc2WwuLS3V6XShoaF8xwGAAOZ0OjMyMuRyuVarFYlEfMeBAOaPITg8h75cbZKKzn3ycKvPFZGRimvXKXvg0/RPhuA3EgBoenr16tWrV6+SkhKz2SwWi5OSkhQKjJb1j8jIyOeff37+/Pkmk6m8vFytVicmBsh9lwAAjaCYJgs8RGIQq8SXOwBoAK/XazQaKYrS6XQY9BkAGqK0tDQvLy82NjYiIoLvLBDw/HFCImVhsZq0CE3Nw79Jm0fcsJs1W3J605frD5wy2BTadv3H/Gdk2/BqvT640h9femLFae/VB0QJI9/44LHmonosCwDAp4iICJywayOVSvV6Pd8pAAD4xBFEjpt0sGSKjJVj/CEAaACn02k0GpVKZVxcHEniezEA+IjjOIvFUlJSotVqQ0JC+I4DtwN/FKAl3V/49vsXfF+eMWz+v9c3Mn3+M2NMZOGhtV+8vkT09v8N11zT+4O15FvI5g/MGtH6n0m7SHlCPFW/ZQEAAAAAhIjmSIObIAlCL2PFKBYBQANYrdacnJyYmJjISOFOZQYAwseyrMlk8nq9er1eKpXyHQduEwK4JcdzZseOrMSR7069VyMiiDZRZZdf2P7D+funplXdy72WglJlatde3e8U3fSyAAAAAACC42JJg5tUiLh4KYfiMwA0hMViKS4uxoBvANBAHo/HYDBIpVKdToeZ4cGP/Lczcfb07ctffOqxMaPGLf/dS18+9OPpQu+NFyMY0/kL9tgOd8VXVpZFSXe1jy6/8FfeNdMZsoUFFi46LpqtKLUU2bzczSwLAAAAACAwVprMdJERYjYB1WcAaACWZY1Go9Vq1el0qD4DQEPY7faMjAyFQqHValF9Bv/yUw9oOmvd44Oe/PpyBUcQZLjscdaT+d6IR3Ylj/94+6djm9XZHZktshRxkeqrA0VTEeoIrshSyBLaf3d2tjCvkC7ct3jiF1lWhhCHJvd49Jlpg5tJbrRsRUWF13tNGZzjOEKQrgYTbEIhq2w0NJ0PsOM1BHY8n2HHawjseD67BTsex3HYNFAfhV6iiCY1QVwoBo4DgAao7KsokUh0Op1IhAMKAPiupKQkPz8/Pj4+LCyM7yxwG/JLAZrNXDlp6vrS9rO+/fBp56utZxEEIb9n4adPGaevmPJ4WseDz7eo40zIeNw0KZfLr/T8IOVyGelxe6p+e+NsRaVeuUL/wMxXeiUQBad3rHx/1f+tUr/35I2WXbJkyQ8//HB1PUqlsri4WMizMdA0XVxczHeKQIWm85nX60Xr+QxN5zOPx4PW8xmazmeNuuM5nU6xWADjm4GAsRxh9pAultQFsUHoWgQADYApBwHALziOy8/Pt1qtKSkpcrmc7zhwe/LHdyTm/NrPDnN93ln35kPJ3o2VtWYyrO249zY5L7eevuabczNfblv764ikQSLOWuHiCBlJEATBVVS4OEnoNb2myfBBL60fdOV/ms6PTB9x6ulvD55+vPcNlo2Pj2/ZsuXV/+bl5YnFYsGem2maJkkSP1z7hmEYNJ1vsOP5jOM4lmXRdL6haZqiKNzY5QPseD7jOI5hmEY94lEUJdjLDBACL0cY3ZSIJPQyVoQ9BQAaoLS0NC8vLy4uLjw8nO8sABDAGIYxGo0Mw+j1eolEwnccuG35owBNZ1zMIFJH9NFUKyNQ8d17NCPeupzNEHUUoKlIdRSZVVzKEmEigiAItqy4jIxsHVlXTYKKSogP8pbaPBE3WHbKlClTpky5utygQYPCwsKE+c2Q47ji4mKRSISbHXzAsmx5eTmazgeVO55YLFapVHxnCTwMw9hsNux4PmBZtqSkRCwWK5VKvrMEHpqmHQ4HPrM+YBimtLRUIpE03o4nl8tZFlNRQM2cLGF0U0oRESdlhXgxCgABguM4i8VSUlKi1WpDQkL4jgMAAcztdhuNRplMhkGfobH5Y/ciVWFKosRSxFT/g7cgr5BThCrqvMQWJbVuGZJ36nRh5bgZbP7pM/mhrVonVO2b5Dz6wbSn3j1svTr5YE6GwROu0YRpb7wsAAAAAAC/ymgi20WpxWw8qs8A0AAMwxgMBpvNptfrUX0GgIaw2WyZmZlKpVKj0aD6DI3NH3uYtMPAfmE5X7+x6m931Ycrzq1Ysj5P2bN/h7q78EvTBg9Oyv7u/a9/yzBdPrr2g80m/ZDBbaQEQWfs/fLzb48XsIT8zq5tvL98uvSrA2cu/X3+6Jblb20pbD3i/pbiWpcFAAAAAOAfxxEFXirPQ2llXCRubAWABvB4PJmZmSRJ6nQ6qRRfewHAd8XFxSaTKSEhISYmhu8s0CT4ZZ4c1ZCFiwbufnpGt677Hk65SLtDd37w2u4D69bsvCTu8/ZLw8Jv0M1DrBv13znej1d/MG+zKzih3ZC5U4ZrRQRB0Dm/79iWxXQb1SVG0XHyq3PCVm9Yu3hbuSgisXnHJ18dNyCeIgiqlmUBAAAAAHjGEoTJQ3o5Qi9jpehaBAANYLfbTSZTREQEqkUA0BAcx+Xm5trtdkw5CLeSfyZqFzefunF/6IKZCz9ducXBcsSKF46JQnX9Z3zx9qLxrevR00Ok7jhuQcdx1R6V9f7vxt5X/iOJ7TJ2bpex9V0WAAAAAIBPHo4wuEgpRaYEYcpBAGiQkpKS/Pz8+Ph4zD4CAA1ROeUgx3F6vV4s9k9JEKA+/La3hbQe+87eRxcXZqRnWipEyjh9i+Rw3GQITYjdbj9+/LjBYOA4LikpqUuXLj5McpWXl3f8+HGLxRIcHNysWbO77rrrdpqF9tKlSydPniwpKSkuLpZKpUqlMjo6ukuXLgkJCXUsxbLsqVOn0tPTbTZbZGRkp06dtFptA5Pk5uZWtrNCoUhNTe3QoUP9T72lpaXHjh0zm81isVir1bZq1aqBYXxQXl5+7Ngxo9FIUVRycnKXLl1uagTAhrx9AACogjYf/mrhim27z+UU00GxurZDH53y8sN3Vk6H7WAIk4dSibg4Kb/zUtYVEgCEr7Kvos1mQ1/Feqn4+ZGus9c7uGselPb64tflj4fhl0Bo6lwul8FgCA4OTkhIwKDP9eHM2PnWkhXfHDqfXeoJiW3VZ/jUV+YMbxMirINJQIQk/FiAJgiCIEiZulk7dTO/rhNA6Gia/vTTT9etW3f27NmgoCCCINxud5s2bR599NHJkyfXs4JcVFT01ltv/fzzz5cvX5ZKpSzLulyuXr16zZgx4957723kd9Do0tPTlyxZsnHjRoqiPB6Px+MhCCIoKEgqlaampvbt23f27Nk13kt4+PDht99+e8+ePTKZTCQSeb1et9s9ceLEuXPnJiYm+pDEYrEsXbp0//79GRkZV9u5T58+zz777N133133shUVFe+///7mzZvT09OlUinHcW63Oy0tbfLkyePGjbs152+Px/PRRx9t2LDh/PnzlTuby+Vq167dhAkTJk6ceMMMDXn7AABwLa744OJ+kzcZI+4cOfqxVGnJn3t//GjhE0fyVh2edaeLJvI9VHwQFybibrwmnkIG85oMAOqjsq8iwzB6vf526pjSeJgCc7abjLmzTz9t0L+Piu9IkQquFgNwi5WXl5vNZrVarVar+c4SGLx/fzHy3rm7bbHdh40blUhn/LJ90/Kp+47nHNj6TNugGy9+awREyEr+K0Bz9vQdn6358USmhek294unw4/ucbS8u60aJ0m4vXk8nueee27dunUxMTGpqalXHy8qKpo/f/6ZM2fef//9G84QkpOTM3ny5N9++y0mJkav11c+yLLshQsXRo0atXTp0mnTpjXie2hkR48enT17dmZmZkRERE5OjlgslsvlHMfRNM0wTElJyZo1a86ePbty5cqUlJSqC27YsGHixImRkZHNmze/Wlr1eDwbNmz466+/PvzwwzvuuOOmkhgMhilTppw4caJaO58/f37YsGHLly+f3l1lHAAAIABJREFUNGlSbcvabLZp06bt3LkzJiamWbNmV5fNy8ubPn36hQsXXn/99cauQVdUVEyfPn3z5s3Vdrb8/Pznn3/+3Llzb731Vh19mRvy9gEAoDrG9OUH2zLD+n/5/VvjYymCIIjpD8wePunt1V98OX5ZfwWlDWJDeJ+YpPaQWya+/Sg6AwIIm8vlMhqNcrlcq9Wir2I9MWZzNhc84Kkl6wYKrPQCwKvCwsLCwkKNRhMaGsp3lgDBWbcuXvxTmeY/a3d9ep+aIgiCfX7vvKGDP1m2YOPD28ZGC+IqKiBCXuGn0xidtW58+w4PPrt4xZpvN+88WcB6/nxvRPuUtMfWXfb45xUAhOndd99dt25dcnJyteN4aGhocnLyhg0bli5dWvcaaJqeNWvWn3/+mZSUJJPJrj5OUVRkZGRSUtLs2bP37t3bKOkbX15e3rx588xms1KpzMnJkUqllRVSkiQlEglN04WFhbGxsWfPnn3++ecre0ZXOnHixLJlyxISEtRqddULbqlUqtFoLl68OGvWLIfDUf8klT8VnD59WqPRVPYdrlTZzhqNZubMmQcPHqxt8ZdffvnHH39MTk6uOtgFSZJKpTI5Ofmjjz767LPP6h/GN4sXL/7++++Tk5MVCkXVxyszfPnllx9++GFtyzbw7QMAQHXOs7/85Q3tPmRk7JWTVHCbob1iqYrsc0ZOL+P4rz4TNYcc1juWqsg6b+Z3YBAAuAGbzZaVlRUWFqbRaFB9rjeu1JxTSsSlJmJ8OYB/cBxnNptLS0v1ej2qzzeBPn/ouFXUZtzzg9T/HIKpyP4zH+8usf9y8ISb32xXBUTIK/xyJmMzV06aur60/axvT2Z+MUJGEAQhv2fhp0+1yls75fH3LzL+eA0AATKZTJs2bYqPj6+x26lYLI6Pj9+6dWtmZmYdK9mxY8euXbvi4+NJsoZfp4KDg6Oiot577z2WDcgviqtWrbpw4UJUVJTFYhGLxdWunkUikcvlqqxB79u3b+PGjVf/tHz5crPZXNsJMiYm5ujRo19//XX9k2zZsmXfvn1xcXE1tnNISEhkZOTy5cs5roZ7pU+dOvXxxx/XNk6WVCqNjY1dvXp1aWlp/fPcrEuXLi1btiw+Pl4kqqGkIZFI4uLi1q9fn5+fX+PiDXn7AABQA1HLyYteXjkh7epPx26WuWRzcZQyNZqTkMI4nF4XkiAYm8PFUSq1SlB9YgDgGsXFxSaTKSEhITo6mu8sgYXNNuYykgR9WM7BXVs/XP3tF3vOGCqEcUAG4IPX683MzPR6vTqdrmo/JLgx2kmE6+/s2U5f5fs3KZPLSYJ2e4RSnQmIkFf4owDNnF/72WGuzyvr3nyoXbyi8l2TYW3HvbfpzYHUb2u+OUf74UUABGjv3r0ZGRnBwbUOoiiXy7Oysuruv7x7926VSlVHv4aIiIh9+/adPXu2QVn5QNP0zz//HB4e7nK5rFZrjZVTsVhss9kIgggLC9u9e3flg2azeePGjREREbWtmSTJiIiIq8+vj127doWFhdXdzj/99NOFCxeu/9Pu3bsVCkUdQ6mEhoaeO3euUXsQ7969Ozg4uGof+WpCQkIuXry4b9++Gv/akLcPAHxxX4vvOHCtYN3gkcPGtI+iCNZlL/s7++KaL19buqM0/t5HH04QTF/Fa0PmGtN3f/XqC9tK4+999CHhhIQrqn3k/fWrMMuyDMPgYBIoKvsqFhUVpaSk+DCleZPnzjZaGPbMvKEj+01/efqrSyZOe7z5gKn/O1rS1IrQVT/yXq/XX52ZOI7zeDw4ngQKp9OZkZEhl8uTk5Mx7fxNk9/93uFf/3y9X5WyPWveseOoV9KuU1qtX8tvsVsSstrFic/XJ/7YBemMixlE6og+mmrXsVR89x7NiLcuZzNEW+zqcDuqPJrX/Ry5XH758uW6V1JHCZsgCIqigoKCLl++3LZtW19S8qegoOD3339PTU11OBwkSdbY95aiqIqKCo/HExwcfLWhMjIyxGJx3WNny+Vyg8Hg9XrrOR/LDTeWSCSSSqWXL19u1arVzS5L1GNDN1B9MlRtw5tdvI63DwC8YFm28ve5q9BvRaCY7NfHjn7tHE0QVHjHaTtfHxgvwNIuk/3OuNEvnhV2yCav2kfeXwVohmE8Hk/VleNgIlg0TRsMBpIk9Xo9qkW+YAoyzF6OlqY89OaeJ7onE5Y/93w5Y/GW1555RbvtnYlN6cBX9SPvcrkYxj/3pbMsa7fbq/YrwvFEsKxWa05ODqYc9B9P9s5FD83f50gav2CcVqhHk0YJWfV4wjCMzz9o+eOsRqrClESJpYghiGv7N3oL8go5RagCd/jBbcrtdtdYVK2KoiiXy1XHE1wu1w1XQpJk3SsRpsqfxCmKuuE3KI7jSJKs/HGeoqj6NCxJkpW/wNezAO3xeHxuZ5fLdcOh9264oRuonm1SW4aGvH0A4AVJkjf82Ql4xxFELh3b47mlXxYWmM7uX7VxxZAnRTtXTepc1y/LfKBiRsx9MznHknFGwCGbvGof+RueuOtJJBJVTgHtl7VB43G5XAaDQaFQ1DY0H9wYFTFs7jvtZSl92icEEwRBaHo9NH87aWnz4pH3NmY8NiNVCIPz3xpVP/JSqdRfw4hTFCWTyXA8ET6LxVJcXJyUlFRt9iDwjSf30PIFL772/UVP8rCV37x+ryCncW68kFU/8hRF+Xw88UcBWtphYL+wj79+Y9WMbk8l/ftwxbkVS9bnKQf271Cv6hBA4ImJiak6b16N3G53bGxsHU+IjY3NycmpOrXd9bxeb90rESa1Wt26dWun0ykWi2urQVc+LpFIHA5HcnJy5bEsJiaGpunKYnRtK/d4PFFRUXW3W1XR0dGFhYV1dDbnOK62do6Njb3hhvZ4PI26jWJiYrxer88ZGvL2AYAXJEnW/xAHvGAI0ugmOUJxd5/+YpIgRj/8aOrUtos+XbjtgR/HRAurawwZ0qLbgBYEQYwScMgmr9pH3l8lSIqiJBIJjicCh76K/kGqWnXree3dfFTCgAHdJEcOnL9kJ1JVPOW69ap+5IOCgmocC9EHJEkGBwfjeCJkLMuazWaXy4VBn/2DK/v98xefeHnjWU/CgOkr35kzok2o8KrPjRyy6keeoiifr0/8ctmpGrJw0UDRTzO6dR016+sLtPvSzg9ee+aBDj1e2Ef2XvjSsHDhbR0Av+jWrZvD4ajjhiaGYRwOR7du3epeSXl5eR1PcDgcLVu27NSpk+9BeRIaGtqmTZvy8vLg4ODg4OAaG4phGJVKJRaLy8vLu3fvXvlg69atO3fuXO1G1GrKy8vrbthqunfvfsN2btOmTceOHa//U9euXW02Wx39uL1eb0VFxdX8jaFbt242m62Ou11omq5jZ2vI2wcAgOuVZx9/59sfT+QxyVJW/M+1LqXt3aMN5U6/aBTIFNwe4/G13+/8JbfquUNwIQGgsLAwNzdXo9Gg+twYSEVomIjgGIZpauNAQ9Pj8XgyMzNZltXr9ag++wFj3vjMfX2e31LWedaWo7/ueXWkEKvPARGSIAg/FaAJcfOpG/eveaadddfKLee8zqMrXnhpxUFvlxlfHNg6szX6P8Ntq1u3bkOGDCkoKKjtCRaL5d577+3du3cdKxkzZkxqaqrVaq3xryzLFhQUjBgxIkAnIXnsscdKS0u9Xm94eDhNV5+QlOM4mqYjIyNtNltKSsq4ceMqHxeLxWPHji0sLKytuO9wODQazYQJE+qf5JFHHtHpdLUVYSvbefTo0TX2ER48eHC3bt2KiopqW3l+fv748eMbdfTk/v379+/fv7CwsLYnFBQUjBw5srYKckPePgAAVGNjyOzLu5csWLD8QB5R5SKfs9ttHCmXy4Ry4Z+9a9acl+b/lF+1Ai24kABNGMuyRqOxtLRUp9OFhobyHSfg0efXPDBywoSNOVUPeozJcNlLxiUnCrUmA+AfTqczMzMzODhYq9X6q89700Zf+GjqxHV5rWd88/t384bqhDnyTECE/Ic/CtCMs6ykhG326Dt7M4ryL508duTX389mFhZf/umdCXfiIA+3M4qiFi1a1KxZs/z8/GrdYzmOKygoSElJefXVV+s++sfFxc2ePTsvL+/6GjRN0yaT6e6773766af9n/6W6NOnz5w5c4xGo0KhUKlUHo/nakNVjuAcHR1NkmRubu6MGTO0Wu3VBSdMmDB69Gij0Xj92Bc2m81sNj/55JN33HFH/ZMkJSU999xztbWz0Wi87777pk6dWuOyMpls0aJF8fHxRUVF1TY0y7I5OTlpaWkLFy6sfxgfSCSS1157TaPRWCyW6zPk5eXdcccdr7zySm23wzTk7QMAQFWFXsLkJrTtO/cLZY5v+O4355U/MMU/frUznYjq272ZQOYOk6R16SP4kABNltfrzcrKQl9FPxJrk8LN57/+cNXO4itXy9687z7aeJJLGn1/G/SMg9tYaWlpdnZ2TEwMBpH3G9eR9z763d3+2TUv9RHumGUBEfIKf1x5VuyYrB1f8Pql/TO0MnWzdupmflgnQIBITU1duXLl3Llzf/nlF5VKFRQUVDmTm9Vq7dGjxxtvvNGiRYsbrmT48OHr1q1bunRpenp6aGioVCplWbaiosJqtT766KOLFy8O6GG2XnzxxZCQkPXr1xcXF4eEhNhstsqRnVmWValUXq83Kirqtddee+ihh6ouJZFIli9frlKpVq5cqVQqQ0JCKIqiabq8vFyv18+fP/+muj9Xevjhh0Ui0bJlyy5duqRUKiUSCcuyTqezvLx8/PjxixcvrmM+jU6dOr377rvz58//888/Kzc0x3GV2+iee+5ZunRpfHy8D41zU9q0afPRRx/Nmzfv2LFjKpVKJpNxHFe5s/Xr1+/NN99MTk6uY/GGvH0AACAIgiOIHA/pZEi9nAsK7v+/ae33vPnlfcMvjxl4ZxxXdPbIni3nyhOHvD6/u4zvpP8gwwIgJEDT5HQ6jUajUqmMi4tDtchvFL0WzOqx56Wto4YaRt/fMUVUcubw3h3p3jufePfFdlK+wwE0Co7jLBZLSUmJVqsN6LqB0DAZvx0rZKXKY0tmPHNtaZdUdp/29riWQvghPyBCXuWPMMFdBnSXLzj6u/UZLYZ7hiaoVatWGzdu3Lp164EDB7KzswmC0Gq1ffr0GTZsmExW3293Dz74YLdu3TZu3Hjs2LH8/PyQkJDU1NT77ruvb9++gX5JKhKJZs2aNWTIkE2bNp08eTIrK8tut1MUpVKpdDpd586dH3rooRrnvgsODn7rrbdGjx69ffv2Cxcu2Gy2qKioTp06jRo1SqPR+BZm1KhRPXv2/O67744fP26xWBQKRfPmzQcPHlz3MCmVunTpsmXLls2bNx86dCgnJ0ckEqWkpHTv3n306NFi8S06sLdr127z5s1btmw5ePCgyWQiCCIlJaVfv35Dhw6VSm98Vd2Qtw8A0MTRHGlwEyRB6GSVgz5L2zzxweHYTxet3rv5q+NldFCsru3kl/6zYOxdcQLqgRIQIQGanLKystzc3JiYmMjISL6z3GZEzR9+62jcN69//sOPG9ds8MgSWnR8YenkeQ82Dwvsb1QANWMYxmQy0TSt1+vr830Q6o82G400Z0/fuya92l+oaPGwpeNa8pKqmoAIeRVZx7Ra9cfkbH9+5PzM4W+9M22AXincsWYGDRq0e/duYZbzOI4rLi4Wi8VhYWF8Zwk8LMuWl5ej6XxQueNJJBKVqulMCu03DMPYbDbseD5gWbakpEQqlQbo4Ob8qpxwEp9ZHzAMU1pa2qg73ldffcWy7GOPPdbwVQ0cOHDPnj0NXw/ULPPMTT3dxZEGF6kQcfFSTojXkfzSpfGd4PZ03333bd++veE/cm/ZsiUnJydwx3O7zVztq5iUlIS+itVlnOI7Qf3o2/Gd4Obs3r377NmzL7zwQsNX9dBDD3388cfh4eENXxU0nMfjMRgMUqlUo9FU3mQM/yov5jvBbUT572+lEyZMWLJkiW/3f/uj15734GsTl52mXKdevDd1vkwVFa6QVNn1ZUNWnltxP4a0AgAAAIAAZGXIHDeplrBqDCAKAA3AsqzJZPJ4PDqdDoM+A0BD2O12k8kUERERExPDdxaAevHLbeNimUKhkLboObimsW6lyWH4JQYAAAAAApDFSxbTZFIQqxDuPX4AEACu9lXU6XR1T1EOAFC3kpKS/Pz8+Ph43IwLAcQfBWhJj7mbts/1w4oAAAAAAASBJQizm3KxnC6IDUJ3CgBoAIfDYTKZVCpVXFwc31kAIIBxHJeXl1deXp6SkoI55CGw+KUHtNtqKXNdP5Q0SYokQfJgRUgQfuAFAAAAgIDh5QijmxKRnF7GiTDqMwA0QGVfxbi4OIycCwANwTCM0WhkGEav10skGBcMAow/CtDu7U9qR3/nqvmPJClRxKZ26Dts4guzxnaIRCkaAAAAAITMyZJGN6kUEXGYchAAGoDjuPz8/LKyMq1WiykHAaAhXC6X0WiUy+VarRZTDkIg8ssQHJ2fWfmya+FrOwoi7uw3sEfrRCVlz79wdPfe03T7R8d3V1kNZw/vevPxLTv+2vPrkh447wIAAACAQJXSZJ6HjJNy4eLr7+8DAKgvhmFMJhNN082aNUNfRQBoCJvNZjabIyMjo6Oj+c4C4CN/FKCpWEX21p8r+r15dOPzHZRX+4nYzywffe9yy6xf1rydQBQdmDto8IdLvluy/XE/vCIAAAAAgF9xHGGhqRIvoZVxIRSqzwDgO7fbbTQag4KCdDod+ioCQEMUFxcXFBQkJiYqlUq+swD4zh/nQu9vX60+Hz124Ywq1WeCIBRpT730KLVx0crTNEFF9Xlhai/6j6N+eDkAAAAAAL9iCcLoIW0MoZexqD4DQEPY7fbMzEylUpmUlITqMwD4jOM4s9lcVFSUkpKC6jMEOn/0gGZLi0u5YEXIdadWMlgRwpoMZoZoLyaDFcGkw+GHl2sAjuPsdjtJCnE0P47jCIJgWdZut/OdJfBwHIemawiGYdB6PuA4Dk3nm8ojHlrPNyzLoul8U7nj0TTdeK3ndrtRawhEHo4wuCkpSehkHLYfADRE5ZSD8fHxYWFhfGcBgABG07TBYCBJUq/Xi8X+qN0B8MovY0C36ZAm+vq7z/Y/135g5L+1Xa700GcbLojufLyVhCBYy64dxxndFD+8XMNIJBLBFqDdbjdJkhggzAccx9E0jabzjcvlwo7nG5ZlvV4vms4HOOI1BMMwDMOg6XzAsmxlgbjxWk8kwnTLgcfOECYPFSbi4qTo+AwAvuM4Ljc31263p6SkyOVyvuMAQABzuVwGg0GhUMTHxwuzhAVws/wyBnTyfxZN/+y+ZQ92TJ8wcVSvVvEKwp534fCmz9fss7SZ88kTydnrJj8ye80fzt7vj/PDyzUASZJBQUHC/PRe7Z0dFBTEd5bAw7Ksy+VC0/mgsj8gRVFoPR8wDON2u9F0PmBZlsCO5yuapr1eL5rOBwzDOByORt3xxGJx5e4NgaKEJvI9VHwQFyZC9RkAfMcwjNFo5DgOfRUBoIGsVmtOTo5arVar1XxnAfAbv5waSWWfN/bujp01840v/rfv48qrd1KkajnijV0fzeoZyv524USh9qGlS5dN1fvj5QAAAAAAGoQjiHwvZaW5FBknx6DPANAALpfLaDTK5fKEhAQMxAQADVFYWFhUVKTRaEJDQ/nOAuBP/vptloru9fzaE8+8d/nUyfQcKyOLSk67686EEMpTeP4i0/G1PzJf89MLQUAyGo3btm07c+aM1WpVqVTt2rV78MEHExIS+M7lTxkZGTt27Dh79qzNZgsPD7/rrrsefPDB6OjoW/PqOTk5W7duPXXqlNVqDQ0Nrby73Gq1ikQijUbTv3///v3713E1nJWVdfDgwTNnzly+fLm8vDwoKCgxMTE1NbVv374DBw6kKMrj8ezatevw4cMmk0kikWi12rvvvrtnz5779+/fv3+/0WhkGEaj0fTp02fQoEFisTgnJ2fbtm0nT56s3OJpaWlDhw5NSkq6Na1Rt/Ly8v9n787Dmyi3BoDPTPYmTdqkSZt0CU1ooWVRdoosAl5ERMQNBVE+RRGuIi7XBUVFReWCCyhuIIIKKIiAoCIiIIsKIggoIGBLkiZt9n2ZZLbvj7k3N3ajtGmT0vN7fHzKZJYz78wkk5Mz77t169ZDhw7Z7XaxWFxSUnLttdf27t27pqaGbUOv1yuVStmYtVptquNFfv755507d54/fz4SiWg0mvLycoIgTpw44Xa7ORwOQRAcDodhmOS2M8Mwe/fu3bVrl9FoJAiisLBw6NChY8eO5fP5rV85AACkHIUgJhylEEYvZHjp+GgcAKDDCAQCZrNZoVC0250/AOCSRNO02WzGcVyn08HDjuDSk9yHg/jyrgNHd0UQhPKe27vxpec//WzT7vOj1nk23AzXTmdF0/R777330UcfVVVVSSQSDodDkuSmTZs++eSTe++996677krPHlEuCkVRb7zxxoYNGwwGg1gsZvfx888/X7169QMPPDB58uQ23TrDMCtXrly5cuW5c+ckEgnDME6nMxKJ8Hg8qVQqlUpxHF+2bNl11123aNGi+kl/iqLefvvtrVu3GgyGaDQaiUTYI3L8+HGRSPT2229fc80199xzz1tvvbV3716pVMrmH3ft2vXGG2/k5ubabDaZTCYUChEE2bdv33vvvTd69Oj+/ftv27aNjYfL5VIUtXnz5k8++WTatGkzZ85MbVXIzp07X3755WPHjkmlUh6PR9P0N99889JLL40YMcLpdFZWVsZj3rJly5o1a+68885Zs2alKmaPx/P0009//PHHUqlUKBSiKOrz+bxeL4ZhCoWCoii/308QBJfLzczMlEgkyWpnq9X6xBNPbNq0id0ugiAHDhx4//33R4wYsXDhwvLy8uTtIgAApACO4yYcE2GMlsdgHf42BACQSg6Hw+FwFBQUSKXSVMcCAOjACIIwmUwYhul0OujGB1ySkntaM+HqQ19t+PSzTz/ffrQWZxAUE2kqeuXDQ0id2MKFC//9739rNJrEStKcnByPx/PQQw/5/f6HHnooheG1HsMwzzzzzDvvvJOfn59YeZqTk+NwOGbMmBGJRO6+++62C2DJkiXPPfecRqPp0qVLNBo1GAwEQYhEIpqmPR6PQCBQq9UqlWrXrl133333Rx99lJeXlxj8s88+u2zZMqVSSRBELBaLd5JOUZTP58vPz9+zZ8+OHTtEIpFer4/nNAmCCAQCBoNBIpEolcr4B6RKpdq9e/fWrVu1Wm2XLl3iG1IoFH6/f+7cuV6v96mnnmq71mjaN998M2nSJJVKpdf/rzsguVxeU1Ozfft2qVSq1+vjv4iwMT/11FNer/fpp59u/2gDgcCMGTN++OEHvV7PlrQ7nU6Px8Pj8RiGcbvdJEny+XyhUEjTtNfrZSvTW9/OTqdz+vTpv/76a50eDJVK5dGjR2fMmLFixYqysrLk7CQAALQ7tlZRzkFyedDtBgCg5RiGsVgs4XBYr9dDrSIAoDXC4bDJZJJKpWq1+hIo0QOgQclJQMfsx7/74rPPPl2/9SdDgGIQlJtVetWUyVNun3LjiBIZjAffae3Zs+eVV17RarVsEWUiiURSWFg4b968ioqKQYMGpSS8pNi2bduyZcu6dOlSv2sCqVTK4XAefPDBQYMG9ejRoy22fvDgwWeeeUar1bIDbVsslmg0yiYrMQzj8/m1tbVisTgzM7OgoODYsWPz589/77336gRfUFBgs9lwHGcXZHE4HBRFLRaLWCwOhUJcLjexorampiYSiQiFwnA4XFtbW1hYyE6PRCKBQADDMI/Hk52dnRiqWCwuLCx85ZVXKioqRo4c2Rat0TSbzfbSSy/l5eVlZWUlTg+FQjabTSAQBINBp9OZOM4DG/PChQsrKipGjRrVzgG//vrru3fv1mq1bMvjOF5dXc3n8zEMY0fdxDCMfYk91g6HQywWZ2VltbKdFyxYcPjw4cLCwjq3PhiG5eXlGQyGp556asOGDYlnCwAAdBQul8tmsxUUFEhP7U91LM0w75FUR9A8675LdQTNIM668DwpJ5alOgLQXCRJGo1GFEWhVjGZ9JenOgIAUoAdcjA3N1ehUKQ6lkuItCM0ZjSc6gjaVauKkynv2d2rX7x3bA9NQZ/r/rlw7YFqrHjomH65HMENy4/tXPncXaMg+9y5rVq1Kjs7u372mSUSibKyslauXNnOUSXXqlWrFApFYx3jisViqVS6atWqttt6dnY2m30OBAI+ny/xDhhFUS6X63K52H/m5eWtWbPmxIkTdYInSdLr9da/dWbzm8FgUCAQeDyeUCjETo9EIm63m80/8ng8p9MZjUbZl1wuF4fD4fF4Pp8vEAjUWaFQKMzOzv7www+T2QTNtnbt2rNnz9bJPiP/jRnDMC6X63a7aZpOfFUoFMrl8vY/S+12+9dff52XlxfP+zudTjZOBEFIkkRRlGEYiqLYV1EU5XA47LFuTTufPXv2gw8+yMvLa+yHd7bIfefOnS3ZKwAASB2GYcxms9PpLC4uhiflAQCtgeN4ZWWlUCgsLi6G7DMAoMUYhrHZbDU1NVqtFrLP4JLX8gT0slv6F6q7j77r2Q++q8S6jZn+7PKvfzPbzu156xYthiDw0ABwuVynT5+WyZoq5cjKyjp27FgwGGy3qJLLYDB89913Te+jTCb7+eef44nCJAoGg7/99lt868FgkC1bTpyHw+FEIhGSJBEE4fF4GRkZ+/fvrxN8KBSqv2AiNrkZP0zBYBDDMHZ+FEUxDGNzzTRNh8NhdlWJ8yeSyWR//vmn0+lMwv5fpAMHDtQ/UvGYEQThcDjhcDgcrvsjpEwmO3PmjMPhaKdAEQRBkB9//PHcuXPsTwss9jCxf9M0He8pJT4Dh8Px+/3sjwEtbucDBw4IhcImRhpLzrQuAAAgAElEQVTEMCwzM/PAgQMXu2YAAEghkiQNBkMsFtPr9YlvrQAAcLF8Pl9VVZVcLs/Pz4cn5QEALUbTtMlk8vv9Op1OLBanOhwA2lzLE9D7vjpSG5P0vP2NHX/W1vz+7QfP3zvuslzo+wrEWa3W06dPN5HJQhCEz+efPHnSarW2W1TJVVtby+Fwmi58EAgE0Wg0XoacRHa7/eTJk/EWJgii/k0wiqI4jhMEEQ+mpqaG/TsefIMLshiGYf+Pomh8JXXmj79EEEQkEmFLdBPnTyQQCE6fPh2PoT1Zrdb6ZyNJkvFxFxEEwTCsfth8Pv/PP/9s55hra2sToyVJMp50ZhgmXqbNHiAWiqLxZm9xO9fW1l6wE0M+n5+SIwgAAC3D1iryeDyoVQQAtJLdbq+pqSkqKkrstA0AAC5WLBarrKxkGEan00En8qCTaHkCWiHno3Tgj3VPTL35jtmvrN13PkBfeCHQiXC53MTsWIPYGTpuZ7LN38e2+MbLrjMeQNMlzPFg4q0dD745Cyb+3WCau/70BlfLMExiDO2pmQerftgpOUvrbK6Z9TXx+FvczuwIhxfcSse9ZgEAnY3f72drFQsKCqBWEQDQYmytotfr1el0Eokk1eEAADqwUChUVVUlkUi0Wm38IVcALnktT0C/a7Ac/+qdJycPEp/f/v5TU6/smtel4tZ/vbnlqC2axPhAx1VQUNC7d28cx5uYB8fxPn36qNXqdosqubp06dK9e/d4D8gNikQi2dnZ9bsebr28vLy+ffvGW5jP59fpvxhBEJqmRSJRvJY2EokUFxezf8eDb3DBRCiK0jQdXwmfz0/MUdI0zf5my3bxwa4qcf5EOI736tUrPmhhe+rSpUv9s5GNOb47DMPU//0Zx/EePXq0c8x1omVr1dm2Zbs9YacnjgzJMIxQKGTjb3E7N9hKdeA4Hj+LAAAgnTkcDovFUlhYCLWKAIDWIAji/PnzNE3r9XqoVQQAtIbb7TYajbm5uWq1Gn4aB51KKwYh5OX0unbWK2v3VVmr9q9bOGtcSfS3z1+bc/PkN44T5LH1Sz//pQa/QB0duKSJxeKKigq3293EPG63e/jw4U1305HOlErlZZdd5vF4mpjH4/GMHj06MVGYLHw+f9iwYfGtS6VSmqbrlK9SFCWRSNitRyIRvV4/cuTIOsFLJJL6C7LYiTRN0zQdH7IpMzNTIBDEE81CoTAzMxNBEBRFJRIJSZJsHxENDvHkdrsrKipSUjZy1VVXeTyeOruJomhmZibbRzZJkpmZmfX7BnW73YMHD2b3sd0MGTLksssu8/v98SmZmZnxHp85HA67I4nnFUmSIpGIrYtvcTtfeeWVpaWl8QEn6yMIIhAIXHXVVRe7ZgAAaE/skIMej0en07XzGzgA4BITDocrKytFIhHUKgIAWoNhmNraWpvNptVqs7OzUx0OAO0tCUkxVKy9YvITb287Zrb8/s17T00doZMyf218YtJgrab86nsXrPnVAXnozmrmzJldunTx+XwNvur1ert27Xrfffe1c1TJdf/993u93sbGUXS5XOXl5XfffXcbbX3GjBk6nc7r9SIIIhKJlEplYhfGFEXx+fycnBz275qamokTJxYVFdUJniRJpVIZi8XqrJxNaGZnZ0ej0dzc3Hi5B5/Pz8rKIgiCpmmCIORyebyDEaVSKRAIYrGYUqmsn8n1+XxdunSZNWtWspuhWW655ZYrrrjCZrPVmZ6TkyMUCkmSZNuhzqt+vz8lMYvF4rvuustms8WPSzxO5L+9r7CDPbKv0jRNUZRKpUJa184qlWrSpEm1tbXshupgGKampmbatGkDBw5s2X4BAEA7IAiiqqqKIAjoVxEA0Eoej8dgMKhUKo1GA7WKAIAWoyjKaDSGQqGuXbvCkIOgc0pmVSZP0eOa+1765Ie/as//+NmiB67rxT+/84Nn7l20t25eC3QWpaWlc+fOra2tdTgciZ080DRtt9tzcnKee+45rVabwghbr0+fPitWrDCbzS6XK7G6lqIoq9WqVqtffvllNi3YFrp06TJ//vycnBy73U7TtFqtzszMjEajNE2TJMnlcvPy8oRCYSgUMhgMN95446OPPlon+OXLl9fU1PD5fJlMxi7IvkQQBI/Hy8nJoSiqsLAwGo0m9syQm5srkUii0ahUKk1M2lIUhWFYVlZWvL8IFk3TDodDoVDMnTu3tLS0jVqjaSKR6LXXXistLTWbzYlpeh6PJ5VKKYqSSqWJVXJszDU1NU8++WT37t3bP+Bp06bNmjXLaDQGAgEEQbhcbn5+Po/HIwiCIIiMjIx4PpokyVgsptVqhUJh69t59uzZU6ZMMRgMdX5WwXHcaDQOGzZswYIFrd87AABoI/FaxS5dusCQgwCAFmMYxmazWa1WrVYrl8tTHQ4AoAOLxWJVVVUYhul0OhhNB3RabXFfjmYUVtz6WMWtj73hPr3ri421XZLf9wDoMCZMmPDdd9/9+9//3r17d0ZGBofDIUkyEomMGTNm7ty5/fv3T3WASTB58uTc3NxXX311//798X0Mh8PXXXfd008/3bNnzzbd+pgxY7KzsxcuXPjdd9+JRCKBQCAUCiORCIfDYVPPLperW7du06dPf/DBB+v3djJ58mSRSPTuu+/+/PPPQqEwFouxXVoLhUIOh6NSqWbMmHH33XcvXbp06dKlbBfDDMNEIpGysjKVSmW1Ws+ePSsUClEUxXG8a9eu//rXv0aOHLlkyRI2Hi6XS1FUOBweNWrUE088MWTIkDZtjaZ179591apVCxYs+PTTT0UiEY/Ho2k6Eon069dvzpw5v/zyy44dO9InZgzDXn755a5du3700Ue///67UCjEMIzH4+E4jmEY2+aBQCAcDvP5/Ozs7FAo5HA4Wh8zj8dbunRpt27d1q9ff/r0aXZD7C8QDz/88OOPP95g5yoAAJAOfD6fxWLJzc1VKBSpjgUA0IHRNF1dXU0QhF6v77i9BQIA0kEwGKyurpbL5bm5uamOBYBUatPCEK687Op7n2nLLYCOYMiQIV988cUvv/xy4sQJt9utUCguv/zy/v37X0p9qI0aNWro0KEHDx78448/fD6fQqHo169fnz592qLr5/oGDBiwYcOGX3/99dixYy6XSy6XazSaYDBYU1ODYZhWqx02bFgTVdjDhg0bOnTo6dOn//jjD7PZ7HQ6xWJxfn4+u2BeXh6CIC+//PLMmTMPHDjArlOn0w0bNkyhUNjt9gMHDhgMBpqmCwsLhw0bptFoEAQZMmRIYjy9e/ceOHBgOlSiabXaFStWPPzwwwcPHnQ4HBkZGd26dRs6dGhGRgZFUUeOHDl27JjT6WRjHjBgQGp/oMYw7J577rnlllv279//119/xWIxtVpdUVHh9/uPHDnidDozMzPZdLnP50tiO/N4vDlz5kydOnXfvn3skDsajWbYsGEpGT0SAACayW63u1yuoqKilIw0AAC4ZMRiMaPRyOfzdTpd+9zMAwAuVW6322q1ajSarKysVMcCQIqlPh8EOgMulztkyJDUVr+2NT6fP3z48OHDh6dk6xwOZ9CgQYMGDWrZ4s0JvqioaMqUKXUmqlSqG2+8MenxtLXy8vLy8vI6EzkczsCBA9Owd2OZTDZ+/Pg6E/v27dvW21UoFDfccENbbwUAAFqPpmmz2RyNRqHTZwBAK7G1illZWWq1OtWxAAA6MHb4nGAwWFxcXH94JAA6IUhAAwAAAACAjoqtVeTxeDqd7lJ6uAoA0P6gVhEAkBQURZlMJoZh9Hp9OjwHDEA6gCsBAAAAAAB0SOFw2GQyyWSyvLw8FEVTHQ4AoKNiGMZqtfp8PqhVBAC0Eo7jJpNJJBLl5+dDNz4AxEECGgAAAAAAdDwej6e2tlatVmdnZ6c6FgBAB8bWKlIUpdfrUzv+BwCgowsEAmazWaFQNDEIEwCdE/waAwAAAAAAOhKGYWw2m9Vq1Wq1qcw+4z9NHn0dWjH+b/8Nf361n0lZSH/D/GSoua06StaZTAUn/3AW3fX3//ZYVhMpCfJ/wlXfvfDPSWW9e4kKu+cMuP6mBVv/CKVJS9aH//Tanbe9c6Ju24IOKBqNVlVVcblcnU4H2WcAQGs4HI7q6ur8/HzIPoNUwH9afPtty46n7c0JVEADAAAAAIAOg6Ko6upqkiT1ej2fz09lJI5aQwzNLRs0siAhDK6+mJcWnYEwseCy6tA+ZRb99+lUlDDQSK5UMlKUECcqKE5pXQrx15qbJjy7I5A7ZMJtN+eTlT9u/2LZQ7t/qflh48zLUnmQG8Y4dyx755t9102nLzwvSGtsraJcLs/NzU11LACADoxhGIvFEg6HdTqdUChMdTigM2Kc25ct+2rfhHvT9uYEEtAAAAAAAKBjYIcc5PP5Op0u5f0qUrVWAy0a/X+Prx2eXinSCEGc9IfXGJzrY0z9pBqFxwwINrqLeq0yLRLlCIIgjP/Lxa995yu4a9WmFWNyMARB6NnfP3PruJXL5m26aett6RMoFXGZTh7Zu2bxgvU2GhKWHZ3L5bLZbAUFBVKpNNWxAAA6MJIkjUYjiqI6nQ6GHATtjoq4jCd//WHNv59P85uT9Lg2aPfxL1Z/9sMxY0CivXzUbXfddFl23ftMJmLYvWb1lgOnayN8RZfL/jH5/yb2yeEijGf7s/e8e/x/jwxy8m/697JppTAGOgAAAADAJSUYDFZXV6dNrSLjqbF6UGWJOr1uO5mY74YfbTsar37xRAgPwitJq1HWyNP7Dvs5Pe55dHTOf35VwOSj7r99yEfP799/LHrbP9KkloxxrL2h+4M7ouy/oCfDDoxhmJqammAwCEMOAgBaCcdxo9EokUg0Gg2MhwzaH+P45Iau93eIm5N0SEBTxk0vv7SRGnHXg7cpHPvWrHppIee1l28oTLyZZ3w/vf3csj+KJt7xWH81Y9i99pMFz/lfeO3uHjy71Y6WXvfIjT3+U3mCivI1ad3iAAAAAADgYrndbqvVqtFosrKyUh0LizZY7BS3UC+17d196g8nnpHXddSAblpRir98ojzJ0n4CL4IwseCDJ9zmuq8zhghJoXw9l9hrx/+I0hlC4Si5UJvaLDoZRrKLe1X01ieEgQpFIhQhY0T6PEmKZo9b+l25l0YY17YHJ79Vr21Bx8AOOcgwjF6vh1pFAEBr+Hw+i8WiVCqVSmWqYwGdFJo9fumuHl4GYZxfPjhpaTrfnKTBJ27sxFdfnS+4acnMsYUcBOmZ4/3rX9u+PnntzN7/e5iR8fy84xA5+MHH7xyWiSJIj+554fNztuz8fWqPXnabR1oyeNiQXulVfAIAAAAAAJKBrVUMBAJpVqtIGCwuig49+X//rPWSDIIgCMrP6f3kc4/N75+VyiQ0yukm5SAIwkSj0gbiYAwRkkKoJ38x1hIMO8YfX5DxZA/1/GxOysIWjXxz18i/T6LN32z/meRd3q9HmpQ/IwiCcHO69ctBEISxnpBCxUvHxNYqZmRk5Ofnp7wbHwBAh2a3251OZ2FhYWZmZqpjAZ0YN6dbf/bm5Hia35ykPjqq+uTpYF7ffho2g8wp6tdH5T99qjax2IEJEAJt/wHdJf+5LeYo1bncWCRM0g6bnVGpVXTEY3cGiLQdKBsAAAAA4GIwDIP/XaojSg2KogwGQyQS0ev16ZR9RhDaUVlLMhRVfN2Tf2zfFNq+Yt/cMeX4iQXz3lxlS+NbUoasjDAMgxRr1H8MLwkNL95XJiunwgt+t65Ko1MsZtix4Kb5+0KFN8+7rSj1X1faS51LnmGScyLRNE2SJLyZIAji9/urqqrkcnlhYSFkn8GlLfGSJwiCppPzMAnDMNFoFN5PaJo2mUxer1ev10P2GVzyEi95mqZbfH+S+gpo2ml3Mgql/L93AJhcKWecdgeNaOM3BZj2uqdf/d8ilH3f7hNI11u7ieiaWgfp2P3K3avO+yiEm9nliimzZ43rmgEd7wAAAACgI2MYJhgMJk7phIOq4zhuMplEIpFWq027bBGaNfH+eX2EhSN65mYgCIKoh014YBvq6vnKkTe/Mk6b3iVNH85DORNLNH0w/ggZLwNBEIQ3TJO7DSF7ng6/WRudVixIedixmh+XPv/8gq3nYtpr3/v42bEprSZvZ3Uu+WQloCmKIggiceWd8M0EQRCHw+FwOKBWEXQSiZc8juMURSVltTRNh0KhxL5rOuH7CUEQJpOJw+Ho9XoOJ+UfmwC0ucT3E5qmW/yDVuoT0FQsSqIiUby/PFQkEqKxaKyRG66o9Zcv3nt/U6Vu6gtX5yGBEx5CJNFfN+f5YfmI7fhX7731wcsfKN+cPfA/tdLPPffc119/HV9YKpU6nc507hieJEmn05nqKDqq9m86j8cTCoVkMlk63MhGo1GHwyEUCrOzsymKcrvdCILI5XI+n48gCE3TXq83HA7L5fKMjIw6yxIEUaf1aJp2u912u10oFCoUCplM1vTWY7GYy+XCMEwul/N4vAtGGwqFPB5PRkZGdnZ2g5ckTdMejycSiSgUiuSWvDV21CiK8ng8OI6rVCq20ZrJ6XQGAgGfzycWi7Ozs+PT/X6/3++XSCRt0V2p2+0Oh8NZWVkSiSTpK283sVgM3vFaDJquxdr0xKvzraw1UBTt0Bd46wUCAbPZrFAoVCpVqmNpCJpZ3r9/+d8n5Q8bUrH4yA9nzgeRLhf44EwZTnm2+O9hI/k5kgos9IM/GkQEqQyb8R3+6Pl7Xtrye1Q9euaSNx6Z0DMzfW/a20KdSz5Z31k4HA6Px+vM7ycMw1gslnA4rNfrBQJBqsMBoD0kXvJCoTBZeVIMw8RicWd+PwmHwyaTSSqVqtXqdM4sAZBEiZc8hmEtLgpJfQKawxdwGF8EZxAhiiAIwkQiOMPLbCD7Q9gOb3hv+ZY/kF4Tn3ht0gAVD0EEY579bMx/Xy8cOPmBG4/dv37v8XsHXsHmqzQaTVlZWXwNtbW1XC43bd8mSJJEURR+Q2sZiqLarekikciGDRu+/fZbq9V69uzZ0tJSvV4/ceLEa665JiWH79dff/3000+PHz9++vRprVYbCARQFGV/a+nZs2ffvn3FYvGxY8dcLtfZs2e7devWvXv3m2++eeTIkey1UOfEczgcq1ev/uKLL6xWayAQQBAkOzu7vLx82rRpEyZMqJ9cPnPmzMcff3z48OGTJ08iCNK7d++Kiopp06Zptdr6odI0vXPnzk2bNp07d+7MmTOlpaVKpXLs2LG33nqrWCxm5/H5fOvWrdu1axcbcPfu3bt3737LLbeMGDGiNRcvjuMbN2785ptvamtr2aOm0+muv/76a6+91ul0fvzxx/v37z9y5AiCIGVlZZdddtntt9/et2/fptdJkuTXX3+9devWqqoqdp15eXlXX321UCjcsWOHwWBgJ+bn548fP/7GG2+8qLx2g8Lh8Pr163fs2GGz2diVd+3a9cYbb7z66qvTrjbwQkiSbM2nV2fGMAxN0/Bh0QIMw1AU1aYftRiGJes2A0XRTlhVFOdyuWw2W0FBgVQqTXUsFwEVS7K4CENRFIMgaXq/2QCUy8lCEYZBklMg1zJUzcZ/3XHnp9XKkQ9seXnWhOJ06m6lvdS55JP1ZoJhGJfL7bTvJ2ytIoZhOp0OhhwEnUfiJc/j8ZJ1y42iqEAg6LTvJx6Pp7a2Ni8vTy6XpzoWANpP4iXfmi87qf8MxhTKHPS8y0MjWRwEQRDa6/Kiih6Kv79BMuE/N7y4YKOj9KYnlt3YP7eRJA6Wk68REJ4AziBsRfV999133333xV8fM2ZMVlZWeiagGYZxuVwcDidtxnbvSGia9vv97dN01dXVc+bM2bNnj1wuF4vFpaWlJEn++uuv33333e23375o0aL2rIZmGOaNN9549tlns7KyZDKZSqUyGo2xWIxhGKFQqFarnU7nqlWrKIrKyclRqVSlpaWxWOzHH3/ctm3b/fff/8ILL/B4PJfLxeVy2RrnX3755eGHHz5y5AhBEFwul02Y+v3+H3/88fDhw3v37l2yZEnix+0nn3wya9YsqVSalZVVUlKCIIjH41m3bt3Bgweffvrpa6+9NjHacDg8d+7cVatWyeVyiURSWlpK03RVVdWCBQt++OGHJUuW6HS6U6dOPfLII4cPH2YrtUtLS6PR6P79+7du3Tp79uz58+e3LIdbU1MzZ86cnTt3KhSK+FE7evTo999/v3HjRpfLde7cuezs7JKSEhRFI5HIjh071q9f//LLL8+ePbuxdwy/3//UU0999tlnCoWC3R2Kov7888/du3czDJOXlyeTydiJp06dOnDgwL59+5YsWdKaOj6j0Thnzpy9e/cm7sXhw4d37Nhx5513/vvf/44n8dMfW2LP5XI7VmopTZAkyVbxpzqQjod90IHH47XdiScSiZLVzWKnxdYqhkKhNBtysC7yzKYbFv2UfcNjq8fnxu9aKYvlLwJVF6rTtnKXDHhu+DOQXaBereb9L+xI7C8aUWfwUvc8F3l6+Zy7P7P2+OeHX88bqoKfJkGSQK0iACApGIax2+1ut1ur1Xag71wApJXUJ6A5RT3KxF8eO+6YXJyHIghtPX7CmlneI/9vtUn475+8/rn/iqdendk3sSO48M/LHv2EvP2VOUNlKIIgCGWpNMayexSm7U0/6Oj8fv/s2bMPHjyo0+nid7EcDkcgEGRlZW3YsAFF0WXLlrVbUed77703f/58rVYrEon8fr/JZOLxeGyKliCI2tpaFEVpmuZyuXa7PTMzUyqVcjgcoVAok8nef/99Pp///PPPx9d29uzZhx566MSJExRF1fmNi8PhEASxefNmBEE++OADdhNbtmyZNWtWQUFB4hMZEolEIpE4HI4XX3xRJpMNHTqUnc4wzLx58z755JPi4uJ4GTX7i4tMJvv1118feOCBV1999cEHH/zzzz+7dOmS2LxCoTArK+udd97h8/nz58+/2FYKBoMPPPDATz/9pNPp4oeGPWoCgWD79u0ikYhNPbMviUQikUgkk8nmzZsnFounT59ef500TT/++ONffPGFVquNP8uJYVggEKBpGkXRQCCgUCg4HA6Hw5HL5VlZWd9///2cOXM+/PDDluVTPB7PAw888OuvvzZ47n366acYhi1ZsgQKigEAHRpJkkajEUVRvV6f5rWK3AJNdu2ZdavXT7pi9vhsFEEQhLB/vnr7b4zmkatKL9wXVYpwRbxsHF933j1JkTue/UmXJj43+H5D+I/kClMWdvTgm8uPRi979OOnIPsMksbn81ksltzcXIVCkepYAAAdGE3T1dXVBEHo9frWP9IKQKeVBnf2/N7jxhU9+flb6zR3D5fb96zcVK2/cXZPPoKQld+v2esqu/aWQfJTew841YNLqL+O/BpfDpPrL+81uCfxyorFcnLS4HyO6+SOtVscPaZdW5YGewUuTR988MH+/fsT06NxXC63sLBwzZo111xzzXXXXdcOwRgMhtWrV+fn57MFdzabjcfjxZ8r53K5kUgE+e/jEjwez2azSSQSNkHJ5/MLCgpef/31cePGde3alV1k4cKFp06dwnG8fu94GIbxeDyaprds2TJmzJipU6d6vd433ngjLy+vwS7AZDKZ1Wp95ZVXNm/ezH5I7969e8WKFTqdrn4nHiiKqtXqX3755b777jtz5kxRUVH9FfL5/MLCwldfffXaa68dMGDARTXUhx9++MMPPxQXF9c/ag6HA0XRcDjs8/nqVNCLRCKNRrNixYoxY8YUFhbWWXDbtm3r1q0rLi5OTPh6PB6v18vn89kEtMvlitc7YxhWUFDw7bffrlmz5t57772o+FnLly//6aefGjv3CgoKVq1aNW7cuLFjx7Zg5QAAkA5wHDcajRKJRKPRdIBaRfGAeff137lo583TzLdc1bsY85745cev/iJ6TXn2qR5pm39GEK54nk6884zv5l9it+SKilHqhCv4VZDppdU8JUtZm1NVRw46aL7kl4WPVv09/4xKB9/z2uRucG8PLpbdbne5XEVFRZ25s1oAQOvFYjGj0cjn84uLi6EHPABaIx1u57i6m+c+Trz/0bInN+EZ+ZePf+K+G7QcBEFIy+Gvtp6nKm4eiFlqQqRxx5sv7vjfUqhw2JNrH6uY8eLjWR9tWPPKVj9HXlDa/94Xp47WQOEEaBOxWOzLL7/Myclp7Fsxl8uVy+Wff/55+ySgN2/efP78eTZdGwgEQqFQYuKYHTmdHaKULWEOhUKJHZUIBAKZTLZx48Ynn3wSQZCzZ89u2LCBw+E0VnGGYVgsFpNKpRs3bpw6der27dtPnDih1+sbC0+hUOzfv3///v2jR49GEOSLL77IyspqbHxCFEXlcvmxY8fqp3rj2IA///zzi0pAkyS5ZcuWBo9aJBLxer0CgYB9Kr9+Fy4SiaSysnLLli2zZ8+u89Lnn38ul8u5XG7is/YejyfeyzyPx/N6vUqlMr5dDMMUCsUXX3wxffr0i61TxnF827ZtiWurg8fjseceJKABAB0UW6uoVCqVSmWqY2kmTun1c3/O3fbSp3u2b9u0gRDk63v/65nbnhxbnJXWyXO0NF/zs9D7ksm/vcazgcbyJaJ/9VA8mSdIYR9wpLnaRDLBsz98fLbOK5iKc93iyd1SEhXooGiaNpvNOI7rdDoYchAA0BqhUKi6ulomk6nV6lTHAkCHlw4JaAThKPtPndd/ap2pwuFzNw5n/7zulU2NJfTyBt3+xKDb2zI6AFhnz549cuRIt25NfQuSSCSnT5/GcbwdRmb47bff4jUd4XC4Tk6TpmmGYdguONiXMAwLh8OJaVaJRHL06FH276NHj/J4PL/f38SdOofDYe/p7XZ74tYbhKKoWCw+evTo6NGjGYb57bffLtg7digUYvPmjZFIJL/99lvTK6mjsrLy0KFDDR41ttHY4chwHI831AW3GA6Hz5w5U2f3SZKMxWLxNWAYFgqFotFo4gZJRhQAACAASURBVJkgkUj2799fXV3d4AiNTTh9+vSxY8cueO79/vvvJEmm+UPrAABQn8PhcDqdhYWF7TmOQjLwuwy+acXgm1IdRsNQgez7kQ12Fo92UWSvUGS3czxNEPzjVZf11VRHcRHQvLu/d92d6ihAA9haRR6Pp9froVYRANAabrfbarVqNBoYpgt0CGjePd/77kl1FE2BYmEAmsvj8VxwxE8ul3vq1Cmv19sO8Xi93niqkaKoCz6tjKIoRf1tfHs248xO9Hq9bPK06fXQNH369Gm2r4kLJjq5XK7H40EQJBgMsqMaNjEzG0adCOuv0Ov1XtQAX+xRa7DimCRJdmdRFMVxnCTJBrfodrvrTPR6vadOnaqzOxRF4Tie2HooitZZJ1sfzbbJRfF4PBwO54Ln3smTJ30+38WuHAAAUoimaZPJ5PF4dDpdR8s+AwDSSzgcrqqqEovFWq0Wss8AgBZjGKa2ttZutxcXF0P2GYBkgUI5AJpLJpPFy4obm4eiqLKyMqlU2g7xZGZmxtO1GIY1XTuMIAjDMHXuxUmSFIvF7ESpVHrBNbAbYmdO3HpjKIpim4LdCkmSTQzawIbRdN8UFEVlZmZeVP8V7H41eNQ4HA67ywzDCIXCBr+oxHehzjrLysqi0WjiImxUiRuq3+AURTEM04LTgz33mp6Hoqjy8nJI3wAAOhCCIEwmE4fDgVpFAEAreTye2tpatVqdnZ1G1f0AgA6HoiiTyURRlF6vb6wDSQBAC0AFNADNVVJSctlll4XD4SbmCQaDXbt2zcjIaId4evfuHQqF2L/ZcQgTX2WLtRmGiadraZoWiUSJ84RCod69e7N/9+zZMxaLZWRkNJFWZjupGDFiRF5eXuLWG8QwTHz9GIb16NGj6flRFM3IyGg6AREMBnv16tXEDPV17dq1b9++DW463mg0TfP5/AY3ndhEcRKJRKfT1Vknj8fLzMyMHwWapjMyMur0ZxIKhQYPHnyx/W8gCNK9e/eePXte8Nzr3r07jMsMAOgowuFwZWWlSCSCWkUAQGswDGOz2axWq1arhewzAKA1otFoVVUVl8vV6XSQfQYguSABDUBziUSiq6++2ul0NjYDRVFut/v6669vn3gmTJgQDAZxHEcQRCqVikSixNwx+l9sApqiKJFIlFh7SxCE1+uNR9uzZ89rr72Wy+U22BMFgiA0TVMURRDEhAkTUBS95pprunXrFggEGgvP4/EMHDhwxIgR7D8nTpzo8XiayG57PJ7S0tL6/V0kBuzz+SZOnNjYDA3i8/ljx451Op3167szMjKkUilJkiRJNvhoVSQS0Wq1EyZMqP/S9ddf73K56iT9s7Ky4q1HkqRUKk0s1mYYxul0jh8/vgV5FrFYfNVVVzkcjsZmYMdRbLdzDwAAWsnr9RoMBqVSqdFoLtiFFAAANIaiKKPRGAgE9Hq9WCxOdTgAgA4sGAxWVVVJpdLCwsKLHTQeAHBBcFEBcBFmzZrVp08fq9Va/yWapi0Wy4QJE26++eb2CaasrOzpp582m82xWIzD4ahUKoIg4ilRiqIEAoFIJCJJkqZpgiBUKlU89UmSpNlsvuuuu0aNGsVOwTDsiSeeKCkpEQgEBEHU2RbDMARBZGRk/OMf/7jzzjsRBFGpVDNmzKitrY1EIvVjCwaDdrv94Ycfjn8TGD9+/KRJk6qrqxvMQdtstp49e7799tslJSUNpvjZgKdPnz5y5MiLbaiZM2cOGDDAarXWyUGjKMo2WkZGhlwur7NULBazWCy33npraWlp/XXecsst48ePt1gsiTlouVwulUpjsRi7TqVSGX+JYZiampqhQ4dOnz79YuNn3X///ZdddpnNZqv/Ejsy5A033HCx2XkAAGh/bK1ibW2tVqtVKBSpDgcA0IHFYrGqqioURXU6HTwEBgBoDZfLZTKZ8vPzc3NzUx0LAJcmSEADcBGUSuXSpUt79OhhMBiCwSCb0KQoyufznT9//qqrrnrttdfa81Gdxx57bNasWQaDwel0SiSSgoICNvsZi8W4XK5Go1Gr1SiKRqNRlUrFFvmSJOnxeM6fP3/TTTe99NJLiXVnffv2ffHFF7t3745hWDQaZVOrDMOQJBmNRnk83ujRo5csWRLvYGTatGnz5883Go12uz0Wi7ETcRy3Wq1ms/ntt98eN25cfOUYhi1evHjcuHHnz5/3er1sGpphmGAwaDQaS0tL33jjjYqKikWLFmm1WpPJFAqF2OaNB3zzzTcvWLCgBa0kl8uXLl3au3dvtkCGXS1N0z6fz263DxkypLS0NDGTThCE0+k8f/78Aw888NBDDzW4Tj6f/8Ybb4wcOdJoNPp8PnZ3UBSVy+Xsr+XZ2dnsHzRNBwIBg8EwYMCAJUuWtLh/8Ly8vCVLlpSVldU597xeb1VV1dVXX/3aa69dcFhIAABILXbIQahVBAC0XjAYrKyslEqlWq0WahUBAC3GMIzFYnE6ncXFxe0zmBMAnRNkKwC4OGVlZevWrXv//fe//fbbI0eOYBhG0/QVV1zx2GOP3XnnnUKhsD2D4XK5L7/88hVXXLFq1apvv/0WwzA+n88O0+f3+2tra8vKyvr165eRkXHmzJnjx4+z0V555ZW33377pEmTuFxunaLgq6++WqfTLV26dNu2bRaLhc2rcjicHj16TJ8+ffr06RKJJD4ziqKPPPJI//79V6xYcfr06T///BNBkPLy8oqKilmzZvXt27dOtNnZ2R988MHatWvXr1+/f/9+Npg+ffpMmTJl5syZKpUKQZDBgwevXbv23Xff3bNnT4MBt6yhSktL165du3z58m+++SZ+1IYMGfLII49MmzbNZDK98847Bw8ePHXqFIqiNE2PGzfu7rvvHjt2bBMPhqtUqpUrV65YseKbb7756aef2HX269fvjjvuEAgE33333aFDh9iJAwcOnDFjxr333tvKG5qePXuuXbv2/fff37Fjx9GjR+Pn3ty5c6dOnVqnv2kAAEg3sVjMaDTy+fzi4mLo9BkA0Bput9tqtWo0mgZ7UQMAgGZihxxkGEav10M1DwBtCq3fL+olbMyYMTt27EjPrgYZhnG5XFwuF+6iWoCmab/f385Nxz705/f7c3JyunTpkvLKC4vFYrPZuFxucXFxNBo1m80IghQUFOTk5CAIEolEqqqqwuGwUqnUarXxq4A98Xg8nkwmS1xbMBg8d+6cwWDg8XjdunXT6XRNJwvsdrvFYkFRtKioqH53FnXQNG0wGFwul1gs1uv1DWZOw+Hw+fPnI5FITk5OYsCtFIvFzp8/7/P5FApFcXFx4lHz+/0Gg4Ekyby8PI1G05y1URQVCASkUun58+ddLpdUKo0/AUpRVFVVlcfjycrK0ul0yb2bYQfHCAQCaXLutQBN0263m8/nQ5VBC5AkGQqF6lyzoDnY3tLb9MT75JNPaJqeNm1a61f1j3/8Y+fOna1fT5oIhULV1dUymUytVqc6FgRBEOTg16mOoBnmPZLqCJpn3XepjqAZxB3hBlv8tzf2a665Ztu2ba2/hdiyZYvFYrn//vtbuZ40wTBMbW2t3+/XarV1htcGADRox44dv//++7/+9a/Wr2rSpEnvv//+JTPaJ47jRqMxIyMjPz+/I36lAh1eNJzqCJpHkBH/884771y4cGEzEyZ1wC88ALQQn8/v3r17qqP4n/z8/Pz8fPbvzMxMNu8cJxKJevTo0fy1SSSSPn369OnTp5nzq1QqtoS5OTAM0+l0Op2uiXkyMjIuKuBm4vP53bp1a/AlqVTau3fvFqwTwzC9Xq/X6xMncjickpKSloTYDAKBoKysrI1WDgAASQe1igCApGBrFSmK0uv17dnrHQDg0uP3+81ms1KpTBy5BwDQdiABDQAAAAAA2gTDMFar1efzabVa6PQZANAaOI6bTCaRSASdPgMAWsnhcDgcjsLCwszMzFTHAkBnAQloAAAAAACQfBRFVVdXkyQJtYoAgFYKBAJms1mhUDT/kTsAAKiPHXIwHA431hUkAKCNQAIaAAAAAAAkWTQaNZlMAoFAp9NBrSIAoDVcLpfNZisoKIChIwAArUEQhMlkYjuEhCEHAWhncMkBAAAAAIBkCgaD1dXVcrk8Nzc31bEAADowtlYxFAoVFxfDkIMAgNYIh8Mmk0kqlarV6mQNcQ8AaD5IQAMAAAAAgKRhaxVhyEEAQCuRJGk0GlEU1ev1UKsIAGgNn89nsVhgyEEAUgg+yAEAAAAAQBIwDFNTUxMMBqFWEQDQSjiOG41GiUSi0WigVhEA0Bp2u93lchUVFUkkklTHAkDnBQloAAAAAADQWhRFmUwmhmE6Rq1ir6GpjqAZvj+T6ggASA2oVQQAJAVN02azGcdxnU4HQw6CtCPISHUE7Srtvx4AAAAAAID0huO4yWQSiUT5+fkw5CAAoDUcDofT6SwsLMzMzEx1LACADiwWi5lMJi6Xq9frORxOqsMBoLODBDQAAAAAAGi5QCBgNpsVCoVKpUp1LACADgxqFQEAyQJDDgKQbiABDQAAAAAAWsjhcDgcjoKCAqlUmupYAAAdGEEQJpOJw+FArSIAoJU8Hk9tba1arc7Ozk51LACA/4AENAAAAAAAuGgMw1gslnA4rNfroVYRANAaUKsIAEgKhmHsdrvb7dZqtWKxONXhAAD+BxLQALS3cDh86NChmpoaFEXz8/MHDRokFAovuFQgEDh06JDVasUwTKvVDhgwgM/ntzgGo9F49OhRv98vFouLioq6devW2JwOh+Pw4cNOp1MgEHTr1q13794YhuE4fujQIYvFwjCMRqNRqVRnzpwJBAKZmZmXX365TqdrcWD1xWKxI0eOGAwGiqJUKtXgwYMvWGRHkuTRo0erqqoIgmAXkclkSQypMQzDnDp16uTJk5FIRC6X9+/fX61Wt8N201MsFjt8+LDRaKRpWq1WDxo0CEadBuBSQpKk0WhEUVSn03WAIQcBAGnM6/XW1NTk5uYqFIpUxwIA6MBomq6uriYIQq/Xt+bLMgCgLcAXBgDaD0mSK1euXLNmzfHjx9lisWg02qdPn//7v/+bNm1aY6M2RaPRd999d8OGDSdPnuTz+QzDRKPRgQMH3nvvvbfeeuvFFolUVlYuWrRozZo1AoGAy+WSJBmNRq+//vp58+aVl5cnzulyuV5//fWdO3eePXuWx+MxDIPj+OjRo7t37/7zzz8fO3ZMIBBQFBUMBimKEgqFYrGYXdttt932+OOPN5HUbiaGYTZu3Lh8+fKDBw8KBAIURWOxWHl5+S233PLPf/6zsaz9l19++c477/z000/xRcrKyiZOnDh79uw2/Q380KFDr7322jfffCMQCDgcDnvfc+WVVz766KOdLQ3NMMynn376wQcfHD58OH4UevTocdttt82cORPuBQG4BOA4bjQaJRKJRqOBWkUAQItBrSIAIFlisZjRaOTz+TqdDsZDBiANQQIagHYSi8UeeuihdevWqVSqkpIS9hs7wzA1NTUPPfTQiRMnFi9eXL+ILBwO//Of//zyyy9zc3NLSkrYiQzDGI3GGTNmnDp1av78+c3/fD1y5MjDDz987ty5xN+EcRzfs2ePwWB45ZVXRowYwU60WCz33XffoUOHVCpV165d2YkURe3Zs2fbtm3sLoTDYbPZjCAIj8eLRqNisbi4uJgkye3bt585c2bRokVDhgxpcXMxDLNgwYLFixcrlcrS0tJ4gsPj8bz44otHjx59991364+Nvnjx4hdeeEGpVJaUlMSbxefzLVq06OjRo++//34b9QK2adOmRYsW1dTUlJSUxHstjEajH3/88YkTJ9555514G17yaJp+5pln3nrrLZVKlXjg3G73c889d+zYsWXLlmVkZKQ2SABAa/h8PovFolQqlUplqmMBAHRgbK1iLBaDIQcBAK0UDAarq6vlcnlubm6qYwEANKxzJaAZhgmFQulZqsMwDIIgNE2HQqFUx9LxMAyT/k23ePHidevWFRUVcblchmHYI44gSGZmplAo/PDDD9Vq9f33319nqWeeeWbr1q1FRUUcDoem6fh0qVQqFAqXLFmi0WjuuOOO5gTgcDgeeeQRg8HAFuTG18blcnNzc2tra+fOnbty5cqioiKSJGfPnn348OGCggIUReNzOhyOcDjM5/MdDkdGRobD4YjFYjweD0EQDMPcbjePx8vNzc3Ly6uurn7sscc++uijFhf/fvbZZ4sWLSoqKhIIBInNlZGRodVqt2/f/tRTTy1cuDBxkS+//PKFF14oLCxki6PjYYtEoqKiot27dz/++ONLlixpWTwNYk+8n376aeHChR6PJycnJ3G7PB6voKDgjz/+mDNnzurVqztJ1nXVqlVvvfVWUVERW62feOCKioq2bNmiUCjmz5/PTqcoKs0v2/RE0zQ0Xcu0w4kXi8XS8zYjWex2u8vlKioqgk51AACtwdYq8ng8nU4HQw4CAFrD7XZbrVaNRpOVlZXqWAAAjepcCWgEQbhcbnp+M2S/FaMoCh0ptgDDMARBpHPTGQyGr7/+WqPRsOnaOvh8vlqt3rhx46RJkxIztr///vvy5cuLi4sb3DWBQJCbm7tmzZobbrihOZ+1a9asOXnypFarrf8SiqJyubyysvLDDz9csGDBV199tWvXrjrPLhEE4fV6eTwehmEMw9TW1pIkGS+jRlGUx+N5vV65XM7n83Nycs6dO7dq1apnn332goHVFwgEVq9enZub22A/GxwOR6PRrFq1asqUKX379mUn4ji+cuVKlUolEokaXCQ/P/+zzz6bPHnyFVdc0YKQGsTmmt977z2LxZKXl9fgPHl5eT/++OPmzZunTZuWrO2mLY/Hs27dury8vAbrmLhcrkajeffddydPnsz29wLveC1DURRJktB0LcBes2164l3Cj3zSNG02m3Ech1pFAEArhUKh6upqmUyWl5eXnl/NAAAdAvu11O/3FxcXN/g1EACQPjrX11cURdkOSVMdSAMYhgkGg2yEqY6l46FpGsfxdG66vXv3GgyGBpO/LIlEUllZuW/fvjvvvDM+cffu3RKJpIn9kslkf/zxx6FDhyZMmNB0AGzvGXK5vLHzH0VRhULx448/UhS1a9eurKysOtUogUAgGo2yGWcOhxOJROoEhmFYLBYLBAJsIbBcLt+3bx+Koi3o83fXrl0nTpyIdzlSn0AgyMzM3L17d0VFBTvl4MGDhw8fjvdtUh+Px5NKpbt27Ro1atTFxtMYiqIMBsOpU6cUCkUTDSuXy7///vsZM2Yka7tp6+effz516lQT/Y2wfYXv2bPn8ssvRxAEw7B0vmzTFkmSBEFA07UAW/vcpicel8tNfFrlkkEQhMlk4nA4er0eahUBAK3B1iqq1eo26hgNANBJUBRlMpkoitLr9Q2WeQEA0solW6cDQFo5d+7cBX+SFYlEf/31V+KUv/76qzlLnT179oIBOByOgwcPNt0LhEgkOn78uNFobHC70Wj0gj/eYBiG4zj7d0ZGxtGjR9lOoi9WM3f83Llz8X+eO3dOKBQ2HWGdRZKiqqrq3LlzTSfZMzIyDAYDSZLJ3XQaOnfu3AV7GsnIyEj6UQAAtKlwOFxZWSkSibRaLWSfAQAtxtYq2mw2rVYL2WcAQGvgOF5ZWcnlcnU6HWSfAegQOlcFNACpEo1GL/hcNoZhkUgkcQqO481ZKp7zbQI7T9P5WRRFURSNRCINbpem6eY8PRDv85educ4eNVMzdzxx5Ulsq4uC4/gFm4XtRzsajV7yfSY0szVadlYAAFLC4/HU1tZCrSIAoJUoiqquriZJsmvXrpAtAgC0RiAQMJvNCoVCpVKlOhYAQHNBBTQA7UGpVMZisabnicVidQbtValULViqsQB69OhBEEQT8xAEwTBMXl5eg9vl8Xjx5DLSSC6bYZh4jpUgiLKyspYNQ5ybm3uxO57EtrooSqWSJMnElmlwuxKJRCwWJ3fTaSg3N7fpcwxBEIIgYHBqADoEhmFsNpvVaoVaRQBAK8VisaqqKgzDoFYRANBKLperuro6Pz8fss8AdCyQgAagPVRUVASDwSY6BmV7Jo33aBxfKhAINJHcJAgiEonUWapBYrG4V69efr+/iXn8fv/YsWM1Gs3gwYPrzykWiymKYv9mGIbD4dQPjKZpiUQSX1tJSQnbH/TFqqiowHG8iYQywzCBQCBxxwcPHhyNRqPRaBOr9fv9zWmri1JWVjZgwIBAINDO201PFRUV4XC4ic5G6h84AEB6omnaZDIFAgG9Xt8Zfj8DALSdYDBYWVkplUqLioou4ZFaAQBtjWEYs9nsdDqLi4ulUmmqwwEAXBy4AwCgPVx55ZWjR492OByNzWC328ePH18nMTdu3LhBgwa5XK7GlrLZbFOmTOnZs2dzYrjjjjs8Hk9jKVqCIFwuFzsE4pQpU4qLi+skVSUSiUwmY+tbCYLIysqqU/lLEERmZiabgI7FYvG1tUBpaem0adNsNltjM7jd7v79+ycOvVhUVDRr1iybzdZYvt7j8fTu3fvGG29sWUiN4fF4t912m91uj2fn6wiHw4FA4I477kjudtNT7969J02aZLVaG5vB6XRWVFRcc8017RkVAOBixWKxyspKBEF0Ol0LBpIFAIA4t9ttMpnUajU8/wQAaA2SJKuqqmKxmF6vv+BwQQCANAQJaADaA5fLfeGFFwoLCx0OR50MKfuMs06ne/755+tUhYhEoueffz4vL69+Dpqm6dra2vLy8meeeaaZMVx55ZWPPvpodXV1/R54o9GoyWS65557rrvuOgRBioqK5syZU1NTUycHrdFo+Hw+juNSqbSwsJDt9YLdHZIk+Xy+RqNBURTHcZPJdP/9948dO7aZsdX39NNP9+7du6ampn7ZuNvtdjgczz77bJ2ivCeeeKJfv34Wi6X+Ih6Px2azPf3001lZWS0OqTF33XXXxIkTq6ur6/c+EQwGzWbz4sWLy8vLk77d9PTcc8+Vl5fX1tbW/yXA6XSq1ernn39eKBSmJDYAQHOwtYoSiUSr1UKtYrPhP712523vnLj0R5sFoNkYhrFYLA6Ho7i4uC1uwAAAnQc75KBQKCwuLr7kh9UB4FIF3ysAaCe9evVatmxZt27dqqqqnE5nMBgMBoNOp7OysrJXr17vvPNOaWlp/aUGDx786quvdunSpaqqyuVysUs5HI6qqqoBAwYsX768sLCw+THMmzdv7ty5RqPRbDb7fL5QKOTz+axWq9FonD179iuvvBLPNUyZMmX58uVyudxoNHo8nmAwGAgEfD4fwzAajYamabfbLZVKs7OzcRzHcZzL5bL9XFssFoPB8Oijj77wwgvNGbSwMRqNZvny5YMHD66srHQ4HIFAIBgMut3u8+fPFxUVffXVV8OGDauziFKpXL58+YgRIyorK+12e3wRg8GQn5//xRdf/OMf/2hxPE3g8/lvvvnmlClTqqqqrFar3+8PhUJer7e6ulomk7322mszZ85si+2mJ61W+9577/Xr1489cOwZ63K5qqqqdDrd66+/PnDgwFTHCABoVLxWUa1WpzqWjoRx7lj2zjf7znoa7WkLgE6GoiiDwRCNRqFWEQDQSj6fr6qqSi6X5+fnt+YLJgAgteC3IwDaT9++fTdv3rxx48Y9e/ZYLBYURQsKCkaNGnXTTTc1cWs+dOjQLVu2rF+/fv/+/bW1tRwOR6vVXnXVVRMnTrzYJ6O5XO4TTzxx7bXXbtq06ejRoz6fLzMzs6Sk5Prrrx8+fHidmSdPnjx8+PD169cfPHjQ6XQKhcJu3bpdc801V1xxxebNm3fv3m02m4uKijIyMjAMIwgiFAplZmZefvnlN9544+WXX96SBvq74uLi9evXb926defOnQaDgSTJvLy8oUOH3nrrrY0Nh1VYWLh27dqvv/56x44dVVVV7Hh37CIKhaL1ITVGKpW++eabN99881dfffXHH39EIhGFQjFgwIBbbrlFp9O13XbTU2lp6caNGzdv3rxr1y6j0UhRlEajGT58+KRJk6CzNgDSFsMwVqvV5/MVFxdDtqjZqIjLdPLI3jWLF6y30dC/AAAs9mE4kUiUn58PD1IAAFrD4XA4nc7CwsLMzMxUxwIAaBVIQAPQrsRi8bRp06ZNm3ZRS8lkshkzZsyYMSMpMfTs2TPebTTDMC6Xq7HhyPPz8x955JH606dOnTp16tSkBNM0Ho9300033XTTTc1fhMvlXn/99ddff33bRdWY4cOH18/jd058Pv/WW2+99dZbUx0IAKBZKIoymUwURen1+sY+EUB9jGPtDd0f3PGfsRUgywYAgiBIIBAwm80KhUKlUqU6FgBAB0bTtNlsxnFcp9MJBIJUhwMAaC1IQAMAAAAAdF7xWkXo9Pliodnjln5X7qURxrXtwclvmVMdDwAp53A4HA5HQUEBPPMEAGgNgiBMJhOGYTqdDjp9BuDSAFcyAAAAAEAnxdYqyuXy3FzoQOLicXO69ctBEISxnpBC6h50buyQg+FwWKfTwWjDAIDWCIfDJpNJKpWq1Wro9BmASwYkoAEAAAAA0g7DMKFQKHGKWCxO7iZcLpfNZoNaRQDSRJ1LnmGYpKyWpml2rI74lKS/mZAkaTQaURSFWkUA0kTiJR+NRimKSspqGYYJh8OJAxEl/f3E5/NZLJbc3Nw2HcIHANB8ie8nNE23+P4E7g8AAAAAANIOwzCRSCRxShK/47G1iqFQCIYcBCB91Lnkk5WApiiKJMnElSc3YYTjuNFolEgkGo0GahUBSBOJl3wsFqNpOimrpWkax/E2ej9hGMZut7vdbq1Wm/S8NgCgxRIveZqmW/x+AgloAAAAAIC0g2FYGw34TpJkdXU1wzB6vR5qFQFIH3Uu+WQlczkcDp/Pb6P3E7ZWUalUKpXKtlg/AKBlEi95oVDI4XCSsloMwyQSSVu8n9A0XV1dHYvFYMhBANJN4iXP4XBaPGYMfOsAAAAAO9CLvwAAFe9JREFUAEhHbfEFjK1VFIvFGo0GhhwEIK3UueSTlYDGMIzD4bTF+4ndbne5XEVFRRKJJOkrBwC0RuIlz+PxkvWJj6Ion89P+vtJLBYzGo08Hk+n0yUrVw4ASJbESx5F0Rbfn0ACGgAAAACgU/D7/WazGWoVAQCtRNO02WzGcRxqFQEArRQKhaqrq2UyWV5eHnTjA8AlDBLQAAAAAACXPofD4XQ6CwsL2+hJfABAJ0EQhMlk4nA4er0eahUBAK3hdrutVqtarc7Ozk51LACAtgUJaAAAAACASxk75GA4HIZaRQBAK4XDYZPJJJVK1er/b+/ew6Mo7wWOz+wtWUg2m839TnYVCqEqwcZ6sFbgmHK4eAn4gFZrASmIolZ6bL0VfSzWVkUtWGpRQARvIFIgoPXaU5RT6yOEAh6VQLJJyD2b62aT3Z05f6wgWJJsNpmdvXw//2Xzzry/Z/Puu5nf/OZ9M6hVBBAwthwEog0JaAAAgIjlq1XUaDRWq5UtBwEMhcPhqK2tTU9Pt1gsascCIIx5vd6qqiqPx3Peeefp9Xq1wwEQDFyHAAAARCZqFYNDTF/wbvMCtaMAFEStIoDh4ttyMCYmxmq1sh8yED1IQAMAAESgtra2mpqatLS0pKQktWMBEMYkSaqqqnK73TabzWAwqB0OgDDW2dlZVVVlsVjS0tLUjgVAUJGAhgrsdntpaenhw4fb29stFkthYeHMmTODcHmsVr8AAARZQ0NDc3Nzbm5uXFyc2rEACGO+WkWDwUCtIoAh8m05mJmZaTab1Y4FQLCFRgJaail7Y+OrHx6s7IjLu2jKvPmzL0z8t6dE+2rjz7EIGZIkPfvss5s3bz5+/PjIkSO1Wq3H43nppZeef/75O+6447rrrouwfgEACDJJkqqrq3t6ethyEMAQ+WoVzWZzRkaG2rEACGOyLJ88ebKzszM/P99oNKodDgAVhMJNbG/l9kdXbqvKnnXHL5fNyqx8feVjO6q8frbx51iEkEceeeSBBx5ob2/Py8tLTk5OTExMSUmxWq11dXULFizYuHGjKv1u2LBBoX4BAAim3t7e8vJySZLIPgMYopaWFrvdnpGRQfYZwFB4vd6Kioqenh6bzUb2GYhaIVAB3Xto9+4T2bOfXjItRysI45Nbj/1iV+mRGUsuMAzc5jtHBj4WIeOtt9564oknRo0a9e+XxAkJCVqt9vbbby8qKho3blww+9XpdMuWLSsqKiooKBjefgEACCa2HAQwLGRZrqura2tro1YRwBC5XC673W40GrOysljGB4hm6n/+vVVHPu9ML5yYqRUEQRC0uRMnpLZ/frRW8qON249jETpeeOGFpKSkvgqy4uLiTCbT+vXrh73f9evX99PvyJEjFeoXAICgcTgcFRUVaWlpmZmZZJ8BBMxXq9jV1UWtIoAh6ujoOHHihNlszsnJIfsMRDn1pwCpqaFJTkqxnIpEY0mxyE0NjZIfbTx+HIsQUV1dvWfPnoSEhH7aJCQk7N+/3+12D2O/NTU1paWlwe8XAIDgkGW5vr6+rq4uLy8vMTFR7XAAhLGenp7jx4/rdDqr1arX69UOB0AYa2xsrKqqysrKSk1NVTsWAOpTfwkOb2+PRzQajadKdUSjMVbs7emV/WjjGejYFStWlJaWnj6PyWRqamoK5bIgj8fT1NSkdhSKOHr0qCiKoih6PJ6+2mi12gMHDnz11VeBfUWd8607cuSIP/0ePHjwyy+/TEtLC6DfCOB2uyN14AUBb13Aent7efcCxlsXMEUHXldXl04X1H+uvF5vVVWVx+Ox2WwGA0uQAQhcR0dHdXW1xWKJ2n+JAQwLWZZramqcTqfVao2NjVU7HAAhQf0EtNYQo5Xbul2yECsKgiDI3d0uWR9v8KfNgMdmZmaOHTv29I+1tbU6nS5kE9Aej0cURa1Wq3YgivCtgDHgmz9mzBiDwRDA1bvX6z3nW+dPv6IoBtxvBIjsgacoWZYlSeKtC4zH49FoNDyLFwAGXsBkWfZ6vYrOeBqNJpj/ZvT29lZWVhoMBqvVyqcJwFA0NzfX19dnZ2ebTCa1YwEQxjweT2VlpSiKVqs1Oq+vAZyT+tOBJiklWTzR7JAEs1YQBEFqbW4VkwqSNH600Q107OLFixcvXnz6PMXFxWazOTQT0LIsNzc3a7Vas9msdiyKKCgoGDt2rMvl6mstZkEQnE5nampqAFfRkiS1t7ef860bP368P/2mpKTYbLYovHr3DTydTtf/KiU4J6/X29HREamfWUVJktTS0qLT6bjKDYDH4+nq6uIzGwCv1+twOPR6vXIDz2g0SlKQVgLr7OysqqqiVhHAEMmyfPLkyc7OTrYcBDBELpersrIyLi6OHSkAfIv66TZtbsHYkbUHyxp962ZIdWWH6uLHFWRp/Whj8ONYhIjk5OQLL7zQ4XD008bhcEyePHl4s8BJSUkXXXTRgP1eccUVUZh9BgCEqZaWFrvdnpGRQfYZwFD4thzs6elhy0EAQ9TW1nb8+HGLxZKVlUX2GcC3hEDGzXDB9Om5FVtXv/xJedWx/ZvXbK+yzZw+3iAInvJ3N65/7R/1Ut9t+jwWoWjp0qWtra2dnZ3n/G1LS8uYMWMWLlw47P3eeuut/fTrcDjGjBlzyy23DHu/AAAMO9+6ig0NDfn5+TyBAWAoXC7XsWPHdDrdqFGjeFIewFA0NDTU1NTk5OSkpKSoHQuAUBQCCWhBZ51z7z3/ZfzfNb+6674/fRo/85e/vDZPKwiCp+afu3e+d7hF7qdNX68jFBUWFq5du7a6urq5uVmWv9lmUpKk+vr6tLS0hx9+ODMzM8j9pqamKtQvAADDy1er2N3dTa0igCFqb2/31Srm5OTwICCAgEmSZLfbW1tbbTZbfHy82uEACFGhcaNbm3LxjQ9cfOO3Xo29/N5tlw/Qpu/XEZJuuummtLS0VatWffzxxyNGjNDpdG632+l0FhcX33///YWFhRHWLwAAw8XlctntdqPRmJeXR7YIwFA0NjY2Njbm5OSQLQIwFG632263a7Vam83GFtkA+hEaCWhEk+Li4ssvv/yjjz46dOhQR0dHYmLixIkTL7nkEqW/rs7Zb1FREc8bAgBCX0dHR3V1dVJSUmpqqtqxAAhjvmV8nE6nzWbrZ49uABiQ0+m02+0mkykjI4NFnwH0j9QbVBAbGzt16tSpU6dGSb8AAAxFc3NzfX19dna2yWQarnN2dXV1d3cnJCTo9frhOuewkySppaVFr9cnJCQM86lHDucJOzs7XS6X2WwO5bvaXq/X4XAYDIZhHEVK6Ojo6OnpSUxMDOVKOo/H09raGhMTE3blw75aRY1GY7Vah3G4NjU16XS6EF+V3jfpmUwmgyF0dwySZbm5uVmRSW9Y+Sa96P0GGVa+SS/Ev0HOyeFw1NbWpqenWyyW4Tpnd3d3V1dXfHx8iN8ea2pq0mq1iYmJagfSH6fT6XQ6Q/zN9E16fIMMi9Cf9MJsjgMAAIgevlrFrq6u/Px8Fn0GMBTUKgIYFrIsNzQ0tLS05OXljRw5Uu1wAIQHEtAAAAChyOPxVFZWiqJos9nCrjAKQEhpa2urqalJS0tLSkpSOxYAYcy35aDb7bbZbKFcDQog1LCDDQAAQMiRZbm8vDw2NjY/P5/sM4ChcDqdJ0+ezM3NJfsMYChkWa6oqBAEIT8/n+wzgEGJruuZuLi4UF7/V5IkQRDY1z4wsizzLGFgJEkSRZF3LzAMvMDIsizLssCMFygGXsCC8FW7aNGiYTmPTqdbsmSJcn9o32cw9AdSWMQZFkEKYRJnWAQphE+cgiB4PJ7S0tK9e/cq10VYvBthEaQQJnGGRZBCmMQZnCCvvfbaYTmPXq9fvny5cv9HhcWfTAiTOMMiSCFM4gyLIIVgxRnwDCD64oPqXC7XZZddNm7cuE2bNqkdC6JIW1vb1KlTJ0yYsG7dOrVjQRSpr6+fMWPGpZdeunr1arVjQRSprKycPXv25MmTH3/8cbVjAQAAAIBoQekZAAAAAAAAAEARJKABAAAAAAAAAIogAQ0AAAAAAAAAUER0bUIYyrRabUlJSXp6utqBILoYDIaSkpLs7Gy1A0F0MRqNJSUl+fn5ageC6BIfH19SUjJ69Gi1AwEAAACAKMImhAAAAAAAAAAARbAEBwAAAAAAAABAESSgAQAAAAAAAACKYA1o9UgtZW9sfPXDg5UdcXkXTZk3f/aFieLZLWTH3l/fsrbMffoFbdbs3625ebQ2yJEiQgw85PxrAwwKcx1UJNft+vVvGuc9s6DgXMOJGQ8AAAAAlEcCWi3eyu2Prtzm/eH8O+YlNf7P5g0rH9M++ei1OWddIEsNdQ3i6Fl3lxQYfC+IxqxMitYRGH+GnD9tgEFhroN6ZFfNBy/tOOwsks75a2Y8AAAAAAgGEtAq6T20e/eJ7NlPL5mWoxWE8cmtx36xq/TIjCUXGM5o5G6od5jO//4P/uO7XA5jqPwZcn4NS2AwmOugDrnx/VUrNuyvae+VheRzN2HGAwAAAICgoMRMHd6qI593phdOzPRlW7S5Eyektn9+tPasIi2psb5BTs1IlbodDU0dblmVSBEh/Blyfg1LYDCY66AS0Vw4d/mKx55cMWd0H7famfEAAAAAIDiogFaH1NTQJCelWE7dANBYUixyU0OjJOR9c09Aaqxt9DS+/9sFG060eQVd/KhJNyy7dfp5I1igEoPnz5Dza1gCg8FcB7Xozdk2syA7vjL2MZCY8QAAAAAgOLjIUoe3t8cjGo2nL4tFozFW7O3pPbPyT+5ocriNcbZZD2/cuvWlNb+aHnfw+Uef/2cn1YEIgD9Dzp82wKAw1yFkMeMBAAAAQHBQAR0k7n+suvHRD7tlQRDjpjzw4m2GGK3c1u2ShVhREARB7u52yfr4s9adFBOLf/1q8amfcoquv73k4G2v/a1sUdEkY7DDR9jT+jHk/GkDDIo/g4q5DqpgxgMAAACA4CABHST6wiV/3rRAlgVBFA0j9JrKlGTxRLNDEsxaQRAEqbW5VUwqSOqvIl2TnJUZ43Z0uGShrweKgb5okgYecv60AQYlkEHFXIegYMYDAAAAgODgOitY9CMSEsxms9mckDBCL2hzC8aOrD1Y1uh71FeqKztUFz+uIEt7xhHO/WtuXfr0vrZTTwN7a8orexNzcuLJyGDw/Bly/rQBBoW5DiGLGQ8AAAAAgkP70EMPqR1DVNKmJPd+su3Nz9w5oxK7v9j53Iufmq9eesN3zRpP+bubdvyzJ3NcttmiqdyzZVdZT2Ky0d305d+3PLftWN71t103hqwMAuDHkIvT9dVG7eARvpjroC7XsQ92HTVdcdXFab6JjBkPAAAAAIKNBLRaNIljC/NdZaWvbNn6dlln3vTb75wzdqQoCL2HX3ts42cJk2YUpsRmTiga5fr8/Z3btu/96AtH/IR5dy0tzjWQkkFA/Bhymr7aAAFjroOqvp2AZsYDAAAAgGATZZn93gEAAAAAAAAAw48HTQEAAAAAAAAAiiABDQAAAAAAAABQBAloAAAAAAAAAIAiSEADAAAAAAAAABRBAhoAAAAAAAAAoAgS0AAAAAAAAAAARZCABgAAAAAAAAAoggQ0AAAAAAAAAEARJKABRJQDD47Xa3Nu/8B99su9xzbNHWXQxBfe/dcGSZ3IAAAAAAAAoo9O7QAAQGmeilcXTlu0tWnssm17nyhO5cYbAAAAAABAkJCABhDZvNXbl0z76cu1o299/e2npqWRfQYAAAAAAAgecjEAIphUW7ps2o0b7LZFr7z9hxnpg5/xvG53/yt2DNgAAAAAAAAgipGABhCppIa/Lp8+97nyvAUvv/3sVZnaM37Vc2LPb+dPHZ9lNhpi4lKs37t6+Ytl7fKpX755Q3zMJSvf2XHPlflmY4w+1pw78er/3vwv/xsM2AUAAAAAAEB0YAkOABFJav7wwZlznjk04qoX3lp7TfaZ2We5ftvCy+e90mq9cu7PZucanZX7d7z+1IJP6uIPby5JEn1tvMf++JPr693nT5//8zGG6o92/uXJm//+acPf3r77uwZ/GvjTBQAAAAAAQOQjAQ0g8kiOfQ9dterxsl697Pzs/c9abs5LPSPr2/HBKztOmq5+cd8bN/pelu66+Mrzlv3tvTJ3yZSv88tSS51wzZ/3v7Lw/FhBEKQV79x95azVD9+35fqd8zPEgRv40wUAAAAAAEDkYwkOABFHrn11xe+PjnvwnX+snWmpeXnZnVtrz1ynOe6aDfbGE1uuP52U9vb0SILscXvOaKQbt2jFzefH+n7QpP7nintnmTrff/Mdh+xPA7+6AAAAAAAAiHhUQAOIOLIY//37du5e8YNEOf+JXRfPf/3OO2ZNeu2GrK/vuGliTab2A7vX7fn40BfHK+wVXx05XN7UI6addY4RF078zhkTpGiaWPQd7Y7jX1V4BcuADXR+dQEAAAAAABDxqIAGEHE06TesfPAHiaIgaHJuXLPq2tSG7T+/7SX711XQsuPD+yaNvnjuiq1Hu5PHT5l315Pb9//5OtO/r8x81iuiRqsRBckr+dPA7y4AAAAAAAAiGxXQACKPRiOeSvZqsq7/w1M7P/7xtl8s3fDDvywcpZXsmx966tPYOS8ffGVu+tf34Lq3/1GSzz6F818HvvBcfcHpObLj4Kf/59F9z5qjFQTvAA387AIAAAAAACDiUQENIMJpMuc+88zcDMfee5asK/cKUktDk0djsdmSTs1/vRVvbt3X/a2jPEfWPbLleK/vB6npw5WP7nAYJ11dnCIO3MDPLgAAAAAAACIeFdAAIp6YPufp1bv2Xbfl3sVrp7x1y7Rp1t89tfon86RbrswT649+8NqrB2RzvNCw/7UN74768dTRekEQhNjMmI+XXHrpzjlXjtFX73vzjX3VMZc+8vuf5p6+a9dPA83YgbqIYzUOAAAAAAAQFaiABhAFxNRrnlxzU3bH+/f/bPWJot/s2rJ88ogD61fc8/Bzeyvy7tpb9smmuy9LKt/8q8ffa/atkyGafrT679uX5Bzb8cdVf9pZbp5y5/MflN5baPzmjP01iJ3kRxcAAAAAAACRT5RlUiEAcIaeN29InvPevD1V635kCKwBAAAAAAAABEGgAhoAAAAAAAAAoBAS0AAAAAAAAAAARbAJIQCcTZNeOG2m5oKUPm/QDdgAAAAAAAAAgiCwBjQAAAAAAAAAQCEU8AEAAAAAAAAAFEECGgAAAAAAAACgCBLQAAAAAAAAAABFkIAGAAAAAAAAACiCBDQAAAAAAAAAQBEkoAEAAAAAAAAAiiABDQAAAAAAAABQBAloAAAAAAAAAIAiSEADAAAAAAAAABRBAhoAAAAAAAAAoAgS0AAAAAAAAAAARZCABgAAAAAAAAAoggQ0AAAAAAAAAEARJKABAAAAAAAAAIogAQ0AAAAAAAAAUAQJaAAAAAAAAACAIkhAAwAAAAAAAAAUQQIaAAAAAAAAAKAIEtAAAAAAAAAAAEX8P5VHNd58Sa9LAAAAAElFTkSuQmCC" width="1536"></p>
</div>
</div>
<div id="column-1" class="section level2 tabset" data-width="45">
<h2 class="tabset">Column</h2>
<div id="individual-results" class="section level3">
<h3>Individual results</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><a name='648'></a></p>
<div
id="coronis-collaborative-group-2013-caesarean-section-surgical-techniques-coronis-a-fractional-factorial-unmasked-randomised-controlled-trial"
class="section level4">
<h4>648.
<a href='https://doi.org/10.1016/S0140-6736(13)60441-9' title='Open publication'>CORONIS
Collaborative Group (2013): <i>Caesarean section surgical techniques
(CORONIS): a fractional, factorial, unmasked, randomised controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial based on the provided full text:

Eligibility:
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.&quot;</span>

The eligibility criteria seem very inclusive, with few exclusions besides having had more than one previous C-section or already being recruited to the trial. The criteria match what would be used in usual practice.

Score: [5] 

Recruitment:
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent. Information leaflets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up. The trial was discussed with all eligible women and their partners and relatives as appropriate. If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting (eg, a thumb print).&quot;</span>

Recruitment seems to occur through routine prenatal care. No special efforts like advertising or incentives are mentioned.

Score: [5]

Setting:  
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.&quot;</span> 

The settings seem to be routine maternity care facilities where C-sections normally occur. 

Score: [5] 

Organization:
No details provided on staffing, resources, etc. But given the pragmatic nature of the other domains, it seems reasonable to assume organization mirrors usual care.

Score: [5] 

Flexibility (delivery):
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.&quot;</span>

The interventions were protocolized but other aspects of care were flexible.

Score: [4]

Flexibility (adherence): 
- No mention of special efforts to enforce adherence beyond routine clinical encouragement. Compliance was assessed but not enforced: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Compliance with all the allocated interventions was high, 87% overall.&quot;</span>

Score: [5] 

Follow-up:
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.&quot;</span>

Follow-up schedule seems reasonable for a post-surgical trial and does not seem excessive.

Score: [4]

Primary outcome: 
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.&quot;</span>

The composite outcome consists of major clinical events that would be of clear importance to patients.

Score: [5]

Primary analysis:
-<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Women were analysed in the groups into which they were allocated; for example, comparing women allocated to blunt abdominal entry with those allocated to sharp abdominal entry, regardless of what interventions they actually received.&quot;</span> 

Analysis seems to be intent-to-treat.

Score: [5]</pre>
<p><a name='650'></a></p>
</div>
<div
id="van-dijk-de-vries.-a-2015-lessons-learnt-from-a-cluster-randomised-trial-evaluating-the-effectiveness-of-self-management-support-sms-delivered-by-practice-nurses-in-routine-diabetes-care"
class="section level4">
<h4>650.
<a href='https://doi.org/10.1136/bmjopen-2014-007014' title='Open publication'>van
Dijk-de Vries. A, (2015): <i>Lessons learnt from a cluster-randomised
trial evaluating the effectiveness of Self-Management Support (SMS)
delivered by practice nurses in routine diabetes care</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 99.1%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning:

Eligibility:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with score DFT >4 and DS >3 were eligible for trial participation.&quot;</span>

Reasoning: The trial recruited patients with an existing diagnosis of type 2 diabetes from routine primary care practices. However, additional eligibility criteria of DFT>4 and DS>3 on screening questionnaires were used to select patients for the trial. This introduces some exclusions beyond usual care.

Score: [3] 

Recruitment:

Relevant quotes:
<span title='Moderate quote deviation. Best match in fulltext (Similarity 90%):

s were sent a letter by their GPs to introduce the SMS project.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patients were sent a letter by their GPs to introduce the SMS project.&quot;</span> 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.&quot;</span>

Reasoning: Patients were recruited through letters sent by their regular GP introducing the study. This reflects routine practice recruitment fairly well. However, the use of screening questionnaires deviates somewhat from complete usual care.

Score: [4]

Setting: 

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.&quot;</span>

Reasoning: The study was conducted in routine primary care settings, reflecting the setting where the intervention would be delivered in usual care.

Score: [5]

Organization:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎PNs in the intervention arm were trained to integrate the detection and follow-up phase of SMS into their daily practice.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.&quot;</span>

Reasoning: There was some additional training and reimbursement provided to deliver the intervention, but it does not seem substantially different from resources in usual care.

Score: [4] 

Flexibility (delivery):

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.&quot;</span>

Reasoning: The intervention involved following some specific techniques and tools, suggesting reduced flexibility versus usual care.

Score: [3]

Flexibility (adherence): 

Relevant quotes:
No relevant quotes found.

Reasoning: The text does not provide enough information to assess flexibility in adherence/compliance.

Score: [NA] 

Follow-up:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were measured at baseline and at 4-month and 12-month follow-ups.&quot;</span>

Reasoning: Follow-up measurements were more frequent than in usual care.

Score: [2]

Primary outcome: 

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The effect of SMS on patients’ daily functioning was measured by means of the DFT.&quot;</span>

Reasoning: The primary outcome of daily functioning is patient-centered and clinically meaningful.

Score: [5]

Primary analysis:

Relevant quotes:
No relevant quotes about analysis found.

Reasoning: The text does not provide enough information about the primary analysis.

Score: [NA]</pre>
<p><a name='651'></a></p>
</div>
<div
id="price.-d-2011-leukotriene-antagonists-as-first-line-or-add-on-asthma-controller-therapy"
class="section level4">
<h4>651.
<a href='https://doi.org/10.1056/NEJMoa1010846' title='Open publication'>Price.
D, (2011): <i>Leukotriene antagonists as first-line or add-on
asthma-controller therapy</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 scores for each domain based on the provided full text:

Eligibility:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta2-agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire27 [ACQ]).&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Main exclusion criteria were prior treatment within 12 weeks with an inhaled glucocorticoid or LTRA (in the first-line controller therapy trial) or LTRA or LABA (in the add-on therapy trial).&quot;</span>

The eligibility criteria are relatively broad, focusing on impaired asthma control or quality of life. There are some exclusions based on prior treatment, but overall the criteria seem fairly similar to real-world practice.

Score: [4] 

Recruitment:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Study enrollment is shown in Fig. E1 and E2 in the Supplementary Appendix; additional results are detailed in Tables E1 through E28 in the Supplementary Appendix. In both trials, the reason for most exclusions after randomization was a missing MiniAQLQ or ACQ score or a baseline score that was not within the specified range for eligibility.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The trials were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician's diagnosis of asthma.&quot;</span>

Patients seem to be recruited through regular primary care clinics, suggesting a pragmatic approach. However, there is limited detail provided on recruitment methods.

Score: [4]

Setting: 

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician's diagnosis of asthma.&quot;</span>

The study is conducted in primary care settings, which matches real-world care.

Score: [5]

Organization:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.&quot;</span>  

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients who withdrew from the study continued to receive care from their usual clinician.&quot;</span>

The organization of care seems very similar to real-world practice - patients received individualized treatment plans per normal guidelines, and withdrew patients continued usual care.

Score: [5] 

Flexibility (delivery):

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment with either an LTRA (montelukast or zafirlukast) or an inhaled glucocorticoid (beclomethasone, budesonide, or fluticasone) in the first-line controller therapy trial and with either an LTRA or LABA (salmeterol or formoterol) together with an inhaled glucocorticoid in the add-on therapy trial.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.&quot;</span>

There was some flexibility in drug choice and delivery per usual care. However, the protocol discouraged changes for the first 2 months, indicating some explanatory aspects.

Score: [3]

Flexibility (adherence):

Quotes:
None relevant.

No information is provided about encouraging or measuring adherence.

Score: [NA] 

Follow-up:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.&quot;</span>

Follow-up assessments were scheduled but don't seem overly intensive compared to real-world care. Data was collected blinded to minimize bias.

Score: [4]

Primary outcome:

Quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was the MiniAQLQ score.&quot;</span>

The MiniAQLQ measures asthma quality of life, which is relevant and important to patients.

Score: [5]

Primary analysis:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.&quot;</span> 

The primary analysis was intention-to-treat, a pragmatic approach.

Score: [5]</pre>
<p><a name='655'></a></p>
</div>
<div
id="galdiz-j.-b.-2020-telerehabilitation-programme-as-a-maintenance-strategy-for-copd-patients-a-12-month-randomized-clinical-trial"
class="section level4">
<h4>655.
<a href='https://doi.org/10.1016/j.arbres.2020.03.034' title='Open publication'>Galdiz,
J. B. (2020): <i>Telerehabilitation Programme as a Maintenance Strategy
for COPD Patients: A 12-Month Randomized Clinical Trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning for the given trial:

Eligibility: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, 134 patients were screened and 94 were eventually randomized into two groups: 48 to the CG and 46 to the IG.&quot;</span>

Reasoning: The study had broad inclusion criteria, enrolling patients with moderate-to-severe COPD who were clinically stable. There were some exclusions like those with significant cognitive impairment. The eligibility seems similar to what would be used in usual care.

Score: [4] 

Recruitment:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.&quot;</span>

Reasoning: Patients were recruited during their participation in an initial 8-week PR program. This seems like routine recruitment through standard clinical appointments. No special efforts like advertising or incentives were mentioned.

Score: [4]

Setting: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.&quot;</span>

Reasoning: The study was conducted across 13 hospitals, suggesting a varied real-world setting similar to usual care.

Score: [5]

Organisation:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.&quot;</span>

Reasoning: The intervention involved providing some additional equipment like mobile phones and pulse oximeters to enable remote monitoring. But it did not seem to increase staffing or training significantly beyond usual care.

Score: [4]  

Flexibility (delivery):
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.&quot;</span>

Reasoning: The intervention group had a structured program to follow with training 3 times per week. This reduces flexibility compared to usual care.

Score: [3]

Flexibility (adherence): 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.&quot;</span>

Reasoning: The control group received usual encouragement to exercise regularly as part of standard care. The intervention group had their adherence more closely monitored. This reduces flexibility in the intervention compared to usual care.

Score: [3] 

Follow-up:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.&quot;</span> 

Reasoning: Follow-up schedule of 3, 9 and 12 months seems reasonable and similar to usual care. No mention of more extensive or frequent data collection.

Score: [4]

Primary outcome:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.&quot;</span>

Reasoning: The 6MWT is a relevant and validated outcome measure for exercise tolerance in COPD patients. It is important to patients and feasible to implement in usual care.

Score: [5]

Primary analysis:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All patients were analyzed in the group to which they were randomized.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Missing values were not imputed. All patients were analyzed in the group to which they were randomized.&quot;</span>

Reasoning: Analysis seems to follow intention-to-treat principles with no exclusions. 

Score: [5]</pre>
<p><a name='657'></a></p>
</div>
<div
id="arntzen-e.-2019-group-based-individualized-comprehensive-core-stability-intervention-improves-balance-in-persons-with-multiple-sclerosis-a-randomized-controlled-trial."
class="section level4">
<h4>657.
<a href='https://doi.org/10.1093/ptj/pzz017' title='Open publication'>Arntzen
E. (2019): <i>Group-Based Individualized Comprehensive Core Stability
Intervention Improves Balance in Persons With Multiple Sclerosis: A
Randomized Controlled Trial.</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with quotes and explanations:

Eligibility:

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid). The exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Among the 93 individuals who consented to participate, 13 were not included: 5 could not commit the time, 3 scored 0 on the EDSS, 2 did not attend the baseline assessment, 1 was waiting for heart surgery, 1 was pregnant, and 1 had moved out of the catchment area.&quot;</span>

The eligibility criteria reflect typical inclusion/exclusion criteria for an MS clinical trial, including confirmed diagnosis, age, disability level, ability to consent, and excluding acute exacerbations. The EDSS range of 1-6.5 represents a broad range of disability levels among ambulatory patients. Some patients were excluded due to issues not directly related to the intervention itself. Overall, the criteria appear moderately pragmatic.
Score: [3] 

Recruitment:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To ensure maximum patient enrollment, 1 reminder letter was sent out to the nonresponders.&quot;</span>

Patients were recruited through an MS clinic registry, reflecting typical recruitment in clinical practice. One reminder letter was sent to encourage recruitment, but no other special efforts were made. Overall, recruitment was moderately pragmatic.
Score: [3]

Setting: 

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.&quot;</span>

The intervention was delivered in participants' local municipalities by physical therapists working in those areas. This reflects a typical clinical setting.
Score: [4]

Organisation:

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.&quot;</span> 

The physical therapists received specialized training in the intervention, which is more resources than would be typical in standard care. However, they did not require extensive extra qualifications beyond their existing clinical roles. The organization was moderately pragmatic.
Score: [3] 

Flexibility (delivery):

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual's impairments underlying his or her balance disturbance.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The physical therapists individualized the exercises by tailoring them according to each individual's symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.&quot;</span>

The intervention involved an initial individualized examination and tailored selection of exercises for each patient. However, the overall protocol and categories of exercises were standardized. Delivery was moderately flexible.  
Score: [3]

Flexibility (adherence): 

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.&quot;</span>

Patients were encouraged to adhere to the protocol and not receive other physical therapy during the intervention period. However, no specific measures to enforce adherence were mentioned. Adherence requirements appeared moderately pragmatic.
Score: [3]

Follow-up:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments were conducted at baseline and at weeks 7, 18, and 30.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two assessors masked with regard to the group allocation carried out the assessments.&quot;</span> 

Follow-up assessments were more frequent than would occur in standard practice. However, they did not involve home visits or extensive additional interaction beyond the outcome measurements. Follow-up was moderately pragmatic.
Score: [3]

Primary outcome:

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The outcome measures were the Trunk Impairment Scale–Norwegian Version (TIS-NV), the Mini Balance Evaluation Systems Test (Mini-BESTest), and the Patient Global Impression of Change–Balance (PGIC-Balance).&quot;</span>

The TIS-NV and Mini-BESTest are standardized clinical outcome measures focused on balance and trunk control. The outcomes are clinically meaningful for patients.
Score: [4]

Primary analysis:

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.&quot;</span>

An intention-to-treat analysis was used, reflecting a pragmatic approach. 
Score: [4]</pre>
<p><a name='662'></a></p>
</div>
<div
id="bogosian-a.-2015-distress-improves-after-mindfulness-training-for-progressive-ms-a-pilot-randomised-trial"
class="section level4">
<h4>662.
<a href='https://doi.org/10.1177/1352458515576261' title='Open publication'>Bogosian
A. (2015): <i>Distress improves after mindfulness training for
progressive MS: A pilot randomised trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">15 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial described in the full text:

Eligibility:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).&quot;</span>

The eligibility criteria are moderately pragmatic. The trial included patients with progressive MS, which matches usual care. However, participants were screened for distress and excluded if they had severe cognitive impairment or high suicide risk. While appropriate for a trial, these additional inclusion/exclusion criteria make the sample less representative of the full population that would receive the intervention in routine care.
Score: [3] 

Recruitment:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.&quot;</span> 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Reasons for not attending included: medical appointments, planned holidays, pain/fatigue and technical problems, e.g. computer virus, stolen computer, problems with audio.&quot;</span>

The recruitment process was moderately pragmatic. Participants were recruited through advertisements and NHS centers, which requires some extra effort beyond usual care. However, they completed screening questionnaires remotely by telephone. The reasons for missing sessions also reflect real-world situations.
Score: [3]

Setting: 
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.&quot;</span>

The setting is very pragmatic. The intervention was delivered remotely using Skype, matching how it would be implemented in routine practice. No special trial centers or facilities were used.
Score: [5] 

Organization:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.&quot;</span>

The organization is moderately pragmatic. The mindfulness teacher had training in psychology and mindfulness, which provides some additional resources compared to routine care delivery. However, the intervention format and materials were developed specifically for MS patients through case studies, making it more reflective of real-world practice.
Score: [3]

Flexibility (delivery):
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We restricted the number of participants to five for each group based on Skype user guidance, which suggests the quality of videoconferences drops with more than this number.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS, and described homework for the week ahead.&quot;</span> 

The delivery of the intervention has low flexibility like an explanatory trial. The sessions followed a structured manual and participants received audio recordings and guides for home practice. The group size was restricted. This level of standardization is not reflective of how mindfulness training would be implemented in routine care.
Score: [2] 

Flexibility (adherence): 
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.&quot;</span>

The adherence requirements are moderately pragmatic. Participants were encouraged but not required to complete home practice or diaries, similar to routine care. No participants were excluded based on adherence.
Score: [3]

Follow-up:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments occurred between January 2013 and October 2013. The blinded assessor (SW) notified participants by email when questionnaires were due.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the waiting-list group, two participants (9.5%) at post-intervention and three (14.3%) at three-month follow-up failed to complete the questionnaire. In the mindfulness group, two participants (10.5%) did not complete the post-intervention questionnaires and four participants (21%) the three-month follow-up questionnaires.&quot;</span>

The follow-up is moderately pragmatic. Participants completed questionnaires remotely at home like in routine practice. However, the trial required completion of questionnaires at specific timepoints, with reminders if not completed on time. The attrition rate is fairly high.
Score: [3]

Primary outcome:
Quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Higher scores on this scale represent high distress.&quot;</span>

The primary outcome is moderately pragmatic. The GHQ measures general psychological distress rather than MS symptoms specifically. However, it is still a standardized self-report measure unlike outcomes measured in routine care.
Score: [3] 

Primary analysis:
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.&quot;</span>

The analysis is very pragmatic. All randomized participants were included in the analysis following the intention-to-treat principle, similar to how data would be analyzed in routine practice.
Score: [5]</pre>
<p><a name='663'></a></p>
</div>
<div
id="callesen-j.-2020-how-do-resistance-training-and-balance-and-motor-control-training-affect-gait-performance-and-fatigue-impact-in-people-with-multiple-sclerosis-a-randomized-controlled-multi-center-study"
class="section level4">
<h4>663.
<a href='https://doi.org/10.1177/1352458519865740' title='Open publication'>Callesen
J. (2020): <i>How do resistance training and balance and motor control
training affect gait performance and fatigue impact in people with
multiple sclerosis? A randomized controlled multi-center
study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">5 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the provided trial text:

Eligibility:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.&quot;</span>

The trial recruited participants from MS clinics and had inclusion/exclusion criteria typical for an MS intervention trial. While it excluded some patients, the criteria seem generally pragmatic and similar to what would be used in clinical practice.

Score: [4]


Recruitment:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.&quot;</span>

Participants were recruited through MS clinics and advertisements, which required some extra effort beyond routine clinical practice. However, the recruitment still seems reasonably pragmatic.

Score: [3] 


Setting:

No direct quotes, but the paper states the interventions were delivered at local physiotherapy clinics. This matches routine clinical practice.

Score: [5]


Organization: 

No clear quotes, but the interventions were delivered by physiotherapists at local clinics, similar to typical clinical practice.

Score: [4]


Flexibility (delivery):

The interventions had protocols specifying exercises, progression criteria, etc. This provided some flexibility but with more structure than routine clinical practice.

Score: [3]


Flexibility (adherence):

No clear quotes, but no special measures to enforce adherence beyond routine encouragement were mentioned.

Score: [4] 


Follow-up:

Participants were assessed at baseline and after the 10-week intervention period. No unusually extensive follow-up.

Score: [4]


Primary outcome:

The primary outcomes were gait speed (T25FW) and a test of walking requiring multiple direction changes (SSST). These are clinically meaningful for MS patients.

Score: [5]


Primary analysis:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.&quot;</span>

An intention-to-treat analysis was used.

Score: [5]</pre>
<p><a name='664'></a></p>
</div>
<div
id="carter-a.-2014-pragmatic-intervention-for-increasing-self-directed-exercise-behaviour-and-improving-important-health-outcomes-in-people-with-multiple-sclerosis-a-randomised-controlled-trial"
class="section level4">
<h4>664.
<a href='https://doi.org/10.1177/1352458513519354' title='Open publication'>Carter
A. (2014): <i>Pragmatic intervention for increasing self-directed
exercise behaviour and improving important health outcomes in people
with multiple sclerosis: a randomised controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and justifications:

Eligibility:

Quote 1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.&quot;</span>

The eligibility criteria are reasonably broad, including patients with mild to moderate MS who are ambulatory and stable. This is likely similar to eligibility for exercise programs in usual care. However, the upper age limit of 65 excludes older patients who may benefit.

Score: [3] 

Recruitment:

Quote 1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.&quot;</span>

Quote 2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Many eligible PwMS declined to take part in the study without giving a reason (N = 126; 66%) and a more comprehensive understanding of the barriers and facilitators to exercise in PwMS could be used to inform the design of future programmes.&quot;</span> 

Recruitment was done through routine clinic visits and community adverts. No extraordinary efforts like newspaper ads or incentives were used. However, many patients declined to participate, suggesting recruitment was challenging.

Score: [3]

Setting: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.&quot;</span>

The setting included both a specialized research facility as well as the patient's home environment. While not identical to usual care, it does incorporate community-based exercise.

Score: [3]

Organization:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.&quot;</span>

The intervention provided additional training in behavioral techniques and likely had more staffing and resources compared to usual care.

Score: [2] 

Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The home-exercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance.&quot;</span> 

The home exercise portion allowed some flexibility but the supervised portion followed a structured protocol. Overall, there was some but not complete flexibility.

Score: [3]

Flexibility (adherence): 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Using the Transtheoretical Model as a guiding framework, this aspect of the intervention was aimed at equipping PwMS with the skills, knowledge and confidence to engage in a more physically active lifestyle.&quot;</span>

The intervention incorporated strategies to encourage adherence but did not measure or mandate adherence. Flexibility was likely close to usual care.

Score: [4] 

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were blindly assessed by an experienced researcher not directly involved with the day-to-day running of the trial.&quot;</span>

Follow-up assessments were performed by blinded outcome assessors at discrete time points. This is more intensive than usual care.

Score: [2]

Primary outcome:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).&quot;</span>

The primary outcome of self-reported exercise is highly patient-centered and pragmatic.

Score: [5] 

Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.&quot;</span>

The primary analysis was a pragmatic intention-to-treat approach.

Score: [5]</pre>
<p><a name='665'></a></p>
</div>
<div
id="cooper-c.-2011-computerised-cognitive-behavioural-therapy-for-the-treatment-of-depression-in-people-with-multiple-sclerosis-external-pilot-trial"
class="section level4">
<h4>665.
<a href='https://doi.org/10.1186/1745-6215-12-259' title='Open publication'>Cooper
C. (2011): <i>Computerised cognitive behavioural therapy for the
treatment of depression in people with multiple sclerosis: external
pilot trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 97.5%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial based on the provided full text:

Eligibility

Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).&quot;</span>

The eligibility criteria are fairly broad, including adults with MS and mild to moderate depression based on BDI scores. However, some patients are excluded, like those with severe depression, cognitive impairment, psychosis, etc. Overall, the criteria attempt to target patients similar to those who would receive CCBT in usual care, but with some exclusions.

Score: [3]


Recruitment

Relevant quotes:  
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At Sheffield potential participants were identified from clinic attenders, MS nurse patient visits and from patients with MS from the caseload of the neuropsychologist. At the Walton Centre potential participants were identified solely from the MS register.&quot;</span>

Participants were recruited through routine clinic visits and an MS registry, reflecting usual methods to engage patients in care. No extraordinary recruitment efforts like advertising or incentives were used.

Score: [4]


Setting

Relevant quotes:
- <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.9%):

(Sheffield Teaching Hospitals NHS Trust). We reached our recruitment target on 30 July 2009 (in 281 days; 2.6 participants/month) after adding a second centre (The Walton Centre NHS Foundation Trust, Liverpool)' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The study was conducted at two UK centres - Sheffield Teaching Hospitals NHS Foundation Trust and The Walton Centre NHS Foundation Trust, Liverpool.&quot;</span>

The settings were routine NHS hospital clinics rather than specialized trial or academic centers. This matches the setting where patients would receive CCBT in usual care.

Score: [4]


Organisation

Relevant quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The CCBT service provided to trial participants was the routine service provided to all patients referred to the PCT mental health care teams.&quot;</span>

The CCBT intervention arm received the same organizational resources and delivery model as in usual NHS care. No additional staffing, training, etc. was provided.

Score: [4]


Flexibility (delivery)

Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No PCT with whom we worked offered advice or support for defining problems on which to work or applying the CBT model to individual problems.&quot;</span>

The CCBT was delivered according to routine procedures, without extra support or flexibility. This matches usual care.

Score: [4]


Flexibility (adherence) 

Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The advice given was essentially technical, focusing on using the software.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PCTs delivering CCBT reported that they assumed that patients who were non-adherent and non-contactable beyond two weeks had discontinued treatment and made no further effort to contact them.&quot;</span>

No special efforts were made to improve adherence. Patients received usual encouragement and were not excluded for non-adherence. This matches usual care.

Score: [4]


Follow-up

Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Identification of prognostic variables, particularly the EDSS and MS Type, from patient records was not always possible and had to be obtained directly from participants' neurologists for the purposes of the study in some cases.&quot;</span>
- <span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):

collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data collection by postal questionnaire was challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.&quot;</span> 

Extra visits or data collection were not done. Follow-up matched usual care, though some additional coordination was needed to obtain prognostic data.

Score: [4]


Primary outcome

Relevant quotes:  
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants found problems with the face validity of the depression inventories which include somatic symptoms of depression which are also symptoms of MS.&quot;</span>

The BDI is a common depression scale, though participants questioned its face validity. It measures an important outcome but earlier than in usual care.

Score: [3]


Primary analysis

Relevant quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.&quot;</span>

An intention-to-treat analysis was used including all participants as randomized. This matches usual care.

Score: [5]</pre>
<p><a name='666'></a></p>
</div>
<div
id="cutter-g.-2019-higher-satisfaction-and-adherence-with-glatiramer-acetate-40-mgml-tiw-vs-20-mgml-qd-in-rrms"
class="section level4">
<h4>666.
<a href='https://doi.org/10.1016/j.msard.2019.04.036' title='Open publication'>Cutter
G. (2019): <i>Higher satisfaction and adherence with glatiramer acetate
40 mg/mL TIW vs 20 mg/mL QD in RRMS</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are my assessments for each PRECIS-2 domain based on the provided full text:

Eligibility:

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.&quot;</span>

Score: [3]

The eligibility criteria seem moderately pragmatic. They allow a broad range of adult RRMS patients to participate, with some restrictions on prior treatments and disease activity. However, they exclude patients with progressive MS or neuromyelitis optica, which limits generalizability. Overall, a moderate score seems appropriate.

Recruitment:

Quotes: No relevant quotes found.

Score: [NA] 

The text does not provide details on the recruitment methods used in the trial.

Setting: 

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This trial was registered with ClinicalTrials.gov (NCT02499900).&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study protocol was approved by Independent Ethics Committees or Institutional Review Boards according to national or local regulations.&quot;</span> 

Score: [2]

The trial was conducted across multiple countries which suggests a pragmatic setting. However, participants were recruited at study centers and the protocol required ethics approval, indicating a more explanatory design. Overall, the setting seems moderately explanatory.

Organisation:

Quotes: No relevant quotes found.

Score: [NA]

The text does not provide information about the resources, provider expertise, or organization of care delivery compared to usual care.

Flexibility (delivery):

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).&quot;</span> 

Score: [2] 

The treatment duration and scheduled study visits indicate a standardized protocol with limited flexibility in delivery, suggestive of an explanatory approach.

Flexibility (adherence): 

Quotes: No relevant quotes found.

Score: [NA] 

The text does not mention flexibility in adherence or measures to enforce adherence.

Follow-up:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2).&quot;</span>

Score: [3]

Adverse events were monitored throughout the study, indicating moderately intensive follow-up. However, there is no mention of additional unscheduled visits or extensive data collection beyond standard safety assessments. Overall, follow-up seems moderately pragmatic.

Primary outcome:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All endpoints were compared between the GA40 and GA20 treatment groups during the 6-month treatment period. Patient-reported endpoints used self-reported questionnaires, whereas safety endpoints were assessed by the physicians. The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied) (Canuso et al., 2010).&quot;</span> 

Score: [5] 

The primary outcome is patient satisfaction measured by a simple 7-point scale. This is a highly pragmatic choice focused on subjective patient experience rather than an objective biomarker or clinical endpoint.

Primary analysis:

Quotes: No relevant quotes about analysis methods found.

Score: [NA]

The text does not provide information about the primary analysis methods.</pre>
<p><a name='668'></a></p>
</div>
<div
id="dodd-k.-j.-2011-progressive-resistance-training-did-not-improve-walking-but-can-improve-muscle-performance-quality-of-life-and-fatigue-in-adults-with-multiple-sclerosis-a-randomized-controlled-trial"
class="section level4">
<h4>668.
<a href='https://doi.org/10.1177/1352458511409084' title='Open publication'>Dodd
K. J. (2011): <i>Progressive resistance training did not improve walking
but can improve muscle performance, quality of life and fatigue in
adults with multiple sclerosis: a randomized controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given clinical trial publication:

Eligibility

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.&quot;</span>

The eligibility criteria are specific to people with relapsing-remitting MS who have mild to moderate walking disability. They exclude other types of MS and other concurrent medical conditions. Overall, the criteria seem moderately pragmatic and aim to recruit a specific population of interest.

Score: [3] 

Recruitment

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.&quot;</span>  
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.&quot;</span>

Participants were recruited through MS support organizations rather than advertisements or referrals from clinics. This seems moderately pragmatic.

Score: [3]

Setting

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.&quot;</span>

The training took place in community gymnasiums rather than specialized trial centers. This is very pragmatic.

Score: [5] 

Organization

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The training also took the form of small group-based training; this is important because it made exercising a more social activity, and it was more cost effective and time efficient than individual training.&quot;</span>

The training was delivered in a group format with experienced trainers. This seems moderately pragmatic.

Score: [3]

Flexibility (delivery)

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.&quot;</span>

The exercise program allowed for some individualization and flexibility in delivery. This is moderately pragmatic.

Score: [3] 

Flexibility (adherence)

No relevant quotes. The study does not mention encouragement or measures to improve adherence.

Score: [NA]

Follow-up

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measures were taken by a registered physiotherapist blinded to group allocation, and experienced in musculoskeletal evaluation.&quot;</span>

Follow-up assessments were done at 10 weeks and 22 weeks post-intervention. Assessors were blinded. Frequency of follow-up seems moderately pragmatic.

Score: [3]

Primary outcome

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Changes in walking endurance were measured with the 2-minute walk test (2MWT)&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch&quot;</span>

The primary outcomes of walking endurance and speed are highly relevant for participants and measure functional ability. This is very pragmatic.

Score: [5]

Primary analysis

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.&quot;</span>

An intention-to-treat analysis was used. This is very pragmatic.

Score: [5]</pre>
<p><a name='669'></a></p>
</div>
<div
id="feys-p.-2019-effects-of-an-individual-12-week-community-located-start-to-run-program-on-physical-capacity-walking-fatigue-cognitive-function-brain-volumes-and-structures-in-persons-with-multiple-sclerosis"
class="section level4">
<h4>669.
<a href='https://doi.org/10.1177/1352458517740211' title='Open publication'>Feys
P. (2019): <i>Effects of an individual 12-week community-located
“start-to-run” program on physical capacity, walking, fatigue, cognitive
function, brain volumes, and structures in persons with multiple
sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.6%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations for the given clinical trial text:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.&quot;</span> 

Reasoning: The study had quite broad eligibility criteria - adults with MS who could walk 5km without assistance. This matches eligibility in usual care reasonably well. There were no exclusions based on factors like comorbidities, age, disease duration, etc.

Score: [4]

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.&quot;</span>

Reasoning: Participants were recruited through rehabilitation centers, MS society and a sports program. This involved some additional effort beyond routine referrals at usual care clinics.

Score: [3] 

Setting: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).&quot;</span>

Reasoning: Assessments were done at a research institute, not routine clinical settings. Participants did their exercise training in the community.

Score: [3]

Organisation:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.&quot;</span>

Reasoning: The exercise program was delivered with remote supervision by email. Participants did the training on their own in the community. This matches usual care reasonably closely in terms of resources and provider expertise.

Score: [4]

Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute. Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.&quot;</span> 

Reasoning: Participants followed a prescribed personalized training plan with intensity monitoring and E-monitoring. There was some flexibility in terms of when and where to exercise, but overall the delivery was fairly protocolized.

Score: [3]

Flexibility (adherence):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎If a participant had been inactive, a phone call was made for enquiry.&quot;</span>

Reasoning: Adherence was monitored and participants were contacted if found to be inactive. But no participants were excluded based on poor adherence. Encouragement was provided to adhere to the protocol.

Score: [3] 

Follow-up:

Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):

Patients were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Participants were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points.&quot;</span>

Reasoning: Follow-up was limited to two assessment timepoints matching the intervention duration. No additional unscheduled visits or more extensive data collection.

Score: [4]

Primary outcome:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.&quot;</span>

Reasoning: The primary outcomes of fitness, walking ability, mobility and quality of life are clinically meaningful to patients.

Score: [5] 

Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Intention-to-treat analysis was performed.&quot;</span>

Reasoning: An intention-to-treat analysis was done, implying that all randomized participants were included. This matches real-world practice.

Score: [5]</pre>
<p><a name='670'></a></p>
</div>
<div
id="finch-p.-2014-effects-of-an-individual-12-week-community-located-start-to-run-program-on-physical-capacity-walking-fatigue-cognitive-function-brain-volumes-and-structures-in-persons-with-multiple-sclerosis"
class="section level4">
<h4>670.
<a href='https://doi.org/10.1016/j.jbmt.2013.04.001' title='Open publication'>Finch
P. (2014): <i>Effects of an individual 12-week community-located
“start-to-run” program on physical capacity, walking, fatigue, cognitive
function, brain volumes, and structures in persons with multiple
sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the clinical trial described in the full text:

Eligibility:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis. Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.&quot;</span>

The eligibility criteria included a diagnosis of MS, which aligns with usual care. The broad spectrum of MS presentations and self-selection of participants makes the trial pragmatic in terms of resembling real-world practice.

Score: [4]


Recruitment:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.&quot;</span>

Participants were recruited during their regular clinic visits, which is a pragmatic approach. There is no mention of using advertisements or incentives that would make recruitment more explanatory.

Score: [4]


Setting: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An appropriate history and physical examination was performed, and a treatment plan determined, this being reflective of the therapist's assessment and the mutually set goals for the treatment series.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.&quot;</span>

The setting was a student teaching clinic, which may not exactly match real-world practice but is still reasonably pragmatic. Treatments reflected usual massage therapy care.

Score: [4]


Organisation:
No relevant quotes.

The text does not provide information about staffing, resources, or organization of care delivery.

Score: [NA]


Flexibility (delivery):
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.&quot;</span> 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.&quot;</span>

The treatment delivery allowed flexibility and was tailored to each participant's needs, which is pragmatic. There was no strict protocol or monitoring of compliance mentioned.

Score: [4]


Flexibility (adherence):
No relevant quotes.

The text does not discuss adherence or compliance with the intervention protocol.

Score: [NA]


Follow-up:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.&quot;</span>

Follow-up assessments were more frequent than would occur in usual care, making this domain more explanatory.

Score: [2]


Primary outcome:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.&quot;</span>

The primary outcome of self-efficacy is patient-centered and pragmatic. No surrogate or clinical measures were used.

Score: [5]

Primary analysis:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.&quot;</span>

The intention-to-treat analysis is pragmatic and includes all participants.

Score: [5]</pre>
<p><a name='671'></a></p>
</div>
<div
id="freeman-j.-2019-assessment-of-a-home-based-standing-frame-programme-in-people-with-progressive-multiple-sclerosis-sums-a-pragmatic-multi-centre-randomised-controlled-trial-and-cost-effectiveness-analysis"
class="section level4">
<h4>671.
<a href='https://doi.org/10.1016/S1474-4422(19)30190-5' title='Open publication'>Freeman
J. (2019): <i>Assessment of a home-based standing frame programme in
people with progressive multiple sclerosis (SUMS): a pragmatic,
multi-centre, randomised, controlled trial and cost-effectiveness
analysis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations based on the provided full text:

### Eligibility
Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald's criteria,21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease-modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.&quot;</span>

The inclusion criteria focused on adults with progressive MS and significant mobility impairment based on EDSS scores. The exclusions were minimal, related to recent medication changes. Overall, the criteria reflect a typical MS population that would receive this intervention in usual care.

Score: [4] 

### Recruitment  
Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health-care organisation had been reached.&quot;</span>

Participants were recruited through routine health care organizations, rather than through advertisements or other special recruitment efforts. This pragmatic approach mirrors how patients would access this intervention in real-world practice.

Score: [5]

### Setting
Relevant quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were asked to stand for 30 min, three times per week over 20 weeks, and encouraged to continue in the longer term, although no further physiotherapy support was provided.&quot;</span> 

The intervention was delivered entirely within participants' own homes, the same setting where it would be implemented in usual care. 

Score: [5] 

### Organization
Relevant quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The use of standing frames is a recognised core skill for UK-trained neurological physiotherapists. To standardise and optimise implementation of the intervention, we provided educational materials and assessed fidelity to them.16 All participants received their usual health and social service input throughout the study period.16 This input was recorded on a self-report health-care and social-care resource form, which included changes in medication.&quot;</span>

The physiotherapists delivering the intervention were those already working in the participating NHS organizations, without additional training or resources provided. This matches how the intervention would be organized and delivered in real-world practice.

Score: [5]

### Flexibility (delivery)
Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In line with previous research,14 participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This allowed for a graduated introduction to standing.&quot;</span>

The protocol specified a recommended standing duration and frequency, but allowed flexibility in how participants gradually increased their standing time over 20 weeks. This pragmatic approach provides guidance while accommodating individual needs and abilities.

Score: [4] 

### Flexibility (adherence)  
Relevant quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At the end of the 20-week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.&quot;</span>

After the initial 20-week intervention period, participants were encouraged but not required to continue standing regularly. This mirrors how adherence would be managed in usual care.

Score: [5]

### Follow-up  
Relevant quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The SUMS study was an individually randomised, controlled, pragmatic, multi-centre, superiority trial with masked outcome assessments in people with progressive multiple sclerosis. Participants were randomly assigned to receive either usual care or usual care plus a standing programme, with masked assessments done at baseline, 20 weeks post-randomisation (aligned with the end of the protocol intervention period for those allocated to the intervention group), and again 16 weeks afterwards (36 weeks post-randomisation).&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We achieved this by using daily, self-reported, preformatted diaries.&quot;</span>

Follow-up assessments were limited to 3 major time points over 36 weeks, consistent with monitoring in usual practice. Adverse event monitoring used self-report diaries, avoiding extensive clinic visits. This pragmatic approach minimizes study-specific data collection.

Score: [4] 

### Primary outcome
Relevant quote:  
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score23 at the primary endpoint of 36 weeks post-randomisation. This score was developed for use by physiotherapists in a clinical setting to assess motor function in people with multiple sclerosis and has shown validity, reliability, and responsiveness.&quot;</span>

The AMCA scale measures functional mobility and motor impairment, outcomes that are clinically meaningful to patients. It was specifically developed for assessing MS patients in clinical settings.

Score: [5]

### Primary analysis
Relevant quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.&quot;</span>

The primary analysis was modified ITT, including all participants with baseline and final data regardless of compliance. This pragmatic approach mirrors how data would be analyzed in real-world practice.

Score: [5]</pre>
<p><a name='673'></a></p>
</div>
<div
id="garrett-m.-2013-exercise-in-the-community-for-people-with-minimal-gait-impairment-due-to-ms-an-assessor-blind-randomized-controlled-trial"
class="section level4">
<h4>673.
<a href='https://doi.org/10.1177/1352458512461966' title='Open publication'>Garrett
M. (2013): <i>Exercise in the community for people with minimal gait
impairment due to MS: an assessor-blind randomized controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

## Eligibility

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.&quot;</span>

The eligibility criteria seem fairly broad, including adults with confirmed MS diagnosis who did not have a recent relapse or other issues preventing exercise. Some participants with comorbidities were excluded if they impacted exercise ability. Overall, the criteria seem moderately pragmatic.

Score: [3] 

## Recruitment

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were enrolled following their eligibility assessments, performed by the regional offices of MSI. Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to the control or an intervention.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.&quot;</span>

Recruitment was done through regional MS offices and healthcare providers, allowing self-referral. No special efforts like advertising or incentives were mentioned. This approach seems moderately pragmatic.

Score: [3]

## Setting

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.&quot;</span>

The interventions were delivered in community settings like gyms and health centers. This is very pragmatic.

Score: [5] 

## Organization

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the PT-led programme, there was a home exercise component consisting of 10 aerobic sessions to be performed during weeks 1 – 5 (i.e. resulting in a frequency of two per week).&quot;</span> 

The interventions were led by physiotherapists, fitness instructors, and yoga instructors. No mention of increased staffing levels or resources. Seems moderately pragmatic.

Score: [3]

## Flexibility (delivery)

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.&quot;</span>

The PT-led class followed a standardized protocol. The yoga and fitness instructor classes were not pre-defined. Overall, moderate flexibility. 

Score: [3] 

## Flexibility (adherence)

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Treatment fidelity was optimised by the instructors and participants documenting programme adherence.&quot;</span>

No mention of special efforts to enforce adherence. Seems pragmatic.

Score: [4]

## Follow-up

Quotes: None relevant.

No mention of follow-up being more intensive than usual care.

Score: [4] 

## Primary outcome

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale- 29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.&quot;</span>

The primary outcome was patient-reported physical impact of MS, which is pragmatic.

Score: [4]

## Primary analysis

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants were analysed in the groups to which they were randomised.&quot;</span>

An intention-to-treat analysis was used, which is pragmatic.

Score: [5]</pre>
<p><a name='674'></a></p>
</div>
<div
id="giovannoni-g.-2016-alemtuzumab-improves-preexisting-disability-in-active-relapsing-remitting-ms-patients"
class="section level4">
<h4>674.
<a href='https://doi.org/10.1212/WNL.0000000000003319' title='Open publication'>Giovannoni
G. (2016): <i>Alemtuzumab improves preexisting disability in active
relapsing-remitting MS patients</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">5 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with relevant quotes and explanations:

Eligibility:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).&quot;</span>


Explanation: The trial included patients with RRMS who had inadequate response to prior DMTs, making them similar to patients who would receive alemtuzumab in real-world practice. However, the trial still had some exclusions like excluding patients with progressive forms of MS.

Score: [4]

Recruitment:

Relevant quotes:
No relevant quotes found.

Explanation: The paper does not provide details on the recruitment methods used. Based on the randomized trial design, participants were likely recruited systematically rather than reflecting real-world practice.

Score: [2] 

Setting: 

Relevant quotes: 
No relevant quotes found.

Explanation: The paper does not provide details on the settings where the trial was conducted. However, given the multicenter nature and the inclusion of Russia/Ukraine sites, it likely included both specialized trial centers as well as more routine clinical settings.

Score: [3]

Organisation:

Relevant quotes:
No relevant quotes found. 

Explanation: The paper does not provide details on the expertise of providers or resources available in the trial. However, given the randomized controlled trial design, the organization of care was likely more structured than in routine practice.

Score: [2]

Flexibility (delivery):

Relevant quotes:
No relevant quotes found.

Explanation: The paper does not provide details on flexibility in delivering the interventions. However, the protocolized administration schedules and specified dosing suggest reduced flexibility compared to routine care.

Score: [2]

Flexibility (adherence):

Relevant quotes:
No relevant quotes found.

Explanation: The paper does not provide details on flexibility in adherence. However, the trial design likely involved measures to ensure and monitor adherence more closely than routine care.

Score: [2]

Follow-up:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Raters administered the MSFC16 3 times before baseline to attenuate practice effects, then every 6 months.&quot;</span> 

Explanation: Patients underwent frequent scheduled follow-up visits with blinded raters along with additional unscheduled visits for suspected relapse, representing more extensive follow-up than routine care. 

Score: [2]

Primary outcome:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Among MSFC components (figure 3, B–D), the greater benefit seen at month 24 with alemtuzumab vs SC IFN-β-1a reached statistical significance for the 9-HPT (p = 0.0007).&quot;</span>

Explanation: The primary outcome was disability improvement measured by EDSS and MSFC. These outcomes are clinically meaningful for patients.

Score: [5]

Primary analysis:

Relevant quotes: 
No relevant quotes about analysis population found.

Explanation: The paper does not provide details on the analysis population. However, the randomized controlled trial design likely involved an intention-to-treat approach with all available data.

Score: [4]</pre>
<p><a name='675'></a></p>
</div>
<div
id="grossman-p.-2010-ms-quality-of-life-depression-and-fatigue-improve-after-mindfulness-training-a-randomized-trial"
class="section level4">
<h4>675.
<a href='https://doi.org/10.1212/WNL.0b013e3181f4d80d' title='Open publication'>Grossman
P. (2010): <i>MS quality of life, depression, and fatigue improve after
mindfulness training: a randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores based on the trial publication:

Eligibility:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.&quot;</span>

The trial had some eligibility criteria around diagnosis, disease severity, and certain exclusions that limit generalizability. However, the criteria seem reasonably pragmatic overall.

Score: [3]


Recruitment:

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 164 patients self-referred to the study.&quot;</span>

The participants self-referred to the study after receiving information through various channels. This seems like a reasonably pragmatic recruitment approach.

Score: [4]


Setting: 

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted from February 2007 to March 2009.&quot;</span> 

No details are provided on the setting. However, this was conducted at a university hospital in Switzerland. Academic medical centers tend to be more explanatory in nature.

Score: [2]


Organization:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.&quot;</span>

The MBI intervention involved a structured program with trained instructors. This level of resources and expertise exceeds usual care.

Score: [2]


Flexibility (delivery):

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.&quot;</span>

The MBI program followed a standardized protocol over 8 weeks. This allowed little flexibility in delivery. 

Score: [2]


Flexibility (adherence): 

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59–5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).&quot;</span>

Homework adherence was monitored and emphasized. This level of encouragement for adherence exceeds usual care.

Score: [2]


Follow-up:

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments were made at baseline, postintervention, and 6 months follow-up.&quot;</span>

Follow-up assessments were limited to two time points, which seems reasonably pragmatic.

Score: [4]


Primary outcome:

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.&quot;</span>

The primary outcomes of HRQOL, depression, and fatigue are patient-centered and clinically meaningful.

Score: [5] 

Primary analysis:

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).&quot;</span>

An intention-to-treat analysis was used, which is pragmatic.

Score: [5]</pre>
<p><a name='677'></a></p>
</div>
<div
id="hermens-h.-2008-clinical-assessment-of-the-hellodoc-tele-rehabilitation-service"
class="section level4">
<h4>677. <a href='https://doi.org/' title='Open publication'>Hermens H.
(2008): <i>Clinical assessment of the HELLODOC tele-rehabilitation
service</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations for the given clinical trial text:

Eligibility: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighty-one patients with chronic stroke, traumatic brain injury (TBI) and multiple sclerosis (MS) were recruited&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎subjects passed the screening criteria&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exclusions were: A) disturbed upper limb function not related to MS, TBI or stroke; B) serious cognitive and/or behavioral problems; C) serious emotional problems; D) major visual problems; (E) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.&quot;</span>

The trial recruited patients with specific diagnoses (stroke, TBI, MS) who met inclusion/exclusion criteria. The criteria seem fairly typical for trials of this intervention, not highly selective. Some patients were excluded due to medical/cognitive issues, but overall the eligibility seems reasonably representative of real-world usage.

Score: [3]

Recruitment:
- No relevant quotes

The text does not provide details on how patients were recruited, beyond mentioning they were recruited from 3 rehabilitation centers. Without more details on recruitment procedures, it is difficult to assess pragmatism.

Score: [NA] 

Setting:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS)&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium)&quot;</span>

Patients were recruited from real-world rehabilitation clinics and underwent the intervention at home, suggesting a pragmatic setting highly representative of routine care.

Score: [5]

Organisation: 
- No relevant quotes

The text does not provide details on the expertise/resources required to deliver the intervention. Without more information, the pragmatism is unclear.

Score: [NA]

Flexibility (delivery):
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following exercises are part of the H-CAD system: key, light bulb, book, jar, writing, checkers and keyboard tasks.&quot;</span>

The intervention was delivered via a standardized protocol with specific exercises and durations. This suggests reduced flexibility compared to real-world routine care.

Score: [2]

Flexibility (adherence): 
- No relevant quotes

The text does not describe any strategies to enforce or monitor adherence. The pragmatism of adherence is unclear without more details.

Score: [NA]  

Follow-up:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All measurements were performed at the centre where the patient had been treated.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after T2 a follow up measurement was performed (T3) for the intervention group. The control group received their last measurement (T3) 4 months after baseline.&quot;</span>

Follow-up measurements were performed at protocol-specified timepoints rather than as part of routine care. This indicates a more explanatory approach.

Score: [2]

Primary outcome:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two outcome parameters representing the performance of the affected arm on functioning as well on disability level were used in the present study as main outcome parameters. In case both arms were affected, the dominant hand was used The main outcome parameters were the ARA test and the NHPT.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The ARA is an observational test consisting of 19 items focusing on grasping objects of different shapes and sizes, and gross movements in the vertical and horizontal planes (score range: 0 to 57)&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The NHPT measures manual dexterity (and reaching and grasping). The total time needed to move the 9 pegs with the affected arm was used as outcome parameter. When the patient was unable to move all nine pegs, the total time of 180 seconds was used.&quot;</span>

The primary outcomes assessed function and dexterity, which are clinically meaningful to patients. The measures used were simple observational/timing assessments that could be performed in routine practice. Overall this seems reasonably pragmatic.

Score: [4] 

Primary analysis:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A significance level of 0.025 and a confidence interval of 95% were used.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎When the confidence bounds remained between these boundaries, no difference between usual care and H-CAD was found.&quot;</span>

The analysis was based on a strict protocol. There was no mention of analyzing participants similar to real-world routine care. This indicates a more explanatory approach.

Score: [2]</pre>
<p><a name='678'></a></p>
</div>
<div
id="higginson-i.-j.-2009-is-short-term-palliative-care-cost-effective-in-multiple-sclerosis-a-randomized-phase-ii-trial"
class="section level4">
<h4>678.
<a href='https://doi.org/10.1016/j.jpainsymman.2009.07.002' title='Open publication'>Higginson
I. J. (2009): <i>Is short-term palliative care cost-effective in
multiple sclerosis? A randomized phase II trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations for the trial based on the full text:

1. Eligibility

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients in South East London who were severely affected by MS were referred by clinicians to the trial.&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).&quot;</span>

The eligibility criteria seem fairly broad, as patients only needed to be referred by clinicians and have some palliative care needs. The trial was limited to a specific geographic region, but within that region the criteria reflect usual care.

Score: [4] 

2. Recruitment

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Referrals were screened by a consultant in palliative medicine who was independent from delivering the service (P. M. E./I. J. H).&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Educational seminars informed local health and social care professionals about the PCT.&quot;</span>

Patients were referred through their usual clinicians rather than through targeted recruitment efforts. This reflects how patients would access palliative care in real-world settings.

Score: [5]

3. Setting

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital.&quot;</span>

The interventions were delivered in the patients' usual care settings rather than in specialized trial centers. This matches real-world care.

Score: [5] 

4. Organization

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT. This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.&quot;</span>

The palliative care team appears to have staffing and resources consistent with real-world palliative care teams.

Score: [4]

5. Flexibility (delivery)

Quote:  
- <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Care was provided in a similar way to palliative care consultation services described elsewhere,9, 11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were. Patients had one to three contacts (visits and/or phone calls) from the PCT,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Care was provided in a similar way to palliative care consultation services described elsewhere,9, 11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were. Patients had one to three contacts (visits and/or phone calls) from the PCT...&quot;</span>

The palliative care was delivered flexibly, tailored to each patient's needs, which matches real-world care.

Score: [5] 

6. Flexibility (adherence)

No relevant quotes. The text does not discuss any measures to enforce or monitor adherence.

Score: [NA] 

7. Follow-up

Quote:
- <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient&#39;s functional status (' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient's functional status...&quot;</span>

Follow-up data collection seems quite extensive, going beyond what would occur in usual care. This includes multiple interviews, questionnaires, and functional assessments.

Score: [2]

8. Primary outcome

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8), comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0–4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers' burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).&quot;</span>

The primary outcomes of pain, anxiety, caregiver burden are clinically important to patients. However, they rely on specialized scales rather than simple outcomes like survival.

Score: [3]

9. Primary analysis

Quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.&quot;</span> 

An intention-to-treat analysis was used, suggesting a pragmatic approach.

Score: [4]</pre>
<p><a name='679'></a></p>
</div>
<div
id="jongen-p.-j.-2019-effect-of-an-intensive-3-day-social-cognitive-treatment-can-do-treatment-on-control-self-efficacy-in-patients-with-relapsing-remitting-multiple-sclerosis-and-low-disability-a-single-centre-randomized-controlled-trial"
class="section level4">
<h4>679.
<a href='https://doi.org/10.1371/journal.pone.0223482' title='Open publication'>Jongen
P. J. (2019): <i>Effect of an intensive 3-day social cognitive treatment
(can do treatment) on control self-efficacy in patients with relapsing
remitting multiple sclerosis and low disability: A single-centre
randomized controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 97.5%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.&quot;</span>

The eligibility criteria are moderately pragmatic. Patients had to have a diagnosis of RRMS for at least 1 year and mild disability per the EDSS score. While the RRMS diagnosis matches usual care, restricting to only patients with low disability levels makes the trial less pragmatic. The other criteria around relapse status, willingness/capability to participate, and internet access are reasonable.

Score: [3] 

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.&quot;</span>

The recruitment through the patient organization NMSF and initial screening by phone are moderately pragmatic approaches that go somewhat beyond referral at usual care appointments but are not as intensive as mailings or advertising.

Score: [3]

Setting: 

Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):

CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎CDTs were given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.&quot;</span>

The setting at the Zorghotel is more intensive than usual care, though reasonable for delivering this multiday intervention. It's not as highly specialized as an academic hospital.

Score: [2] 

Organization:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.&quot;</span>

The multidisciplinary team and training goes beyond the expertise and resources typical in usual care.

Score: [2]

Flexibility (delivery): 

Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 82.3%):

During the consultations they had a professional and informative role. In the small group sessions every team member focused on its own area of interest.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎During the consultations they [multidisciplinary team members] had a professional and informative role. In the small group sessions every team member focused on its own area of interest.&quot;</span> 

The delivery of CDT appears protocolized with professional roles and areas of interest for each session. This reduces flexibility compared to usual care.

Score: [2]

Flexibility (adherence):

Score: [NA] The paper states adherence is not applicable for this intervention.

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).&quot;</span>

The follow-up assessments were more frequent than usual care but reasonable for capturing outcomes in this trial. The online questionnaires are a pragmatic approach.

Score: [4]

Primary outcome:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.&quot;</span> 

The MSSES measures confidence in managing symptoms and coping with illness demands. This patient-centered outcome is relevant and pragmatic.

Score: [5] 

Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.&quot;</span>

The intention-to-treat analysis is a pragmatic approach that includes all available data. 

Score: [5]</pre>
<p><a name='680'></a></p>
</div>
<div
id="kiropoulos-l.-a.-2016-a-pilot-randomized-controlled-trial-of-a-tailored-cognitive-behavioural-therapy-based-intervention-for-depressive-symptoms-in-those-newly-diagnosed-with-multiple-sclerosis"
class="section level4">
<h4>680.
<a href='https://doi.org/10.1186/s12888-016-1152-7' title='Open publication'>Kiropoulos
L. A. (2016): <i>A pilot randomized controlled trial of a tailored
cognitive behavioural therapy based intervention for depressive symptoms
in those newly diagnosed with multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

## Eligibility

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.&quot;</span>

The eligibility criteria are quite restrictive, excluding those with psychosis, substance dependency, and cognitive impairment. Participants must score above a certain threshold on the BDI-II and cannot receive other psychological treatment during the trial. This excludes many patients who would be eligible for the intervention in routine care.

Score: [2] 

## Recruitment

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.&quot;</span> 

Recruitment was done through neurologists at an MS clinic, which is fairly typical for recruitment in usual care. Additional recruitment was done through advertisements, which requires more effort than standard referral/recruitment processes.

Score: [3]

## Setting

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study took place at a large teaching and research hospital in Melbourne, Australia.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.&quot;</span>

The study took place at a specialized hospital research center with psychologists providing the intervention. This is more explanatory than care provided in a standard clinical setting.

Score: [2] 

## Organization 

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.&quot;</span>

The intervention was provided by clinical psychologists, which requires specialized expertise beyond that of typical care providers.

Score: [2]

## Flexibility (delivery)

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.&quot;</span>

The CBT intervention followed a standardized protocol with specific modules and exercises. This allows little flexibility or tailoring in how the intervention is delivered.

Score: [2]

## Flexibility (adherence)

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’,&quot;</span>

Participants seem highly adherent to the full protocol, with no mention of flexibility in adhering to components of the intervention.

Score: [1]

## Follow-up

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.&quot;</span>

Follow-up assessment was more frequent than would occur in routine care.

Score: [2]

## Primary outcome

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II)&quot;</span>

The BDI-II is a standard self-report measure of depressive symptoms that captures outcomes relevant to patients.

Score: [4]

## Primary analysis

Quotes:
- No mention of how missing data or protocol deviations were handled.

Insufficient information provided to assess approach to primary analysis.

Score: [NA]</pre>
<p><a name='681'></a></p>
</div>
<div
id="learmonth-y.-c.-2012-the-effects-of-a-12-week-leisure-centre-based-group-exercise-intervention-for-people-moderately-affected-with-multiple-sclerosis-a-randomized-controlled-pilot-study"
class="section level4">
<h4>681.
<a href='https://doi.org/10.1177/0269215511423946' title='Open publication'>Learmonth
Y. C. (2012): <i>The effects of a 12-week leisure centre-based, group
exercise intervention for people moderately affected with multiple
sclerosis: a randomized controlled pilot study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial based on the provided text:

Eligibility

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination34 and access to the intervention sites using their own or public transport.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.&quot;</span>

The eligibility criteria appear moderately pragmatic - participants had confirmed MS diagnosis and a specific range of disability based on the EDSS score, indicating some selectivity beyond usual care. However, they did not exclude based on medication use or comorbidities, and allowed a range of disability levels that reflects patients seen in usual practice.

Score: [3]


Recruitment

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎NHS Ayrshire and Arran hold a register of all patients known to the multiple sclerosis service. Participants were recruited from this register.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.&quot;</span>

Recruitment was done by screening an existing clinical registry and sending invitations, which goes beyond standard recruitment for usual care. However, they did not use extensive advertising or provide major incentives. 

Score: [2]


Setting

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention took place at two different geographical locations (Site A and Site B). From those living near Site A a list of potential participants (n = 16) was created and, to maximise class occupancy, 10 potential participants were allocated to Site A’s intervention group. A similar system was used for Site B (which had a class capacity of 12), for which a list of potential participants (n = 20) was created.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study aimed to evaluate the effectiveness (as defined by an improvement in disease signs and symptoms) of a group, community leisure centre-based combined exercise (aerobic, resistance and balance exercises) intervention for people moderately affected with multiple sclerosis.&quot;</span>


The setting was at community leisure centers, which matches the usual care setting where patients would access exercise programs.

Score: [4]


Organization 

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.&quot;</span>

The organization of the intervention involved specialized instructors and a structured exercise program, which provides more resources and monitoring than would occur in usual care.

Score: [2]


Flexibility (delivery)

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed. Participants worked at a self-regulated pace for each exercise.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.&quot;</span>

The delivery allowed flexibility in exercise selection and progression based on participant needs, similar to what would occur in usual care.

Score: [4]


Flexibility (adherence)

Quotes:
No relevant quotes found.

The text does not provide enough information to assess the flexibility in adherence.

Score: [NA]


Follow-up

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To counteract the potential effects of fatigue, three versions of the assessment protocol were used, with tests carried out in different orders. The version used was randomly allocated at baseline to each participant, with the same version of assessment subsequently used at weeks 8 and 12.&quot;</span>

The follow-up assessments were more frequent and extensive than would occur in usual care.

Score: [2]


Primary outcome

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Timed 25-Foot Walk Test35 was chosen as the primary outcome measure. The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.&quot;</span>

The primary outcome was walking speed, which is a clinically relevant outcome for MS patients.

Score: [4]


Primary analysis

Quotes:
No relevant quotes found regarding the analysis population and handling of missing data.

The text does not provide enough information to assess the primary analysis.

Score: [NA]</pre>
<p><a name='682'></a></p>
</div>
<div
id="mayo-n.-e.-2020-participation-in-and-outcomes-from-a-12-month-tailored-exercise-programme-for-people-with-multiple-sclerosis-mstep-a-randomized-trial"
class="section level4">
<h4>682.
<a href='https://doi.org/10.1177/0269215520923089' title='Open publication'>Mayo
N. E. (2020): <i>Participation in and outcomes from a 12-month tailored
exercise programme for people with multiple sclerosis (MSTEP�): a
randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
2
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

Eligibility:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ambulatory and sedentary.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.&quot;</span>

The eligibility criteria are fairly broad, including ambulatory and sedentary adults with MS. The few exclusions are reasonable for an exercise trial. Overall, the criteria appear similar to what would be used in usual care.

Score: [4]

Recruitment:

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.&quot;</span> 

Recruitment was done through MS clinics during regular appointments and through media postings. This level of effort seems consistent with what would be done in usual care to engage patients.

Score: [4] 

Setting: 

Quote:
No information provided on setting.

Score: [NA]

Organization:

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.&quot;</span>

The level of monitoring and follow-up provided by the exercise instructor is more intensive than what would occur in usual care.

Score: [2]

Flexibility (delivery):

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.&quot;</span> 

The MSTEP intervention was personalized and flexible in delivery.

Score: [5] 

Flexibility (adherence): 

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months.&quot;</span>

Adherence was monitored but participants were not excluded based on adherence. Flexibility in adherence appears consistent with usual care.

Score: [4]

Follow-up:

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Evaluators were blinded to the group that the participant was in.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.&quot;</span>

Follow-up was more frequent than usual care, with four evaluation visits in one year. Missing data was thoroughly analyzed.

Score: [2]

Primary outcome:

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome was peak oxygen consumption (VO2peak) at 12 months&quot;</span>

VO2peak is a direct measure of exercise capacity and highly relevant to participants.

Score: [5] 

Primary analysis:

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group.&quot;</span>

The analysis plan was intention-to-treat. All available data were included.

Score: [5]</pre>
<p><a name='684'></a></p>
</div>
<div
id="miller-l.-2011-evaluation-of-a-home-based-physiotherapy-programme-for-those-with-moderate-to-severe-multiple-sclerosis-a-randomized-controlled-pilot-study"
class="section level4">
<h4>684.
<a href='https://doi.org/10.1177/0269215511398376' title='Open publication'>Miller
L. (2011): <i>Evaluation of a home-based physiotherapy programme for
those with moderate to severe multiple sclerosis: a randomized
controlled pilot study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 96.5%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 45.6%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
Here are the PRECIS-2 domain scores for the provided trial text:

1. Eligibility

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎People moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.&quot;</span>

<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.3%):

se of arms).10 People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over11 and had at least three identiﬁable physiotherapy goal' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over11 and had at least three identifiable physiotherapy goals were included.&quot;</span> 

<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.4%):

were included. Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking pa' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.&quot;</span>

The eligibility criteria are quite narrow, focusing only on people with moderate to severe MS based on a specific EDSS score range. There are several exclusion criteria based on cognitive function, disease progression, concurrent physiotherapy, and other medical conditions. This suggests a more explanatory approach rather than being fully inclusive as in usual care.

Score: [3] 

2. Recruitment

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Subjects were asked not to discuss their group allocation with the assessor.&quot;</span>

The participants were recruited from an MS clinic/service. There is no mention of extra recruitment efforts like advertisements or incentives. However, the assessor was blinded to group allocation, indicating tighter experimental control. This suggests a mix of pragmatic and explanatory recruitment.

Score: [3]

3. Setting

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation.&quot;</span>

The intervention was delivered in the participants' homes, reflecting a pragmatic, real-world setting. However, the outcome assessments were done at a specialized rehabilitation center with a blinded assessor. This indicates more explanatory trial conditions for measurement.

Score: [3] 

4. Organization

Relevant quote:
<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.1%):

atch. Intervention Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.&quot;</span>

The physiotherapy was provided by an experienced community/domiciliary physiotherapist at the patients' homes. This matches regular care and does not indicate additional resources or training, suggesting a pragmatic approach.

Score: [4]

5. Flexibility (delivery)

Relevant quote:  
<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.9%):

within their home. Each session lasted up to 60 minutes, and a task-speciﬁc programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit ﬁts) and stretching activities were used depending on the subjects previ' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.&quot;</span>

The physiotherapy program was individualized based on each patient's goals and abilities. However, it followed a structured protocol focused on core strengthening and functional tasks. This indicates some flexibility but not complete flexibility as in usual care.

Score: [3]

6. Flexibility (adherence)

Relevant quote:
No relevant information provided.

The text does not mention any strategies to enforce or monitor adherence. There is no indication that participants were excluded based on adherence. However, there are no details provided about encouraging adherence as in usual care.

Score: [NA] 

7. Follow-up

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16).&quot;</span>

The participants were followed-up at 8 weeks and 16 weeks post-intervention to assess outcomes. There is no mention of additional unscheduled visits or more extensive data collection. The follow-up matches what would be done in usual practice.

Score: [4]

8. Primary outcome

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.&quot;</span>

<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 45.6%):

setting of the trial and the usual care settin' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎Neither of these trends reached statistical significance.&quot;</span>

The primary outcome was the MSIS-29, which measures patient-reported impact of MS. This is a relevant pragmatic outcome. However, the focus on statistical significance is more explanatory.

Score: [3]

9. Primary analysis

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twenty-eight subjects completed the study as two control subjects did not complete follow-up assessments (Figure 1).&quot;</span>

No details are provided about the primary analysis method. Dropout rates were fairly low, with 93% of participants providing follow-up data. This suggests an intention-to-treat approach, but is not conclusively stated.

Score: [3]</pre>
<p><a name='685'></a></p>
</div>
<div
id="ohara-l.-2002-evaluation-of-the-effectiveness-of-professionally-guided-self-care-for-people-with-multiple-sclerosis-living-in-the-community-a-randomized-controlled-trial"
class="section level4">
<h4>685.
<a href='https://doi.org/10.1191/0269215502cr478oa' title='Open publication'>O’Hara
L. (2002): <i>Evaluation of the effectiveness of professionally guided
self-care for people with multiple sclerosis living in the community: a
randomized controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given clinical trial text:

Eligibility:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.&quot;</span>

Reasoning: The trial had very broad eligibility criteria, simply requiring a confirmed diagnosis of MS with no other exclusions. This is very similar to eligibility in usual care.

Score: [5]


Recruitment:

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.&quot;</span>

Reasoning: Participants were recruited through voluntary organizations rather than clinics or targeted advertising/incentives. This pragmatic recruitment is fairly similar to engagement in usual care.

Score: [4]


Setting: 

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted with people with MS living in the community.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Sessions were conducted either at participants’ homes or in local therapy centres.&quot;</span>

Reasoning: The setting was the community and participants' homes, very similar to usual care and not specialized trial centers. 

Score: [5]


Organisation:

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.&quot;</span>

Reasoning: The intervention used existing community resources and did not require extensive additional training or expertise beyond usual care.

Score: [4]


Flexibility (delivery):

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As findings from the Delphi study highlighted the need for flexibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.&quot;</span>

Reasoning: The delivery allowed some flexibility in format and topics based on individual priorities, similar to usual care. It was not a rigid protocol.

Score: [4]


Flexibility (adherence): 

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were invited to join the study and were accepted when informed consent had been given in writing.&quot;</span> 

Reasoning: After consenting, there was no monitoring or enforcement of adherence. This is very similar to usual care.

Score: [5]


Follow-up:

Relevant quote:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow-up assessments were conducted six months after baseline.&quot;</span>

Reasoning: Follow-up was at a single 6 month timepoint, similar to or less than usual care. No extra visits were triggered.

Score: [4]


Primary outcome:

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Total scores on a postal version of the Barthel Index, a scale measuring mobility, the United Kingdom version of the SF-36 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.&quot;</span>

Reasoning: The outcomes measured were functional status, health-related quality of life, and dependency in daily activities. These are meaningful and relevant to participants.

Score: [4]


Primary analysis:

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It was not possible to perform an ‘intention to treat’ analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.&quot;</span>

Reasoning: The lack of intention-to-treat analysis means some participants were excluded, less pragmatic than usual care.

Score: [3]</pre>
<p><a name='686'></a></p>
</div>
<div
id="papeix-c.-2015-evaluation-of-an-integrated-multidisciplinary-approach-in-multiple-sclerosis-care-a-prospective-randomized-controlled-study"
class="section level4">
<h4>686.
<a href='https://doi.org/10.1177/2055217315608864' title='Open publication'>Papeix
C. (2015): <i>Evaluation of an integrated multidisciplinary approach in
multiple sclerosis care: A prospective, randomized, controlled
study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 96.4%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial based on the provided full text:

Eligibility:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were excluded.&quot;</span>

The trial has some exclusions such as patients not living independently in the community. However, the other eligibility criteria of having MS and needing a multidisciplinary approach are consistent with patients who would receive this intervention in usual care.

Score: [4] 

Recruitment:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Signed informed consent was obtained for each patient at inclusion.&quot;</span>

No extra effort beyond usual care is described for recruiting patients. Patients were recruited during regular clinic visits.

Score: [5]

Setting: 

Relevant quotes:
<span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):

This prospective, randomized study is the first attempt to evaluate the multidisciplinary approach in MS patients. The results show that, contrary to our expectations, an integrated multidisciplinary approach is not superior to usual care on QoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This prospective, randomized, controlled study is the first attempt to evaluate the multidisciplinary approach in MS patients. The results show that, contrary to our expectations, an integrated multidisciplinary approach is not superior to usual care on QoL.&quot;</span>

The setting is a single MS clinic, which is more explanatory. Usual care would involve multiple, non-specialized settings.

Score: [2]

Organisation:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitié-Salpêtrière MS clinic&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the control group, interventions with the different health professionals were planned after the inclusion visit&quot;</span> 

The organization of care delivery appears very similar between the intervention and control groups, with the only difference being simultaneous vs staggered visits. Resources are not increased beyond usual care.

Score: [4] 

Flexibility (delivery):

Relevant quotes: 
No relevant quotes.

The full text does not provide information about flexibility in delivering the intervention.

Score: [NA]

Flexibility (adherence): 

Relevant quotes: 
No relevant quotes.

The full text does not discuss adherence or measures to enforce adherence.

Score: [NA] 

Follow-up:

Relevant quotes:
<span title='Moderate quote deviation. Best match in fulltext (Similarity 75.6%):

the committee was judged unnecessary. Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The clinical evaluating team was masked to the treatment arm. Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.&quot;</span>

Follow-up frequency and assessments appear similar between groups and consistent with usual care.

Score: [4]

Primary outcome:

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.&quot;</span>

The primary outcome of QoL is patient-centered and relevant to patients' lives.

Score: [5]

Primary analysis: 

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To perform an intention-to-treat analysis, missing data were replaced with the mean variation of the group for the comparisons of the six-month variation criteria and the analysis of predictive factors of the six-month evaluation of the MSIS-29.&quot;</span>

An intention-to-treat analysis was used including all available data.

Score: [5]</pre>
<p><a name='687'></a></p>
</div>
<div
id="paul-l.-2014-web-based-physiotherapy-for-people-moderately-affected-with-multiple-sclerosis-quantitative-and-qualitative-data-from-a-randomized-controlled-pilot-study"
class="section level4">
<h4>687.
<a href='https://doi.org/10.1177/0269215514527995' title='Open publication'>Paul
L. (2014): <i>Web-based physiotherapy for people moderately affected
with Multiple Sclerosis; quantitative and qualitative data from a
randomized, controlled pilot study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with quotes and explanations:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.&quot;</span>

Explanation: The eligibility criteria are moderately pragmatic, requiring a confirmed diagnosis of MS and moderate disability level based on EDSS score. However, there are some explanatory elements like requiring stable drug therapy and no relapses in past 3 months. Overall, eligibility seems aimed at a typical MS population that would receive this intervention in usual care.

Score: [3]


Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part.&quot;</span>

Explanation: Recruitment was done by sending letters to patients in a database, which requires some additional effort beyond usual care. However, it doesn't seem as intensive as methods like advertising or providing incentives. Overall, recruitment has some explanatory elements but is moderately pragmatic.

Score: [3]


Setting:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Rehabilitation centre and participants’ homes.&quot;</span>

Explanation: The setting includes both a rehabilitation center and participants' homes. Home-based exercise is very pragmatic, while the rehab center is more explanatory. Overall, the mixed setting is moderately pragmatic.

Score: [3]


Organization: 

Score: [NA]


Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.&quot;</span> 

Explanation: The intervention delivery allows for flexibility and individualization based on patient goals and assessment, which aligns with usual care. This is a very pragmatic approach.

Score: [5]


Flexibility (adherence): 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were advised to undertake the exercise programme a minimum of twice a week.&quot;</span>

Explanation: Patients were advised but not required to complete exercises twice weekly. There was no exclusion based on adherence. This lacks intensive strategies to enforce adherence, and aligns with a pragmatic approach.

Score: [4]


Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measures were only taken before and after the 12 week intervention.&quot;</span>

Explanation: Follow-up assessments were done at baseline and after 12 weeks, with no additional unscheduled visits or extensive data collection. This frequency of follow-up aligns with usual care.

Score: [4]


Primary outcome:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.&quot;</span> 

Explanation: The primary outcome of gait speed is highly relevant and important to patients. It does not use specialty adjudication or any departure from usual care.

Score: [5]


Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.&quot;</span>

Explanation: The analysis approach is not described in enough detail to assess pragmatism.

Score: [NA]</pre>
<p><a name='688'></a></p>
</div>
<div
id="pozzilli-c.-2002-home-based-management-in-multiple-sclerosis-results-of-a-randomised-controlled-trial"
class="section level4">
<h4>688.
<a href='https://doi.org/10.1136/jnnp.73.3.250' title='Open publication'>Pozzilli
C. (2002): <i>Home based management in multiple sclerosis: results of a
randomised controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 98.9%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with quotes and explanations:

Eligibility:

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.&quot;</span>
<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.2%):

Ninety six patients declined to participate. The majority of refusers (n = 62) were young, fully ambulant, and employed.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Ninety six patients declined to participate in the study. The majority of refusers (n = 62) were young, fully ambulant, and employed.&quot;</span> 

Explanation: The eligibility criteria are quite broad, including any patient with clinically definite MS living in Rome. The main exclusions were patients with mild MS who declined to participate. Overall the criteria seem moderately pragmatic.

Score: [3]


Recruitment:

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.&quot;</span>

Explanation: Patients were recruited during regular clinic visits at MS centers. No extra efforts like advertising or incentives were mentioned. This pragmatic recruitment is very similar to usual care. 

Score: [5]


Setting: 

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted in Rome and was approved by the ethics committee of La Sapienza University. Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.&quot;</span>

Explanation: The setting was regular MS clinics and centers in Rome, identical to the usual care setting. This is very pragmatic.

Score: [5]


Organization:

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up. A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted the different specialists according to the specific requirement.&quot;</span>

Explanation: The home-based intervention had additional resources like a dedicated phone line and home visits from a specialized multidisciplinary team. This is more explanatory in organization.

Score: [2]


Flexibility (delivery):

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator. These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.&quot;</span>

Explanation: The delivery of the intervention was very flexible, with specialists available by cell phone and making home visits as needed. This is very pragmatic.

Score: [5]


Flexibility (adherence): 

Quote: No relevant quotes.

Explanation: Adherence does not seem to be applicable here, as this is not a trial of a medication or therapy requiring compliance.

Score: [NA]


Follow-up:

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After 5 pm and during the weekend an answering machine was on, and recorded messages were regularly listened to by the operator.&quot;</span> 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.&quot;</span>

Explanation: Follow-up in the intervention arm was more intensive than usual care, with 24/7 access by phone and monthly calls to monitor resource utilization. This is more explanatory.

Score: [2]


Primary outcome:

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Quality of life was measured by means of the 36 item short form health survey questionnaire (SF-36).&quot;</span>

Explanation: The primary outcome of quality of life measured by SF-36 is patient-centered and clinically meaningful. This is very pragmatic.
  
Score: [5]


Primary analysis:

Quote:
No mention of exclusions from analysis.

Explanation: There is no evidence that the primary analysis excluded participants post-randomization or was limited to completers. This likely indicates an intention-to-treat approach, which is very pragmatic.

Score: [5]</pre>
<p><a name='689'></a></p>
</div>
<div
id="renfrew-l.-m.-2019-the-clinical--and-cost-effectiveness-of-functional-electrical-stimulation-and-ankle-foot-orthoses-for-foot-drop-in-multiple-sclerosis-a-multicentre-randomized-trial"
class="section level4">
<h4>689.
<a href='https://doi.org/10.1177/0269215519842254' title='Open publication'>Renfrew
L. M. (2019): <i>The clinical- and cost-effectiveness of functional
electrical stimulation and ankle-foot orthoses for foot drop in Multiple
Sclerosis: a multicentre randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with supporting quotes and explanations:

### Eligibility

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.&quot;</span>

Explanation: The eligibility criteria are fairly broad, aiming to recruit typical MS patients with foot drop lasting over 3 months. However, some exclusions are applied, such as excluding those who previously used AFOs or FES, those with cognitive impairment, and those with other gait issues besides foot drop. Overall, the criteria attempt to target MS patients who would be candidates for these interventions in regular practice.

Score: [4] 

### Recruitment

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.&quot;</span> 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Potential participants contacted the researchers if they were interested in participating.&quot;</span>

Explanation: Participants were recruited through typical clinical settings where MS patients receive care. Healthcare providers informed eligible patients about the study, rather than using advertisements or incentives. Patients then self-referred if interested. This recruitment process mirrors how patients would likely be identified and engaged in real world practice.

Score: [5]

### Setting

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study was prospectively registered with the UK Clinical Trials Gateway (Identifier: 15884) https://www.ukctg.nihr.ac.uk/clinical-trials/search-for-a-clinical-trial/. The study was funded by the Multiple Sclerosis Society, UK (Grant Reference: 001). It commenced on 1 April 2014 and was completed on 31 March 2018. Ethical approval was granted by the West of Scotland Research Ethics Committee (14/WS/0014) and the study was sponsored by NHS Ayrshire and Arran Research and Development department.&quot;</span>
- <span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):

The multicentre design of this study enhances the generalizability of results. However, although the ankle-foot orthoses prescription was standardized, variations did occur across sit' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A multicentre design of this study enhances the generalizability of results. However, although the ankle-foot orthoses prescription was standardized, variations did occur across sites.&quot;</span>

Explanation: The study took place across 7 NHS hospital sites, reflecting real-world care settings for MS patients in Scotland. It had NHS research ethics approval, indicating it followed NHS research governance. The multicenter design in routine care settings enhances generalizability. 

Score: [5] 

### Organization

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.&quot;</span>

Explanation: The AFO devices and fitting process reflect typical real-world standards of care by NHS orthotists. No additional resources or expertise beyond routine care were provided.

Score: [5]


### Flexibility (delivery)

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The angle of the tibia was inclined forward, approximately 10° to vertical, and each orthosis was ‘tuned’ by the addition or removal of small heel wedges.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.). Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).&quot;</span>

Explanation: The AFO and FES interventions were delivered according to standardized protocols and optimized for each patient, but with some flexibility allowed in fine-tuning the devices. This mirrors flexible delivery in routine practice.

Score: [4] 

### Flexibility (adherence)

Quote:  
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.&quot;</span>

Explanation: Patients were instructed to increase wear time gradually over 6 weeks, but no specific adherence requirements were enforced. This provides flexibility similar to real world adherence.

Score: [5]

### Follow-up

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score15 which was administered at 12 months only.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For the Timed 25 Foot Walk, participants walked along a 25 foot course ‘as quickly as possible, but safely’. The test was repeated four times, twice with and twice without the device.&quot;</span>

Explanation: Follow-up frequency and outcome assessments were more intensive than would occur in routine practice. Patients had study visits at 0, 3, 6, and 12 months with multiple outcome measures evaluated at each visit. This exceeds typical clinical follow-up.

Score: [2]

### Primary Outcome

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was walking speed as measured by the 5-minute self-selected walk test. Participants walked twice, once with their device and once without, resting for 20 minutes between. The order of testing was randomized between participants but was kept consistent for each participant throughout the trial. Participants walked at their preferred walking speed around a 9.5 m elliptical course for 5 minutes, resulting in a 10-meter shuttle length. The total distance walked was recorded and the mean walking speed (m/s) calculated.&quot;</span>

Explanation: The primary outcome of self-selected walking speed is clinically meaningful and patient-centered. It assesses effectiveness on an outcome directly impacting patients' daily lives.

Score: [5]

### Primary Analysis

Quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.&quot;</span>

Explanation: An intention-to-treat approach was used for the primary analysis to include all randomized participants. This mirrors real-world analysis.

Score: [5]</pre>
<p><a name='690'></a></p>
</div>
<div
id="solari-a.-2018-randomized-controlled-trial-of-a-home-based-palliative-approach-for-people-with-severe-multiple-sclerosis"
class="section level4">
<h4>690.
<a href='https://doi.org/10.1177/1352458517704078' title='Open publication'>Solari
A. (2018): <i>Randomized controlled trial of a home-based palliative
approach for people with severe multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with justification:

Eligibility:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS,1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16 The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.&quot;</span>

The eligibility criteria are focused on adults with severe progressive MS, defined by an EDSS score of at least 8.0. This represents a more narrow patient population compared to all MS patients who would receive palliative care in usual practice. However, the criteria are not highly selective beyond disease severity.

Score: [3]


Recruitment:

No relevant quotes. The full text does not describe the recruitment process.

Score: [NA]


Setting: 

No relevant quotes. The study was conducted at 3 centers in Italy, but details of the settings are not provided. 

Score: [NA]


Organization:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course. Prior to study start, all team members were trained in the HPA intervention; 3 and 6 months after trial initiation they met again to share experiences, fine-tune the protocol, and discuss difficult cases.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎UC consisted of the health and social services provided by the Italian National Health Service in the study area. Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).&quot;</span>

The HPA intervention involved specialized teams with PC training and additional resources compared to usual care. This represents an explanatory approach.

Score: [2]


Flexibility (delivery):

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services). Subsequently, the team verified program implementation and reviewed it as necessary.&quot;</span> 

The HPA intervention was personalized for each dyad based on assessments, but still followed a protocol with verification and review of implementation. This allows some flexibility but is more restrictive than usual care.

Score: [3]


Flexibility (adherence):

No relevant quotes. The study does not report on monitoring or measuring adherence.

Score: [NA]


Follow-up:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).&quot;</span>

The follow-up in the UC group included 3 in-person study visits and monthly phone interviews, which is more intensive than usual care.

Score: [2]


Primary outcome: 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).&quot;</span>

The co-primary outcomes of quality of life (SEIQoL-DW) and symptom burden (POS-S-MS) are clinically meaningful to patients.

Score: [5]

Primary analysis:

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).&quot;</span>

The primary analysis was intention-to-treat, including all randomized participants. This represents a pragmatic approach.

Score: [5]</pre>
<p><a name='691'></a></p>
</div>
<div
id="thomas-s.-2013-a-pragmatic-parallel-arm-multi-centre-randomised-controlled-trial-to-assess-the-effectiveness-and-cost-effectiveness-of-a-group-based-fatigue-management-programme-facets-for-people-with-multiple-sclerosis"
class="section level4">
<h4>691.
<a href='https://doi.org/10.1136/jnnp-2012-303816' title='Open publication'>Thomas
S. (2013): <i>A pragmatic parallel arm multi-centre randomised
controlled trial to assess the effectiveness and cost-effectiveness of a
group-based fatigue management programme (FACETS) for people with
multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning:

Eligibility:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.&quot;</span>

The eligibility criteria are fairly broad, including clinically diagnosed MS patients with significant fatigue impacting daily life who are ambulatory. The main exclusions are to avoid carryover effects from recent other fatigue programs or medications. Overall, the criteria seem aimed to recruit a sample similar to MS patients who would receive fatigue management in usual care.

Score: [4]

Recruitment:

Relevant quotes:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.&quot;</span>

Patients were recruited through routine primary and secondary care settings or MS Society communications, reflecting typical pathways for engaging patients in usual care. No special advertising or incentives were mentioned.

Score: [5] 

Setting:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.&quot;</span>

The intervention was provided primarily in hotel meeting rooms, similar to settings for usual care delivery. One site used a rehabilitation hospital, also a routine practice setting.  

Score: [5]

Organization:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The FACETS intervention uses health professionals routinely involved in managing MS, supported by a clinical psychologist.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists. Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).&quot;</span>

The intervention was delivered by existing MS healthcare providers like occupational therapists, physiotherapists, and nurses. The staffing model and qualifications match usual care.

Score: [5] 

Flexibility (delivery):

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists). The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework. The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be replicated. A companion participant handbook, along with existing information booklets, reinforces programme content.&quot;</span>

The intervention delivery is highly standardized with a structured manual, suggested script, and no tailoring mentioned. This differs from the flexible approach in usual care.

Score: [2]

Flexibility (adherence): 

Relevant quotes: No relevant quotes about flexibility in adherence.

The text does not mention flexibility in adherence to the intervention. However, there is no indication that there were measures to enforce adherence that go beyond usual encouragement.

Score: [NA]

Follow-up:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Individuals who had attended a fatigue management programme in the past year were excluded from the trial as were those who had received a fatigue intervention from a health professional in the past 3 months (see protocol).&quot;</span>

The only mention of follow-up is the exclusion criteria related to recent other fatigue interventions. There is no indication of more intensive measurement or follow-up than would occur in usual care.

Score: [5]

Primary outcome:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome measures: These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)),18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1))19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).&quot;</span>  

The primary outcomes of fatigue severity, disease-specific QOL, and fatigue self-efficacy are clinically relevant and important to patients.

Score: [5]

Primary analysis:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).&quot;</span>

The primary analysis was intention-to-treat, consistent with a pragmatic approach. 

Score: [5]</pre>
<p><a name='692'></a></p>
</div>
<div
id="torkhani-e.-2021-improving-health-of-people-with-multiple-sclerosis-from-a-multicenter-randomized-controlled-study-in-parallel-groups-preliminary-results-on-the-efficacy-of-a-mindfulness-intervention-and-intention-implementation-associated-with-a-physical-activity-program"
class="section level4">
<h4>692.
<a href='https://doi.org/10.3389/fpsyg.2021.767784' title='Open publication'>Torkhani
E. (2021): <i>Improving Health of People With Multiple Sclerosis From a
Multicenter Randomized Controlled Study in Parallel Groups: Preliminary
Results on the Efficacy of a Mindfulness Intervention and Intention
Implementation Associated With a Physical Activity Program</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given clinical trial text:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.&quot;</span>

The eligibility criteria are fairly broad, including adults aged 18-65 with a diagnosis of MS who are able to consent and undertake physical activity. The main exclusion criteria are being currently engaged in rehabilitation/therapy or having risk factors that preclude PA participation. Overall, the criteria seem pragmatic and aim to recruit a sample similar to patients who would receive the intervention in real world practice.

Score: [4] 

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.&quot;</span>

The participants were recruited from hospitals providing usual care for MS patients. No additional efforts like advertising or incentives were mentioned. Recruitment seems to rely mainly on identification of eligible patients already receiving care at the study sites.

Score: [4]

Setting: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Practicing sessions were conducted under the supervision of a physical and sports activity trainer specializing in sports training. Participants were randomly assigned to one of the three experimental groups: MBI group, II group or Control Group (CG) (n = 12).&quot;</span>

The PA intervention took place under a specialist trainer, but the setting is not described in detail. The psychological interventions were delivered remotely via internet/phone. Overall, the setting seems fairly pragmatic and similar to real world care.

Score: [3]

Organisation:

No relevant quotes. The staffing, resources, and delivery of the interventions are not described in detail.

Score: [NA] 

Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mindfulness practice took place individually at home six times per week, without any assistance.&quot;</span> 

The delivery of the mindfulness intervention seems highly standardized with no flexibility, while the PA allows some flexibility in choosing time/place. Overall moderately flexible delivery.

Score: [3]

Flexibility (adherence): 

No discussion of adherence requirements or monitoring.

Score: [NA]

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).&quot;</span>

Follow-up assessment was done at baseline and 8 weeks after randomization. No details on frequency/duration of study visits. Follow-up seems pragmatic.

Score: [4]

Primary outcome:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mobility, fatigue, and the impact of the disease on the patient’s life were measured.&quot;</span>

Outcomes assessed are clinically meaningful for patients - mobility, fatigue, disease impact.

Score: [5]

Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎According to the recommendations of McCoy (2017), concerning the randomized controlled trials and the assess of the psychological interventions efficacy all the patients of the study were analyzed.&quot;</span>

An intention-to-treat approach was used with all randomized patients analyzed.

Score: [5]</pre>
<p><a name='693'></a></p>
</div>
<div
id="velikonja-o.-2010-influence-of-sports-climbing-and-yoga-on-spasticity-cognitive-function-mood-and-fatigue-in-patients-with-multiple-sclerosis"
class="section level4">
<h4>693.
<a href='https://doi.org/10.1016/j.clineuro.2010.03.006' title='Open publication'>Velikonja
O. (2010): <i>Influence of sports climbing and yoga on spasticity,
cognitive function, mood and fatigue in patients with multiple
sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<p><i><span style="border-bottom: 1px dashed #2780e3; color: #2780e3;">1
quote(s) from the LLM prompt briefing</span> (mean similarity 100%) -
were instructions quoted (ok) or examples (unwanted beahviour)?</i></p>
<pre>
Here are the PRECIS-2 domain scores with explanations:

Eligibility:
Quote 1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.&quot;</span>

The eligibility criteria are fairly narrow, excluding patients outside a specific age range and disability level. This suggests a more explanatory approach.

Score: [2]

Recruitment:
Quote 1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants gave their written consent prior to the inclusion.&quot;</span> 

Quote 2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was approved by the National Medical Ethics Committee.&quot;</span>

The study appears to have recruited participants through an ethics committee approval process rather than routine clinical appointments. This suggests a more explanatory approach.

Score: [2] 

Setting: 
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.&quot;</span>

The climbing intervention took place in a specialized facility with adjusted equipment, rather than a real-world setting. This suggests a more explanatory approach.

Score: [2]

Organization:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.&quot;</span>

The yoga intervention involved specialized staff and tailored programming, beyond what would be available in routine care. This suggests a more explanatory approach.

Score: [2]

Flexibility (delivery): 
Quote 1: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.&quot;</span> 

Quote 2: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.&quot;</span>

The interventions were delivered in a standardized protocol by specialized staff. This suggests limited flexibility like an explanatory trial. 

Score: [2]

Flexibility (adherence):
No relevant quotes. The study does not mention assessing or enforcing adherence. However, the nature of supervised exercise interventions implies some encouragement to adhere.

Score: [3] 

Follow-up:
Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures:&quot;</span>

The use of specialized assessment tools like Modified Ashworth Scale and extensive neuropsychological batteries suggests more intensive follow-up than usual care.

Score: [2]

Primary outcome:
Quote: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.&quot;</span>

The outcomes of spasticity, cognitive function, fatigue and mood are highly patient-centered.

Score: [5] 

Primary analysis:
No relevant quotes. The study does not mention details about the analysis plan. In the absence of information suggesting otherwise, we can assume an intention-to-treat approach typical of pragmatic trials.

Score: [4]</pre>
<p><a name='694'></a></p>
</div>
<div
id="vermöhlen-v.-2018-hippotherapy-for-patients-with-multiple-sclerosis-a-multicenter-randomized-controlled-trial-ms-hippo"
class="section level4">
<h4>694.
<a href='https://doi.org/10.1177/1352458517721354' title='Open publication'>Vermöhlen
V. (2018): <i>Hippotherapy for patients with multiple sclerosis: A
multicenter randomized controlled trial (MS-HIPPO)</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 94.6%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

Eligibility:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion.&quot;</span>
2. The trial used fairly broad eligibility criteria, enrolling patients with confirmed MS, lower limb spasticity, and moderately impaired mobility based on EDSS score. These criteria reflect typical patients who would receive hippotherapy in clinical practice. Some patients were excluded, like those with acute exacerbations, but overall the criteria seem pragmatic.
Score: [4]

Recruitment:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.&quot;</span>
2. Patients were recruited from multiple clinical sites in Germany. Beyond confirming eligibility, no special recruitment efforts are described. Recruitment appears to align with routine clinical practice.
Score: [4] 

Setting: 

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.&quot;</span>
2. The trial was conducted at established hippotherapy centers, reflecting the typical setting this intervention would be delivered in routine care. 
Score: [5]

Organisation:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.&quot;</span>
2. Hippotherapy was provided by existing staff at the participating centers, following standard regulations. No additional resources or training were described. This matches real-world care.
Score: [5] 

Flexibility (delivery):

1. <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 57.1%):

pplied. The study was approved by the respective ethical committees of the participating sites and reg' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Hippotherapy was provided by existing staff at the participating centers, following standard regulations.&quot;</span> 
2. Hippotherapy was delivered according to standard regulations, with no mention of deviations, monitoring, or measures to enforce compliance. This reflects the flexibility of routine practice.
Score: [5]

Flexibility (adherence):

1. No relevant quotes.
2. Adherence to hippotherapy is inherent once patients consent to the intervention. No compliance issues are mentioned. 
Score: [NA]

Follow-up:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).&quot;</span>
2. Follow-up assessments were performed at baseline, 6 weeks, and 12 weeks. This schedule provides adequate data while minimizing patient burden beyond what would occur in routine care.
Score: [4]

Primary outcome:  

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary endpoint was the change in the BBS (difference from BBS baseline to week 12).&quot;</span> 
2. The BBS measures balance and risk of falling, outcomes that are clinically relevant and important to patients. It does not require special expertise to administer.
Score: [4]

Primary analysis:

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses were based on the modified intention-to-treat set (modified ITT).&quot;</span>
2. The primary analysis was done according to the modified ITT principle, including all randomized patients with baseline data. This pragmatic approach includes all available data, as would be done in clinical practice.  
Score: [5]</pre>
<p><a name='695'></a></p>
</div>
<div
id="ward-c.-d.-2004-education-for-people-with-progressive-neurological-conditions-can-have-negative-effects-evidence-from-a-randomized-controlled-trial"
class="section level4">
<h4>695.
<a href='https://doi.org/10.1191/0269215504cr792oa' title='Open publication'>Ward
C. D. (2004): <i>Education for people with progressive neurological
conditions can have negative effects: evidence from a randomized
controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">11 quote(s) from
publication full text</span> (mean similarity 94.1%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial based on the provided text:

Eligibility:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.&quot;</span>

The trial excluded participants with dementing disorders and those whose diagnoses were incompatible or had additional causes of severe disability. This suggests the trial used several exclusions beyond what would occur in usual care.
Score: [2] 

Recruitment:
Quotes:
<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.1%):

. We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000)...We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.&quot;</span>

Participants were recruited through searching GP records rather than inviting them directly. This is similar to how patients would be identified for an intervention in usual care.
Score: [4]

Setting: 
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK).&quot;</span>

The trial was conducted at a single academic medical center rather than in a more pragmatic setting like a primary care clinic.
Score: [2]

Organisation:
Quote: 
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information...&quot;</span>

The intervention was delivered by a research occupational therapist, suggesting more resources and expertise than would be typical in usual care.
Score: [2]

Flexibility (delivery):
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.&quot;</span> 
<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit...&quot;</span>

The education intervention was standardized with a set timeline and components. This is less flexible than education delivery in usual care.
Score: [2]

Flexibility (adherence): 
No relevant quotes. The text does not mention whether participants' adherence was monitored or enforced.
Score: [NA] 

Follow-up:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments.&quot;</span>
<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.7%):

Participants were assessed at baseline and 12 months later.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We assessed participants at baseline and 12 months later.&quot;</span>

Follow-up was more frequent than would occur in usual care, with phone calls every 2 months.
Score: [2]

Primary outcome:
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome measures were reports of one or more falls or skin sores.&quot;</span>

The primary outcomes of falls and skin sores are clinically relevant for the study population.
Score: [5]

Primary analysis:
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analyses were performed both with and without adjustment for baseline rates of events in the groups.&quot;</span>

The analysis appears to include all randomized participants. 
Score: [5]</pre>
<p><a name='696'></a></p>
</div>
<div
id="weinstock-guttman-b.-2016-randomised-natalizumab-discontinuation-study-taper-protocol-may-prevent-disease-reactivation"
class="section level4">
<h4>696.
<a href='https://doi.org/10.1136/jnnp-2015-312221' title='Open publication'>Weinstock-Guttman
B. (2016): <i>Randomised natalizumab discontinuation study: taper
protocol may prevent disease reactivation</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given clinical trial text:

Eligibility:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.&quot;</span>
2. The eligibility criteria are moderately pragmatic - participants had relapsing MS, were on natalizumab for at least 24 months, and had an EDSS ≤7.0. This captures a reasonably broad population of MS patients who were stable on natalizumab therapy. However, there are some restrictions around diagnosis, prior treatment, and disability level that make it not fully representative of the wider MS population.
Score: [3] 

Recruitment:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.&quot;</span> 
2. Participants were recruited from a single academic MS center, which requires some extra effort compared to recruiting patients already engaged in usual care. This makes recruitment moderately explanatory.
Score: [2]

Setting: 
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.&quot;</span>
2. The trial was conducted at a single academic MS center, which is more explanatory than a pragmatic multicenter design. 
Score: [2] 

Organization:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Standardised MRI were performed using the same 3 T General Electric Signa Excite HD 12.0 (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy.&quot;</span>
2. Standardized MRI scans were performed at a specialized research center with specific equipment. This level of organizational resourcing is more than what is typical in usual care.
Score: [2]

Flexibility (delivery):
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT- fingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).&quot;</span>
2. The protocol defines specific treatments to be started within precise time windows after discontinuing natalizumab. This is more rigid than typical care.
Score: [2]

Flexibility (adherence): 
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Treatment compliance was assessed by interviews during scheduled visits.&quot;</span>
2. The text does not mention exclusion or encouragement related to adherence. However, there is likely some assessment and encouragement as part of participating in a clinical trial.
Score: [3] 

Follow-up:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).&quot;</span> 
2. Follow-up occurred at protocol-specified intervals more frequently than would occur in usual care.
Score: [2]

Primary outcome:
1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Safety parameters evaluated as primary outcomes were defined as: (1) MRI parameters quantified by lesion activity analyses and changes in lesion volume (LV) and (2) clinical parameters that included the number of clinical relapses during the cessation period compared to the number of relapses before cessation in both the group as a whole as well as between the two randomised groups.&quot;</span>
2. The primary outcomes of MRI lesion activity and clinical relapses are relevant and important to patients.
Score: [5]

Primary analysis:
1. The text does not specify details about the primary analysis.
Score: [NA]</pre>
<p><a name='697'></a></p>
</div>
<div
id="williams-k.-l.-2021-center-based-group-and-home-based-individual-exercise-programs-have-similar-impacts-on-gait-and-balance-in-people-with-multiple-sclerosis-a-randomized-trial"
class="section level4">
<h4>697.
<a href='https://doi.org/10.1002/pmrj.12377' title='Open publication'>Williams
K. L. (2021): <i>Center-Based Group and Home-Based Individual Exercise
Programs Have Similar Impacts on Gait and Balance in People With
Multiple Sclerosis: A Randomized Trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

## Eligibility

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.&quot;</span>

The eligibility criteria are fairly broad, including people with MS who can walk 10 meters in 2 minutes with or without an aid. However, some people are excluded such as those already engaged in regular exercise programs and those with recent medication changes or relapses. Overall, the criteria seem moderately pragmatic.

Score: [3] 

## Recruitment

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.&quot;</span>

The participants were recruited from the community through a MS society rather than referred from clinics or targeted advertising. This pragmatic approach mirrors how people would access interventions in routine practice.

Score: [4]

## Setting
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The group program was conducted at a local community center and included four to six participants per class.&quot;</span> 

The group intervention took place in a community center, a real world setting. This is more pragmatic than a specialized hospital or research setting.

Score: [4] 

## Organization
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.&quot;</span>

The group intervention was delivered by physiotherapists who work for the MS Society rather than specialized research staff. However, they did receive additional training for standardization. This is moderately pragmatic.

Score: [3]

## Flexibility (delivery)
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.&quot;</span>

The exercise program allowed for some flexibility and individualization in delivery while still following guidelines. This balances flexibility with standardization. 

Score: [3] 

## Flexibility (adherence)
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In both group and home exercise sessions, participants completed eight, 6 minute exercises/stations per session plus a 5-minute warm up and cool down as outlined in the Appendix S1.&quot;</span> 

The intervention involved a structured program with set stations and duration. There was no mention of assessing or encouraging adherence. This protocol-driven approach is more explanatory.

Score: [2]

## Follow-up
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome assessments were conducted at baseline, immediately postintervention and at 8-week follow-up.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adherence (proportion of exercise sessions completed) was recorded in both groups.&quot;</span> 

Follow-up assessments were limited to two post-intervention time points and adherence was monitored closely. This is more explanatory.

Score: [2]

## Primary outcome
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was gait speed, measured using the 10-meter walk test.&quot;</span>

The primary outcome of gait speed is clinically meaningful to patients.

Score: [5] 

## Primary analysis
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were analyzed according to the intention-to-treat principle.&quot;</span>

The intention-to-treat analysis is appropriately pragmatic.

Score: [5]</pre>
<p><a name='705'></a></p>
</div>
<div
id="petrella-r.-j.-2017-hockey-fans-in-training-a-pilot-pragmatic-randomized-controlled-trial"
class="section level4">
<h4>705.
<a href='https://doi.org/10.1249/MSS.0000000000001380' title='Open publication'>Petrella,
R. J. (2017): <i>Hockey Fans in Training: A Pilot Pragmatic Randomized
Controlled Trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with supporting evidence from the text:

Eligibility:
Extracted quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).&quot;</span>

Reasoning: The eligibility criteria specify age, BMI, gender, and physical activity safety requirements. The criteria seem designed to select a specific population of overweight/obese middle-aged male hockey fans, rather than being highly representative of patients who would receive the intervention in routine practice.

Score: [2]

Recruitment:
Extracted quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).&quot;</span>

Reasoning: Participants were actively recruited through methods like advertisements and direct contacts. This level of effort and targeting goes beyond what would be used in routine practice.

Score: [2] 

Setting:
Extracted quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.&quot;</span>

Reasoning: The program was delivered in settings affiliated with the hockey teams, rather than specialized trial or academic centers. This matches routine practice.

Score: [4]

Organization: 
Extracted quote: 
"Twelve-week active phase

The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team (see Gill et al. [14] for information on coach background and training)."

Reasoning: The intervention was delivered by specialized research staff. The level of staffing and their training/expertise differs from what would be available in usual care.

Score: [2]

Flexibility (delivery):
Extracted quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice. Sessions were designed to appeal to men; they included elements of friendly competition and encouraged banter, humor, and peer support.&quot;</span>

Reasoning: The program has a defined curriculum and exercise protocol. There is less flexibility in delivery compared to usual care.

Score: [2]

Flexibility (adherence): 
Reasoning: No relevant quotes found in the text. The study does not provide enough information to assess this domain.

Score: [NA]

Follow-up:
Extracted quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.&quot;</span>

Reasoning: Follow-up measurements were more frequent and extensive than would occur in usual care.

Score: [2]

Primary outcome:
Extracted quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Percentage of baseline weight was examined using an ANCOVA, and total PA from the IPAQ was analyzed using quantile regression; all models adjusted for age, site, and either baseline weight (weight model) or baseline total PA (total PA model).&quot;</span>

Reasoning: The primary outcome is a clinical measure of weight loss. This is relevant to participants but assessed in a more standardized way than usual care.

Score: [3] 

Primary analysis:
Extracted quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.&quot;</span>

Reasoning: The analysis followed an intent-to-treat approach, including all randomized participants regardless of adherence. This matches routine practice.

Score: [4]</pre>
<p><a name='712'></a></p>
</div>
<div
id="mafetoni-r.-r.-2016-the-effects-of-acupressure-on-labor-pains-during-child-birth-randomized-clinical-trial1"
class="section level4">
<h4>712.
<a href='https://doi.org/10.1590/1518-8345.0739.2738' title='Open publication'>Mafetoni,
R. R. (2016): <i>The effects of acupressure on labor pains during child
birth: randomized clinical trial1</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given clinical trial text:

1. Eligibility

Quotes: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.&quot;</span>

The eligibility criteria are reasonably similar to real-world practice. Women in the late stages of pregnancy with contractions are representative of typical patients in labor who would receive this intervention. However, some women are excluded, such as those with medical complications or advanced cervical dilation, indicating a moderately pragmatic design.

Score: [3] 

2. Recruitment

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel(r) and they were distributed in three groups&quot;</span>

Participants were allocated randomly from the eligible pregnant women already admitted to the maternity ward, suggesting routine recruitment consistent with real-world practice.

Score: [4]

3. Setting

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).&quot;</span>

The study was conducted at a single public maternity hospital that appears to provide care typical of real-world practice, including allowing support persons and non-drug comfort measures. The setting seems moderately pragmatic.

Score: [3] 

4. Organization

Quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The researcher that was responsible for applying the acupressure went through 32 hours' worth of training.&quot;</span> 

The intervention providers received specific training on acupressure technique, suggesting more resources than in typical care. However, it is not clear if other aspects of care delivery differed from usual practice.

Score: [3]

5. Flexibility (delivery)

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g) 15 . In both groups the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.&quot;</span>

The acupressure protocol is highly standardized, involving specified pressure measured with a scale. This level of monitoring and control is more explanatory than real-world practice.

Score: [2]

6. Flexibility (adherence)

No relevant information. The intervention is provided by the researcher, so patient adherence is not applicable. 

Score: [NA]

7. Follow-up

Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain (Table 3).&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For conducting evaluations on the pain we opted for the VAS model which is a rising scale from 0 10, 0 meaning no pain to 10 which is the worst pain felt. The patients registered their pain using a picture of a grimacing face and writing down a number next to it. The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.&quot;</span>

Outcomes were assessed more frequently and rigorously than in routine care, including pain scales at multiple time points. This indicates a more explanatory approach.

Score: [2]

8. Primary outcome

Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Through an evaluation of the pain we saw a significant reduction in the group that received acupressure in the SP6 point in comparison with the TG and CG groups.&quot;</span>

The primary outcome of pain is a patient-centered outcome that is clinically meaningful.

Score: [4] 

9. Primary analysis

Quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The analgesia epidural or the spinal anesthesia were available for women depending on their need. Their use was as follows: 69.23% in the SP6 group (n 36) and 79.92% (n 40) in the other groups (Chi-squared test, p=0.5840).&quot;</span>

The analysis appears to follow an intention-to-treat approach without excluding participants post-randomization.

Score: [4]</pre>
<p><a name='713'></a></p>
</div>
<div
id="jonsdottir-h.-2015-effectiveness-of-a-partnership-based-self-management-programme-for-patients-with-mild-and-moderate-chronic-obstructive-pulmonary-disease-a-pragmatic-randomized-controlled-trial"
class="section level4">
<h4>713.
<a href='https://doi.org/10.1111/jan.12728' title='Open publication'>Jonsdottir,
H. (2015): <i>Effectiveness of a partnership-based self-management
programme for patients with mild and moderate chronic obstructive
pulmonary disease: a pragmatic randomized controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.4%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and justifications:

Eligibility:
Quotes:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.&quot;</span>

The study had specific inclusion and exclusion criteria, including age range, COPD severity, and exclusions for major comorbidities and prior structured rehab participation. This indicates a more explanatory approach.

Score: [2]


Recruitment:
Quotes:  
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An invitation letter signed by the patient's physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.&quot;</span>
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One to two weeks later the patient was contacted by phone. In the phone call, possibilities for participation were explored. An appointment at the research centre was set up for those who accepted the invitation.&quot;</span>

Participants were identified via medical records and invited by letters from their physicians. This is more explanatory than recruiting patients presenting for routine care. However, they were recruited broadly from multiple sites rather than just a specialized trial center.

Score: [3]


Setting: 
Quote:
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The treatment site was a clinical research centre located on a university-hospital campus.&quot;</span>

The study took place at a specialized clinical research center affiliated with a university hospital. This is more explanatory.

Score: [2]


Organization:
Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Attendance at treatment sessions in the experimental group was more than 80% in the patient/family conversations (43/48 attended three or four out of the four possible meetings) and the group meeting (40/48).&quot;</span>

There was a high rate of session attendance, indicating flexibility in organization and delivery of the intervention. No descriptions of enhanced resources compared to usual care.

Score: [4] 


Flexibility (delivery):
Quotes:  
- <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):

) Number and length of conversations varied depending on identified needs' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The number and length of conversations varied depending on identified needs.&quot;</span>
- <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Being ready to quit, having a belief in one&#39;s capacity to quit, and having a strong motivation to quit were of central importance (Miller & Rollnick 2002). The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed (DiClemente et al. 1991)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Being ready to quit, having a belief in one's capacity to quit, and having a strong motivation to quit were of central importance (Miller & Rollnick 2002). The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed (DiClemente et al. 1991).&quot;</span>

The intervention allowed for flexibility in number and length of sessions based on patient needs. The smoking cessation component was also tailored and allowed patients time to progress.

Score: [4]


Flexibility (adherence): 
No relevant quotes. The study does not mention any measures to enforce or monitor adherence.

Score: [NA]


Follow-up:
Quote: 
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.&quot;</span> 

Follow-up data collection timepoints were at 6 and 12 months, which does not seem substantially different from usual care.

Score: [4]


Primary outcome:
Quote: 
- Primary outcomes included quality of life, anxiety and depression, illness intrusiveness, physical activity, exacerbations, and smoking.

The primary outcomes are clinically meaningful and relevant for COPD patients.

Score: [5]


Primary analysis:
No clear description of how missing data or protocol deviations were handled.

Score: [NA]</pre>
<p><a name='714'></a></p>
</div>
<div
id="pinnock-h.-2003-accessibility-acceptability-and-effectiveness-in-primary-care-of-routine-telephone-review-of-asthma-pragmatic-randomised-controlled-trial"
class="section level4">
<h4>714.
<a href='https://doi.org/10.1136/bmj.326.7387.477' title='Open publication'>Pinnock,
H. (2003): <i>Accessibility, acceptability, and effectiveness in primary
care of routine telephone review of asthma: pragmatic, randomised
controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with supporting quotes and explanations:

Domain: Eligibility
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From their computerised asthma registers the practices identified adults (⩾18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner's request) for major social or medical reasons.&quot;</span>

Explanation: The study recruited adults with asthma who were overdue for their routine annual review. The eligibility criteria aimed to identify patients typical of those who would receive asthma care in usual practice. There were some minimal exclusions for comorbidities and communication barriers.
Score: [4] 

Domain: Recruitment
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We wrote to all eligible patients inviting them to take part in the study.&quot;</span>  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were free to arrange any consultations they wished.&quot;</span>

Explanation: Patients were recruited via invitation letters, a passive form of recruitment similar to routine care where patients make their own appointments. There was no extra effort to incentivize participation.
Score: [4]

Domain: Setting
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.&quot;</span>

Explanation: The study was conducted in real-world general practice settings providing usual asthma care.
Score: [5] 

Domain: Organization 
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Using validated instruments we obtained data on several clinical and practice related outcomes.&quot;</span>

Explanation: The study aimed to assess the intervention under real-world conditions. There was no modification of care delivery or additional resources/training provided beyond routine practice. 
Score: [5]

Domain: Flexibility (delivery)
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Clinical care and follow up were the same as for the intervention group but without a telephone option.&quot;</span>

Explanation: Nurses delivered care flexibly according to patients' needs. The intervention allowed the same flexibility in care as usual practice.
Score: [5] 

Domain: Flexibility (adherence)
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were free to arrange any consultations they wished.&quot;</span>

Explanation: There was no monitoring or enforcement of adherence. Patients could choose whether to attend consultations.
Score: [5] 

Domain: Follow-up
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study was of short duration and so we can't comment on the long term impact of telephone assessments.&quot;</span>

Explanation: Follow-up was limited to 3 months with questionnaires. This matches usual care without extensive long-term monitoring.
Score: [4]

Domain: Primary outcome  
Quote:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.&quot;</span>

Explanation: The outcomes measured access to routine care and quality of life, which are meaningful to patients. No surrogate outcomes or special testing was used.
Score: [5]

Domain: Primary analysis
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm (risk difference 26% (95% confidence interval 14% to 37%; P<0.001; number needed to treat 3.8 (2.7 to 7.1)).&quot;</span>

Explanation: The analysis was intention-to-treat including all randomized participants. 
Score: [5]</pre>
<p><a name='715'></a></p>
</div>
<div
id="ndosi-m.-2014-the-outcome-and-cost-effectiveness-of-nurse-led-care-in-people-with-rheumatoid-arthritis-a-multicentre-randomised-controlled-trial"
class="section level4">
<h4>715.
<a href='https://doi.org/10.1136/annrheumdis-2013-203403' title='Open publication'>Ndosi,
M. (2014): <i>The outcome and cost-effectiveness of nurse-led care in
people with rheumatoid arthritis: a multicentre randomised controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 97.7%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

Eligibility:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria),29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.&quot;</span>

The eligibility criteria are fairly broad, including adults with a diagnosis of RA who can complete questionnaires. The few exclusions are reasonable. This suggests the participants are likely similar to patients who would receive the intervention in usual care.

Score: [4]

Recruitment:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness.&quot;</span>

Patients were recruited during their normal clinic visits. No special efforts were made to recruit participants beyond the clinic setting.

Score: [4] 

Setting:
<span title='Minor quote deviation. Best match in fulltext (Similarity 97.7%):

The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This study was conducted in outpatient clinics of 10 rheumatology centres across the UK.&quot;</span>

The study took place in regular rheumatology clinic settings, suggesting a pragmatic approach.

Score: [5]

Organization: 
No information is provided about staffing, resources, or care delivery being substantially different from usual care.

Score: [4]

Flexibility (delivery):
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The usual RLC is similar to the above except that it usually involves an allocated 15-min time slot.&quot;</span>

The nurse-led and rheumatologist-led interventions were delivered per protocol with allocated time slots. This suggests some flexibility in how the intervention was delivered, but protocolized care.

Score: [3] 

Flexibility (adherence): 
No information is provided about how patient adherence was addressed.

Score: [NA]

Follow-up:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.&quot;</span>

Follow-up was more frequent than usual care to allow comparison between groups.

Score: [2]

Primary outcome:
<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.6%):

The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The primary outcome was disease activity score in 28 joints (DAS28) and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.&quot;</span>

The primary outcome of DAS28 is a disease-specific measure that is clinically meaningful. 

Score: [4]

Primary analysis:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.&quot;</span>

The study used both PP and ITT analysis, suggesting a pragmatic approach.

Score: [4]</pre>
<p><a name='722'></a></p>
</div>
<div
id="patel.-a.-2015-a-pragmatic-randomized-trial-of-a-polypill-based-strategy-to-improve-use-of-indicated-preventive-treatments-in-people-at-high-cardiovascular-disease-risk"
class="section level4">
<h4>722.
<a href='https://doi.org/10.1177/2047487314530382' title='Open publication'>Patel.
A. (2015): <i>A pragmatic randomized trial of a polypill-based strategy
to improve use of indicated preventive treatments in people at high
cardiovascular disease risk</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 99.5%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the trial based on the provided text:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Men and women aged ≥18 years at high CVD risk, defined as either established CVD (history of coronary, ischaemic cerebrovascular, or peripheral vascular disease) or an estimated five-year CVD risk of ≥15% (using the Framingham risk equation, including a 5% increment for Aboriginal or Torres Strait Islander identification)21 were eligible. Each participant had to have, in their doctor’s view, indications for all and no contraindications to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg).&quot;</span>

The eligibility criteria are relatively broad, including adults at high CVD risk. The criteria align with guidelines for prescribing the medications in the polypill. Some patients were excluded if the doctor felt it was inappropriate to change medications, but overall the eligibility seems pragmatic.

Score: [4] 

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All participants were treated by their regular doctor following randomization.&quot;</span> 

Participants were recruited through their regular doctors at primary care clinics. No extra efforts were made to recruit participants.

Score: [5]

Setting: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All patient care was provided through existing primary healthcare practices, with rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.&quot;</span>

The study was conducted in real-world primary care settings. This matches the setting where the intervention would be implemented in practice.

Score: [5]

Organization:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Prescription and dispensing of the polypill occurred in the same way as for other medications. This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to designated local pharmacies where all drugs (including the polypill) were dispensed.&quot;</span>

The polypill was prescribed, dispensed, and paid for in the same way as usual medications. No extra resources or provider training was provided. This matches real-world care.

Score: [5] 

Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor. No attempt was made to influence any other aspect of their management. The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.&quot;</span>

Doctors had flexibility in prescribing the polypill or individual medications. There was no strict protocol or monitoring of compliance. This matches real-world flexibility.

Score: [5]

Flexibility (adherence): 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.&quot;</span>

No special measures were taken to improve adherence. Patients likely received usual encouragement to take medications as prescribed.

Score: [5] 

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.&quot;</span>

Follow-up schedule was reasonable and similar to what would occur in routine practice. Assessments were done at the regular primary care clinics.

Score: [4]

Primary outcome:

Quote: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):

Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 blood pressure lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.&quot;</span>

The primary outcomes of medication adherence, blood pressure, and cholesterol are clinically important to patients.

Score: [5] 

Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analyses were conducted on an intention-to-treat basis without imputation of missing data.&quot;</span>

An intention-to-treat analysis was used including all randomized participants. This matches real-world analysis.

Score: [5]</pre>
<p><a name='725'></a></p>
</div>
<div
id="rangan-a.-2015-surgical-vs-nonsurgical-treatment-of-adults-with-displaced-fractures-of-the-proximal-humerus-the-profher-randomized-clinical-trial"
class="section level4">
<h4>725.
<a href='https://doi.org/10.1001/jama.2015.1629' title='Open publication'>Rangan,
A. (2015): <i>Surgical vs nonsurgical treatment of adults with displaced
fractures of the proximal humerus: the PROFHER randomized clinical
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">14 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning:

ELIGIBILITY:

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excluded patients had associated dislocation of the injured shoulder joint, open fracture, insufficient mental capacity to understand the trial or instructions for rehabilitation, comorbidities precluding surgery or anesthesia, clear indication for surgery such as severe soft-tissue compromise, multiple injuries (upper limb fractures), pathological fracture (other than osteoporotic), terminal illness, or were not a resident in the hospital catchment area.&quot;</span>

The eligibility criteria are reasonably broad, including adults over 16 with displaced proximal humerus fractures involving the surgical neck. However, some patients are excluded due to comorbidities, insufficient mental capacity, and terminal illness. These exclusions likely make the study population slightly healthier than patients seen in usual care.

Score: [3] 

RECRUITMENT:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients received their allocated treatment from the recruiting hospital.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Reflecting known differences in osteoporosis-related fracture risk among different races, trial participants were asked to identify whether they were white, black, Asian, or other.&quot;</span>

Patients were recruited during routine clinical care at the orthopedic departments of the hospitals. No special efforts were made to enhance recruitment beyond approaching eligible patients at their usual appointments. The study population demographics match what would be expected based on epidemiology.

Score: [5]  

SETTING: 

Relevant quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There was 1 additional National Health Service hospital that screened but failed to recruit patients into the PROFHER trial. All 33 hospitals routinely provide surgical and nonsurgical fracture treatment.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Physiotherapy treatment log data demonstrated equal access and implementation between groups, with similarly high numbers of participants recorded as performing home exercises (109 in surgical group vs 103 in nonsurgical group) in both groups.&quot;</span>

The study was conducted at routine NHS hospitals providing standard surgical and nonsurgical treatment. Rehabilitation was provided through routine NHS services. The setting matches real-world clinical practice.

Score: [5]

ORGANIZATION:

Relevant quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.&quot;</span> 

The study used typical NHS resources, staffing, and clinical pathways. Good standard of care was emphasized. No additional resources or training were provided beyond routine practice.

Score: [5]  

FLEXIBILITY (delivery):

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To avoid learning curve problems, surgeons and physiotherapists used surgical interventions and procedures with which they were familiar.&quot;</span>

The surgeons used techniques they were experienced with, avoiding experimental procedures. No strict treatment protocols were enforced beyond normal clinical practice. Flexibility appears very similar to usual care.

Score: [5]

FLEXIBILITY (adherence):

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.&quot;</span>

After randomization, there seem to be no extraordinary measures to enforce adherence beyond giving the recommendation for sling use. Patients likely had flexibility similar to usual care.

Score: [5] 

FOLLOW-UP:

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow-up was up to 2 years (until April 2013) for all patients.&quot;</span>

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There was no trial-related clinical assessment or radiological follow-up of patients.&quot;</span> 

Follow-up was limited to patient questionnaires sent by mail at fixed times up to 2 years. No extra visits or exams were done. Follow-up intensity matches usual care.

Score: [5]

PRIMARY OUTCOME:

Relevant quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population. The OSS provides a total score based on the patient’s subjective assessment of pain and function.&quot;</span>

The primary outcome is a patient-reported functional scale, which is highly relevant to patients. No surrogate outcomes are used.

Score: [5] 

PRIMARY ANALYSIS:

Relevant quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.&quot;</span>

The primary analysis was intent-to-treat including all randomized patients. This matches real-world practice.

Score: [5]</pre>
<p><a name='733'></a></p>
</div>
<div
id="iliffe-s.-2015-promoting-physical-activity-in-older-people-in-general-practice-proact65-cluster-randomised-controlled-trial"
class="section level4">
<h4>733.
<a href='https://doi.org/10.3399/bjgp15X687361' title='Open publication'>Iliffe,
S. (2015): <i>Promoting physical activity in older people in general
practice: ProAct65+ cluster randomised controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with quotes and explanations:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise. Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.&quot;</span>

Explanation: The eligibility criteria are fairly broad, including community-dwelling adults aged 65+ who are mobile and can participate in group exercise. The exclusions are limited to those at high fall risk, with unstable conditions, inability to follow instructions safely, or in palliative care. This reflects eligibility in usual practice quite closely. Score: [4] 

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.&quot;</span>

Explanation: Participants were recruited through their regular general practices by inviting all eligible patients via letter. This is similar to recruitment in usual practice. Score: [4]

Setting: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.&quot;</span>

Explanation: The settings were community venues and participants' homes, which are routine settings for delivery of exercise programs in usual care. Score: [5]

Organization:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks.&quot;</span> 

Explanation: The trial used postural stability instructors to deliver the interventions, which represents greater resources and specialized providers compared to usual care. Score: [3] 

Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.&quot;</span>

Explanation: The exercise programs were standardized protocols tailored to individuals' capabilities. This allows less flexibility than usual care. Score: [3]

Flexibility (adherence): 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.&quot;</span>

Explanation: Participants were categorized as adherent if they completed >75% of intended exercise time. This represents fairly high adherence expectations. Score: [2]

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were followed up every 6 months after the end of the intervention period, until 24 months. The primary time point was chosen as 12 months post-intervention to match other trials.&quot;</span>

Explanation: Follow-up was limited to questionnaires every 6 months post-intervention. This is less intensive than a usual care exercise program. Score: [4]

Primary outcome:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using three validated questionnaires.&quot;</span> 

Explanation: The primary outcome is achieving physical activity guidelines, which is a patient-centered and clinically relevant outcome, assessed through questionnaires as in usual practice. Score: [5]

Primary analysis:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.&quot;</span>

Explanation: Analysis was by intention-to-treat. Score: [5]</pre>
<p><a name='1528'></a></p>
</div>
<div
id="humphreys-i.-2013-cost-effectiveness-of-an-adjustment-group-for-people-with-multiple-sclerosis-and-low-mood-a-randomized-trial"
class="section level4">
<h4>1528.
<a href='https://doi.org/10.1177/0269215513488608' title='Open publication'>Humphreys
I. (2013): <i>Cost-effectiveness of an adjustment group for people with
multiple sclerosis and low mood: a randomized trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with supporting quotes and explanations:

Eligibility

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.&quot;</span>

The eligibility criteria used screening tools commonly used in clinical practice to identify patients with low mood. No other exclusions are mentioned. This matches eligibility in usual care.
Score: [5] 

Recruitment

Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.&quot;</span>

No extra recruitment efforts beyond random allocation are described. This matches recruitment in usual care.
Score: [5]

Setting

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.&quot;</span>

The intervention was delivered in a clinical setting with appropriately trained staff. This matches the usual care setting.
Score: [5] 

Organisation

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The total running costs for the programme were £17,824. This was based on 54 three-hour sessions (including room hire and refreshments) and the salary of two NHS Band 5 assistant psychologists and one Band 8a clinical psychologist.&quot;</span> 

The staffing and costs described are within the normal NHS organization. No additional resources were provided.
Score: [5]

Flexibility (delivery)

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants randomly allocated to the adjustment group received six group treatment sessions.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.&quot;</span>

The intervention followed a standardized protocol over six sessions. This is less flexible than usual psychological care which is individualized.
Score: [2] 

Flexibility (adherence)

No discussion of measuring or enforcing adherence.
Score: [5] 

Follow-up

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.&quot;</span>

Follow-up matched what would occur in usual care.
Score: [5]

Primary outcome 

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were assessed four and eight months after randomization, blind to group allocation. The costs were assessed from a service use questionnaire and information provided on medication. Quality of life was assessed using the EQ-5D.&quot;</span>

Outcomes included costs, EQ-5D quality of life, and mood scales. These are measures of direct importance to patients.
Score: [5]

Primary analysis

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Owing to the level of missing EQ-5D data at follow-up, a ‘last value carried forward’ imputation approach was adopted.&quot;</span>

An intention-to-treat approach was used with imputation of missing data. This matches analysis in usual care.
Score: [5]</pre>
<p><a name='1529'></a></p>
</div>
<div
id="khayeri-f.-2016-effect-of-fordyce-happiness-model-on-depression-stress-anxiety-and-fatigue-in-patients-with-multiple-sclerosis"
class="section level4">
<h4>1529.
<a href='https://doi.org/10.1016/j.ctcp.2016.09.009' title='Open publication'>Khayeri
F. (2016): <i>Effect of Fordyce Happiness Model on depression, stress,
anxiety, and fatigue in patients with multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">6 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given trial based on the full text:

Eligibility criteria:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.&quot;</span>

The eligibility criteria seem fairly broad - patients only needed a definite diagnosis of MS and to be registered with the society. The few exclusions are reasonable. Overall, the criteria seem similar to what would be used in usual care.

Score: [4] 

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants. Accordingly, 70 numbers, equal to the number of people required in each group, were developed and the numbers 1–70 were randomly assigned to two groups: experimental and control. After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.&quot;</span>

The recruitment process seems fairly typical - patients were recruited as they presented to the clinic over a set period of time. There is no mention of special efforts above usual care to recruit participants.

Score: [4]

Setting: 

Quote: No relevant quotes found.

The setting is not described in the text.

Score: [NA] 

Organization:

Quote: No relevant quotes found. 

The text does not provide information about staffing, resources, and organization of care delivery.

Score: [NA]

Flexibility (delivery):

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This training program was conducted within eight 1- to 1.5-h sessions, two sessions a week through lecturing, group discussions, and question and answering, such that the scientific materials were offered within the first half-time of each session and, after a rest, the group discussions and questioning and answering were run about the drills of the subject of interest in the second half-time.&quot;</span>

The intervention delivery seems fairly standardized with set session times, formats, and content. This lacks the flexibility of usual care. 

Score: [2]

Flexibility (adherence):

Quote: No relevant quotes found.

The text does not describe measures to enforce or assess adherence.

Score: [NA] 

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To measure fatigue, the Piper Standard Scale was used. This scale consists of 27 items that measures fatigue in terms of four domains: behavioral, affective, tactile, and cognitive.&quot;</span> 

<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.&quot;</span>

Follow-up seems typical - patients were assessed during their regular clinic visits using standard scales over 2 months. There is no mention of extra visits or extensive additional data collection.

Score: [4]

Primary outcome: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.&quot;</span>

Standard scales were used to assess depression, anxiety, stress and fatigue. These are clinically meaningful outcomes that would also be of interest in usual care.

Score: [4]

Primary analysis:

Quote: No relevant quotes about the analysis plan.

Score: [NA]</pre>
<p><a name='1567'></a></p>
</div>
<div
id="stuifbergen-a.k.-2018-computer-assisted-cognitive-rehabilitation-in-persons-with-multiple-sclerosis-results-of-a-multi-site-randomized-controlled-trial-with-six-month-follow-up"
class="section level4">
<h4>1567.
<a href='https://doi.org/10.1016/j.dhjo.2018.02.001' title='Open publication'>Stuifbergen
A.K. (2018): <i>Computer-assisted cognitive rehabilitation in persons
with multiple sclerosis: Results of a multi-site randomized controlled
trial with six month follow-up</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">12 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain assessments based on the provided full text:

# Eligibility

Quotes: 
1) <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.&quot;</span>
2) <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Perceived Deficits Questionnaire19 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.&quot;</span>

This study recruited participants with MS who had subjective cognitive concerns, as measured by a screening questionnaire. The criteria appear to align with real-world eligibility for an intervention targeting cognitive impairment in MS patients.

Score: [4] 

# Recruitment

Quotes:
1) <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.&quot;</span> 
2) <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 347 persons who were initially screened as “eligible” were later contacted by phone to invite their participation during specific dates.&quot;</span>

Participants were recruited through routine clinical and community channels like physician referral and MS support groups. This pragmatic approach mirrors how patients would find out about and be recruited to cognitive therapy in routine practice. 

Score: [4]

# Setting

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.&quot;</span>

The study was conducted at multiple sites in the community setting, not restricted to specialized trial or academic centers. This matches the setting where cognitive therapy would normally be delivered.

Score: [4]

# Organization 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).&quot;</span>

The intervention was delivered through a feasible model involving limited group and individual sessions. It did not require substantially more resources or expertise than would be available in routine care.

Score: [4]

# Flexibility (delivery)

Quotes:
1) <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the integration of Bandura’s self-efficacy theory20 with the investigators’ prior intervention studies,21,22 the program’s conceptual model proposes accurate knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges will support persons with MS in the use of compensatory cognitive strategies and cognitive skills.&quot;</span>
2) <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The first four sessions focused on common cognitive problems experienced with MS (attention and processing speed, memory and language, visuospatial and executive functioning) and development of relevant compensatory strategies. The final four sessions focused on lifestyle behaviors to support cognitive functioning, including managing fatigue and stress and increasing physical activity.&quot;</span> 

The group sessions covered a range of cognitive issues, compensatory strategies, and lifestyle recommendations. The delivery allowed flexibility in tailoring the content to participants' individual needs and priorities.

Score: [4] 

# Flexibility (adherence)

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although individuals varied their computer training time from week to week, 68% met or exceeded the total time prescribed over the 8-week intervention. About half met or exceeded the goal each week.&quot;</span>

While participants were encouraged to complete a target number of computer training sessions, there was flexibility in how strictly participants needed to adhere to the full protocol. This level of flexibility mirrors what would occur in routine practice.

Score: [4]

# Follow-up

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.&quot;</span>

The follow-up schedule involved only 3 post-intervention assessments over 6 months. It did not include more extensive follow-up than would occur in routine practice.

Score: [4]

# Primary outcome  

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games. Participants completed self-report and performance measures of cognitive functioning, compensatory strategies and depression at baseline, immediately after the MAPSS-MS intervention, and three and six months post-intervention.&quot;</span>

The primary outcomes of self-reported cognitive functioning, use of compensatory strategies, and objective cognitive tests are highly relevant to the daily lives of participants.

Score: [5]

# Primary analysis

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.&quot;</span>

The use of intention-to-treat analysis mirrors how data would be analyzed in routine practice.

Score: [5]</pre>
<p><a name='1568'></a></p>
</div>
<div
id="riemenschneider-m.-2022-investigating-the-potential-disease-modifying-and-neuroprotective-efficacy-of-exercise-therapy-early-in-the-disease-course-of-multiple-sclerosis-the-early-multiple-sclerosis-exercise-study-emses"
class="section level4">
<h4>1568.
<a href='https://doi.org/10.1177/13524585221079200' title='Open publication'>Riemenschneider
M. (2022): <i>Investigating the potential disease-modifying and
neuroprotective efficacy of exercise therapy early in the disease course
of multiple sclerosis: The Early Multiple Sclerosis Exercise Study
(EMSES)</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 99%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with quotes and explanations:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were (1) 18–60  years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.&quot;</span>

The eligibility criteria are quite broad, only excluding based on age, disease duration, and recent relapses/medication changes. Patients of any disability level were included as long as they had RRMS diagnosed within the past 2 years. This is fairly similar to patients who would receive exercise as part of usual care.

Score: [4]

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.&quot;</span>

Patients were recruited through their regular clinic visits and an MS advocacy organization. No extra efforts like advertising or incentives were used. This matches usual care recruitment.

Score: [5] 

Setting: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax. The exercise sessions consisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30–60 minutes with an interval duration of 1–10 minutes and intensities varying from 65%–95% HRmax.&quot;</span>

The exercise intervention took place in a supervised setting, likely a research/clinical facility. This is more specialized than a typical exercise setting like a gym or community center used in usual care.

Score: [2]

Organization:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients received the exercise intervention in addition to usual care.&quot;</span> 

The exercise was delivered by study personnel, not the patients' usual healthcare providers. No details are provided on staff training or resources. The organization seems more structured than usual care exercise.

Score: [3] 

Flexibility (delivery): 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.&quot;</span>

The exercise had a structured progression plan and heart rate monitoring. This is less flexible than usual care exercise without a set protocol.

Score: [2]

Flexibility (adherence):

No relevant quotes. The paper states the planned and achieved attendance but does not discuss encouragement or consequences for non-adherence. 

Score: [NA]

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.&quot;</span>

Patients had study-specific MRI scans at 3 set time points. This monitoring is much more extensive than typical patient follow-up.

Score: [1]

Primary outcome:

Quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):

The relapse rate and the global brain atrophy rate were the primary outcomes of this study.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The annual relapse rate and the global brain atrophy rate were the primary outcomes of this study.&quot;</span>

Relapse rate is very clinically relevant. Brain atrophy is a surrogate marker not assessed in usual care.

Score: [4] 

Primary analysis:

No details provided on handling of missing data.

Score: [NA]</pre>
<p><a name='1569'></a></p>
</div>
<div
id="straudi-s.-2022-combining-a-supervised-and-home-based-task-oriented-circuit-training-improves-walking-endurance-in-patients-with-multiple-sclerosis.-the-ms_toct-randomized-controlled-trial"
class="section level4">
<h4>1569.
<a href='https://doi.org/10.1016/j.msard.2022.103721' title='Open publication'>Straudi
S. (2022): <i>Combining a supervised and home-based task-oriented
circuit training improves walking endurance in patients with multiple
sclerosis. The MS_TOCT randomized-controlled trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">7 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations:

Eligibility:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎inclusion of PwMS with an unassisted but limited walking competency (100–500 m)&quot;</span> 

This quote indicates that the eligibility criteria are quite broad, including patients with MS who have limited but unassisted walking ability. No exclusions are mentioned besides impaired cognition that interferes with consent. The criteria seem reasonably similar to patients who would receive this intervention in usual care.

Score: [4]

Recruitment:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.&quot;</span>

The patients were recruited from a rehabilitation clinic where they were already receiving care. No special efforts like advertising or incentives were mentioned. Recruitment seems moderately pragmatic.

Score: [3] 

Setting:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step). PwMS exercised for 5 min in each one (3 min of activities and 2 min of rest).&quot;</span>

The supervised training took place in a rehabilitation setting with specialized equipment like treadmills and workstations. This indicates a moderately explanatory setting.

Score: [3]

Organisation:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One session included up to three patients and lasted 120 min, five days/week for two weeks.&quot;</span>

The supervised training involved long sessions 5 days per week for 2 weeks. This intensive delivery required significant provider time and resources beyond usual care. 

Score: [2] 

Flexibility (delivery): 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎During TOCT, they received feedback (visual and auditory) from the physiotherapist.&quot;</span>

The supervised training followed a strict protocol with close monitoring and feedback from providers. This suggests low flexibility in delivery.

Score: [2]

Flexibility (adherence):

No relevant quotes. The home program seems reasonably flexible regarding adherence.

Score: [4] 

Follow-up:

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.&quot;</span>

Follow-up assessment was more frequent than usual care, with multiple study visits for outcome measurement. 

Score: [2]

Primary outcome: 

Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance&quot;</span>

The 6MWT is a meaningful outcome directly relevant to patients' walking ability.

Score: [5]

Primary analysis:

No exclusions are mentioned. Analysis seems to follow intent-to-treat principles.

Score: [5]</pre>
<p><a name='1570'></a></p>
</div>
<div
id="mazdeh-m.-2010-the-therapeutic-effect-of-avonex-rebif-and-betaferon-on-edss-and-relapse-in-multiple-sclerosis-a-comparative-study"
class="section level4">
<h4>1570. <a href='https://doi.org/' title='Open publication'>Mazdeh M.
(2010): <i>The therapeutic effect of Avonex, Rebif and Betaferon on EDSS
and relapse in multiple sclerosis: a comparative study</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">2 quote(s) from
publication full text</span> (mean similarity 96%)</i></p>
<pre>
Here are the PRECIS-2 domain scores and explanations based on the provided full text:

Eligibility:
<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.1%):

the following criteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of βinterferon under the supervision of a neurologist in a period of no more than 30 days prior to th' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Inclusion criteria were as follows: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β- interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.&quot;</span>
"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 109/ L , platelet count ≤ 100 x 109/ L , neutrophil count ≤ 1.5 x 109/ L ,and hemoglobin level ≤ 8.5 g/dl 
5)any kind of definite functional abnormality in body organs that disables the patient for treatment with β-interferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥
2.5 x maximum normal values , alkaline phosphatase
≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of
antimetabolites or cytotoxic drugs within six months
prior to the study 8) patients with PPMS 9)any kind of
elective surgery during the study 10)rise in hepatic
enzymes or severe drug reactions during the follow up
period."

The study had strict inclusion/exclusion criteria including age limits, requiring MRI confirmation, excluding pregnant/lactating women, requiring recent beta-interferon use, and excluding patients with certain medical conditions or taking certain medications. This is not very similar to eligibility criteria used in usual care.
Score: [2] 

Recruitment:
No relevant quotes. The recruitment process was not described.
Score: [NA]

Setting: 
No relevant quotes. The study setting was not described.
Score: [NA] 

Organisation:
No relevant quotes. The study organization was not described.
Score: [NA]

Flexibility (delivery):
No relevant quotes. The flexibility in intervention delivery was not described.
Score: [NA]

Flexibility (adherence):
No relevant quotes. The flexibility in intervention adherence was not described.
Score: [NA]

Follow-up:
"The patients in all three groups were evaluated at the end of 
months 6, 12, 18, 24 and in case of development of 
reactions were excluded from the study. At the end of 24 
months the patients were again evaluated for EDSS, and 
the number of relapses for each patient was calculated 
(cases of pseudoexacerbation were not considered as 
relapse)."

The patients were evaluated every 6 months for 2 years to assess EDSS and relapses. This follow-up schedule is more frequent than would occur in usual care.
Score: [2]

Primary outcome:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).&quot;</span>

The primary outcomes were EDSS and relapse rate. These are clinically meaningful outcomes relevant to patients.
Score: [4]

Primary analysis:
No relevant quotes. The analysis methods were not described.
Score: [NA]</pre>
<p><a name='1769'></a></p>
</div>
<div
id="millar-j.h.-1967-long-term-treatment-of-multiple-sclerosis-with-corticotrophin"
class="section level4">
<h4>1769.
<a href='https://doi.org/10.1016/s0140-6736(67)90850-1' title='Open publication'>Millar
J.H. (1967): <i>Long-term treatment of multiple sclerosis with
corticotrophin</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">13 quote(s) from
publication full text</span> (mean similarity 99.9%)</i></p>
<pre>
Here are the PRECIS-2 domain scores for the given clinical trial text:

Eligibility:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.&quot;</span> 

Reasoning: The eligibility criteria exclude patients with certain comorbidities and require patients to be ambulatory at baseline. The trial also limits enrollment to patients who have relapsed recently in one center. This suggests somewhat selective eligibility criteria compared to usual care.
Score: [3]

Recruitment:
Quote:
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

This controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This controlled study was started in 1963 in three cities-Belfast, Leeds, and Manchester.&quot;</span>

Reasoning: The text does not provide details on recruitment methods. Running the trial at multiple centers likely involved typical referral/recruitment from those centers. There is no evidence of special recruitment efforts.
Score: [NA] 

Setting:
Quote: 
<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

It could not be a doubleblind study. A separate trial was carried out in the three centres using the same treatment and scoring methods.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎It could not be a double-blind study. A separate trial was carried out in the three centres using the same treatment and scoring methods.&quot;</span>

Reasoning: The trial was conducted at 3 centers in major cities, which does not seem very different from a regular clinical setting.
Score: [4]

Organization: 
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.&quot;</span>

Reasoning: The intervention involves a drug, diet changes, and supplements. It does not appear that extra staffing or training was required to deliver the intervention beyond a typical clinic.
Score: [4]  

Flexibility (delivery):
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The dose of corticotrophin was adjusted to produce just enough " mooning " of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both treated and control groups were given aneurin 100 mg. by injection monthly.&quot;</span>

Reasoning: The corticotrophin dose was titrated and held constant during relapses, suggesting a protocolized administration schedule. Both groups received vitamin B12 injections, indicating some flexibility in allowed co-interventions. Overall, delivery of the intervention seems moderately flexible.
Score: [3]

Flexibility (adherence):
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎When possible a glucose-tolerance test was carried out before corticotrophin was started.&quot;</span>

Reasoning: The text does not describe measures to enforce or assess adherence. A baseline glucose tolerance test was done when possible, but there is no evidence that participants were excluded based on adherence issues.
Score: [4]

Follow-up:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.&quot;</span> 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The treated group were weighed, their urine was tested, blood-pressure recorded, and blood analysed for electrolytes.&quot;</span>

Reasoning: Follow-up occurred every 3 months, with clinical scoring and lab tests. This seems slightly more frequent than typical follow-up.
Score: [3]

Primary outcome: 
Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Again there was no evidence to show that corticotrophin prevented deterioration or reduced the number or severity of the relapses; nor was there any evidence that corticotrophin adversely affected the disease process, apart from side-effects due to the drug itself.&quot;</span>

Reasoning: The primary outcomes of disability progression, relapse rate, and relapse severity are clinically meaningful to patients.
Score: [5]

Primary analysis:
Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same.&quot;</span> 

Reasoning: All participants appear to be included in the analysis. There is no mention of excluding patients post-randomization. 
Score: [5]

In summary, the clinical trial described in the text appears moderately pragmatic based on the PRECIS-2 assessment. The eligibility criteria, intervention delivery, and follow-up have some explanatory elements, but the trial was conducted in a regular care setting, used clinically meaningful outcomes, and analyzed all participants.</pre>
<p><a name='1770'></a></p>
</div>
<div
id="hoogstraten-m.c.-1990-long-term-effect-of-acth-treatment-of-relapse-in-multiple-sclerosis"
class="section level4">
<h4>1770.
<a href='https://doi.org/10.1111/j.1600-0404.1990.tb01590.x' title='Open publication'>Hoogstraten
M.C. (1990): <i>Long-term effect of ACTH treatment of relapse in
multiple sclerosis</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning for each:

Eligibility

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.&quot;</span>

The eligibility criteria are quite restrictive, requiring a definite MS diagnosis based on strict criteria and focusing only on patients currently experiencing a relapse. This excludes patients with less certain diagnoses or stable disease who would likely receive the intervention in usual care.

Score: [2] 

Recruitment

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessment of patients was performed by their own neurologist.&quot;</span> 

2. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.&quot;</span>

Patients were recruited through neurology clinics at academic and general hospitals. This seems fairly typical of how patients would access this intervention in usual care. No special efforts beyond routine practice are mentioned.

Score: [4]

Setting

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.&quot;</span>

The study took place across both academic and general neurology departments, suggesting a range of settings fairly representative of usual practice.

Score: [4] 

Organisation 

1. No details are provided about staffing, training, resources etc. 

There is insufficient information to assess differences from usual care.

Score: [NA]

Flexibility (delivery)

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎ACTH (100 units intramuscular, tapered over 12 weeks)&quot;</span> 

The ACTH intervention is delivered via a standardized 12-week tapering protocol. This is likely more regimented than typical care.

Score: [2]

Flexibility (adherence)

No relevant quotes.

As an injected medication protocol, there are no details suggesting flexibility in adherence was assessed. This domain is probably not applicable.

Score: [NA] 

Follow-up

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.&quot;</span>

Follow-up is more frequent than would occur in usual care, with visits scheduled every 3 months for a year after starting treatment.

Score: [2]

Primary outcome

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessment included: EDSS, FS, AI, ISS&quot;</span>

The primary outcomes are standard neurological function scales, which seem clinically relevant and routinely used in practice.

Score: [4]

Primary analysis

1. <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three patients were withdrawn because of subsequent treatment with ACTH, corticosteroids or immunosuppressive drugs during the follow-up period.&quot;</span>

Some patients were excluded from analysis due to receiving additional treatments. However, it's not clear if there were other exclusions.

Score: [3]</pre>
<p><a name='1771'></a></p>
</div>
<div
id="langeskov-christensen-m.-2021-efficacy-of-high-intensity-aerobic-exercise-on-cognitive-performance-in-people-with-multiple-sclerosis-a-randomized-controlled-trial"
class="section level4">
<h4>1771.
<a href='https://doi.org/10.1177/1352458520973619' title='Open publication'>Langeskov-Christensen
M. (2021): <i>Efficacy of high-intensity aerobic exercise on cognitive
performance in people with multiple sclerosis: A randomized controlled
trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">10 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning:

Eligibility:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the Z-scores, 37 pwMS (43%) were classified as cognitively impaired (22 participants in the PAE group, 15 participants in the waitlist group).&quot;</span>

The study recruited a representative sample of MS patients from several clinics with minimal exclusion criteria as reported in the cited reference. 43% of participants had cognitive impairment at baseline. The eligibility criteria appear very similar to patients who would receive this intervention in usual care.
Score: [5] 

Recruitment:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).&quot;</span>

Patients were recruited from regular clinic visits, suggesting a pragmatic recruitment approach similar to usual care. No additional effort beyond routine appointments seems to have been made.
Score: [5]

Setting:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.&quot;</span>

The exercise intervention took place in a supervised setting, which is likely more controlled than a real-world usual care setting. However, this is necessary for an exercise trial to ensure intervention fidelity.
Score: [3] 

Organization:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HRmax).&quot;</span>

The exercise program involved increasing duration and intensity in a structured, protocolized manner. This level of organization and monitoring exceeds what would occur in usual care.
Score: [2]

Flexibility (delivery):
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al.&quot;</span>

The paper cites the protocol paper which likely contains details on flexibility in delivery. However, supervised exercise trials tend to have limited flexibility in delivery of the intervention.
Score: [2]

Flexibility (adherence):
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax during the last 8 weeks of the intervention (mean intensity for the 12 subjects = 87.8% of HRmax).&quot;</span>

They measured adherence to the prescribed exercise intensity. The intervention involved a strict protocol with target heart rate goals. This level of monitoring exceeds usual care.
Score: [2]

Follow-up:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test). Each test session was separated by at least 48 hours from the last exercise bout.&quot;</span>

Participants were followed closely with outcome assessments at baseline, 24 weeks and 48 weeks. The intensity of measurement exceeds usual care.
Score: [2]

Primary outcome:  
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N), self-reported mood, and cardiorespiratory fitness.&quot;</span> 

The primary outcome was performance on a battery of neuropsychological tests evaluating clinically meaningful cognitive domains. This is very relevant to patients.
Score: [5]

Primary analysis:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.&quot;</span>

They used an intention-to-treat approach including all randomized participants. This pragmatic approach mirrors real-world clinical care.  
Score: [5]</pre>
<p><a name='1772'></a></p>
</div>
<div
id="calkwood-j.-2014-impact-of-a-switch-to-fingolimod-versus-staying-on-glatiramer-acetate-or-beta-interferons-on-patient--and-physician-reported-outcomes-in-relapsing-multiple-sclerosis-post-hoc-analyses-of-the-epoc-trial"
class="section level4">
<h4>1772.
<a href='https://doi.org/10.1186/s12883-014-0220-1' title='Open publication'>Calkwood
J. (2014): <i>Impact of a switch to fingolimod versus staying on
glatiramer acetate or beta interferons on patient- and
physician-reported outcomes in relapsing multiple sclerosis: post hoc
analyses of the EPOC trial</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">8 quote(s) from
publication full text</span> (mean similarity 99.8%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with explanations:

### Eligibility

Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the case of Canadian patients, only those with relapsing–remitting MS and who had an inadequate response to, or were unable to tolerate, one or more therapies for MS were eligible.&quot;</span>

The eligibility criteria seem fairly broad, including patients with relapsing-remitting MS who have been on a variety of iDMTs. The main eligibility factor is being a candidate for therapy change based on physician judgement, inadequate response, or intolerance. This suggests the trial population is reasonably similar to patients who would receive fingolimod in usual care.

Score: [4]

### Recruitment

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The protocol and informed consent form were reviewed and approved by an institutional review board (Quorum Review) at each study center, and every patient provided written informed consent.&quot;</span>

The text does not mention any special recruitment efforts beyond standard informed consent at participating centers. Patients were likely recruited during routine clinic visits.

Score: [4] 

### Setting

Quote: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.&quot;</span>

The trial was conducted at multiple centers in the USA and Canada. No mention of specialised trial centers. The setting seems very similar to routine clinical practice.

Score: [5]

### Organisation

The text does not provide enough details on trial organization, staffing, resources etc. to assess this domain.

Score: [NA] 

### Flexibility (delivery)

Quote:  
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients were randomized 3:1 to switch to fingolimod (FTY720; Gilenya®, Novartis Pharma AG, Basel, Switzerland) 0.5 mg or remain on/switch to an iDMT for 6 months with no intervening washout period.&quot;</span>

Patients immediately switched to fingolimod or remained on iDMT, with no washout period. This matches real-world flexibility.

Score: [5]

### Flexibility (adherence)

The text does not mention efforts to enforce or monitor adherence. Likely matches usual care.

Score: [4]

### Follow-up

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary analysis evaluated two groups, namely fingolimod versus any iDMT. Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.&quot;</span>

Follow-up seems to occur at a single 6 month time point, with physician consultation, matching usual care.

Score: [4]

### Primary outcome  

Quote: 
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].&quot;</span>

The TSQM measures patient satisfaction with treatment, a very pragmatic and patient-centered outcome.

Score: [5] 

### Primary analysis

Quote:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Missing data were imputed using the last observation carried forward.&quot;</span>

The primary analysis appears to be a modified intention-to-treat approach, matching real-world practice.

Score: [4]</pre>
<p><a name='1773'></a></p>
</div>
<div
id="medina-perez-c.-2014-effects-of-a-resistance-training-program-and-subsequent-detraining-on-muscle-strength-and-muscle-power-in-multiple-sclerosis-patients"
class="section level4">
<h4>1773.
<a href='https://doi.org/10.3233/NRE-141062' title='Open publication'>Medina-Perez
C. (2014): <i>Effects of a resistance training program and subsequent
detraining on muscle strength and muscle power in multiple sclerosis
patients</i></a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRECIS-2
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Eligibility">
D1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Recruitment">
D2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Setting"> D3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Organization">
D4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (delivery)"> D5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="Flexibility (adherence)"> D6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Follow-up">
D7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary outcome">
D8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black" title="Primary analysis">
D9</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
5
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
5
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
2
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
3
</td>
<td style="text-align:left;">
4
</td>
<td style="text-align:left;">
3
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<p><i><span style="border-bottom: 1px dashed black;">9 quote(s) from
publication full text</span> (mean similarity 100%)</i></p>
<pre>
Here are the PRECIS-2 domain scores with reasoning for the given clinical trial:

Eligibility:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study.&quot;</span>
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.&quot;</span>

Reasoning: The eligibility criteria are focused on relapsing-remitting MS patients who are able to walk at least 20m. There are some exclusions like other diseases affecting muscle function. Overall the criteria seem reasonably pragmatic and similar to what would be used in usual care.

Score: [4] 

Recruitment:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.&quot;</span>

Reasoning: Patients were recruited through MS rehabilitation centers after a group meeting explaining the study details. No other special recruitment methods were mentioned. This seems moderately pragmatic.

Score: [3]

Setting:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.&quot;</span>

Reasoning: The training took place in MS rehabilitation centers with supervision. This seems moderately pragmatic and similar to what would occur in usual care. 

Score: [3] 

Organisation:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.&quot;</span>

Reasoning: The intervention used commonly available gym equipment and typical training frequency/volume. No mention is made of additional resources or expertise beyond usual care. This seems quite pragmatic.

Score: [4]

Flexibility (delivery): 
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎After a standardized cycling warm-up, and one set of 5 repetitions (reps) with a light load, participants performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period (Table 2). Recovery time between sets was 3 minutes.&quot;</span> 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.&quot;</span>

Reasoning: The training protocol, including sets/reps, load progression and recovery, was standardized. Training occurred in rehab centers with continuous supervision. This indicates limited flexibility similar to an explanatory trial.

Score: [2]

Flexibility (adherence):
Quotes: None relevant.

Reasoning: There is no discussion of measures taken to enforce or improve adherence. It seems patients received usual encouragement but no additional efforts were made. This seems reasonably pragmatic. 

Score: [3]

Follow-up:
Quotes:
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).&quot;</span>

Reasoning: Follow-up testing was done at baseline, after the 12-week training program, and after 12 weeks of detraining. The testing schedule seems reasonably pragmatic.

Score: [3] 

Primary outcome:
Quotes: 
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Maximal voluntary isometric contraction (MVIC), maximal torque, average muscle power and muscle endurance.&quot;</span>

Reasoning: The primary outcomes of maximal strength, muscle power and endurance are clinically meaningful and pragmatic outcomes relevant to patients.

Score: [4]

Primary analysis:
Quotes:
No relevant quotes.

Reasoning: The analysis methods are not described in detail. There is no mention of excluding patients post-randomization or analyzing completers only. This seems reasonably pragmatic.

Score: [3]</pre>
</div>
</div>
<div id="quote-accuracy" class="section level3">
<h3>Quote accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>553 quotes for 56 / 56 (100%) publications, median 9 (IQR 8-12,
range 2-15)</li>
<li>520 / 553 (94%) perfect <span
style="border-bottom: 1px dashed black;">quotes from the publication
full text</span></li>
<li>1 / 553 (0.2%) perfect <span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">quotes from
the LLM prompt briefing</span> - were instructions quoted (ok) or
examples (unwanted beahviour)?</li>
<li>32 / 553 (5.8%) quotes with deviations from source, where the
accuracy was measured by a <a
href="https://maxbachmann.github.io/RapidFuzz/Usage/distance/Levenshtein.html#normalized-similarity">“normalized
Levenshtein similarity”</a> <span
style="border-bottom: 1px dashed black;"
title="Weights for insertion: 1, deletion: 0.5, substitution: 1.5. Penalizes &quot;positive hallucinations&quot; (insertions) more than omissions of e.g. brackets and references (deletions).">with
custom weights</span>, ranging from 0-100%
<ul>
<li><span style="background-color: #ffe9e2">15 minor</span> deviations
(95% ≤ similarity &lt; 100%); mean: 98%</li>
<li><span style="background-color: #ff9e81">13 moderate</span>
deviations (75% ≤ similarity &lt; 95%); mean: 88.1%</li>
<li><span style="background-color: red">4 major</span> deviations
(similarity &lt; 75%); mean: 56.9%</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-bf49ef44636d99d50ad2" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-bf49ef44636d99d50ad2">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["Riemenschneider M. (2022)","Mazdeh M. (2010)","Millar J.H. (1967)","Millar J.H. (1967)","Calkwood J. (2014)","van Dijk-de Vries. A, (2015)","Cooper C. (2011)","Cooper C. (2011)","Feys P. (2019)","Higginson I. J. (2009)","Higginson I. J. (2009)","Jongen P. J. (2019)","Jongen P. J. (2019)","Miller L. (2011)","Miller L. (2011)","Miller L. (2011)","Miller L. (2011)","Miller L. (2011)","Papeix C. (2015)","Papeix C. (2015)","Pozzilli C. (2002)","Renfrew L. M. (2019)","Vermöhlen V. (2018)","Ward C. D. (2004)","Ward C. D. (2004)","Ward C. D. (2004)","Ward C. D. (2004)","Jonsdottir, H. (2015)","Jonsdottir, H. (2015)","Ndosi, M. (2014)","Ndosi, M. (2014)","Patel. A. (2015)"],["fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext"],["<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.9%):\n\nThe relapse rate and the global brain atrophy rate were the primary outcomes of this study.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The annual relapse rate and the global brain atrophy rate were the primary outcomes of this study.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.1%):\n\nthe following criteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of βinterferon under the supervision of a neurologist in a period of no more than 30 days prior to th' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Inclusion criteria were as follows: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β- interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nThis controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This controlled study was started in 1963 in three cities-Belfast, Leeds, and Manchester.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nIt could not be a doubleblind study. A separate trial was carried out in the three centres using the same treatment and scoring methods.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎It could not be a double-blind study. A separate trial was carried out in the three centres using the same treatment and scoring methods.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nThe primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90%):\n\ns were sent a letter by their GPs to introduce the SMS project.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Patients were sent a letter by their GPs to introduce the SMS project.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.9%):\n\n(Sheffield Teaching Hospitals NHS Trust). We reached our recruitment target on 30 July 2009 (in 281 days; 2.6 participants/month) after adding a second centre (The Walton Centre NHS Foundation Trust, Liverpool)' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The study was conducted at two UK centres - Sheffield Teaching Hospitals NHS Foundation Trust and The Walton Centre NHS Foundation Trust, Liverpool.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):\n\ncollection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data collection by postal questionnaire was challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.7%):\n\nPatients were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Participants were tested at two time points (0 and 12 weeks). The EXP group completed a 12-week gradual “start-to-run” program in between time points.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nCare was provided in a similar way to palliative care consultation services described elsewhere,9, 11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were. Patients had one to three contacts (visits and/or phone calls) from the PCT,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Care was provided in a similar way to palliative care consultation services described elsewhere,9, 11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were. Patients had one to three contacts (visits and/or phone calls) from the PCT...&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nWe conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient&#39;s functional status (' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient's functional status...&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):\n\nCDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎CDTs were given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 82.3%):\n\nDuring the consultations they had a professional and informative role. In the small group sessions every team member focused on its own area of interest.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎During the consultations they [multidisciplinary team members] had a professional and informative role. In the small group sessions every team member focused on its own area of interest.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.3%):\n\nse of arms).10 People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over11 and had at least three identiﬁable physiotherapy goal' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over11 and had at least three identifiable physiotherapy goals were included.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.4%):\n\nwere included. Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking pa' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 87.1%):\n\natch. Intervention Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.9%):\n\nwithin their home. Each session lasted up to 60 minutes, and a task-speciﬁc programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit ﬁts) and stretching activities were used depending on the subjects previ' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 45.6%):\n\nsetting of the trial and the usual care settin' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎Neither of these trends reached statistical significance.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.3%):\n\nThis prospective, randomized study is the first attempt to evaluate the multidisciplinary approach in MS patients. The results show that, contrary to our expectations, an integrated multidisciplinary approach is not superior to usual care on QoL.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This prospective, randomized, controlled study is the first attempt to evaluate the multidisciplinary approach in MS patients. The results show that, contrary to our expectations, an integrated multidisciplinary approach is not superior to usual care on QoL.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 75.6%):\n\nthe committee was judged unnecessary. Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The clinical evaluating team was masked to the treatment arm. Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 90.2%):\n\nNinety six patients declined to participate. The majority of refusers (n = 62) were young, fully ambulant, and employed.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Ninety six patients declined to participate in the study. The majority of refusers (n = 62) were young, fully ambulant, and employed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.8%):\n\nThe multicentre design of this study enhances the generalizability of results. However, although the ankle-foot orthoses prescription was standardized, variations did occur across sit' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A multicentre design of this study enhances the generalizability of results. However, although the ankle-foot orthoses prescription was standardized, variations did occur across sites.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 57.1%):\n\npplied. The study was approved by the respective ethical committees of the participating sites and reg' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Hippotherapy was provided by existing staff at the participating centers, following standard regulations.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 56.1%):\n\n. We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000)...We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nWithin six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information...&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nApproximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit,' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit...&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80.7%):\n\nParticipants were assessed at baseline and 12 months later.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We assessed participants at baseline and 12 months later.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):\n\n) Number and length of conversations varied depending on identified needs' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The number and length of conversations varied depending on identified needs.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nBeing ready to quit, having a belief in one&#39;s capacity to quit, and having a strong motivation to quit were of central importance (Miller & Rollnick 2002). The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed (DiClemente et al. 1991)' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Being ready to quit, having a belief in one's capacity to quit, and having a strong motivation to quit were of central importance (Miller & Rollnick 2002). The change from being a smoker to becoming a non-smoker was considered a process and participants given time to progress through that process as needed (DiClemente et al. 1991).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.7%):\n\nThe study was conducted in outpatient clinics of 10 rheumatology centres across the UK.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This study was conducted in outpatient clinics of 10 rheumatology centres across the UK.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 81.6%):\n\nThe primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The primary outcome was disease activity score in 28 joints (DAS28) and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.4%):\n\nPrimary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 blood pressure lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.&quot;<\/span>"],[92.8571428571429,92.0595533498759,98.876404494382,99.2700729927007,98.7096774193548,90,68.9189189189189,95.8083832335329,96.6666666666667,99.6527777777778,99.4974874371859,97.8378378378378,82.258064516129,92.274678111588,93.4426229508197,87.0748299319728,91.9161676646707,45.6140350877193,95.3488372093023,75.625,90.2255639097744,97.8260869565217,57.1428571428571,56.0975609756098,98.780487804878,99.4318181818182,80.7017543859649,94.7368421052632,99.6996996996997,97.7272727272727,81.6425120772947,95.4372623574145]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Author & Year<\/th>\n      <th>Source<\/th>\n      <th>Quote with deviation<\/th>\n      <th>Similarity<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","order":[[3,"desc"]],"columnDefs":[{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 1, 3, \",\", \".\", null);\n  }"},{"visible":false,"targets":1},{"className":"dt-right","targets":3}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="formatting-accuracy" class="section level3">
<h3>Formatting accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>56 / 56 (100%) usable responses with correctly formatted scores</li>
<li>0 / 56 (0%) usable responses with minor fixable score formatting
issues <br><br></li>
<li>56 / 56 (100%) publications yielded usable responses in the first
try</li>
<li>0 / 56 (0%) publications yielded usable responses after a median of
NA retries (IQR NA-NA, range Inf–Inf), thus being ultimately
successful</li>
<li>0 / 56 (0%) publications yielded no usable responses and were thus
ultimately unsuccessful. <a href="https://doi.org/"></a></li>
</ul>
</div>
<div id="llm-prompt" class="section level3">
<h3>LLM prompt</h3>
<ul>
<li>Model: <a href="https://www.anthropic.com/index/claude-2">Claude
2</a></li>
<li>Temperature: Chat interface (<a
href="https://docs.anthropic.com/claude/reference/complete_post">probably
<code>1</code></a>)</li>
<li>Briefing derived from: <a
href="http://precis-2.org/Help/Documentation/ToolkitDownload">PRECIS-2
Toolkit page 4</a></li>
</ul>
<div id="user-prompt" class="section level4">
<h4>User prompt</h4>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<pre>
You are an expert in clinical trial design and are tasked to assess the PRECIS-2 scores of a trial based on the full text of its publication. You have the following briefing:
---
# PRECIS-2 Domains
* Eligibility: To what extent are the participants in the trial similar to those who would receive this intervention if it was part of usual care? For example, score 5 for very pragmatic criteria essentially identical to those in usual care; score 1 for a very explanatory approach with lots of exclusions (e.g. those who don’t comply, respond to treatment, or are not at high risk for primary outcome, are children or elderly), or uses many selection tests not used in usual care.
* Recruitment: How much extra effort is made to recruit participants over and above what that would be used in the usual care setting to engage with patients? For example, score 5 for very pragmatic recruitment through usual appointments or clinic; score 1 for a very explanatory approach with targeted invitation letters, advertising in newspapers, radio plus incentives and other routes that would not be used in usual care.
* Setting: How different is the setting of the trial and the usual care setting? For example, score 5 for a very pragmatic choice using identical settings to usual care; score 1, for a very explanatory approach with only a single centre, or only specialised trial or academic centres.
* Organisation: How different are the resources, provider expertise and the organisation of care delivery in the intervention arm of the trial and those available in usual care? For example, score 5 for a very pragmatic choice that uses identical organisation to usual care; score 1 for a very explanatory approach if the trial increases staff levels, gives additional training, require more than usual experience or certification and increase resources.
* Flexibility (delivery): How different is the flexibility in how the intervention is delivered and the flexibility likely in usual care? For example, score 5 for a very pragmatic choice with identical flexibility to usual care; score 1 for a very explanatory approach if there is a strict protocol, monitoring and measures to improve compliance, with specific advice on allowed co-interventions and complications.
* Flexibility (adherence): How different is the flexibility in how participants must adhere to the intervention and the flexibility likely in usual care? For example, score 5 for a very pragmatic choice involving no more than usual encouragement to adhere to the intervention; score 1 for a very explanatory approach that involves exclusion based on adherence, and measures to improve adherence if found wanting. In some trials eg surgical trials where patients are being operated on or Intensive Care Unit trials where patients are being given IV drug therapy, this domain is not applicable as there is no compliance issue after consent has been given, so this score should be left blank.
* Follow-up: How different is the intensity of measurement and follow-up of participants in the trial and the likely follow-up in usual care? For example, score 5 for a very pragmatic approach with no more than usual follow up; score 1 for a very explanatory approach with more frequent, longer visits, unscheduled visits triggered by primary outcome event or intervening event, and more extensive data collection.
* Primary outcome: To what extent is the trial's primary outcome relevant to participants? For example, score 5 for a very pragmatic choice where the outcome is of obvious importance to participants; score 1 for a very explanatory approach using a surrogate, physiological outcome, central adjudication or use assessment expertise that is not available in usual care, or the outcome is measured at an earlier time than in usual care.
* Primary analysis: To what extent are all data included in the analysis of the primary outcome? For example, score 5 for a very pragmatic approach using intention to treat with all available data; score 1 for a very explanatory analysis that excludes ineligible post-randomisation participants, includes only completers or those following the treatment protocol.
---

This is the full text to be assessed:
---
%FULLTEXT%
---

For each of the 9 domains of PRECIS-2, perform the following steps:
1. Extract 1-3 relevant quotes from the full text.
2. Explain your reasoning in 1 paragraph.
3. Give a score X from 1 (very explanatory) to 5 (very pragmatic) in square brackets like this: "Score: [X]". If the full text does not contain enough information to assess a specific domain, report "Score: [NA]".

Do not provide a final summary paragraph in the end.
 
</pre>
</div>
</div>
</div>

</div>

<script>
$(document).ready(function() {
  // add bootstrap table styles to pandoc tables
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed table-sm');

  // initialize mathjax

});
</script>

<script type="text/javascript">
$(document).ready(function () {
  FlexDashboard.init({
    fillPage: true,
    orientation: "columns",
    storyboard: false,
    defaultFigWidth: 576,
    defaultFigHeight: 460,
    defaultFigWidthMobile: 360,
    defaultFigHeightMobile: 460,
    resize_reload: true
  });
  var navbar = $(".navbar").first();
  var body = $("body").first();
  var sidebar = $(".section.sidebar").first();
  function addNavbarPadding() {
    var navHeight = navbar.outerHeight();
    body.css("padding-top", (navHeight + 8) + "px");
    sidebar.css("top", navHeight + "px");
    var resizeEvent = window.document.createEvent("UIEvents");
    resizeEvent.initUIEvent("resize", true, false, window, 0);
    window.dispatchEvent(resizeEvent);
  }
  if (!window.Shiny) setTimeout(addNavbarPadding, 100);
  $(document).on("shiny:idle", function() {
    setTimeout(addNavbarPadding, 50);
  });
});
</script>

</body>
</html>
